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Abstract 
 
This thesis presents the use of Virus Induced Gene Silencing (VIGS) for the discovery of enzymes 
and transporters involved in monoterpene indole alkaloid (MIA) metabolism in the medicinal 
plant Catharanthus roseus. 
C. roseus is the source of a number of MIAs that are used as chemotherapeutic agents in the 
treatment of a variety of cancers, however the complete biosynthetic pathway for these 
metabolites remains to be elucidated. Additionally, this metabolic pathway is subcellulary 
compartmented with the key branch point enzyme, strictosidine synthase, localised to the plant 
vacuole. There is therefore a need for the import of the substrates for strictosidine biosynthesis; 
secologanin and tryptamine, across the vacuolar membrane, and export of the product, 
strictosidine, for synthesis of the downstream alkaloids. 
This thesis presents the identification of two proteins that act as trans-tonoplastic transporters 
in MIA metabolism. The multidrug and toxic compound extrusion (MATE) protein, CrMATE1952, 
was localised to the vacuolar membrane and silencing its expression in planta resulted in the 
accumulation of a secologanin derivative. This implicates CrMATE1952 in the transport of 
secologanin into the vacuole and highlights the importance of the spatial organisation of the 
pathway in preventing secologanin derivatisation. Secondly silencing the expression of a 
tonoplast localised nitrate/peptide (NPF) transporter, CrNPF2.9, resulted in the 20-fold 
accumulation of strictosidine, suggesting this transporter is the exporter of strictosidine from 
the vacuole.  Furthermore, VIGS also allowed the identification of a reticuline oxidase like 
protein, CrRO, which resulted in the accumulation of two new MIAs in leaf tissue upon silencing. 
This thesis highlights a reverse genetics strategy for gene identification in metabolic pathways 
and is the first time the MATE and NPF transporters, and the reticuline oxidase like enzymes, 
have been shown to be involved in MIA metabolism in C. roseus. 
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1 Introduction 
1.1  Plant Alkaloids 
 
Plant-derived alkaloids are a diverse class of compounds that have had profound societal impact 
throughout human history (Dewick, 2002). These compounds contain a basic nitrogen, and are 
typically derived from an amino acid precursor, such as tryptophan, tyrosine, lysine, arginine or 
histidine (Dewick, 2002). From a medical perspective these compounds have been richly 
exploited for millennia due to their diverse range of pharmacological activities. These 
compounds have been used in the treatment of pain- morphine (Lipp, 1991), used as local 
anaesthetics- cocaine (Ruetsch et al., 2001), as anti-asthmatic agents- ephedrine (Maitai, 1975), 
anti-arrythmic agents- quinidine (Markel et al., 1993), anti-hyptertension drugs-reserpine (Doyle 
et al., 1955)  and anti-cancer agents- vinblastine (Dyke and Nelson, 1977)  (Figure 1-1). 
 
Figure 1-1 Representative plant alkaloids of medical importance 
As highlighted, alkaloids are chemicals that contain a basic nitrogen, and have a broad range of 
structural scaffolds 
 
As well as the diverse range of pharmacological functions, from a chemical perspective, these 
compounds are structurally diverse, as highlighted in Figure 1-1, and to date there has been 
concerted effort in the elucidation of the biosynthetic pathways of a number of plant alkaloids.  
The chemical complexity of natural products, due to the diversity in ring structures, oxygenation 
patterns, and stereocentres, together with the fact that these natural product scaffolds can also 
be further modified by glycosylation and other tailoring reactions, makes these compounds 
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challenging for chemical synthesis on an industrial scale (Leonard et al., 2009). Additionally, the 
plant alkaloids are often isolated in low yields from the plant, and therefore the extraction of 
these compounds is labour intensive and requires the cultivation of large quantities of the 
plants, which in turn increases the cost of these small molecules (Leonard et al., 2009; Ro et al., 
2006) 
The elucidation of the biosynthetic pathway and subsequent reconstitution in a heterologous 
host offers the potential for a platform that would allow for the high production of expensive 
compounds that can be easily extracted and grown in a fermentable system on cheap inputs, 
such as glucose. 
 This has most recently been seen with the reconstitution of morphine biosynthesis in 
Saccharomyces cerevisiae (DeLoache et al., 2015; Fossati et al., 2015; Winzer et al., 2015), the 
reconstitution of artemisinin, a terpene natural product from Artemisia annua used in the 
treatment of malaria (Ro et al., 2006) in S. cerevisiae, as well as in the reconstitution of 
strictosidine biosynthesis in S. cerevisiae, which as will be highlighted subsequently in this 
chapter, is a key metabolic branchpoint for monoterpene indole alkaloid (MIA) biosynthesis, 
(Brown et al., 2015). 
Additionally, such biosynthetic platforms allow diversification of the structural backbones of 
these natural products, either in the generation of ‘unnatural’ natural products, as highlighted 
through halogenation (Glenn et al., 2011) or through the combinatorial use of enzymes from 
diverse plant families to generate new products that would not exist in nature. 
1.2  The pathway of monoterpene indole alkaloid biosynthesis 
 
The MIA pathway is commonly encountered in the Apocynaceae, Loganiaceae and Rubiaceae 
plant families (De Luca et al., 2012) and the focus of this thesis will be centred on the 
biosynthesis of the MIAs present in the Madagascar periwinkle, Catharanthus roseus 
(Apocynaceae). C. roseus produces in excess of 130 MIAs, with a diverse range of structural 
scaffolds (O'Connor and Maresh, 2006). The two alkaloids of highest economic importance are 
the anti-cancer agents, vincristine and vinblastine, which are used in the clinical treatment of a 
variety of cancers. These compounds act by inhibiting cell division, by interacting with α and β 
tubulin, thereby preventing the polymerisation of microtubules during cell division (Bowman et 
al., 1988). 
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1.2.1 Biosynthesis of secologanin, tryptamine and strictosidine 
 
All MIAs are derived from a convergent metabolic pathway that utilises an amino acid product 
from the shikimate pathway, tryptophan, as well as the seco-iridoid glycosylated terpene, 
secologanin (O'Connor and Maresh, 2006). 
The entire pathway for the formation of secologanin has been elucidated. Secologanin is derived 
from the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway for terpene synthesis (Contin et 
al., 1998). Isopentyl diphosphate (IPP), the precursor for all terpenoids, can be produced by 
either the mevalonate or MEP pathways, however [1-13C]-glucose feeding studies of C. roseus 
cell suspension cultures suggest that the dominant route of secologanin synthesis is via the MEP 
pathway (Contin et al., 1998). The MEP pathway produces geranyl-pyrophosphate (GPP) which 
is used for the biosynthesis of secologanin.  
Geraniol, which is derived from GPP via geraniol synthase (Simkin et al., 2013), is hydroxylated 
by geraniol 8-hydroxylase (G8H), CYP76B6, to 8-hydroxygeraniol. G8H can further oxidise 8-
hydroxygeranial, forming 8-oxogeraniol, together with the enzyme 8-hydroxygeraniol 
oxidoreductase, to the linear dialdehyde, 8-oxogeranial (Miettinen et al., 2014). 
This molecule, 8-oxogeranial, is cyclised by iridoid synthase (Geu-Flores et al., 2012), resulting in 
the equilibrium mixture of cis-trans-iridodial and cis-trans-nepetelactol. A cytochrome p450, 
iridoid oxidase (IO), CYP76A26,  oxidises cis-trans-neptelactol to 7-deoxyloganetic acid 
(Miettinen et al., 2014; Salim et al., 2014) which is subsequently glycosylated by 7-
deoxyloganetic acid glucosyltransferase (Asada et al., 2013; Miettinen et al., 2014), hydroxylated 
by a cytochrome p450, 7-deoxyloganic acid hydroxylase (7DLH) (Salim et al., 2013), CYP72A224, 
and methylated by loganic acid methyltransferase (LAMT) to form loganin (Murata et al., 2008), 
before being oxidatively cleaved by  the cytochrome p450 secologanin synthase (SLS), CYP72A1, 
to yield the iridoid terpene secologanin, (de Bernonville et al., 2015; Irmler et al., 2000; Kellner 
et al., 2015b) (Figure 1-2). 
In parallel, the amino acid tryptophan is decarboxylated by the pyridoxal phosphate dependent 
enzyme, tryptophan decarboxylase (Pennings et al., 1989) to form tryptamine, (Figure 1-2). 
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Figure 1-2 Overview of secologanin and tryptamine biosynthesis 
A Secologanin is a glycosylated iridoid terpene derived from the MEP pathway. It is synthesised by a nine-
step biosynthetic pathway comprising the enzymes G8H-geraniol 8-hydroxylase, 8-HGO- 8-
hydroxygeraniol oxidoreductase, IS-iridoid synthase, IO-iridoid oxidase, 7-DLGT- 7deoxyloganetic acid 
glucosyltransferase, 7-DLH - 7-deoxyloganic acid hydroxylase, LAMT-loganic acid methyltransferase and 
SLS- secologanin synthase. B Tryptamine is synthesised by the decarboxylation of tryptophan by the 
enzyme tryptophan decarboxylase (TDC). 
 
 
The first committed step in the formation of MIAs is the Pictet-Spengler condensation of 
secologanin and tryptamine to form the central metabolic intermediate, strictosidine, which 
represents a key branchpoint in this pathway (Maresh et al., 2008; Treimer and Zenk, 1979). The 
deglycosylation of this central intermediate results in a reactive di-aldehyde species, that 
subsequently rearranges to 4,21-dehydrogeissoschizine, an intermediate from which nearly all 
structural scaffolds of MIAs are derived (O'Connor and Maresh, 2006) (Figure 1-3). The 
reconstitution of strictosidine biosynthesis has been achieved in both S. cerevisiae and N. 
benthamiana (Brown et al., 2015; Miettinen et al., 2014). 
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Figure 1-3 Strictosidine is the central branchpoint for MIA production in a broad range of plant species 
Secologanin and tryptamine condense by the action of strictosidine synthase (STR) to form strictosidine, 
which is deglycosylated and rearranged to 4,21-dehydrogeissoschizine. This forms the structural basis for 
a diverse range of alkaloids in multiple plant species. Highlighted in red are alkaloids present in C. roseus, 
highlighted in blue are alkaloids from Rauwolfia serpentina, and other structural scaffolds from Vinca 
minor, Strychnos nux-vomica and Tabernaemontana elegans are also represented. The common name of 
the alkaloid is shown, together with the structural class underneath in italic. C. roseus can also produce 
bisindole alkaloids which form as a result of the condensation of two MIAs, as shown with vinblastine, 
which is derived from catharanthine, an iboga alkaloid, and vindoline, an aspidosperma alkaloid. 
 
1.2.2 Biosynthesis of the aspidosperma, iboga and corynanthe alkaloids 
 
C. roseus synthesises vincristine and vinblastine by dimerising the aspidosperma alkaloid, 
vindoline, and the iboga alkaloid, catharanthine (Figure 1-3). 
The enzymatic steps from deglycosylated strictosidine to catharanthine and the precursor to 
vindoline, tabersonine, are still unknown. In comparison, the conversion from tabersonine to 
vindoline has been fully characterised (Figure 1-4) and comprises seven enzymatic steps. 
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Tabersonine is hydroxylated by tabersonine 16-hydroxylase (T16H) (St-Pierre and De Luca, 
1995). Interestingly this is one of the first enzymes in C. roseus to have two isoforms that show 
tissue specific localisation to the leaves and flowers (Besseau et al., 2013). This hydroxyl group 
is methylated by 16-hydroxytabersonine O-methyltransferase (Levac et al., 2008). 16-
methoxytabersonine is hydroxylated and reduced by the concerted action of two enzymes, 
tabersonine 3-oxygenase (T3O), and tabersonine 3-reductase (T3R) (Kellner et al., 2015a; Qu et 
al., 2015). The nitrogen derived from the indole ring of tryptophan is methylated (Liscombe et 
al., 2010), and this substrate forms the basis for the hydroxylation of desacetoxyvindoline by 
desacetoxyvindoline 4-hydroxylase (D4H) (De Luca and Cutler, 1987), and its subsequent 
acetylation by deacetylvindoline acetyltransferase (DAT) (St‐Pierre et al., 1998), to form the final 
product vindoline. 
 
 
Figure 1-4 The seven step biosynthesis of vindoline from tabersonine. 
T16H- tabersonine 16-hydroxylase, 16OMT- 16-hydroxytabersonine 16-O-methyltransferase, T3O- 
tabersonine 3-oxygenase, T3R- tabersonine 3-oxygenase, NMT- 16-methoxy-2,3-dihydro-3-
hydroxytabersonine N-methyltransferase, D4H- desacetoxyvindoline 4-hydroxylase, DAT- 
deacetylvindoline acetyltransferase. 
 
One of the major limitations in our understanding of the MIA pathway is in the discovery of 
enzymes that act on the major branchpoint of the pathway, namely the deglycosylated product 
of strictosidine. This part of the pathway is fundamental to the shuttling of intermediates into 
all MIA structural scaffolds in C. roseus, however to date the only enzyme that has been shown 
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to work on the deglycosylated product of strictosidine, is an alcohol dehydrogenase that is 
involved in the formation of the corynanthe class of alkaloids, and catalyses the conversion of 
strictosidine aglycone to tetrahydroalstonine (Stavrinides et al., 2015) (Figure 1-5). 
 
 
Figure 1-5 Reaction of tetrahydroalstonine synthase.  
Tetrahydroalstonine synthase catalyses the formation of tetrahydoalstonine from the deglycosylated 
product of strictosidine in an NADPH dependent reaction. 
 
 
There are therefore a number of key missing enzymatic steps in vinblastine and vincristine 
biosynthesis, and this opens up a plethora of interesting questions with regards this metabolic 
pathway. Firstly,   these missing steps are predicted to catalyse novel chemistry and secondly it 
is interesting to understand how the plant diverts the common substrate, strictosidine aglycone, 
into a minimum of at least three separate metabolic pathways for the synthesis of the different 
structural scaffolds of MIAs present in C. roseus (corynanthe, iboga and aspidosperma), 
especially as this dialdehyde has shown to be very reactive with the potential to crosslink 
proteins, nucleic acids and free amines (Guirimand et al., 2010). An overview of the known steps 
in the pathway to vindoline biosynthesis is highlighted in Figure 1-6. 
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Figure 1-6 Overview of the pathway to vinblastine biosynthesis in C. roseus 
Vinblastine biosynthesis encompasses a pathway that utilises in excess of 30 enzymes, through the 
convergence of seco-iridoid and amino acid metabolism, and the common branchpoint intermediate 
strictosidine. Known enzymes are highlighted above the reaction arrows, whilst unknown reactions are 
highlighted by a ?. 
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1.3  The inter- and intra-cellular distribution of MIA metabolism in C. roseus 
 
The pathway for MIA biosynthesis is further complicated in C. roseus due to the fact that it is 
compartmentalised at both the cellular and intra-cellular level. This indicates that there is a 
requirement for transport of biosynthetic intermediates among different cell types, and 
between organelles (Courdavault et al., 2014). 
1.3.1 Intercellular distribution of MIA metabolism 
At least three cell types are necessary for MIA biosynthesis. The sequencing of the leaf 
“epidermome” to generate a cDNA library enriched in transcripts localised to leaf epidermis 
(Murata et al., 2008) suggests that the enzymes involved in secologanin biosynthesis, 1-deoxy-
D-xyulose 5-phosphate synthase (DXS), 1-deoxy-D-xyulose 5-phosphate reductoisomerase 
(DXR) and 2C-methyl-D-erythritol 2,4-cyclodiphsophate synthase (MECS) of the MEP pathway 
and G8H for the generation of 8-hydroxygeraniol are not localised to the leaf epidermis. This 
observation is supported by in situ hybridisation studies (Burlat et al., 2004) which indicate these 
enzymes are localised to the internal phloem parenchyma (IPAP) cells of young organs. 
Additionally 8-hydroxygeraniol oxidoreductase, (Miettinen et al., 2014), iridoid synthase (Geu-
Flores et al., 2012), 7-deoxyloganetic acid glucosyltransferase and 7-deoxy loganic acid 
hydroxylase (Miettinen et al., 2014) have also been shown to be preferentially expressed in the 
IPAP tissue by in situ hybridisation. 
In comparison tryptophan decarboxylase, loganic acid methyltransferase, secologanin synthase 
and strictosidine synthase, as well as the enzymes downstream in the biosynthetic pathway, 
taersonine 16-hydroxylase and 16-O-methyltransferase involved in late stage vindoline 
biosynthesis, are preferentially expressed in the epidermis (Irmler et al., 2000; Murata and De 
Luca, 2005; Murata et al., 2008; St-Pierre et al., 1999). There is therefore a requirement for 
intercellular transport of a terpene intermediate from IPAP cells to epidermal cells in the leaf. 
To date, based on the localisation of the biosynthetic enzymes in the pathway, the most likely 
intermediate for inter-cellular transport between the IPAP cells and the epidermis is loganic acid 
(Miettinen et al., 2014).  
The biosynthesis of vindoline from tabersonine is also likely to be inter-cellularly 
compartmented. Metabolite analysis of leaf epidermis enriched extracts, generated by 
carborundum abrasion, demonstrated an accumulation of tabersonine and 16-
methoxytabersonine in comparison to vindoline (Murata and De Luca, 2005). Expression studies 
have shown that the vindoline biosynthetic genes T3O, T3R and NMT are found in higher levels 
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in the epidermis than in mesophyll cells (Qu et al., 2015), whilst the enzymes catalysing the last 
two steps in vindoline biosynthesis, D4H and DAT, are exclusively localised to the mesophyll (St-
Pierre et al., 1999). This implies the requirement for the transport of the intermediate 
desacetoxyvindoline between the epidermis and mesophyll cells (Qu et al., 2015). 
Biosynthesis of the iboga alkaloid catharanthine is thought to be localised to the leaf epidermis, 
as catharanthine is known to accumulate in leaf wax exudates. However there is also the 
requirement for transport between the epidermis and mesophyll for this compound, as the 
bisindole dimeric alkaloids, such as vinblastine, which form as a result of the condensation 
between vindoline and catharanthine, accumulate in the mesophyll, laticifers and idioblast cells. 
1.3.2 Intracellular distribution of MIA metabolism 
As well as the spatial distribution of the metabolic pathway between different cell types, the 
MIA pathway is localised to different subcellular organelles. 
The enzymes of the MEP pathway are localised to the plastid for synthesis of the terpene 
precursor IPP (Hunter, 2007).  Geranyl pyrophosphate is synthesised from the condensation of 
IPP and DMAPP by the enzyme GPPS. Geraniol synthase catalyses the formation of geraniol from 
geranyl pyrophosphate, which is then exported to the cytosol where it is hydroxylated by G8H, 
a cytochrome P450 associated with the endoplasmic reticulum membrane (Guirimand et al., 
2009). Although (Contin et al., 1999a) suggested that the action of secologanin synthase (SLS) 
was localised to the vacuole, proposing a pathway for the vacuolar conversion of loganin to 
secologanin, it has since been established that SLS is anchored by an N-terminal helix to the 
cytosolic side of the endoplasmic reticulum, leading to the cytosolic production of secologanin 
(Guirimand et al., 2011a).  
Tryptophan is synthesised from chorismate via an anthranilate intermediate in the plastid and 
is exported to the cytosol. Tryptophan decarboxylase (TDC) which catalyses the conversion of 
tryptophan to tryptamine is a cytosolic enzyme (Stevens et al., 1993) and it has been 
demonstrated by a combination of green fluorescent protein imaging, bimolecular fluorescence 
complementation assays and yeast two-hybrid analysis that both LAMT and TDC form 
homodimers in the cytosol (Guirimand et al., 2011a).  
A key step for which substrate transport is required is in the biosynthesis of strictosidine. 
Strictosidine synthase is localised to the vacuole (Guirimand et al., 2010) and therefore its 
precursors, secologanin and tryptamine, must be transported from the cytosol across the 
tonoplast membrane. Similarly the product of the strictosidine synthase reaction, strictosidine, 
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subsequently needs to be exported from the vacuole as strictosidine β-glucosidase is localised 
to the nucleus (Guirimand et al., 2010).  
The subcellular localisation for many of the late-stage vindoline biosynthetic enzymes is known. 
The enzyme tabersonine-16 hydroxylase (T16H), which catalyses the formation of 16-
hydroxytabersonine in the cytosol, is a cytochrome P450 localised to the endoplasmic reticulum 
membrane (St-Pierre and De Luca, 1995) and O-methyltransferase (16-OMT) (Guirimand et al., 
2011b), which directs synthesis of 16-methoxytabersonine, is cytosolic. The N-
methyltransferase (NMT) which catalyses the formation of deascetoxyvindoline is associated 
with the peroxisomal membrane (Liscombe; personal communication), whilst the last two steps 
in the pathway desacetoxyvindoline-4-hydroxylase (D4H) and deacetylvindoline-4-O-
acetyltransferase (DAT), are localised to the cytosol (De Luca and Cutler, 1987).  
The bisindole alkaloids vincristine and vinblastine are generated from the coupling of 
catharanthine and vindoline, perhaps by the peroxidase CPRX1 generating the intermediate 3, 
4-anhydrovinblastine. The peroxidase has been demonstrated to be localised to the vacuole 
(Sottomayor et al., 1998) suggesting the need for transport of both vindoline and catharanthine 
across the tonoplast membrane. However, the physiological role of this peroxidase has not been 
tested by silencing or knock-down experiments. 
An overview of the current model of MIA inter- and intra- cellular transport is presented in Figure 
1-7. 
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Figure 1-7 The current model of inter- and intra- cellular compartmentation in MIA biosynthesis. 
The metabolic pathway to MIA biosynthesis in C. roseus spans three cell types, the internal phloem 
associated parenchyma (IPAP) cells, epidermis and the mesophyll cells. Unknown transport steps that 
require transmembrane movement across different organelles are highlighted by a ?. 
 
 
1.4 Characterised C. roseus transporters 
 
Based on the localisation of the known biosynthetic genes in the MIA pathway, there are 
therefore a number of hypothesised transporters that are required for the transmembrane 
transport of biosynthetic intermediates in MIA metabolism in C. roseus. This encompasses both 
the early part of the pathway involved in seco-iridoid biosynthesis, as well as in the formation 
of the downstream alkaloids. 
Firstly, a terpene intermediate, which is likely to be loganic acid, is exported from the IPAP cells 
and imported into the epidermis (Miettinen et al., 2014). 
Secondly, the intermediates secologanin and tryptamine must be imported into the vacuole, 
and the product of their condensation, strictosidine, must be exported into the cytosol.  These 
intracellular transport activities occur in the epidermal cells (Courdavault et al., 2014).  
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Thirdly, the iboga alkaloid, catharanthine, needs to be exported to the waxy exudate on the leaf 
from the epidermis (Courdavault et al., 2014; Yu and De Luca, 2013). 
 Fourth, both catharanthine, and the intermediate in the tabersonine-vindoline pathway, 
desacetoxyvindoline, need to be transported from the epidermis and into the mesophyll 
(Courdavault et al., 2014; Qu et al., 2015). 
Lastly, the end products of the biosynthesis of MIAs, vindoline and catharanthine, as well as the 
other MIAs such as serpentine, are stored in the vacuole of the mesophyll (Courdavault et al., 
2014).  
To date there has been one report of a functionally characterised transporter from C. roseus. 
The exporter of catharanthine from the epidermis, to the waxy exudate, has been shown to be 
an ABC transporter, CrTPT2 (Yu and De Luca, 2013). This transporter was shown to be enriched 
in the leaf epidermome and could be induced by methyl jasmonate induction, which is a 
hormone that is known to lead to the upregulation of MIAs in C. roseus. This transporter 
localised to the plasma membrane and transports catharanthine when heterologously 
expressed in S. cerevisiae. Furthermore, transient silencing of this transporter by Virus Induced 
Gene Silencing (VIGS), resulted in a decrease in leaf catharanthine levels, indicating its 
physiological relevance to this pathway (Yu and De Luca, 2013). 
 
 
 
 
Figure 1-8 Overview of the necessary transmembrane transport steps in the biosynthesis of MIAs in C. 
roseus  
Overleaf: There are five main regions of the pathway that require transport I.) Movement of loganic acid 
between the IPAP cells and the epidermis II.) Movement of secologanin and tryptamine into the vacuole, 
and strictosidine out of the vacuole in the epidermis III.) Movement of catharanthine from the epidermis 
to the wax cuticle IV.) Movement of catharanthine and desacetoxyvindoline from the epidermis to the 
mesophyll and V.) Movement of downstream MIAs such as serpentine, catharanthine and vindoline into 
the mesophyll vacuole. The alkaloids presented here are likely to be protonated. 
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Additionally it has been shown utilising intact protoplasts and vacuolar membranes isolated 
from C. roseus leaf tissue that the transporters for vindoline and catharanthine uptake into the 
mesophyll vacuole are likely to be secondary active transporters that utilise the proton gradient 
(Carqueijeiro et al., 2013). Uptake of vindoline and catharanthine into the vacuole was shown 
to be ATP dependent, with the transport inhibited by NH4Cl and carbonyl cyanide m-
chlorophenyl hydrazone (CCCP), which dissipate the proton gradient across the tonoplast 
membrane. This transport activity was not abolished upon treatment with the ABC transporter 
inhibitor, vanadate. This subsequently suggests that these vindoline and catharanthine 
importers are likely to be secondary active transporters. However, to date, no transporter has 
been identified that can perform this role (Carqueijeiro et al., 2013; Roytrakul and Verpoorte, 
2007). 
The remaining transport steps have yet to be elucidated, and the functional role this spatial 
distribution of MIA metabolism plays in C. roseus is still an enigma. 
1.5 The role and importance in the spatial distribution of metabolism 
 
The spatial distribution of metabolic networks is integral to their function, as metabolite 
transport between subcellular compartments fundamentally affects the structure of the 
metabolic network. 
 A genome wide compartmentalized model of the metabolic network in Arabidopsis using the 
known network structure and localisation of reactions in the cytosol, plastid, mitochondrion,  
endoplasmic reticulum, peroxisome, vacuole and Golgi apparatus, predicts that for a metabolic 
network comprising 1078 metabolites, there is a need for 772 intracellular transporters (Mintz-
Oron et al., 2012). This therefore indicates that in excess of 70% of the metabolites in 
Arabidopsis are engaged in some form of transport. Clearly the role of transporters cannot be 
overlooked when considering engineering of plant metabolism, as the kinetics of transport is 
likely to directly affect metabolic fluxes.  
There are two main hypotheses to explain why subcellular localisation of metabolic pathways 
occurs in eukaryotic cells.  Firstly, subcellular localisation of metabolic pathways is likely to be 
related to the evolutionary history of the metabolic compartment. Organelles derived from 
endosymbiosis, such as the mitochondrion and the chloroplast, would result in the duplication 
of certain enzymes. If there is no selective pressure to keep both enzymes, it is feasible that the 
loss of enzyme functionality resulted in the mixed compartmentation of metabolic pathways, 
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and the need for metabolite transport between different organellar compartments. Examples 
of such pathways are in vitamin biosynthesis, such as with folic acid, as well as with cysteine 
biosynthesis (Sweetlove and Fernie, 2013; Takahashi et al., 2011).  
However the spatial distribution of metabolism can also have direct physiological relevance to 
the metabolic pathway. The importance of localisation occurs at 1.) the organellar level and 2.) 
between organelles. 
1.) The archetypal example of the importance of organellar compartmentation is with the 
specialised bioenergetic organelles such as the mitochondria and the chloroplasts. The 
requirement for strict control of redox potential necessitates the localisation of oxidative 
phosphorylation and the tricarboxylic acid cycle in the mitochondria. Coupling the carbon cycle 
to the electron transport chain is essential to minimise reactive oxygen species (ROS), and to 
control the redox chemistry of the electron transport chain (Lane and Martin, 2010).  
2.) The spatial separation of duplicated metabolic pathways in different subcellular 
compartments also allows for the local control and regulation of the metabolic pathways. 
Separating parallel pathways in different organelles prevents the potential for futile cycling of 
intermediates, and secondly, it also has the potential to divert the end product substrate into 
different metabolic pathways. This is seen for the duplication in the biosynthesis of isopentenyl 
pyrophosphate (IPP), a key intermediate in terpene synthesis for secondary metabolism in 
plants. IPP is derived from either the canonical mevalonate (MVA) pathway, which utilises 
acetyl-CoA as substrate for biosynthesis of IPP and is localised to the cytosol, or the 2-C-methyl-
D-erythritol 4-phosphate (MEP) pathway, which utilises D-glyceraldehyde 3-phosphate and 
pyruvate and is localised to the chloroplast. Compartmentalisation allows for differential flux 
through each parallel pathway and the maintenance of separate pools of IPP (Heinig et al., 
2013). 
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In C. roseus, the functional role that spatial organisation plays in controlling flux through the MIA 
metabolic pathway is unclear (Courdavault et al., 2014).  
The localisation and biosynthesis of strictosidine in the vacuole may control its contact with the 
next enzyme in the pathway, strictosidine β-glucosidase (Guirimand et al., 2010). Although the 
conversion of strictosidine to strictosidine aglycone is necessary in the cell for the formation of 
the downstream alkaloids such as vindoline and catharanthine, it is possible that the localisation 
of strictosidine in the vacuole provides a buffering mechanism to prevent accumulation of 
strictosidine in the cytoplasm and nucleus (Guirimand et al., 2010). 
This in turn restricts the potential uncontrolled deglycosylation of strictosidine to the reactive 
dialdehyde product, strictosidine aglycone. The spatial separation of strictosidine, and the 
strictosidine β-glucosidase therefore acts as a pre-emptive buffer to prevent uncontrolled 
formation of the dialdehyde, that has the potential to crosslink free amines in the cell 
(Guirimand et al., 2010). 
This metabolic scenario is analagous to the ‘mustard oil bomb’ or ‘glucosinolate-myrosinase’ 
complex in Brassicaceae (Bones and Rossiter, 1996). The glucosinolates are a class of 
glycosylated compounds that contain nitrogen and sulphur. Upon deglycosylation by a 
myrosinase enzyme these compounds can re-arrange to form a thiocyanate, an isothiocyanate 
or a nitrile, which are compounds active in plant defense against herbivory (Winde and 
Wittstock, 2011). The spatial separation at the cellular level, of the myrosinase and 
glucosinolates prevents the uncontrolled formation of these reactive compounds, however 
upon herbivory, this spatial distribution is destroyed resulting in their formation (Figure 1-9). 
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Figure 1-9 Compartmentation of strictosidine may prevent its uncontrolled deglycosylation to a 
reactive intermediate in an analogous system to the ‘glucosinolate-myrosinase’ complex. 
A. Spatial separation of strictosidine and strictosidine β-glucosidase (SGD) in separate organelles prevents 
B. The uncontrolled formation of deglycosylated strictosidine which can crosslink free amine. This is 
analogous to C. the cellular separation of glucosinolates and the enzyme myrosinase which can D. result 
in the formation of thiocyanates, isothiocyanates and nitriles. 
 
1.6 Identification of transporters involved in secondary metabolic pathways 
 
There are a four main transporter classes in plants that are known to transport some of the 
diverse array of plant metabolites that are produced in nature and have been functionally 
characterised: The ABC transporters (Kang et al., 2011), The Major Facilitator Superfamily (MFS) 
(Pao et al., 1998), the Drug/Metabolite transporter (DMT) family (Jelesko, 2012) and the 
Multidrug and Toxic Compound Extrusion Proteins (MATEs) (Omote et al., 2006). Briefly, the ABC 
transporters are primary transporters that directly utilise the hydrolysis of ATP as an energy 
source for the transport of a solute against its concentration gradient (Kang et al., 2011) whilst, 
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in comparison, the MFS (Pao et al., 1998), DMT (Jelesko, 2012) and MATE (Omote et al., 2006) 
transporters are secondary transporters that either utilise the energy stored as an 
electrochemical gradient across the lipid bilayer for active transport, or act as facilitative 
transporters of solutes down their electrochemical gradient.  A more thorough review of these 
transporter classes and their role in plant metabolism is presented in Chapter II, III and IV. 
There are a number of limitations to the high-throughput identification of plant natural product 
transporters. 
Traditional approaches to the identification of primary metabolic substrate transporters have 
utilised the functional complementation in yeast knockouts, using plant cDNA libraries. 
However, secondary plant metabolites are often not amenable to the use of such approaches 
as they are not essential for yeast growth (Nour-Eldin and Halkier, 2013). 
An alternative method is a functional genomics screen of plant cDNA libraries utilising an assay 
that is amenable to measure metabolite transport. This has been applied to the identification of 
Arabidopsis glucose and glucosinolate transporters in Xenopus laevis oocytes (Nour-Eldin et al., 
2012; Nour-Eldin et al., 2006), by expression screening of 239 full length transporters in oocytes 
for uptake activity of the substrate of interest. 
As will be highlighted in subsequent chapters, there are two major limitations of utilising a 
functional screening approach to the identification of plant metabolite transporters, and other 
enzymes. 
I.)  The successful heterologous expression of eukaryotic membrane proteins is challenging. A 
large scale functional screening approach, although incredibly useful in identifying new 
substrate specificities of transporter classes (Nour-Eldin et al., 2012; Nour-Eldin et al., 2006), 
may be limited by whether the membrane protein is functional in the heterologous host, and as 
such this screening approach may result in a false negative result. It also requires the 
optimisation of the assay for each substrate to be tested. 
II.) Screening for in vitro activity, by analysing transport uptake, does not assess whether the 
transport activity detected is physiologically relevant to the plant, and whether the spatial 
distribution of the metabolic reaction is integral to the metabolic pathway. Additionally this 
screening approach may also lead to false positive results, in which a transporter may display in 
vitro transport capacity for a substrate, however not be the physiologically relevant transporter 
in vivo. 
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An alternative approach for the identification of metabolite transporters is through reverse 
genetics. A reverse genetics screen of metabolite transporters and assessment for a metabolic 
phenotype results in a clear indication of the physiological relevance of the transporter.  
As well as the identification of the transporter involved for a particular substrate, a reverse 
genetics screen provides more information with regards to the importance to the role of the 
spatial organisation of the metabolic pathway, and whether substrate compartmentation is 
critical in the metabolic pathway. 
Furthermore positive results from the reverse genetics screen can subsequently be confirmed 
by heterologous expression for the in vitro characterisation of transport activity.  
 
1.7  Virus Induced Gene Silencing 
 
One of the most common methods for reverse genetics in non-model plant species is Virus 
Induced Gene Silencing (VIGS), which has proven to be a versatile tool for gene discovery in 
plants (Burch‐Smith et al., 2004). It has been successfully used in a number of medicinal plant 
species, including the benzylisoquinoline alkaloid producing plants: Californian poppy, 
Eschscholzia californica (Wege et al., 2007) and opium poppy, Papaver somniferum (Hileman et 
al., 2005) as well as the tropane alkaloid producing plant Hyoscyamus niger (Li et al., 2006). 
VIGS is used to transiently silence an endogenous plant gene, utilising an RNA interference 
mechanism that results in sequence specific post transcriptional gene silencing (PTGS). This 
process effectively hijacks the innate plant anti-viral defence response (Baulcombe, 1999) 
(Burch‐Smith et al., 2004). 
Upon infection of a plant, plant viruses produce double stranded RNA (dsRNA). Typically, this 
double stranded RNA is formed through the action of host dependent RDR (RNA-dependent RNA 
polymerase)-dependent synthesis of dsRNA from single stranded RNA viral templates (Qu et al., 
2008). This dsRNA is recognised and cleaved by ribonuclease Dicer-like (DCL) proteins into 
siRNAs. In Arabidopsis, there are four DCL proteins, with DCL4 and DCL2 primarily used for viral 
siRNA biogenesis, which cleave the dsRNA into 21 nucleotide and 22 nucleotide fragments 
respectively. The DCL4 cleavage of dsRNA is aided by the dsRNA binding protein DRB4 (Adenot 
et al., 2006). The viral siRNAs generated are recognised by the Argonaute proteins (AGO), of 
which there are ten homologues in Arabidopsis. AGO1 and AGO2 (Baumberger and Baulcombe, 
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2005; Bhattacharjee et al., 2009), are primarily involved in anti-viral silencing. Binding of the 
AGO proteins to the siRNA results in the formation of the RNA-induced silencing complex (RISC) 
(Baumberger and Baulcombe, 2005). This results in the complementary base pairing of the siRNA 
to its RNA target and leads to either cleavage of the mRNA or translational repression of the 
mRNA, and the gene encoded by this mRNA is not expressed (Figure 1-10). 
 
 
Figure 1-10 Overview of RNA interference in plants.  
Viral ssRNA is converted to dsRNA by RNA Ddependent RNA-polymerase (RDR-polymerase), which is 
cleaved into siRNA by Dicer like enzymes (DCL). These siRNAs are loaded into the RISC complex which 
contains the argonaute proteins, and directs cleavage of endogenous RNA (blue) through recognition by 
complementary base pairing. Figure adapted from (Watson and Wang, 2012). 
 
VIGS utilises modified viral vectors for the silencing of endogenous plant mRNAs and thereby 
provides a method for transiently silencing gene of interest in the plant (Ratcliff et al., 2001). 
Although there are many plant viruses that have been used to develop VIGS vectors, the most 
common VIGS vector is derived from the tobacco rattle virus, pTRV (Ratcliff et al., 2001). Tobacco 
22 
 
rattle virus (TRV) has a broad host range, and the virus spreads quickly and uniformly in most 
plants, resulting in efficient silencing in a variety of plant species (Ratcliff et al., 2001). 
The tobacco rattle virus is an RNA virus that is encoded by two RNAs, RNA1 and RNA2. RNA1 
encodes a replicase, and proteins involved in viral movement. RNA2 encodes for the viral coat 
proteins and two non-structural proteins. A set of bipartite VIGS vectors was generated from 
this base structure (Liu et al., 2002). pTRV1 contains the cDNA clones of RNA1 cloned between 
the cauliflower mosaic virus (CaMV) 35S promoter and a nopaline synthase (NOS) terminator in 
a T-DNA cassette. pTRV2 contains the cDNA clones of RNA2 cloned between cauliflower mosaic 
virus (CaMV) 35S promoter and a nopaline synthase (NOS) terminator in a T-DNA cassette, with 
the genes encoding the two non-structural proteins replaced by a multiple cloning site (Liu et 
al., 2002). 
The multiple cloning site in the pTRV2 plasmid allows insertion of a fragment of the gene of 
interest (200 bp-1500 bp) to be silenced in the plant. Cultures of Agrobacterium tumefaciens 
that have been transformed with the pTRV1 and pTRV2 constructs can then be mixed, and 
infiltrated into the plant of choice. This T-DNA cassette inserts into the plant genome, and results 
in the formation of a systemic virus that can infect the plant, and induce the anti-viral RNAi 
silencing pathway (Liu et al., 2002). 
 
 
Figure 1-11 Structure of the TRV based VIGS vectors. 
The RNA1 and RNA2 cDNA clones were cloned between two CaMV 35S promoters (2X35S) and NOS 
terminator (NOSt) in a T-DNA vector, Rz is a self-cleaving ribozyme that is common to both vectors and LB 
and RB highlight the left and right borders of the T-DNA. RNA1, which results in the formation of pTRV1 
contains an RNA-dependent RNA polymerase (RdRp), a movement protein (MP, and a 16Kda cysteine-rich 
protein (16K). In turn RNA2, which results in the formation of pTRV2 encodes for the viral coat protein 
(CP) and contains a multiple cloning site (MCS) for cloning of the VIGS targeting region for the gene of 
interest (Liu et al., 2002). Figure adapted from (Watson and Wang, 2012). 
 
Upon viral infection, the recombinant VIGS vector results in the formation of viral derived dsRNA 
which activates the anti-viral RNA silencing pathway. Because the VIGS vector contains a region 
from a target gene sequence, this results in the formation of siRNAs that target the endogenous 
2X35S MP 16K Rz NOStRdRp
LB RB
pTRV1
2X35S CP Rz NOStMCS
LB RB
pTRV2
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mRNA for degradation or translational repression, and thereby silences endogenous genes in 
the plant. 
 
1.8 Virus Induced Gene Silencing in C. roseus 
 
VIGS has been utilised using the pTRV2 system for the identification and characterisation of a 
number of genes that are involved in the MIA pathway since this technique was first adapted to 
C. roseus leaf tissue in 2011 (Liscombe and O’Connor, 2011). 
This has included the characterisation of genes of a number of steps involved in secologanin 
biosynthesis; iridoid synthase (Geu-Flores et al., 2012), 7-deoxyloganetic acid 
glucosyltransferase (Asada et al., 2013), 7-deoxyloganic acid hydroxylase (Salim et al., 2013), 7-
deoxyloganetic acid synthase, or iridoid oxidase (Salim et al., 2014), genes involved in vindoline 
biosynthesis; including desacetoxyvindoline 4-hydroxylase (D4H) (Liscombe and O’Connor, 
2011), deacetylvindoline 4-O-acetyltransferase (DAT) (Liscombe and O’Connor, 2011), 16-
methoxy-2,3-dihydrotabersonine N-methyltransferase (NMT) (Liscombe and O’Connor, 2011), 
tabersonine 16-hydroxylase (Besseau et al., 2013), tabersonine 3-oxygenase and tabersonine 3-
reductase (Kellner et al., 2015a; Qu et al., 2015) as well  as genes involved in heteroyohimbine 
biosynthesis such as tetrahydroalstonine synthase (Stavrinides et al., 2015). 
The ABC transporter CrTPT2 that is involved in extrusion of catharanthine to the leaf wax 
exudate was subjected to VIGS to confirm its role as the catharanthine exporter. The use of a 
reverse genetics strategy, followed by screening for a metabolic phenotype, demonstrated that 
these genes are physiologically relevant to MIA metabolism in planta (Yu and De Luca, 2013). 
Although a variety of infiltration systems have been used for VIGS in C. roseus including 
‘agrodrench’, vacuum infiltration, and syringe infiltration, the most efficient method for 
silencing genes in C. roseus is through the use of the pinch wounding method (Liscombe and 
O’Connor, 2011). This method uses plants that have at least one pair of full expanded leaves, 
and the stem is wounded with a needle or pair of forceps, and a mixture of Agrobacterium 
cultures harbouring pTRV1 and pTRV2 plasmids are placed on the wound site.  
The Agrobacterium is uptaken by the xylem, causing the systemic infection of the virus in the 
newly developing leaves in the plant. This in turn triggers the post-transcriptional RNAi silencing 
that downregulates the viral RNA, as well as the endogenous mRNA of the gene present on the 
pTRV2 viral vector.  
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An overview of this approach is presented in Figure 1-12.  The phenotype that is observed in the 
positive control is caused by the downregulation of Magnesium chelatase, a gene integral to 
chlorophyll biosynthesis, where the bleaching of the leaf tissue is a result of the decreased 
amount of chlorophyll. Genes that affect MIA metabolism usually do not have a visibly 
observable phenotype, so the newly emerging leaves that occur 21-25 days post pinching must 
be analysed by liquid chromatography mass spectrometry (LC-MS) to assess whether silencing 
has caused a change in the metabolic phenotype. For these experiments a set of Magnesium 
chelatase plants is used as a positive control as a visual indication that the silencing has worked. 
 
Figure 1-12 Overview of the VIGS method applied to C. roseus 
 
It has also recently been shown that efficient VIGS silencing can be achieved independently of 
Agrobacterium mediated infiltration using a biolistic mediated approach (Carqueijeiro et al., 
2015). This methodology resulted in comparable levels of gene silencing in comparison to the 
Agrobacterium mediated methods. 
Mix the pTRV2 and pTRV1 Agrobacterium 
strains and pinch wound the stem (white 
arrow)
pTRV2 containing 500bp region of the 
gene of interest
Clone pTRV2 vector into Agrobacterium 
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There are a number of benefits of utilising VIGS in C. roseus as a reverse genetic approach for 
biosynthetic pathway discovery (Burch‐Smith et al., 2004). 
1.) VIGS is a relatively fast reverse genetics tool, with an experiment in C. roseus completed 
within 3 months, from the time of planting the C. roseus seed. It does not rely on the need for 
transgenic plant formation and selection, as with the formation of stable transgenics, and this 
considerably shortens the screening time. 
2.) The leaf tissue of the C. roseus plant, which is an important site of alkaloid biosynthesis, is 
strongly affected by VIGS. Before the utilisation of VIGS, the most common methods gene 
silencing  in C. roseus used transgenic cell suspension cultures (Papon et al., 2004), or hairy root 
cultures (Runguphan et al., 2009). Although these studies provided a great deal of information 
on MIA biosynthesis in C. roseus, these approaches were limited by the fact that many 
medicinally important alkaloids are not produced in hairy roots or cell suspension cultures. For 
example, the downstream alkaloid vindoline is not synthesised in root tissue or cell suspension 
culture, and therefore attempting to study its biosynthesis in these systems is not possible. 
Furthermore, an understanding of the role the spatial distribution of the metabolic network 
plays, between the different leaf tissues, is not possible in these systems. 
3.) VIGS can be used to silence multiple genes at the same time by stacking regions of different 
genes into the pTRV2 vector. This allows for the combinatorial silencing of genes in order to 
probe the potential for functional redundancy in the plant, as well as the silencing of whole gene 
families in the plant (Burch‐Smith et al., 2004). 
4.) VIGS is a knockdown, and not a knock out of the gene of interest. Although this means that 
complete silencing of the gene to 100% is never observed, and there is therefore always some 
basal residual activity of the gene of interest targeted, this methodology does allow for the 
analysis of genes that might be embryonically lethal if not present in the plant (Burch‐Smith et 
al., 2004). 
1.9  VIGS of transport proteins 
 
As highlighted in the previous section, VIGS has been successfully applied to the characterisation 
of a number of MIA pathway genes, and the use of this reverse genetics strategy is well 
precedented for the elucidation of physiologically relevant enzymes in C. roseus. However, apart 
from CrTPT2, there has been less precedent for VIGS of transport proteins in this medicinal plant. 
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There are a number of examples where VIGS has been used successfully in the characterisation 
of transport proteins. With the exception of the catharanthine transporter CrTPT2, most of these 
have primarily been used to study the role of transport proteins in their physiological response 
to pathogen resistance and plant development, as opposed to screening for novel metabolic 
phenotypes, and the identification of secondary metabolite transporters. 
For example, an ABC subfamily C transporter (ABCC) from wheat was shown to be involved in 
the transport of the mycotoxin deoxynivalenol, which is a fungal virulence factor. VIGS in wheat 
utilising the barley stripe mosaic virus (BSMV)-derived VIGS vectors, showed that this 
transporter resulted in susceptibility to deoxynivalenol, however the precise metabolite it was 
transporting was not determined (Walter et al., 2015). 
The TRV VIGS system was used to silence a hexose transporter, LeHT1, in tomato, which was 
shown to contribute to the resistance of tomato to a variety of viruses including tomato yellow 
leaf curl virus (TYCLV), bean dwarf mosaic virus (BDMV), cucumber mosaic virus (CMV) and 
tobacco mosaic virus (TMV) (Eybishtz et al., 2010). 
S-adenosylmethionine is synthesised in the cytosol, however is utilised in the chloroplast by a 
number of plastid methyltransferases as a methyl donor in the synthesis of chlorophylls, 
plastoquinone, tocopherol and phylloquinone. The SAM therefore needs to be imported in to 
the chloroplast for biosynthesis of these small molecules (Bouvier et al., 2006). Silencing of the 
chloroplast localised S-adenosylmethonine transporter NbSAMT1 using VIGS, in Nicotiana 
benthamiana, resulted in a stunted growth phenotype, together with pale green leaves as a 
result of a decrease in chlorophyll and plastoquinone content. This is consistent with the 
equivalent transporter in Arabidopsis which was analysed by T-DNA insertional mutagenesis 
(Bouvier et al., 2006). 
There is therefore precedent for the use of the VIGS system, in multiple plant species, to assess 
the importance of both enzymes and transport proteins involved in secondary metabolic 
pathways in vivo. 
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1.10 Aims and Scope of Thesis 
 
The primary aim of this thesis is to utilise a reverse genetics approach, VIGS, for the identification 
of genes that are involved in MIA metabolism in C. roseus. As will be shown, although a diverse 
range of genes have been assessed for a metabolic phenotype in this thesis, there is a particular 
emphasis on the identification of transport proteins that could be involved in MIA metabolism 
in C. roseus. 
Chapter II assesses the use of transcriptome mining for the generation of candidate genes that 
could be involved in the MIA pathway, as well as discussing the results from a variety of VIGS 
experiments, which highlights a number of the pitfalls and limitations of utilising this approach. 
Chapter III and Chapter IV discuss the identification of two transporters that have been shown 
to be physiologically relevant to C. roseus MIA metabolism, together with attempts at their in 
vitro characterisation and highlights how the use of this approach can be used for transporter 
identification.  
Chapter V discusses the identification of a reticuline oxidase like enzyme that is involved in MIA 
metabolism in C. roseus. This chapter also highlights the benefits of utilising a reverse genetics 
screen for the identification of novel effects on MIA metabolism that would not necessarily be 
predictable or unlikely to be identified by a functional genetics screen. 
The overarching theme of this research is to utilise VIGS in C. roseus in order to identify genes 
involved in MIA metabolism that may not be amenable to a functional genomics screening 
approach, as well as assess the integral role the spatial organisation of the metabolic pathway 
has on MIA biosynthesis. 
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2 Transcriptome mining and characterisation of gene 
candidates in C. roseus 
 
2.1 Transcriptomic resources in medicinal plants 
 
The utilisation of reverse genetic methods, such as VIGS in medicinal plants, requires the prior 
knowledge of the gene target and its sequence. The field of gene discovery in medicinal plants 
has been greatly advantaged due to the availability of next generation sequencing technologies. 
For C. roseus, there are three full transcriptomes that are available in the public domain, the 
Medicinal Plant Genomic Resources (MPGR, http://medicinalplantgenomics.msu.edu; 
(Góngora-Castillo et al., 2012)), Phytometasyn (http://www.phytometasyn.ca; (Xiao et al., 
2013)), as well as Cathacyc (http://www.cathacyc.org; (Van Moerkercke et al., 2013)). 
Within this thesis the primary source of sequence and expression data has been from the 
Medicinal Plant Genomics Resource, however the other databases have also been used for 
cross-referencing gene sequences. 
The MPGR C. roseus transcriptome contains 32,607 unique transcripts that likely represent 
unique genes expressed in C. roseus (unigenes). These transcripts have been annotated using 
similarity searches using the Arabidopsis thaliana proteome, the UniRef100 database and Pfam 
domain composition (Góngora-Castillo et al., 2012). 
One of the benefits of using this transcriptomic resource is the amount of sequencing data 
derived from different tissues and different experimental conditions. In the MPGR database, for 
C. roseus, transcriptomic sequence data has been obtained from 23 samples taken from 
different tissues under various conditions. These are summarised in Table 1. 
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Table 1 Tissues and experimental conditions available in the C. roseus MPGR transcriptomic resource 
Sequence data is available from the developmental tissues, as well as sterile seedlings, C. roseus 
suspension cultures and C. roseus hairy root lines under a number of different elicitor treatments. The 
suspension cultures were treated with 0.3 mg/ml yeast extract (YE), and the sterile seedlings and hairy 
roots were incubated with 100 µM methyl jasmonate (MeJA). The TDCi hairy roots are antisense lines for 
tryptophan decarboxylase, whilst the RebH hairy root is a line expressing a bacterial halogenase. For 
subsequent graphs of expression presented in this thesis the different lines will be represented by the 
numbers 1-23.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Number Tissue/ experimental condition 
1 Flowers 
2 Suspension culture YE 6 h 
3 Suspension culture YE 12 h 
4 Suspension culture YE 24 h 
5 Sterile seedlings MeJA 0 h 
6 Sterile seedlings MeJA 6 h 
7 Sterile seedlings MeJA 12 h 
8 Sterile seedlings MeJA 24 h 
9 Sterile seedlings 5 d 
10 Sterile seedlings 12 d 
11 Sterile seedlings (control) 
12 Suspension culture (control) 
13 Mature leaf 
14 Immature leaf 
15 Stem 
16 Root 
17 Wild type hairy roots 
18 Wild type hairy roots MeJA 0 h 
19 Wild type hairy roots MeJA 24 h 
20 TDCi hairy root 
21 TDCi hairy root MeJA 0 h 
22 TDCi hairy root MeJA 24 h 
23 RebH hairy root 
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The expression level of each of the 32,607 unigenes, represented as fragments per kilobase of 
transcript per million reads mapped (FPKM), has been calculated in each of the libraries, thereby 
providing expression information on each of the unigenes in different tissues and experimental 
conditions (Góngora-Castillo et al., 2012). 
For gene discovery of MIA pathway genes in C. roseus, the diversity of sequence data across 
different tissues and experimental conditions allows for filtering the dataset based upon 
expression (Geu-Flores et al., 2012). 
Due to the known localisation of the metabolic pathway to leaf tissue, any gene not expressed 
in leaf can be discarded. Additionally the seedlings that have been elicited with methyl 
jasmonate (MeJA) allows for identification of genes that are upregulated upon MeJA induction. 
The MIA pathway responds to MeJA elicitation (Vazquez-Flota and De Luca, 1998), and therefore 
genes that are preferentially expressed in response to MeJA elicitation are preferred candidates. 
Additionally this large dataset provides the opportunity to analyse genes that are co-expressed 
with known MIA genes under all of the tissues and experimental conditions, and this has been 
the primary basis for candidate gene selection in this study. 
2.2 Co-expression analysis 
 
Gene discovery utilising co-expression analysis assumes that a metabolic pathway, or part of a 
metabolic pathway, is co-regulated at the transcriptional level, and therefore the genes in the 
pathway would have a similar expression pattern. 
The data can then be arranged or clustered based on co-expression profiles, with the unigenes 
that have similar expression profiles to known genes in the metabolic pathway of interest, 
highlighted. Candidate genes that have a similar expression pattern to these known genes are 
then characterised by either a functional assay or reverse genetics method. 
There is precedence for the co-regulation of a number of metabolic pathways in plants. This has 
been shown in primary metabolism in Arabidopsis, with the genes in the pathways of glycolysis, 
the tricarboxylic acid cycle, and the pentose phosphate pathway tightly co-expressed (Wei et al., 
2006).  
Arabidopsis also shows co-expression of a number of secondary metabolic pathways, including 
flavonoid biosynthesis (Wei et al., 2006; Yonekura-Sakakibara et al., 2008), as well as in the 
biosynthesis of monoterpenes (Ginglinger et al., 2013). For example the terpene synthases and 
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cytochrome p450s that are involved in the formation of the monoterpene alcohol linalool were 
identified by co-expression analysis (Ginglinger et al., 2013). 
In C. roseus, this methodology has been primarily used for gene discovery for the identification 
of genes in the seco-iridoid branch of the metabolic pathway. Co-expression analysis was utilised 
for the successful identification of iridoid synthase (Geu-Flores et al., 2012) as well as multiple 
unknown genes in the seco-iridoid branch of the MIA pathway (Miettinen et al., 2014). 
 
2.3 Results and Discussion 
2.3.1 Candidate selection for VIGS 
 
Two methods of selection by co-expression analysis were employed to determine genes of 
interest for this study; Hierarchical Clustering and Self-Organising Maps.  
2.3.1.1 Hierarchical Clustering 
 
Hierarchical clustering was implemented using the Multiple Experiment Viewer (MeV) v4.7 
(Eisen et al., 1998; Saeed et al., 2003). The 32,607 unigenes present in the C. roseus dataset, 
were filtered based on expression level in leaf tissue. To decrease the number of unigenes under 
consideration; unigenes with a log2FPKM value of less than 2 in the leaf were discarded. Multiple 
hierarchical clustering dendograms were generated using different distance metrics to calculate 
the differences between unigene expression profiles; Pearson Correlation, Euclidean Distance 
and Manhattan Distance, as well as the average linking criterion as the linking method. Known 
genes involved in the MIA pathway were highlighted, and unigenes in the surrounding cluster 
were selected for further interrogation by the VIGS, with the candidates presented in Table 2. 
As highlighted in both the work of Miettinen et al., 2014 and Geu-Flores et al., 2012, the genes 
involved in the biosynthesis of geraniol via the MEP pathway, the biosynthesis of the seco-iridoid 
secologanin, the biosynthesis of tryptamine and the biosynthesis and deglycosylation of 
strictosidine appear to be co-regulated, whilst genes involved in the downstream MIA pathway 
such as those involved in the conversion of tabersonine to vindoline do not cluster with this 
method. This is supported by the hierarchical clustering analysis presented in this thesis (Figure 
2-1). 
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Figure 2-1 Representative hierarchical clustering dendogram.  
Hierarchical clustering using the Pearson correlation distance metric with average linkage was 
implemented using the MeV v4.7 software. Clusters of unigenes with similar expression profile are 
represented on the y-axis. The heatmap represents the log2(FPKM) across the 23 different tissues and 
experimental conditions highlighted in Table 1. This region of the dendogram highlights the co-expressed 
cluster involved in seco-iridoid and strictosidine biosynthesis. Dark pink- tryptophan decarboxylase, light 
green-Genes in the MEP pathway, Light blue- secologanin synthase isoforms, Dark blue- strictosidine 
synthase isoforms, Dark green- 7-deoxyloganetic acid glucosyltransferase, Yellow- Loganic acid 
methyltransferase, Light Pink-Candidate genes annotated as transport proteins. 
 
 
2.3.1.2 Self-Organising Maps 
 
To corroborate the genes selected by hierarchical clustering, an alternative method for 
clustering transcriptomic expression data was also utilised, self-organising maps (SOM) 
(Kohonen, 1990). This method for application to the C. roseus transcriptomic dataset was 
developed by Marc Jones, John Innes Centre. 
For each node in the SOM there are approximately 40 unigenes presented, with the spatial 
proximity of each node on the map representative of the similarity in expression profile. In the 
SOM, strictosidine synthase, secologanin synthase, tryptophan decarboxylase, strictosidine 
glucosidase, geraniol 8-hydroxylase and loganic acid methyltransferase localised to 5 
neighbouring nodes (Figure 2-2). This indicates that these six genes showed similar expression 
profiles and supports the hierarchical clustering method used in this study, as well as the 
clustering methods utilised in Geu-Flores et al., 2012 and Miettinen et al., 2014, which indicate 
that genes of seco-iridoid and strictosidine biosynthesis are co-regulated. Similarly genes 
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involved in the downstream MIA pathway such as those involved in the conversion of 
tabersonine to vindoline do not cluster in the SOM analysis. 
A full list of the genes highlighted in these 5 nodes is presented in the Appendix, with the genes 
selected for assessment by VIGS in this thesis highlighted in Table 2. 
 
 
Figure 2-2 Self-organising map for C. roseus transcriptomic data. 
Each node represents around 40 unigenes, with each node containing genes with the most similar 
expression profile. Furthermore neighbouring nodes are related to each other by the similarity of their 
expression profile. The average expression profile of genes in the node is plotted as a red line on each 
node. The genes strictosidine synthase, secologanin synthase, tryptophan decarboxylase, strictosidine β-
glucosidase, geraniol 8-hydroxylase and loganic acid methyltransferase all localise to the nodes 
highlighted by the blue circle. Nodes coloured green represent the highest quality nodes as defined in the 
Materials and Methods. 
 
The gene list generated by the SOM analysis was very similar to that generated as a result of 
hierarchical clustering, indicating the robustness of both approaches. The best candidates for 
enzymology and transport in the MIA pathway in both of these datasets were two MATE 
proteins, CrMATE1952 and CrMATE10740 which will be discussed in Chapter III, an NPF 
transporter, CrNPF2.9, which will be discussed in Chapter IV, and a reticuline oxidase like 
enzyme, CrRO, which will be discussed in Chapter V. In subsequent chapters the expression 
profile of these genes are plotted as a line graph to demonstrate co-expression with the known 
MIA genes. 
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2.3.1.3 Alternative candidate selection criteria 
 
Although there is precedence for genes in a secondary metabolic pathway to be co-expressed, 
this does not always occur. The hierarchical clustering analysis and self-organising map analysis 
in this thesis, together with the work of Geu-Flores et al., 2012 and Miettinen et al., 2014, 
highlights this. The genes in the early part of the MIA biosynthetic pathway appear to be co-
regulated in the MPGR transcriptomics dataset; namely the biosynthesis of geraniol via the MEP 
pathway, the biosynthesis of the seco-iridoid secologanin, the biosynthesis of tryptamine and 
the biosynthesis and deglycosylation of strictosidine. 
In contrast the expression pattern of the known genes that act after the deglycosylation of 
strictosidine, that are involved in the biosynthesis of vindoline from tabersonine, as well as in 
the formation of the alkaloid tetrahydroalstonine, do not cluster with each other or these early 
genes. 
The genes that have been selected by co-expression analysis for investigation in this study would 
therefore be predicted to act on the earlier steps of the MIA pathway. To obtain candidates that 
might act on the later stages of the pathway is difficult utilising the transcriptomic resources 
available. The genome of C. roseus has been published (Kellner et al., 2015b), and this work 
highlights alternative routes to gene discovery utilising the spatial proximity of genes on the 
genome, as there are growing reports of the physical clustering of genes in secondary 
metabolism in plants (Osbourn, 2010). This methodology was successful in the identification of 
tetrahydroalstonine synthase (Stavrinides et al., 2015). 
Additionally, an alternative approach in the selection of gene candidates is to utilise homology 
to known genes in other species that have also been implicated in secondary metabolism, 
together with their expression level in leaf tissue, as this is the known site of MIA biosynthesis 
in C. roseus. 
An overview of the gene candidates selected for VIGS, together with their locus number in the 
MGPR transcriptome, the reason for selection and the chapter in which they are discussed in 
this thesis is presented in Table 2. 
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Table 2 VIGS candidates and their reason for selection in thesis.  
Locus number represents the gene number present in the final transcriptomic dataset in the MPGR C. 
roseus transcriptome 
 
 
 
 
 
 
 
 
 
 
Gene class locus 
number 
Gene family Name Chapter Reason for Selection 
Transporter locus_1763 ABC transporter  II Expression level in leaf tissue 
 locus_1443 Purine Permease  II Expression level in leaf tissue and 
homology to purine permeases 
 locus_24210 P-DME transporter  II Co-regulation with MIA pathway 
 locus_2720 MATE protein  III Co-regulation with MIA pathway 
 locus_1952 MATE protein CrMATE_1952 III Co-regulation with MIA pathway 
 locus_10740 MATE protein CrMATE_10740 III Co-regulation with MIA pathway 
 locus_3327 MATE protein  III homology to CrMATE_1952 
 locus_8527 MATE protein  III homology to CrMATE_1952 
 locus_9753 NPF transporter CrNPF2.4 IV Co-regulation with MIA pathway 
and known in vitro activity 
 locus_8319 NPF transporter CrNPF2.6 IV Co-regulation with MIA pathway 
and known in vitro activity 
 locus_9086 NPF transporter CrNPF2.9 IV Co-regulation with MIA pathway 
Enzyme locus_7197 Glutathione s-
transferase 
 II Co-regulation with MIA pathway 
 locus_6502 Glutathione s-
transferase 
 II Homology to locus_7197 
 locus_2878 Glutathione s-
transferase 
 II Homology to locus_7197 
 locus_5608 Reticuline oxidase CrRO V Co-regulation with MIA pathway 
 locus_5372 Reticuline oxidase  V Homology to locus_5608 and 
expression in leaf tissue 
 locus_2174 Reticuline oxidase  V Homology to locus_5608 and 
expression in leaf tissue 
 locus_13163 Progesterone β-
reductase 
CrP5βR2 II Homology to iridoid synthase 
 locus_240 Progesterone β-
reductase 
CrP5βR4 II Homology to iridoid synthase 
 locus_2665 Progesterone β-
reductase 
CrP5βR5 II Iridoid synthase 
Transcription 
factor 
locus_12822 bHLH transcription 
factor 
BIS1 II Co-regulation with MIA pathway 
in vitro activity 
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2.3.2 Reproducibility of the C. roseus alkaloid profile 
 
To assess whether silencing by VIGS of a candidate gene causes a change in the metabolite 
profile, the VIGS-Empty vector (VIGS-EV) control tissue must have a reproducible metabolic 
profile, in which there is minimal variation in alkaloid content between individual plants in a 
given VIGS experiment. The stability of this alkaloid profile has been presented previously in 
(Asada et al., 2013; Besseau et al., 2013; Geu-Flores et al., 2012; Kellner et al., 2015a; Liscombe 
and O’Connor, 2011; Qu et al., 2015; Salim et al., 2014; Salim et al., 2013) 
A representative liquid chromatography-mass spectrometry (LC-MS) total ion chromatogram for 
a methanol extract of the VIGS-EV control is shown in Figure 2-4. For all VIGS experiments 
presented in this thesis, the LC-MS peak areas of the known metabolites secologanin, 
strictosidine, vindoline, catharanthine, and m/z 349 (this contains a mixture of the 
diastereomers of serpentine and alstonine) (Figure 2-3) were calculated, and compared to the 
VIGS samples of the gene of interest to assess the effect gene silencing has on MIA metabolism. 
 For each individual VIGS experiment between 8-15 plants were used for each VIGS pTRV2 
construct under consideration. 
 
 
Figure 2-3 Chemical structures of the compounds analysed by LC-MS in methanolic extracts of C. 
roseus VIGS tissue 
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Figure 2-4 Representative VIGS-EV LC-MS chromatogram.  
A.) Representative total ion chromatogram of VIGS-EV methanol extract B.) Extracted ion chromatogram 
for secologanin (Na+ adduct); m/z 411, strictosidine; m/z 531, serpentine/alstonine; m/z 349, 
catharanthine; m/z 337, vindoline; m/z 457. 
 
 
 
2.3.3 Criteria for assigning a metabolic phenotype resulting from VIGS 
 
As well as changing the levels of the known alkaloids in the MIA pathway, a VIGS phenotype is 
often characterised by the accumulation of new metabolites that do not appear in VIGS-EV 
control tissue (Asada et al., 2013; Besseau et al., 2013; Geu-Flores et al., 2012; Kellner et al., 
2015a; Liscombe and O’Connor, 2011; Qu et al., 2015; Salim et al., 2014; Salim et al., 2013). For 
the identification of new compounds that accumulate in VIGS tissue as a result of silencing, but 
are not present in VIGS-EV tissue, untargeted metabolomics using the peak finding algorithm 
XCMS (Smith et al., 2006) was utilised. This software calculates the peak area for all ions present 
in the total ion chromatogram for each VIGS sample. 
For each individual VIGS sample, XCMS results in the extraction and identification of ~100 peaks. 
The average LC-MS peak area for each identified compound was calculated and compared 
between the VIGS-EV and VIGS-gene of interest samples, utilising a Student’s two sample t-test 
of equal variance to assess whether an identified peak is significantly different between VIGS-
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EV control tissues and VIGS as a result of gene silencing. Three levels of stringency were applied 
in defining whether a new peak has been identified that is a result of silencing the gene of 
interest as opposed to random variation in the C. roseus leaf samples. 
1.) Firstly, the new peak must accumulate a minimum of 3-fold higher in the gene silenced 
samples relative to the VIGS-EV control samples.  
2.) Secondly, the p-value defined by the t-test is corrected for multiple testing by the 
Benjamini-Hochberg method for determining the False Discovery Rate (FDR), and only 
peaks that satisfy the corrected level of significance are assessed to be significant 
(Benjamini and Hochberg, 1995). This is to correct for the rate of false positive results 
that are a statistical artefact of multiple testing of the peaks discovered by XCMS. 
3.) Third, if  VIGS of a gene results in the formation of new peaks that satisfy the two above 
criteria, the whole VIGS experiment is repeated a minimum of 3 separate times utilising 
a targeted method to identify these accumulating compounds. If the compounds 
reproducibly accumulate in these experiments relative to VIGS-EV controls then the 
metabolic phenotype is adjudged to be due to VIGS of the gene of interest. qPCR in these 
samples is subsequently performed to assess the extent of knockdown of the gene of 
interest relative to empty vector controls. 
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2.3.4 VIGS Screening of Candidate Genes 
2.3.4.1 ABC transporters 
 
There are five main families of transporters that function as multidrug resistance pumps, the 
Drug metabolite transporter (DMT) superfamily (Jelesko, 2012),  Resistance/nodulation/division 
(RND) family (Remy and Duque, 2014), ATP-Binding Cassette (ABC) family (Kang et al., 2011), 
Major Facilitator Superfamily (MFS) (Pao et al., 1998), and the Multidrug/Oligosaccharidyl-
lipid/Polysaccharide (MOP) flippase Superfamily (Omote et al., 2006) , in accordance with the 
nomenclature from the transporter classification database (TCB) (Saier et al., 2009). In higher 
plants the DMT superfamily, ABC family, MFS, and MOP flippase superfamily, have all been 
implicated in the movement of secondary metabolites. The gene families for these transporters 
are particularly expanded in planta, for example in A.  thaliana there are approximately 130 ABC 
transporters, 120 MFS and 58 Multidrug and toxic compound extrusion protein (MATE) 
transporters, which is a subfamily of the MOP flippase superfamily (Remy and Duque, 2014). 
ABC transporters are a large class of transport proteins that utilise the direct hydrolysis of ATP 
as an energy source to move solutes across a lipid bilayer (Kang et al., 2011; Rea, 2007). Most 
ABC transporters contain multiple transmembrane domains, which are hydrophobic and form 
the membrane pore and usually consist of 4-6 α-helices, as well as two cytosolic domains. The 
two cytosolic domains are the nucleotide binding domains (NBD), which contain the ATP-binding 
Walker A and B motifs (Kang et al., 2011; Rea, 2007). The NBD’s bind and utilize MgATP, coupling 
the hydrolysis of ATP and release of ADP to the energization of transport. Most classes of ABC 
transporter contain two transmembrane domains and two NBDs, and have a pseudotwofold 
symmetry. These transporters can either be in the form of one contiguous peptide, or expressed 
as two half molecules that subsequently associate as either homo- or hetero- dimers (Kang et 
al., 2011; Rea, 2007). There are eight main families of ABC transporters in plants, named ABC A-
I. The ABC transporter classes A-D have a forward orientation in which the transmembrane 
domain is at the N-terminus, whilst the ABCG class has a reverse orientation with the NBD at the 
N-terminus of the protein. To date, only the full length ABCB (Multidrug resistance/P-
glycoprotein like), ABCC (Multidrug resistance associated protein like) and ABCG (Pleiotropic 
drug resistance protein) families have been implicated in the transport of plant secondary 
metabolites (Figure 2-5) (Kang et al., 2011; Rea, 2007). 
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Figure 2-5 Structure of the ABC transporter families that are involved in transport of secondary 
metabolites in planta. 
The ABCC family and ABCB family are forward orientated ABC transporters, with the ABCC family 
comprising an extra N-terminal domain comprising 5 α-helices. The ABCG family are a reverse 
orientated transporter family. 
 
 
The ABCB (MDR/PGP) family of proteins consist of both full length, as well as half size ABC 
transporters, with a forward orientation (Kang et al., 2011). Most of the full length ABCB 
transporters localise to the plasma membrane, whilst some of the half transporters have been 
localised to other organelles such as the mitochondria. The proteins that have been 
characterised have a diverse substrate repertoire ranging from auxin (Cho and Cho, 2013), to 
their involvement in iron-sulphur cluster assembly (Schaedler et al., 2014). To date, only one 
plant MDR transporter has been implicated in the transport of secondary metabolites, the MDR1 
from Coptis japonica (CjMDR1). Coptis japonica is a medicinal plant that produces the 
benzylisoquinoline alkaloid berberine. The transporter CjMDR1 is localised to the plasma 
membrane in C. japonica cells and when heterologously expressed in Xenopus laevis oocytes, 
results in the import of berberine (Shitan et al., 2003). 
The ABCC (MRP) family of transporters in plants only consist of full length proteins, with no half 
transporters encoded in the family (Kang et al., 2011). They have a forward orientation, however 
unlike the ABCB family, many also contain an additional N-terminal transmembrane domain 
(TMD0) that has 3-5 helices. In terms of subcellular localisation these membrane transporters 
have been shown to reside on both the plasma membrane and the tonoplast, and they are the 
only full length ABC transporters that have been shown to localise to this vacuolar membrane 
(Kang et al., 2011). The localisation to the vacuolar membrane has profound implications for this 
transporter family’s role in detoxification of compounds. Many xenobiotic compounds are 
conjugated to hydrophilic molecules such as glucose, glucuronide or glutathione, and this 
N
N
N
C
C
C
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conjugation has been thought to play an important role in recognition of the substrate for 
transport (Kang et al., 2011). In turn this family of transporters has been directly implicated in 
the transport of glutathione conjugated compounds (GS-X) such as N-ethylmaleimide-GS (NEM-
GS), S-(2,4-dinitrophenyl)-GS, (DNP-GS) as well as the glutathionylated herbicide metolachor-GS 
(Li et al., 1995; Martinoia et al., 1993).  Furthermore this family has the capacity to transport a 
number of chlorophyll catabolite products for detoxification (Lu et al., 1998), folate derivatives 
(Chen et al., 2002) and phytate (inositol hexakisphosphate, InsP6) (Shi et al., 2007). 
As well as in the detoxification of exogenously supplied xenobiotic compounds, the ABCC family 
has been implicated in the transport of endogenous secondary natural products such as 
flavonoids. Although there are multiple mechanisms hypothesised by which flavonoids can be 
sequestered in the vacuole, including through the use of MATE transporters and vesicular 
trafficking (Zhao, 2015), ABC transporters have also been implicated. A transgenic antisense 
construct for the ABCC transporter, ZmMRP3, in maize results in altered anthocyanin 
biosynthesis and reduced pigmentation (Goodman et al., 2004). Additionally the VvABCC1 
transporter in grapevine, Vitis vinifera, has also been shown to be involved in anthocyanin 
vacuolar sequestration. VvABCC1 is localised to the tonoplast membrane, and was shown to 
transport malvidin 3-O-glucoside when overexpressed in yeast vesicles (Francisco et al., 2013). 
Interestingly this is only transported in the presence of glutathione (GSH), and is co-transported 
by VvABCC1. This is an indication that although GSH is needed for transport of the anthocyanin, 
conjugation of the substrate to glutathione is not necessary for co-transport. (Francisco et al., 
2013). 
The final ABC transporter family implicated in secondary metabolite transport in planta are the 
ABCG (PDR) type family, which again are either full or half transporters with a reverse 
orientation (Kang et al., 2011). In Arabidopsis one of the major functions of the ABCG family is 
in the export of lipid precursors for the formation of the cuticular wax (McFarlane et al., 2010), 
however there is growing evidence that these transporters are also involved in the movement 
of secondary metabolites. In Nicotiana tabacum and Nicotiana plumbaginifolia this transporter 
class has been shown to be involved in the export of diterpenes, such as sclaerol (Crouzet et al., 
2013), and, as has been discussed previously, this transporter class also contains the C.  roseus 
transporter CrTPT2 which is involved in the export of catharanthine from the epidermis to the 
cuticle wax (Yu and De Luca, 2013). 
Interestingly the human homologues of the ABCB and ABCC family members, MDR1 and 
MRP1/MRP2 have the capacity to transport the C. roseus bisindole alkaloids vincristine and 
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vinblastine (Loe et al., 1998; Souza et al., 2011). These family members therefore are of potential 
interest in the transport of the MIAs in C. roseus. 
2.3.4.2 ABC transporters in C. roseus 
 
There are in excess of 100 ABC transporters present in C. roseus, however most do not appear 
to co-regulate with the MIA pathway. A member of the ABCC subfamily, locus_1763, was 
selected for silencing based on its expression level in leaf tissue. A ~500 bp fragment of this gene 
was cloned into the pTRV2u vectors for silencing in C. roseus as described in (Geu-Flores et al., 
2012; Liscombe and O’Connor, 2011). 
VIGS of this ABC transporter did not lead to an observable metabolic phenotype, with no 
statistically significant difference in the alkaloid peaks of strictosidine, catharanthine, 
serpentine/alstonine or vindoline. Additionally there was no change in the seco-iridoid 
glycoside, secologanin (Figure 2-6). Therefore, to date, this transporter has not been implicated 
in MIA biosynthesis in C. roseus  
 
Figure 2-6 Metabolite analysis upon silencing of the ABC transporter locus_1763 relative to EV control 
Alkaloid profile for VIGS of CrABC_locus_1763 relative to Empty Vector control tissue in C. roseus cv. 
Sunstorm Apricot, VIGS-CrABC_locus_1763 (n=9), VIGS-EV (n=8) ** p<0.01. All data presented is mean + 
SEM. 
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2.3.4.3 Glutathione S-transferases 
 
Glutathione transferases (GST) are a large group of enzymes that are found all forms of life, 
from bacteria to humans. These enzymes have primarily been characterised as having the 
catalytic ability to detoxify electrophilic xenobiotic compounds through the conjugation with 
the tripeptide glutathione (GSH; gamma-glu-cys-gly) (Figure 2-7) (Dixon et al., 2010). 
 
Figure 2-7 Structure of glutathione 
 
In plants the soluble GST family are a group of dimeric enzymes that have the capacity to form 
either homo- or heterodimers. Each protein in the dimer has a glutathione (GSH) interacting 
domain, which is generally at the N-terminus, as well as a hydrophobic binding pocket in the C-
terminus that is used to bind the substrate (Axarli et al., 2009).  
In plants there are seven main families, dehydroascorbate reductase (DHAR), 
tetrachlorohydroquinone dehalogenase like (TCHQD), GST phi (F), GST tau (U), GST lambda (L), 
GST zeta (Z) and GST theta (T). The GSTF and GSTU classes are large and plant specific (Dixon et 
al., 2010). 
Plant GSTs have been primarily demonstrated to detoxify exogenously applied electrophilic 
herbicides through conjugation with GSH however a definitive physiological role for this large 
protein family has remained elusive (Dixon et al., 2010).  
There are three main roles this plant family has been hypothesised to play in planta: 
Firstly, these enzymes may catalyse the glutathionylation of endogenous metabolites. The 
evidence for this is fairly limited, as not many S-glutathionylated metabolites have been shown 
to accumulate in plant extracts. There is evidence that a number of flavonoid derivatives, such 
as the chalcone isoliquirtigenein and medicarpin are able to be glutathionylated in vitro 
(Cummins et al., 2003). Additionally oxylipin compounds such as oxophytodienoic acid (OPDA) 
are readily S-glutathionylated (Figure 2-8). This was demonstrated by metabolomic analysis of 
plant extracts upon feeding OPDA to plants (Davoine et al., 2006), as well as shown in vitro in 
which the enzymes AtGSTF8 and AtGSTU18 were able to conjugate glutathione to OPDA (Dixon 
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and Edwards, 2009). Additionally GSH conjugates of an unstable protoporphyrinogen as well as 
GSH conjugated fatty acid thioesters have also been detected in planta (Dixon et al., 2008). A 
key difference between the xenobiotic conjugation of GSH and the conjugation of endogenous 
ligands, is that, due to the reaction mechanism of conjugation, the conjugation to the 
endogenous ligand, is likely to be unstable and reversible. One of the limitations of detecting 
endogenous glutathionylated conjugates is therefore the potential for the reversibility of 
conjugation, as well as the fact these compounds can be rapidly degraded and detoxified (Dixon 
et al., 2010) (Figure 2-8). 
 
 
Figure 2-8 Glutathionylation of endogenous compounds and xenobiotics. 
A.) Glutathionylation of the oxylipin OPDA has been demonstrated in planta and is a nucleophilic 
conjugate addition B.) Glutathionylation of atrazine is a substitution reaction releasing HCl. Figure adapted 
from Dixon et al., 2010. 
 
Secondly, as well as the catalytic ability to conjugate reactive species with glutathione some 
families of glutathione S-transferases have evolved novel catalytic function. For example the 
dehydroascorbate reductase (DHAR) class is able to catalyse the conversion of 
dehydroascorbate to ascorbic acid (Dixon et al., 2002) (Figure 2-9). GSTs of the F, U and T classes 
have been shown to reduce hydroperoxide substrates to their respective alcohols with 
concomitant release of GSSG (Dixon and Edwards, 2009). Additionally there are a number of 
examples of this family catalysing cis-trans isomerisation reactions (Fernández-Cañón and 
Peñalva, 1998) (Figure 2-9). 
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Figure 2-9 Non-canonical enzymatic reactions catalysed by GSTs.  
Glutathione S-transferases can catalyse non-canonical reactions such as A.) Reduction of hydroperoxides 
B.) cis-trans isomerisation and C.) conversion of dehydroascorbate to ascorbic acid (Dixon et al., 2010). 
 
Third, it is feasible that the glutathione S-transferases do not play a catalytic role at all in the 
conjugation of either glutathione, or the alternative catalytic capabilities highlighted above. 
Instead their role could be transient, whereby they bind small molecule intermediates, in the 
presence of GSH, and in doing so, act as ligandins. This acts to either protect reactive small 
molecule pathway intermediates by binding, or direct transport of the small molecule to the 
correct subcellular location. 
There have been a number of examples in which Arabidopsis glutathione transferases of the L, 
F and U class have been able to bind to biologically relevant ligands. A ligand fishing approach, 
in which wheat GSTLs were recombinantly expressed in E. coli, affinity- immobilised and 
incubated with plant extracts from Arabidopsis, N. benthamiana and wheat, demonstrated that 
TaGSTL1 selectively bound a number of flavonoids derived from kaempferol and quercetin, such 
as rutin, kaempferol-3-O-rutinoside, and taxifolin (Dixon and Edwards, 2010).  Additionally the 
Arabidopsis GSTF family member AtGSTF2, utilising a similar ligand fishing approach, was shown 
to specifically bind a number of heterocyclic compounds, including norharmane, harmane, 
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indole-3-aldehyde, 1-acetyl-β-carboline and the indole derived phytoalexin, camalexin (Figure 
2-10) (David et al., 2011). To date the physiological relevance of such interactions is not known. 
 
 
Figure 2-10 Compounds binding GSTs ascertained by ligand fishing 
 
In a similar ligandin role, a number of glutathione S-transferases are directly involved in 
flavonoid transport and their sequestration in the vacuole in a variety of plant species. As 
discussed in the previous section, ABCC type transporters have been implicated in flavonoid 
transport, where they are thought to transport either flavonoid-glutathione conjugates, or 
flavonoids together with glutathione as a co-substrate.  
GSTs may bind both the flavonoid and glutathione and act in the delivery of the substrate to the 
transporter. In petunia flowers a mutant allele in anthocyanin biosynthesis that had a decrease 
level of cyanidin 3-O-glucoside but no effect on flavonol accumulation, was identified by 
transposon mutagenesis, An9, and shown to have homology to the glutathione S-transferase 
gene family (Alfenito et al., 1998). Although this protein was shown to have glutathione 
conjugating activity towards the substrate 1-chloro-2,4-dinitrobenzene (CDNB), it was not able 
to efficiently conjugate cyanidin 3-O-glucoside, which would be expected to be its in vivo 
substrate (Alfenito et al., 1998). It is possible therefore that this protein is involved in binding 
and delivery of cyanidin 3-O-glucoside for its import into the vacuole. Similarly in maize, the Bz2 
mutant results in the same metabolic phenotype as An9, with the accumulation of cyanidin 3-
O-glucoside. Bz2 is also a glutathione S-transferase, however in a different structural class to 
An9 (Marrs et al., 1995). The An9 and Bz2 proteins are able to reciprocally complement the 
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phenotypes observed, with overexpression of An9 in bz2 deficient maize, and overexpression of 
Bz2 in an9 deficient petunia, being able to complement the phenotype (Alfenito et al., 1998). 
This demonstrates that these structurally diverse GSTs are likely to be performing the same 
function in anthocyanin transport. Similarly an Arabidopsis mutant, transparent testa 19, tt19, 
also displayed a decrease in anthocyanin pigmentation colouration, and was also shown to be 
involved in proanthocyanidin sequestration to the vacuole (Kitamura et al., 2004). This 
phenotype could be partially complemented by the petunia An9. Additionally in grapevine a GST 
was identified that could complement the maize bz2 mutant (Ageorges et al., 2006) and when 
silenced by RNAi in hairy root resulted in differential compartmentation of anthocyanins. 
To date the precise role by which GSTs function to sequester anthocyanins in the vacuole is still 
unclear, despite the fact that this mechanism is conserved across multiple plant species. There 
is a need for experimental evidence for how its action as a flavonoid carrier protein facilitates 
transport. The two primary hypotheses are that it is involved in either vesicular trafficking or 
providing vacuolar transporters with their co-substrates (Zhao, 2015).  
As has been highlighted, GSTs in planta have been shown to have a range of physiological 
functions, from the detoxification of exogenously supplied herbicides by conjugation with the 
tripeptide glutathione, to flavonoid transport. Often it has been hard to determine the 
mechanistic basis behind the role the glutathione transferase plays in planta. Similarly due to 
the differential roles these enzymes have been shown to display in planta, it has been 
particularly hard to predict the physiological function of orphan GSTs. 
One mechanism by which it is possible to predict function is through transcriptomic profiling, 
and analysis of the coordinated expression of GSTs with known enzymatic activities. A key 
example of this is with TT19 in Arabidopsis, which is transcriptionally co-regulated with genes in 
the anthocyanin biosynthetic pathway (Kitamura et al., 2004). 
This methodology was also elegantly displayed in Sappl et al., 2009 which surveyed the induction 
of GSTs under differential stress conditions, and was able to highlight four GSTs that were 
regulated in accordance with application of salicylic acid. A reverse genetics approach silencing 
all four GSTs resulted in no clear metabolic phenotype, indicating that there might be functional 
redundancy in these GSTs role in vivo (Sappl et al., 2009). This contrasts with the role of the GSTs 
in flavonoid transport, where silencing of one locus results in a clear metabolic phenotype, 
therefore indicating that such functional redundancy may be dependent on the physiological 
role of the GST. 
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2.3.4.4 Glutathione S-transferases in C. roseus. 
 
As highlighted, the diverse nature in which GSTs are involved in plant metabolism, the fact they 
have been shown to interact with indole based substrates in vivo, as well as the fact that they 
have been implicated in the subcellular transport of plant secondary metabolites, makes this an 
interesting category of enzymes to assess their involvement in MIA metabolism in C. roseus. 
Based on the precedence for the GST TT19 to be co-regulated with the anthocyanin biosynthetic 
pathway, GSTs were analysed for co-regulation with genes known in the MIA pathway. 
There are 50 glutathione S-transferases annotated in the C. roseus transcriptome. The most 
abundantly expressed GST in leaf tissue, locus_7197, is also co-ordinately regulated with the 
known genes in the C. roseus transcriptome, as highlighted in Figure 2-11.  
 
Figure 2-11 Co-regulation of locus_7197 GST1 with known genes in the biosynthetic pathway 
Expression profile of locus_7197_GST1 measured as the log2(FPKM) in the 23 different experimental 
conditions highlighted in Table 1. The expression profile of the known co-regulated genes that are 
involved in MIA biosynthesis; secologanin synthase, tryptophan synthase and strictosidine synthase are 
also shown for comparison. 
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2.3.4.5 Virus Induced Gene Silencing of Glutathione S-transferases in C. roseus  
 
The locus_7197 together with two other glutathione S-transferases, locus_6502_GST2 and 
locus_2878_GST3, that, although were not co-ordinately regulated with the MIA pathway, were 
abundantly expressed in leaf tissue, were targeted by VIGS, utilising pTRV2u constructs 
containing ~500 bp of each GST of interest. The silencing experiment was repeated twice in two 
different cultivars of C. roseus, cv. Little Bright Eyes and cv. Sunstorm Apricot (Figure 2-12), to 
assess whether the lack of a phenotype was due to the cultivar used. 
As can be seen in both cultivars, there was no statistically significant difference in the alkaloid 
profile of strictosidine, catharanthine, vindoline or serpentine/alstonine, as well as no significant 
difference in the iridoid terpene precursor secologanin, in either cultivar. Additionally, there was 
no reproducible accumulation of any new peaks when analysed by untargeted metabolomics. 
Therefore there is no definitive evidence that the GSTs analysed are involved in the MIA 
pathway. 
It is possible that the GSTs may have functional redundancy, and therefore to assess whether 
there is a metabolic phenotype there would need to be combinatorial silencing of multiple 
genes. However, this contrasts with the specificity of the role that the GSTs play in flavonoid 
transport.  
These GSTs could be heterologously expressed, and assessed whether they have binding 
capacity to any of the known MIAs, as has been described for a number of Arabidopsis GSTs, 
however the functional relevance of this interaction would still be physiologically unclear. 
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Figure 2-12 Metabolite analysis upon silencing Glutathione S-transferases relative to EV control 
A.) Alkaloid profile for VIGS of GST1_7197, GST2_6502, GST3_2878 relative to Empty Vector control tissue 
in cv. Little Bright Eyes VIGS-GST1_7197(n=11), VIGS-GST2_6502 (n=10), VIGS-GST3_2878 (n=10), VIGS-
EV (n=10) ** p<0.01 B.) Alkaloid profile for VIGS of GST1_7197, GST2_6502, GST3_2878 relative to Empty 
Vector control tissue in cv. Sunstorm Apricot VIGS-GST1_7197(n=8), VIGS-GST2_6502 (n=8), VIGS-
GST3_2878 (n=8), VIGS-EV (n=8) ** p<0.01. All data presented is mean + SEM. 
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2.3.4.6 The Drug/Metabolite Transporter Superfamily 
 
As mentioned there are five main families of proteins that have been shown to be involved in 
multidrug resistance, and this includes a drug/metabolite transporter (DMT) superfamily (Jack 
et al., 2001).  The DMT superfamily is a large ancient family that encompasses 14 subfamilies, 
including the small multidrug resistance (SMR) transporter family, which has previously been 
shown to result in multidrug resistance in bacteria. In plants these subfamilies include the plant 
drug/metabolite exporter (P-DME)- family, the triose phosphate transporter (TPT)-family, the 
nucleotide sugar transporters, which are selective for different nucleotide sugars, and the plant 
purine permease family (PUP) (Jack et al., 2001). 
2.3.4.7 Purine permease family 
 
The purine permease (PUP) family of transporters is a distinct group of transport proteins in the 
DMT superfamily. These transporters typically contain between 9-10 transmembrane helices, 
and are secondary transporters using the electrochemical gradient for energy. 
These plant specific purine transporters have been shown to be involved in the transport of a 
number of alkaloid compounds, including the purine adenine, the purine based phytohromones 
such as the cytokinins (Bürkle et al., 2003; Gillissen et al., 2000) as well as the pyridine alkaloid 
nicotine (Hildreth et al., 2011). 
There are 21 PUP like genes present in the model plant species Arabidopsis, however, to date, 
only 3 PUP-like transporters have been characterised from this species, AtPUP1-3 (Jelesko, 
2012). AtPUP1 was identified as an adenine transporter through functional complementation of 
an Arabidopsis cDNA library into a yeast strain fcy2 that was deficient in adenine and cytosine 
transport. AtPUP1 and AtPUP2 have subsequently been shown to be able to transport the 
cytokinins, trans-zeatin and kinetin, whilst the substrate for AtPUP3 is still unknown (Bürkle et 
al., 2003; Gillissen et al., 2000). Furthermore AtPUP1 has also been shown to be able to transport 
pyridoxine (vitamin B6) (Szydlowski et al., 2013). 
The purine permeases have also been implicated in the transport of secondary metabolites in 
tobacco. The pyridine alkaloid nicotine is a key chemical defense compound of tobacco. The 
biosynthesis of nicotine is upregulated in response to wounding and herbivory, as well as in 
response to the exogenous elicitation of MeJA, and the regulation of this biosynthetic pathway 
is under the coordinate control of two regulatory loci called NIC1 and NIC2 (Hibi et al., 1994). 
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Nicotine is generated exclusively in the root tips, however is localised to other plant tissues, 
including the stem, and leaves. This implicates the need for organ specific transport. Nicotine is 
loaded in the xylem for transport to foliar tissues and, in this leaf tissue nicotine accumulates in 
the vacuoles of mesophyll cells (Morita et al., 2009). The transport of nicotine into the vacuole 
is due to the action of a number of MATE proteins which will be reviewed in Chapter III. 
The purine permease NUP1 has been implicated in nicotine transport in tobacco (Hildreth et al., 
2011). NUP1 shares 56% identity to the Arabidopsis thaliana protein, AtPUP1, and was shown 
to be co-ordinately regulated by the NIC1 and NIC2 loci in N. tabacum, and induced upon 
elicitation with MeJA (Hildreth et al., 2011). Transport of radiolabelled nicotine into 
Schizosaccharamyces pombe was shown for cells heterologously expressing the purine 
permease (NUP1). This appeared to be substrate specific as transport was not efficiently 
competed for with the tropane alkaloids, atropine and scopolamine, the pyridine alkaloids, 
anabasine and anatabine (Hildreth et al., 2011). 
Overexpression of NUP1 as a GFP-fusion in tobacco BY2-cells indicated that this protein localised 
to the plasma membrane, and therefore implicates NUP1 as a nicotine uptake permease 
(Hildreth et al., 2011). Nicotine levels in hairy root cultures of N. tabacum with an NUP-RNAi 
silencing construct resulted in a lower nicotine content in the hairy roots and a comparative 
increase in the nicotine levels in the root culture media. The role of NUP1, as a plasma 
membrane nicotine uptake transporter in roots, that does not influence root to shoot transport, 
suggests it may be involved controlling the capacity of the roots to retain nicotine. This therefore 
implicates this family in controlling the reabsorption of nicotine from the rhizosphere or involved 
in controlling the apoplastic nicotine concentration, which may be involved in maintaining whole 
plant nicotine levels (Hildreth et al., 2011).  
Recently NUP1, has also been shown to have the capacity to transport vitamin B6, as well as 
having substrate preference for the naturally occurring (S)-isomer of nicotine (Kato et al., 2015). 
The role of the purine permeases in the transport of purine and pyridine alkaloids make them 
an intriguing family to decipher their role in other metabolic pathways. 
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2.3.4.8 Purine permeases in C. roseus 
 
In C. roseus there are 30 members of the purine permease superfamily. The putative purine 
permease, CrPUP_1443 does not coregulate with the gene expression profile for known genes 
in the pathway, however is the most highly expressed purine permease present in leaf tissue.  
VIGS of the putative purine permease CrPUP_1443 did not lead to a metabolic change in 
comparison to empty vector controls (Figure 2-13). As can be seen in both replicates, there was 
no statistically significant difference in the alkaloid profile of strictosidine, catharanthine, 
vindoline or m/z 349, as well as no significant difference in the iridoid terpene precursor 
secologanin, in either cultivar. Together with this, there was no reproducible accumulation of 
any new peaks when analysed by untargeted metabolomics. 
 
Figure 2-13 Metabolite Analysis upon silencing CrPUP locus_1443 relative to EV control 
A.) Alkaloid profile for VIGS of CrPUP_1443 relative to Empty Vector control tissue in Little Bright Eyes 
VIGS CrPUP_1443 (n=9) VIGS-EV (n=8) ** p<0.01 B.) Alkaloid profile for VIGS of CrPUP_1443 relative to 
Empty Vector control tissue in Little Bright Eyes VIGS CrPUP_1443 (n=8) VIGS-EV (n=8) ** p<0.01. All data 
presented is mean + SEM. 
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As will be shown in Chapter III this putative purine permease, when expressed as a C-terminal 
GFP fusion in S. cerevisiae localises to the yeast plasma membrane. Therefore even though this 
VIGS experiment does not give a characteristic metabolic phenotype, it would be useful to test 
and screen this yeast strain for uptake of known MIAs to assess whether this protein family has 
substrate specificity for other alkaloids other than the purine based cytokinins, or pyridine based 
alkaloids such as nicotine. To date this reverse genetics approach does not indicate the 
involvement of this transporter in MIA biosynthesis. 
2.3.4.9 The plant drug/metabolite exporter (P-DME) Family 
 
The plant drug/metabolite exporter (P-DME) Family is a subfamily of the DMT superfamily that 
is found exclusively in plants, and is most related to the drug/metabolite exporter (DME) family 
that are found in bacteria (Jack et al., 2001). The majority of proteins in this family contain 10 
transmembrane helices. To date, this protein family has been underrepresented in their 
functional characterisation. In Medicago truncatula a P-DME transporter is thought to be 
involved in nodulation and was designated MtNodulin21 (Gamas et al., 1996), whilst in 
Arabidopsis only one transporter has been thoroughly investigated for its function, WAT1 
(Ranocha et al., 2010). 
WAT1 is a transport protein that is likely to be involved in the transport of auxin. Cellular 
localisation of WAT1 expression demonstrates that this transporter is expressed ubiquitously 
throughout the plant (Ranocha et al., 2010). Overexpression of WAT1 as a C-terminal GFP fusion 
in Arabidopsis and Nicotiana benthamiana demonstrated that WAT1 is localised to the 
tonoplastic membrane (Ranocha et al., 2010). 
Mutant lines carrying a T-DNA insertion in wat1 resulted in a number of physiological 
phenotypes. The mutants had a smaller leaf size, with increased chlorophyll content, shorter 
stems, and irregular organisation of epidermal cells. The wat1 mutant had less lignin, and in 
particular was deficient in S unit lignin present in xylem fibres, together with a decrease in the 
non-cellulosic polysaccharide, xylan, suggesting its involvement in secondary cell wall and fibre 
development (Ranocha et al., 2010). 
Tryptophan metabolism was significantly modified in wat1 mutants, with the free amino acid 
being reduced relative to wild type, together with the accumulation of other indolic compounds 
(Ranocha et al., 2010). This was accompanied by a decrease in the free indole acetic acid (IAA) 
concentration in the basal portion of the stem. This is the first time a tonoplastic membrane 
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protein has been shown to be involved in secondary cell wall formation as well as involved in 
tryptophan and auxin metabolism (Ranocha et al., 2010). 
Isolated vacuoles from wild type and wat1 mutant plants have been fed with 14C-IAA. The wat1 
mutants retained a higher level of 14C-IAA indicating that WAT1 is likely to act as an exporter of 
IAA from the vacuole. Moreover heterologous expression in yeast and Xenopus laevis oocytes 
demonstrated transport of IAA and implicates this transporter as an exporter of auxin from the 
vacuole (Ranocha et al., 2010). 
2.3.4.10  C. roseus WAT1 homologue 
 
In C. roseus a homologue of WAT1 co-regulates with known genes in the metabolic pathway of 
MIA biosynthesis (Figure 2-14). Given that an Arabidopsis WAT1 homologue transports auxin, 
which has an indole moiety much like the MIAs, this candidate appeared to be a good prospect 
for involvement in MIA metabolism.  
 
Figure 2-14 Co-regulation of locus_24210 with known genes in the biosynthetic pathway. 
Expression profile of locus_24210 measured as the log2(FPKM) in the 23 different experimental 
conditions highlighted in Table 1. The expression profile of the known co-regulated genes that are 
involved in MIA biosynthesis; secologanin synthase, tryptophan synthase and strictosidine synthase are 
also shown for comparison 
 
 
VIGS of the WAT1 homologue, locus_24210, which was annotated as an auxin responsive factor 
5NG4, did not result in a metabolic phenotype when targeted by VIGS, in multiple biological 
replicates, suggesting that this transporter is not involved in MIA metabolism in C. roseus (Figure 
2-15). 
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Figure 2-15 Metabolite analysis VIGS locus_24210 relative to EV Control.  
A.) Alkaloid profile for VIGS of WAT1 locus_24210 relative to Empty Vector control tissue in cv. Little Bright 
Eyes VIGS-24210 (n=12) VIGS-EV (n=12) ** p<0.01 B.) Alkaloid profile for VIGS of WAT1 locus_24210 
relative to Empty Vector control tissue in cv. Little Bright Eyes VIGS-24210 (n=16) VIGS-EV (n=14) ** 
p<0.01. All data presented is mean + SEM. 
 
 
 
 
 
 
 
57 
 
2.3.4.11 The role of the transcription factor BIS1 in MIA metabolism 
 
This work was performed in collaboration with Alain Goossens, University of Ghent. VIGS 
constructs were cloned by Alex Van Moerkercke and the VIGS experiment and metabolite 
analysis was performed by Richard Payne. This work has been published in (Van Moerkercke 
et al., 2015) 
As well as the enzymes and transporters that are integrally involved in MIA biosynthesis, a 
reverse genetic approach can be utilised to identify genes that are involved in the regulation of 
the MIA metabolic pathway. VIGS of transcription factors involved in plant secondary 
metabolism has been successfully applied in a number of plant species, including Nicotiana 
attenuata (Woldemariam et al., 2013), Nicotiana benthamiana (Todd et al., 2010) and Capsicum 
eximium (Aguilar-Barragán and Ochoa-Alejo, 2014). 
MIA biosynthesis in C. roseus is induced by the phytohormone jasmonate (JA). This induction is 
controlled by the action of transcription factors, many of which are also inducible themselves by 
JA (De Geyter et al., 2012). The best characterised transcription factor that is known to regulate 
MIA metabolism in C. roseus is ORCA3, which controls expression of the indole branch of the 
MIA pathway (van der Fits and Memelink, 2000). However the iridoid genes upstream of LAMT, 
(Figure 2-16), despite being JA inducible, are not under regulatory control by ORCA3, suggesting 
other transcription factors may be involved in this regulatory network (van der Fits and 
Memelink, 2000).  
 
Figure 2-16 Overview of secologanin biosynthesis.  
Secologanin is a glycosylated iridoid terpene derived from the MEP pathway. It is synthesised by a nine-
step biosynthetic pathway comprising the enzymes G8H-geraniol 8 hydroxylase, 8-HGO- 8-
hydroxygeraniol oxidoreductase, IS-iridoid synthase, IO-iridoid oxidase, 7-DLGT- 7deoxyloganetic acid 
glucosyltransferase, 7-DLH - 7-deoxyloganic acid hydroxylase, LAMT-loganic acid methyltransferase and 
SLS- secologanin synthase. The genes upstream of LAMT are not under transcriptional control of ORCA3. 
58 
 
A basic helix-loop-helix (bHLH) transcription factor from C. roseus, BIS1, was identified that co-
regulates with these early iridoid genes and is induced by JA (Van Moerkercke et al., 2015). The 
bHLH transcription factor family has been implicated in terpene biosynthesis in other plant 
species such as Arabidopsis thaliana (Hong et al., 2012), Artemisia annua (Ji et al., 2014), and 
Solanum lycopersicum (tomato) (Spyropoulou et al., 2014). 
The bHLH transcription factor BIS1, was shown to specifically transactivate the promoters of the 
genes upstream of LAMT in iridoid biosynthesis from C. roseus, namely geraniol synthase, 8-
hydroxygeraniol oxidase, iridoid synthase, 7-deoxyloganetic acid glucosyltransferase, and 7-
deoxyloganic acid hydroxylase, in a Nicotiana tabacum protoplast assay system (Van 
Moerkercke et al., 2015). 
Overexpression of the transcription factor was shown to boost MIA production in C. roseus cell 
suspension cultures, and affect iridoid gene expression when overexpressed in C. roseus hairy 
root lines, however with a lack of effect on MIA production (Van Moerkercke et al., 2015). 
As with the other secoiridoid genes, this transcription factor is preferentially expressed in the 
internal phloem associated parenchyma (IPAP), indicating that this transcription factor localises 
to the same cell type as the early part of the secoiridoid pathway (Van Moerkercke et al., 2015). 
To assess the role of this transcription factor in the whole plant, the bHLH transcription factor, 
BIS1, was silenced by VIGS.  
As highlighted in the Figure 2-17 there was no clear phenotype on the MIAs upon silencing, or 
on the level of secologanin in the leaf tissue. Furthermore there was no accumulation of any 
new peaks when analysed by an untargeted metabolomics approach. 
There are a number of reasons why no major effect on MIA levels was observed by VIGS. It is 
possible that there may be functional redundancy with other transcription factors, and therefore 
despite transactivation of the metabolic pathway in vitro, silencing of this transcription factor 
can be compensated by other genes in the MIA regulatory network. This study therefore 
highlights the need to utilise a reverse genetics approach to determine the physiological 
relevance of a gene of interest in metabolic pathways. 
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Figure 2-17 Metabolite analysis VIGS-BIS1 relative to EV Control 
A.) Alkaloid profile for VIGS of BIS1 relative to Empty Vector control tissue in cv. Little Bright Eyes VIGS-
BIS1 (n=13) VIGS-EV (n=12) ** p<0.01 B.) Alkaloid profile for VIGS of BIS1 relative to Empty Vector control 
tissue in cv. Little Bright Eyes VIGS-BIS1 (n=12) VIGS-EV (n=12) ** p<0.01. All data presented is mean + 
SEM. 
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2.3.4.12 The progesterone 5β-reductase family in C. roseus. 
 
This work was performed in collaboration with Alain Goossens, University of Ghent. VIGS 
constructs were cloned by Alex Van Moerkercke and the VIGS experiment and metabolite 
analysis was performed by Richard Payne. This work has been published in (Munkert et al., 
2015) 
A key early step in the C. roseus MIA pathway is the generation of the seco-iridoid terpene 
moiety secologanin, and, as has been discussed in Chapter I the complete seco-iridoid pathway 
has been recently elucidated (Miettinen et al 2014). 
A key enzyme in the pathway is iridoid synthase, which catalyses the non-canonical cyclisation 
of 8-oxogeranial to cis-trans nepetelactol (Geu-Flores et al., 2012). This enzyme is a member of 
the progesterone 5β-reductases, which are known to catalyse the reduction of the double bond 
of the α,β-unsaturated carbonyl of progesterone (Figure 2-18). 
 
Figure 2-18 Cyclisation of 8-oxogeranial to cis-trans nepetelactol catalysed by iridoid synthase 
A.) Reaction catalysed by iridoid synthase B.) Reaction catalysed by progesterone 5β-reductase 
 
As well as iridoid synthase there are five other homologues of the progesterone 5β-reductase 
family in the C. roseus transcriptome, CrP5βR1-CrP5βR6, with CrP5βR5 being the iridoid 
synthase identified by (Geu-Flores et al., 2012). These five homologues, together with iridoid 
synthase are all localised to the cytosol when overexpressed as N-terminal GFP fusions in 
tobacco BY2 cells (Munkert et al., 2015). 
It has been shown that CrP5βR5 is co-expressed with a number of known genes in the 
biosynthetic pathway, including geraniol synthase, geraniol 8-oxidase, and 8-hydroxygeraniol 
oxidoreductase (Munkert et al., 2015). Similarly CrP5β5R4 also co-expresses with the genes 
involved in MIA biosynthesis, including LAMT, secologanin synthase, strictosidine synthase, and 
strictosidine β-glucosidase. The homologues CrP5βR1, CrP5βR3, CrP5βR6 and CrP5βR2 however 
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are constitutively expressed and do not follow the expression pattern of MIA known genes, and 
are relatively lowly expressed in leaf tissue.  Cellular localisation of CrP5βR4 and CrP5βR5/iridoid 
synthase demonstrate that both localise to the IPAP cells (Munkert et al., 2015).  
Recombinant CrP5βR4, CrP5βR5 and CrP5βR2 could turnover 8-oxogeranial in vitro, to form  cis-
trans nepetelactol, and the steady state kinetic constants were similar for all three enzymes 
(Munkert et al., 2015). This demonstrated that other homologues of the progesterone 5β-
reductase family in C. roseus are capable of catalysing the cyclisation of 8-oxogeranial (Munkert 
et al., 2015). 
It has previously been shown in Geu-Flores et al., 2012 that silencing of CrP5βR5 by VIGS results 
in the net decrease in vindoline and catharanthine, together with the accumulation of three new 
peaks when monitored by LC-MS with m/z values of 526, 528 and 484, which were shown to be 
derivatized products of 8-oxogeranial (Geu-Flores et al., 2012). 
To assess whether CrP5βR4 and CrP5βR2 also contribute to the MIA metabolic pathway, these 
genes were silenced, together with CrP5βR5 as a positive control. VIGS of the two genes CrP5βR4 
and CrP5βR2 did not result in a decrease in vindoline, catharanthine, strictosidine or 
secologanin, and the characteristic iridoid peaks of m/z 526, 528 and 484 did not accumulate 
Figure 2-19. In comparison, the positive control CrP5βR5, although not resulting in a decrease in 
the MIAs as was observed in Geu-Flores et al., 2012, did result in the accumulation of the three 
diagnostic iridoid derived peaks (Figure 2-19). 
This work demonstrates that while CrP5βR4 is able to catalyse the same reaction as CrP5βR5 in 
vitro with similar kinetic efficiency, is co-expressed in the metabolic pathway and localised to 
the same cell type as CrP5βR5, it appears CrP5βR5 is the dominant iridoid synthase enzyme in 
C. roseus MIA biosynthesis for which a metabolic phenotype is observed upon silencing. In the 
presence of CrP5βR5, CrP5βBR4 contributes little to the MIA metabolic pathway. To further 
assess this, combinatorial silencing of these genes by VIGS would be necessary to deduce the 
impact on the metabolic phenotype. This is consistent with the fact that progesterone 5β-
reductases can be promiscuous and therefore in vitro activity and physiological function are not 
necessarily linked (Bauer et al., 2010). 
This result in particular highlights the importance of a reverse genetics approach in determining 
the functional relevance of enzymatic activity in planta.  
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Figure 2-19 Metabolite Analysis upon silencing Progesterone 5β-reductases relative to EV control 
A.) Alkaloid profile for VIGS of the progesterone 5β-reductases family relative to Empty Vector control 
tissue in cv. Little Bright Eyes VIGS-CrP5βR5 (n=10), VIGS-CrP5β4 (n=10), VIGS-CrP5βR2 (n=12),VIGS-EV 
(n=9) ** p<0.01 B.) Iridoid profile for VIGS of the progesterone 5β-reductases family relative to Empty 
Vector control tissue in cv. Little Bright Eyes, measuring m/z 484, m/z 526, m/z 528; VIGS-CrP5βR5 (n=10), 
VIGS-CrP5β4 (n=10), VIGS-CrP5βR2 (n=12), VIGS-EV (n=9) ** p<0.01. All data are mean + SEM C.) 
Representative extracted ion chromatogram for m/z 484, m/z 526 and m/z 528 in VIGS-CrP5βR5, VIGS-
CrP5β4, VIGS-CrP5βR2 and VIGS-EV tissue. 
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2.4 Conclusion 
 
2.4.1 VIGS as a system for gene discovery 
 
Overall this chapter highlights the use of transcriptome mining for the identification of potential 
candidates for screening in C. roseus by VIGS. The principle we have used is the assumption that 
genes within a secondary metabolic pathway are likely to be co-expressed. Utilising multiple 
independent strategies to look at co-regulation we identified a number of candidates with 
expression profiles that cluster with known genes in the MIA pathway. Genes that were 
ultimately disregarded due to a negative metabolic phenotype upon silencing are reported in 
this chapter. Successful candidates will be discussed in Chapters III, IV and V. 
Co-regulation is clearly observed for the early stages in the biosynthesis of MIAs. Co-expression 
analysis has been employed successfully in the identification and characterisation of a number 
of genes in the seco-iridoid pathway (Geu-Flores et al., 2012; Miettinen et al., 2014). After the 
branchpoint intermediate strictosidine, the known genes which are involved in the biosynthesis 
of vindoline do not have a discernible co-expression profile. 
This suggests that although the co-expression transcript mining approach is a good first attempt 
to identify gene candidates that might be involved in the MIA pathway, there are likely to be 
genes that cannot be identified using this approach and alternative strategies are needed. 
This is likely to be true in the identification of enzymes involved in the branches of MIA 
biosynthesis that lead to downstream alkaloids. Alternative approaches to candidate 
identification include genome mining based strategies (Kellner et al., 2015b) whereby genes in 
secondary metabolic pathways may be spatially close on the genome, and this approach has 
been successful in the identification of an alcohol dehydrogenase involved in 
tetrahydroalstonine biosynthesis (Stavrinides et al., 2015).  
Nevertheless this transcriptome mining approach has resulted in the identification of a number 
of genes that will form the basis for this thesis. Additionally the fact we are identifying genes 
that are co-regulated transcriptionally, indicates that the genes we have identified are likely to 
be involved in the early stages of MIA biosynthesis. 
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2.4.2 VIGS screening in C. roseus 
 
In this chapter, we assessed the metabolic phenotypes after targeting a number of candidate 
genes, which have either been shown to co-regulate with known genes in the MIA pathway, are 
highly expressed in C. roseus leaf tissue (the site of alkaloid biosynthesis), have homology to 
genes involved in the MIA pathway, or have been implicated in MIA metabolism due to in vitro 
assays. 
Silencing of the ABC transporter CrABC_1763, three glutathione S-transferases, two DMT family 
proteins, the transcription factor BIS1 and the progesterone 5β-reductases, CrP5βR4 and 
CrP5βR2, did not result in the identification of a gene that results in a discernible metabolic 
phenotype in C. roseus  
There are a number of reasons as to why we do not see a metabolic phenotype. 
Firstly the gene may not be involved in the MIA metabolic pathway, and therefore silencing of 
this gene does not lead to a metabolic phenotype. 
Secondly it is possible that there is inefficient silencing using the vectors we have designed. As 
has been described in Chapter I, a region of the gene of interest is cloned into the pTRV2 vector, 
and this acts as a template for the formation of dsRNA and subsequently siRNA that can target 
the endogenous mRNA of the gene for degradation and therefore silencing. It is possible that 
the region selected for of the gene of interest does not lead to the formation of efficient siRNAs.  
To compensate for this it would be necessary to redesign the region used for silencing and 
repeat the silencing experiments with a new vector to assess whether an alternative metabolic 
phenotype is generated. In this study, for each gene, a ~500 bp fragment has been used to 
generate the vector for silencing. This is a fairly extensive region for each gene of interest and 
increases the chance for the generation of potential silencing dsRNAs in the VIGS tissue as the 
500 bp region is cleaved into 21-24 bp fragments. Additionally this 500 bp region in our study 
was from the centre of the coding sequence and did not contain any homopolymeric sequences. 
This conforms to the observation that for silencing of genes using the pTRV vectors in N. 
benthamiana efficient silencing has been observed with insert lengths in the region of ~200 bp 
to ~1300 bp, with most efficient silencing using regions from the centre of the coding sequence 
and without any homopolymeric sequences (Liu and Page, 2008). 
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A third reason for the negative VIGS phenotype may be due to functional redundancy of the 
gene of interest. If multiple genes can perform the same reaction in the plant, then silencing one 
of the genes might be compensated by the action of others. 
For the transcription factor candidate BIS1, which was shown to transactivate the iridoid gene 
promoters in vitro, and induce MIA production when overexpressed in C. roseus cell suspension 
cultures, silencing of the gene by VIGS does not lead to a metabolic phenotype. Despite this in 
vitro demonstration that this transcription factor is likely to be involved in MIA biosynthesis, the 
regulatory network of MIA metabolism in C. roseus may be more complex than initially assumed, 
and the physiological role of BIS1 could be compensated for by another transcription factor. 
Furthermore despite the fact that the progesterone 5β-reductases CrP5βR4 and CrP5βR2 have 
the catalytic capacity to cyclise 8-oxogeranial, and have similar kinetic constants to the 
characterised iridoid synthase, CrP5βR5, the VIGS screen demonstrates that only the silencing 
of CrP5βR5 results in a physiologically relevant metabolic phenotype. This demonstrates that it 
is necessary to utilise reverse genetics approaches in order to determine the physiological 
relevance of enzymatic activity in planta. 
This work therefore highlights that it is necessary to assess the relationship of the gene of 
interest to other genes in the plant, and determine whether there are any homologues that 
could compensate for enzymatic activity. 
It has been shown that the VIGS silencing approach can be used for the simultaneous silencing 
of multiple genes in planta by cloning multiple gene regions into the pTRV2 vector. This has been 
utilised for the redundant metabolic pathways involved in starch biosynthesis in N. benthamiana 
(George et al., 2012). Therefore for genes where there is the potential for genetic redundancy 
in C. roseus, the combinatorial silencing of the genes may be necessary to induce a metabolic 
phenotype. This approach will be highlighted in Chapters III, IV and V. 
To definitively assess whether the lack of a metabolic phenotype is due to functional redundancy 
or inefficient silencing, qPCR of the gene of interest is necessary between VIGS-EV and VIGS-
gene silenced plants, to validate that the silencing has failed. In this study we have utilised VIGS 
to efficiently screen for metabolic phenotypes, with genes that result in negative metabolic 
phenotype not being optimised further. If further evidence implicates these genes involvement 
in MIA metabolism, then qPCR of the VIGS tissue, and the generation of alternative VIGS vectors 
targeting a different region of the cDNA could be generated. 
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This work documents a number of the pitfalls of using VIGS and other reverse genetic 
engineering strategies for gene discovery. If a positive phenotype is observed then this is 
indicative that the gene is likely to be involved in the pathway. However a negative phenotype 
does not necessarily indicate that the gene is not involved in the pathway, as it is possible that 
there could be extentuating circumstances such as genetic compensation that could preclude 
an observable phenotype.  
Ideally VIGS should be utilised as a methodology in tandem with combinatorial gene silencing, 
as well as functional characterisation of the genes of interest, to definitively assess involvement 
in the metabolic pathway. To date the work presented in this chapter indicates that the genes 
silenced do not have a role in MIA metabolism in C. roseus. If other data supports involvement 
of these genes, such as through a functional screen, then these candidates could be revisited 
using a VIGS approach that utilises a different region of the gene for silencing, or a method for 
combinatorial silencing.  
Despite the negative phenotypes addressed in this chapter, VIGS screening has allowed for the 
relatively fast assessment of whether there is evidence for these genes to be physiologically 
involved in MIA metabolism by reverse genetics. This would not be feasible in the same 
timeframe as other approaches. As will be highlighted in Chapters III, IV and V, this 
transcriptomic mining and VIGS screening approach, has resulted in a number of positive 
phenotypes that indicate involvement in MIA metabolism in C. roseus. 
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3 Characterisation of C. roseus MATE proteins 
 
3.1 Introduction to MATEs 
 
The MATE family of transporters is the most recently characterised family of multidrug 
resistance transporters, and is a subfamily of the MOP flippase superfamily in accordance with 
the transporter classification database (Brown et al., 1999; Jack et al., 2001). The first MATE was 
identified in Vibrio parahaemolyticus NorM, along with its homologue YdhE in E. coli (Morita et 
al., 1998). These proteins possess 12 transmembrane helices, and utilise the electrochemical 
gradient of H+ or Na+ across the cellular membrane for transport, properties that are also found 
in the Major Facilitator Superfamily (MFS), though MATES do not possess sequence identity with 
the MFS transporter family (Brown et al., 1999). These proteins are therefore secondary 
transporters utilising the energy of the electrochemical gradient across the lipid bilayer, as 
opposed to direct hydrolysis of ATP as with the ABC transporter family. In bacteria and yeast 
MATE transporters have been shown to confer multidrug resistance to a variety of cationic drugs 
including ethidium bromide, tetraphenylphosphonium, berberine, acriflavine, norfloxacin and 
ethionine (Omote et al., 2006). 
Two MATE proteins, SLC47A1 and SLC47A2, have been identified in the human genome. 
SLC47A1 is highly expressed in the kidney and liver, as well as in the first trimester placenta, 
whilst SLC47A2 is preferentially localised to the kidney. In the excretory organs, liver and kidney, 
the MATEs act in concert with organic cation transporters, for the transcellular movement of a 
diverse variety of substrates, including drugs, toxins, and a number of physiological compounds 
such as creatinine and thiamine (Motohashi and Inui, 2013; Staud et al., 2013). SLC47A1 
knockout mice are viable and fertile without major genetic abnormalities. To date the major role 
of these proteins in humans is thought to be in excretion and detoxification, where they act in 
concert with other transporter families (Motohashi and Inui, 2013; Staud et al., 2013). 
3.1.1 MATE transporters in plants: roles in growth and development 
 
In plants the MATE family of transporters is large, with approximately 58 family members 
identified in Arabidopsis (Remy and Duque, 2014). This class of transporter has been shown to 
have direct involvement in a number of transport processes in planta, with primary roles so far 
elucidated in heavy metal detoxification (Green and Rogers, 2004), disease resistance (Nawrath 
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et al., 2002), responses to environmental stress (Zhang et al., 2014), growth and development 
(Li et al., 2014), as well as secondary metabolite transport (Morita et al., 2009). 
Salicylic acid is a hormone synthesised by plants after exposure to pathogens, or stress, such as 
UV-light and leads to the expression of a number of pathogenesis related proteins. In 
Arabidopsis, eds5 is a mutant that is hypersusceptible to pathogens and accumulates very little 
salicylic acid upon inoculation with virulent or avirulent pathogens, and after abiotic stress. eds5 
exhibits low level expression of pathogenesis related proteins and is therefore unable to 
establish a defense response. EDS5 was cloned and could complement eds5 mutants when 
expressed in Arabidopsis, and was shown to be a MATE transporter based on sequence 
homology (Nawrath et al., 2002). The transcript of EDS5 was inducible by environmental stress, 
application of an avirulent strain of P. syringae, as well as upon exogenous treatment of salicylic 
acid (Nawrath et al., 2002).   A C-terminal GFP fusion of this protein expressed in Arabidopsis, 
showed that the protein was localised to the chloroplast envelope, and this was confirmed by 
immunoblotting of the chloroplast envelope membranes with anti-GFP antibody (Serrano et al., 
2013; Yamasaki et al., 2013).  Transport assays of radiolabelled 14C-salicylic acid, using 
chloroplasts isolated from both eds5 mutant and EDS5 overexpressing Arabidopsis lines, 
together with transport assays in yeast suggest this transporter can bidirectionally transport 
salicylic acid. This is further supported by a genetic study in which an ethanol inducible, 
chloroplastic salicylic acid synthase is expressed in chloroplasts of eds5 mutants and EDS5 
overexpressing plants. Upon ethanol induction eds5 mutant chloroplasts contained a higher 
level of salicylic acid, indicating EDS5 is required for salicylic acid export from the chloroplast 
(Serrano et al., 2013). A homologue of EDS5, EDS5H, has been shown to also localise to the 
chloroplast envelope, but does not appear to function in salicylic acid biosynthesis 
(Parinthawong et al., 2015) and its physiological function remains cryptic. 
In contrast to EDS5, ADS1, another Arabidopsis MATE protein, that has low homology to EDS5, 
has been shown to be a negative regulator of plant disease. Over expression of this MATE in 
Arabidopsis results in susceptibility to P. syringae, whilst expression of an RNAi construct leads 
to the same susceptibility as wild type plants. ADS1 is also likely to be involved in salicylic acid 
biosynthesis, as ADS1 overexpressing plants have a lower SA content, however the specific 
transporter substrate has not been determined (Sun et al., 2011). 
Overexpression of two rice MATEs, OsMATE1 and OsMATE2 in Arabidopsis have been 
implicated in pathogen susceptibility, together with altered floral morphology and sensitivity 
to arsenic, demonstrating that MATEs can have pleiotropic effects on plant physiology (Tiwari 
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et al., 2014). Again, the specific substrates for the transporters have not been identified, 
highlighting that deconvolution of the molecular function of transporters identfied by in planta 
assays is not always straightforward. 
The role of MATE transporters in hormonal transport is not limited to salicylic acid. Abscisic acid 
(ABA) has been hypothesised to be transported in A. thaliana by a MATE transporter annotated 
as AtDTX50. Abscisic acid plays a variety of roles in plant growth and development, however is 
fundamental in response to environmental stress conditions. Under drought conditions an 
increase in the ABA level results in stomatal closure and an upregulation of stress genes 
(Hetherington and Woodward, 2003; Tuteja, 2007). A T-DNA insertion mutant in the gene of 
AtDTX50 resulted in plants significantly smaller and yellow compared to wild type. In this 
insertion mutant no AtDTX50 mRNA was detectable, and the phenotype was complemented by 
overexpression of AtDTX50 (Zhang et al., 2014).  The dtx50 mutant lines displayed growth 
inhibition when grown on ABA containing medium, together with bleached leaves and root 
defects, and germinated more slowly than wild type seeds in the presence and absence of ABA. 
dtx50 mutants grown in soil contained higher levels of ABA, and this was accompanied by up 
regulation of ABA marker genes in the mutant when analysed by qPCR. AtDTX50 localised to the 
plasma membrane, as determined by overexpression of a AtDTX50-GFP fusion protein in 
Arabidopsis mesophyll protoplasts, as well as in onion epidermal cells (Zhang et al., 2014). The 
fact that the dtx50 mutant plants accumulated ABA and that the protein localised to the plasma 
membrane is indicative that AtDTX50 is likely to be an ABA efflux transporter from the cell. This 
was confirmed by transport assays in three different systems including E. coli, Xenopus laevis 
oocytes and Arabidopsis (Zhang et al., 2014).  
Additionally, a MATE protein ADP1 has been implicated in regulating local auxin biosynthesis in 
Arabidopsis. A dominant Arabidopsis mutant adp1-D resulted in an increase in the number of 
axillary branches, flowers and lateral roots, and is the result of a gain of function mutation that 
overexpresses ADP1 (Li et al., 2014). Transgenic over expression of ADP1 in Arabidopsis resulted 
in these same pleiotropic phenotypes.  This protein is specifically expressed in the shoot apical 
meristem, and associated with endo-membrane organelles. This mutant is associated with a 
decrease in auxin levels in the plant (Li et al., 2014). 
Furthermore MATE transporters have also been implicated in plant development in Arabidopsis.  
In a screen for abnormal shoot mutants (abs), two mutants resulted in loss of apical dominance, 
and demonstrated early flowering, termed abs3-1 D and abs4-1D, and these mutants were both 
shown to have increased expression of two MATE transporters, ABS3 and ABS4. Overexpression 
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of ABS3 and ABS4 together with two other homologues ABS3L1 and ABS3L2, recapitulated this 
phenotype (Wang et al., 2015).  Overexpression of ABS3 and ABS4 also resulted in a decrease in 
the length of the hypocotyls by affecting cell elongation. In comparison a quadruple loss of 
function mutant of ABS3, ABS4, ABS3L1 and ABS3L2 resulted in longer hypocotyls relative to wild 
type controls (Wang et al., 2015). 
Similarly the Arabidopsis ZRZ gene is a MATE protein that localises to the mitochondria, whose 
overexpression results in growth of axillary buds, the production of leaves much faster than wild 
type plants, and is involved in specifying lateral organ initiation rate (Burko et al., 2011). 
As well as the MATEs involvement in hormone transport, that subsequently impacts growth, and 
plant responses to environmental stress, the MATE protein family has also been implicated in 
multidrug transport and heavy metal detoxification. 
An Arabidopsis cDNA library was screened for multidrug resistance in an E. coli mutant strain 
KAM3 (Li et al., 2002). This mutant strain lacks endogenous multidrug efflux carriers, and will 
not grow on the common antibiotic norfloxacin. Arabidopsis cDNA clones that allow KAM3 to 
grow in the presence of norfloxacin were selected and sequenced, and this screening 
methodology identified a MATE transporter annotated as AtDTX1. AtDTX1 is able to efflux 
norfloxacin out of KAM3 cell relative to wild type controls, and norfloxacin accumulates at lower 
levels in AtDTX1 expressing KAM3 cells. Consistent with the MATE mechanism of action, this 
efflux was dependent on the plasma membrane proton gradient across the E. coli plasma 
membrane, as addition of CCCP, a proton gradient decoupler, abolishes norfloxacin efflux (Li et 
al., 2002). Moreover the efflux activity was dependent on the external pH of the medium. Other 
ions, such as sodium, do not affect transport, suggesting this protein is dependent on the proton 
gradient and not other cations. AtDTX1 has a wide substrate range, including ethidium bromide 
as well as the plant alkaloids berberine and palmitine. This strain also displays enhanced 
tolerance to heavy metal ions such as cadmium. Expression of AtDTX1 as a GFP fusion in planta, 
localised the transporter to the plasma membrane, implicating a role in cellular export as a 
means for multidrug efflux in plant cells (Li et al., 2002). 
The MATE protein ALF5 has also been implicated in the multidrug resistance of plants to 
environmental toxins (Diener et al., 2001). Loss of function mutants in alf5 in Arabidopsis 
resulted in aberrant lateral root formation and were hypersensitive to treatment with 
polyvinylpyrrolidone and pyrrolidinone, whilst expression of ALF5 in yeast resulted in resistance 
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to the toxic cation tetramethylammonium. ALF5 localised to the root epidermis, and is therefore 
likely to act as an efflux pump involved in detoxification (Li et al., 2002).  
A key mechanism that has been identified for heavy metal detoxification in soils is through the 
secretion of organic acids such as malate, oxalate and citrate.  These organic acids are able to 
complex heavy metals to form non-toxic complexes, thereby detoxifying acidic soils where heavy 
metals become solubilised. As well as this, the release of organic acids into the vascular tissues 
allows for chelation of heavy metals such as iron which is necessary for their correct distribution 
in the plant (Green and Rogers, 2004). 
In Arabidopsis, ferric reductase defective 3 (frd3) mutants display signs of chlorosis, accumulate 
iron and other heavy metals in their roots, and have a different distribution of iron in plant 
tissues relative to wild type controls. The FRD3 protein is a MATE transporter that localises to 
the pericycle of root cells (Green and Rogers, 2004), and exudes citrate into the plant 
vasculature. Citrate chelates 99.5% of iron in the xylem, and this chelation is integral for correct 
localisation of iron and its translocation in the plant. frd3 mutant plants contain less citrate in 
the xylem, than wild type plants, and the chlorotic and growth phenotype of frd3 mutants can 
be compensated by exogenous supply of citrate (Durrett et al., 2007). Transport of citrate in 
vitro by FRD3 was demonstrated utilising Xenopus laevis oocytes. Due to the orientation of the 
transporter in the Xenopus plasma membrane and the fact FRD3 is an exporter from the cytosol, 
14C-citrate was injected into the oocyte, and FRD3 expressing oocytes were shown to have a 
greater rate of citrate efflux than non-injected controls (Durrett et al., 2007).  The closest 
homologue of AtFRD3 in the Arabidopsis genome is AtFRDL1, and is involved in citrate efflux 
from the root, into the rhizosphere, which is required for aluminium tolerance (Liu et al., 2009). 
An Arabidopsis MATE transporter, BCD1 that is localised to the Golgi apparatus has also been 
implicated in iron homeostasis during stress (Pil et al., 2012). 
In barley, a MATE transporter (HvAACT1), with homology to AtFRD3, was positionally cloned and 
associated with a QTL that conferred aluminium tolerance to barley (Furukawa et al., 2007). This 
transporter was able to transport citrate in vitro in Xenopus laevis oocytes, and preferentially 
expressed in the root epidermal cells, at the plasma membrane. Unlike AtFRD3, which secretes 
citrate into the xylem, HvAACT1, like AtFRDL1, secretes citrate into the rhizosphere which 
increases tolerance to Al3+ in acidic soils (Furukawa et al., 2007). Overexpression of HvAACT1 
increased citrate efflux and aluminium tolerace in both wheat and barley (Zhou et al., 2013). 
Similarly in Sorghum bicolor a major aluminium tolerance locus, AltSB, was cloned and shown to 
be a MATE protein, SbMATE, that localised to the plasma membrane and can transport citrate 
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in Xenopus laevis oocytes. This MATE is therefore thought to confer aluminium tolerance by a 
similar mechanism to HvAACT1(Magalhaes et al., 2007). Furthermore, overexpression of 
SbMATE, as well as FRD3, conferred aluminium tolerance in barley (Zhou et al., 2014). The 
homologues of AtFRD3, SbMATE and HvAACT1, have been cloned from maize (Maron et al., 
2010), rice (Yokosho et al., 2010; Yokosho et al., 2009), rice bean (Yang et al., 2011) and 
Eucalyptus (Sawaki et al., 2013) and shown to either confer tolerance to aluminium, or play a 
role in the translocation of heavy metals in the xylem. 
Interestingly, a citrate transporter that is a homologue of AtFRD3, is utilised specifically in 
symbiotic nitrogen fixation within legume root nodules (Takanashi et al., 2013). LjMATE, which 
is only expressed in nodules, is capable of transporting citrate in Xenopus laevis oocytes, and 
RNAi lines of this transporter resulted in defective legume nodules, with an altered iron 
localisation. Inductively coupled plasma mass spectrometry (ICP-MS) demonstrated that the 
iron content of the ljmate mutant was significantly lower than wild type root nodules. This 
suggests that LjMATE is integral for correct localisation of iron during the process of nodulation 
(Takanashi et al., 2013). 
3.1.2 Role of MATEs in transport of secondary metabolites 
 
Secondary metabolism is spatially separated in many plant species, and there is an increasing 
appreciation of the role transporters play in biosynthesis of these compounds. MATE proteins 
in particular have been implicated in the biosynthesis of flavonoids and alkaloids. 
3.1.2.1 Flavonoid transport 
 
Flavonoids are a diverse family of aromatic secondary metabolites that include the 
anthocyanins, flavanols and proanthocyanidins (Ferreyra et al., 2012; Winkel-Shirley, 2001). 
Proanthocyanidins accumulate exclusively in the endothelium of the seed coat, and although 
they are colourless, upon oxidation they turn brown, which gives the testa its characteristic 
colour upon maturity. Mutants of Arabidopsis that display an altered colouration of the testa, 
termed transparent testa mutants, have been isolated and are altered in enzymes involved in 
flavonoid biosynthesis or in the regulation of flavonoid metabolism (Appelhagen et al., 2014).  A 
mutant, transparent testa 12 (tt12), was identified in a gene that encodes for a member of the 
MATE family of secondary metabolite transporters (Debeaujon et al., 2001).  The tt12 seeds 
displayed reduced seed dormancy, and the phenolic compounds normally present in the 
endothelium layer were not detected. A time course of proanthocyanidin accumulation in planta 
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demonstrated a decrease in pigmentation and a diffuse pattern of localisation in the tt12 
mutants with respect to control plants. The gene conferring the tt12 phenotype was cloned by 
T-DNA tagging, and the resulting full length gene cloned was able to complement the tt12 
mutation, and shown to encode a protein with sequence identity to known MATE transporters. 
In situ hybridization, as well as fusing the promoter of TT12 to a GUS reporter, demonstrated 
that this gene is expressed in the endothelium layer of the seed coat (Debeaujon et al., 2001) 
and that TT12 is expressed specifically in proanthocyanidin producing cells (Marinova et al., 
2007). TT12 is likely, therefore, to be a vacuolar transporter for proanthocyanidin precursors 
such as catechin and leucocyanidins (Debeaujon et al., 2001). 
Targeted LC-MS of tt12 mutant and wild type seeds demonstrated that neither the precursor 
epicatechin, nor proanthocyanidin polymers, were detected in tt12 seeds. Additionally, 
glycosylated quercetin and kaempferol derivatives were reduced in tt12 seeds (Marinova et al., 
2007) further suggesting that TT12 is implicated in flavonoid metabolism.  Overexpression of 
both an N-terminal and C-terminal GFP fusion of TT12, together with a tonoplastic marker 
protein TPK1 fused to DsRed2, in onion epidermal cells, resulted in co-localisation, implicating 
TT12 as a tonoplastic protein, and therefore likely to be involved in the movement of flavonoids 
into the vacuole (Marinova et al., 2007). 
Overexpression of the MATE TT12 in S. cerevisiae as a GFP-fusion resulted in its localisation to 
both the vacuolar and other endomembranes. Transport across the yeast membrane vesicles 
was performed with the flavonoid glycoside cyanidin-3-O-glucoside, which was uptaken in a 
time dependent manner relative to empty vector controls. No uptake of the aglycone cyanidin 
was observed, suggesting that the transport by TT12 may be dependent upon glycosylation of 
the core flavonoid backbone (Marinova et al., 2007). It was subsequently shown that this 
Arabidopsis TT12 protein is also able to transport epicatechin 3-O-glycoside, more efficiently 
than cyanidin 3-O-glycoside (Zhao and Dixon, 2009). Transport of the flavonoids epicatechin, 
catechin and catechin 3-O-glycoside was not observed, highlighting the substrate specificity of 
this transporter (Zhao and Dixon, 2009). 
The transport of cyanidin 3-O-glucoside by TT12 into yeast vesicles was dependent on the proton 
gradient, as uptake was inhibited by NH4+Cl-, which is used to disrupt the pH gradient across the 
membrane, as well as inhibited by bafilomycin A1, an inhibitor of the vacuolar H+-ATPase 
(Marinova et al., 2007). 
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A functional orthologue of Arabidopsis TT12 has also been identified in Medicago truncatula 
(Zhao and Dixon, 2009).  In M. truncatula, a glycosyltransferase has been shown to specifically 
glycosylate epicatechin, forming epicatechin 3-O-glycoside, which is likely to be a good 
candidate for vacuolar transport in proanthocyanidin biosynthesis in the seed coat. Expression 
of a transcription factor from Arabidopsis TT2, lead to upregulation of epicatechin 3-O-glycoside 
production in Medicago hairy roots when ectopically expressed and upregulation of a 
transporter in vacuoles that promotes epicatechin 3-O-glycoside transport (Zhao and Dixon, 
2009). 
This Medicago MATE transporter, homologous to Arabidopsis TT12, was named MATE1, and was 
shown to be up regulated by the transcription factor TT2. Notably, its localised expression in 
flowers, young pods and the seed coat paralleled other Medicago proanthocyanidin biosynthetic 
genes, suggesting a role in anthocyanin metabolism. MATE1-GFP fusions demonstrated 
localisation to the tonoplastic membrane in planta, as well as potential pre-vacuolar vesicle 
structures in tobacco epidermal cells, which is consistent with the localisation properties of 
Arabidopsis TT12 protein (Zhao and Dixon, 2009). Overexpression of the MATE1-GFP in yeast 
demonstrated its localisation to internal vesicles, and uptake assays using the microsomal 
fraction of the yeast cells demonstrated the proton gradient dependent transport of both 
epicatechin 3-O-glycoside and cyanidin 3-O-glycoside (Zhao and Dixon, 2009). Much like the tt12 
mutant in Arabidopsis, mutation of MATE1 in Medicago resulted in a decrease in 
proanthocyanidin accumulation in the endothelial layer (Zhao and Dixon, 2009). The MATE1 
from Medicago was also able to complement the tt12 mutation in Arabidopsis, and resulted in 
restored seed coat colouration in the endothelial layer (Zhao and Dixon, 2009). Conserved TT12 
proteins in other species, such as Brassica napus, Brassica oleracea, and Brassica rapa have also 
been shown to contribute to quantitative traits in yellow seed coats (Chai et al., 2009).  
As well as in the transport of flavonoids involved in proanthocyanidin deposition in the seed 
coat, MATE transporters have also been shown to be involved in the transport of other flavonoid 
moieties. 
In grapevine (Vitis vinifera) two MATE transporters annotated as anthoMATE1 and 3 (AM1 and 
AM3) were highlighted as potential anthocyanin transporters (Gomez et al., 2009). Ectopic 
expression of C-terminal GFP fusions of AM1 and AM3 in Vitis vinifera hairy roots, and onion 
epidermal cells, demonstrated that these transporters localise to the tonoplast membrane, and 
co-localise with a known tonoplast protein from Arabidopsis, TPK1 (Gomez et al., 2009). 
Expression of AM3 correlated with acylated anthocyanin biosynthesis and was localised to the 
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berry skin. Expression of AM1 and AM3 in S. cerevisiae and transport assays across yeast 
microsomal membranes demonstrated that these transporters were not able to transport 
cyanidin 3-O-glycoside or malvidin 3-O-glycoside, however were able to transport the acylated 
variants, such as malvidin 3-p-coumaroyl-glucoside, indicating acylation is integral for substrate 
recognition (Gomez et al., 2009). Again, like TT12 and MATE1 from Arabidopsis and Medicago 
respectively, AM1 and AM3 were shown to utilise proton driven transport. The physiological 
role of AM1 and AM3 through knock down of the gene is yet to be demonstrated. 
Similarly a second MATE from Medicago named MATE2, which shows closer homology to AM1 
and AM3 than to TT12, was shown to be involved in the transport of malonylated and acylated 
anthocyanins (Zhao et al., 2011). When expressed in S. cerevisiae, MATE2 demonstrated 
substrate preference for a wider variety of flavonoid glucosides than MATE1, and in particular 
showed substrate preference for malonylated versus non-manolyated flavonoid glucosides, and 
transported these substrates in a proton gradient dependent fashion (Zhao et al., 2011). In situ 
hybridization and qPCR demonstrated that MATE2 expression localised to floral and leaf tissues, 
and in particular, in the mesophyll of young leaves. Again, this transporter localised to the 
tonoplast when expressed as a C-terminal GFP fusion in Arabidopsis. Tnt1 retrotransposon 
insertion mutants in Medicago for MATE2, which were used to abolish MATE2 expression 
resulted in a decrease in anthocyanin and flavonoid glycoside content in both leaves and flowers 
relative to wild type controls (Zhao et al., 2011). Proanthocyanidin biosynthesis was also 
affected in the seed coat of mate2 mutants, with a higher epicatechin 3-O-glycoside content 
relative to wild type controls. This implicates that blocking the transport of anthocyanins into 
the vacuole may lead to accumulation of epicatechin 3-O-glycoside due to feedback in the 
phenylpropanoid pathway (Zhao et al., 2011). 
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Figure 3-1 Substrate preferences for known MATE proteins involved in flavonoid transport 
AtTT12 from Arabidopsis and MtMATE1 from Medicago preferentially transport the glycosylated 
intermediates epicatechin 3-O-glycoside and cyanidin 3-O-glycoside. In comparison the MtMATE2 from 
Medicago and AM1 and AM3 from Grapevine primarily transport malonylated and acylated derivatives 
such as malonylated cyanidin 3-O-glycoside and malvidin 3-O-p-coumaroyl-glucoside. 
 
 
There have been numerous reports of MATEs being potentially involved in flavonoid transport, 
in other species such as in blueberry and tomato fruit, due to co-regulation of MATEs with known 
flavonoid pathway genes, a correlation between MATE expression and anthocyanin 
accumulation, or upregulation of MATEs by transcription factors known to induce flavonoid 
biosynthesis. However in vitro and in vivo evidence to rigorously establish the function of these 
MATE proteins is still required (Chen et al., 2015; Di Matteo et al., 2013; Mathews et al., 2003). 
3.1.2.2 Alkaloid and nicotine transport 
 
As well as the plasma membrane localised transporter NUP1 that is involved in nicotine import 
at the plasma membrane (Jelesko et al 2012), there are four tonoplastically localised MATE 
proteins, NtMATE1, NtMATE2, NtJAT1 and NtJAT2 that have been implicated in nicotine 
transport (Morita et al., 2009; Shitan et al., 2014; Shoji et al., 2009). The MATE protein NtJAT1 
(Nicotiana tabacum jasmonate inducible alkaloid transporter) is co-regulated with a number of 
genes in the nicotine biosynthetic pathway, including arginine decarboxylase, ornithine 
decarboxylase, aspartate oxidase, and quinolinate phosphoribosyltransferase, and is induced by 
MeJA (Morita et al., 2009). This transporter is also expressed in a number of different plant 
tissues including leaves, stems and roots and has been shown to localize to the tonoplastic 
membrane in leaf tissue (Morita et al., 2009). In contrast the MATE protein NtJAT2, unlike 
NtJAT1, is expressed at low levels in leaves, stems and roots, but shows a specific and strong 
vacuole
AtTT12 AM1MtMATE1 MtMATE2 AM3
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response to MeJA elicitation, after which it is preferentially expressed in leaves. Furthermore, 
NtJAT2 also localised to the tonoplastic membrane, when overexpressed in tobacco BY2 cells 
(Shitan et al., 2014). 
Although NtJAT1 and NtJAT2 localise to the tonoplastic membrane in plant cells, overexpression 
of NtJAT1 and NtJAT2 as C-terminal GFP fusions in yeast resulted in its localisation to the plasma 
membrane for NtJAT1-GFP, and a dual localisation of the plasma membrane and vacuolar lumen 
for NtJAT2, in the yeast strain AD12345678 (Morita et al., 2009; Shitan et al., 2014). When 
incubated with nicotine, NtJAT1, NtJAT1-GFP, NtJAT2 and NtJAT2-GFP yeast cultures 
accumulated less nicotine than control cells, indicating that the yeast cells expressing NtJAT1 
and NtJAT2 had a higher rate of efflux of nicotine from the yeast, and that NtJAT1 and NtJAT2 
are likely acting as nicotine efflux transporters from the plasma membrane (Morita et al., 2009; 
Shitan et al., 2014). The NtJAT1 and NtJAT2 had a similar level of accumulation of nicotine in 
these cells (Shitan et al., 2014). In planta, due to the localisation to the tonoplast membrane, 
these transporters would therefore be importers of nicotine into the vacuole. The NtJAT2 
expressing yeast strain was tested with the other alkaloids, anabasine, anatabine and berberine, 
demonstrating transport for these compounds, however this yeast strain was not able to 
transport cyanidin 3-O-glucoside or rutin indicating that there may be substrate specificity of 
transport, perhaps conferred by the basic, positively charged nitrogen present in all of these 
compounds (Shitan et al., 2014). 
NtJAT1 was expressed in Sf9 insect cell culture and reconstituted into proteoliposomes 
containing a bacterial F-ATPase to generate a proton gradient across the membrane. 14C-
tetraethylammonium (TEA) was utilised as a model substrate and could be transported by 
NtJAT1. Treatment, of the proteoliposomes with azide, ammonium sulphate, nigericin and 
valinomycin, indicated that NtJAT1 resulted in electro-neutral H+/TEA exchange. Additionally 
nicotine inhibited the uptake of TEA in these proteoliposomes indicating that nicotine may 
competitively inhibiting TEA transport, whilst in comparison flavonoids, such as kaempferol and 
quercetin, did not affect TEA transport, suggesting that NtJAT1, like NtJAT2, is specific for 
nitrogen containing plant alkaloids (Morita et al., 2009). Despite the fact that NtJAT1 and NtJAT2 
both transport nicotine and are both co-ordinately controlled by MeJA elicitation, these two 
proteins only have 32% amino acid identity (Shitan et al., 2014). 
NtMATE1 and NtMATE2 are also co-regulated with the nicotine biosynthetic pathway, and were 
identified as genes that were downregulated in nic1nic2 nicotine biosynthesis regulatory 
mutants, relative to wild type tobacco roots (Shoji et al., 2009). The two transporters MATE1 
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and MATE2 share 96.4% sequence identity however are in a different clade than either NtJAT1 
or NtJAT2 (Shitan et al., 2014).  
The NtMATE1/2 genes are preferentially expressed in the root, with very low levels present in 
leaves, stems and flowers. GUS-staining using the NtMATE1 5’ flanking region showed 
expression only at the root tip in the outer cortex cells. This localised expression was 
upregulated upon MeJA induction, though did not affect the spatial localisation of expression. 
This expression pattern is very similar to that of the known nicotine biosynthetic genes (Shoji et 
al., 2009). 
Overexpression of an NtMATE1-GFP fusion in tobacco BY-2 cells, as well as immunogold 
electron microscopy of tobacco BY2 cells with anti-NtMATE1 antibodies and immunolabelling 
of organelle fractions from tobacco roots with anti-NtMATE1 antibodies, show this protein is 
localised to the tonoplast membrane (Shoji et al., 2009). 
RNAi lines of NtMATE1/2 did not lead to significant changes in nicotine and nornicotine alkaloid 
profiles in leaves and roots compared to a vector control line, however there was a subtle root 
growth phenotype of the RNAi lines upon exogenous treatment of nicotine, suggesting 
NtMATE1/2 contribute to nicotine transport into the vacuole. In tobacco BY2 cells, cell lines 
constitutively overexpressing NtMATE1 led to acidification of the cytoplasm upon elicitation 
with MeJA, as well as upon exogenous supply of nicotine, indicating a potential role in transport 
(Shoji et al., 2009). As with NtJAT1 and NtJAT2, when NtMATE1 was expressed in yeast, transport 
assays showed slower nicotine uptake relative to wild type controls, suggesting it is a nicotine 
exporter when expressed at the yeast plasma membrane (Shoji et al., 2009). 
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Figure 3-2 Role of MATE Transporters in nicotine transport 
NtJAT1, NtJAT2, NtMATE1 and NtMATE2 have been shown to localise to the vacuole and transport 
nicotine. 
 
The localisation of NtMATE1/2 to the root tip, together with their ability to transport nicotine in 
vitro, suggests that these transporters are involved in vacuolar sequestration of nicotine in the 
root, potentially preventing the retardation of root growth as a result of newly synthesized 
nicotine in the root tip. 
To date, no metabolic phenotypes in N. tabacum have been reported that demonstrate the 
physiological relevance of NtJAT1 or NtJAT2, and the phenotype for the NtMATE1/2 is relatively 
subtle. Silencing all four tonoplastic MATE transporters could more definitively demonstrate the 
effect these transporters have on nicotine biosynthesis, and would rule out potential functional 
redundancies. If a subtle metabolic phenotype still persists in this quadruple mutant, it may 
implicate other transporters or transporter families in being functionally relevant to tonoplastic 
nicotine import which have yet to be identified. The differential subcellular localisation of 
NtJAT1, NtJAT2, and NtMATE1/2 suggests that different tissues may utilise different proteins for 
the vacuolar sequestration of nicotine (Morita et al., 2009; Shitan et al., 2014; Shoji et al., 2009). 
3.1.2.3 Summary to Introduction 
 
The ability of MATE proteins to transport a wide array of compounds and the diverse role for 
these proteins in the transport of secondary natural products such as flavonoids and alkaloids, 
makes this protein family a good candidate for prospective transport of secondary natural 
products in C. roseus. It is noteworthy that while there is a large gene family in Arabidopsis and 
other plant species, only a few of these transporters have been characterised, suggesting that 
there may be more functional diversity in this transporter class that has not yet been identified.  
vacuole
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3.2 Aims of this Chapter 
 
1.) To assess whether there are any MATE proteins that are involved in MIA metabolism in C. 
roseus using VIGS 
2.) Functionally characterise the MATE transporters that display a metabolic phenotype after 
transient silencing in planta. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
81 
 
3.3 Results and Discussion 
 
3.3.1 MATE Proteins in Catharanthus roseus 
 
In the transcriptome of C. roseus there are 57 genes that are annotated as MATE proteins or 
have a synonymous annotation such as MATE efflux family, transparent testa 12 homologues, 
or Multidrug resistance pumps. The 14 highest expressed in C. roseus leaf tissue, together with 
the known characterised MATE transporters (AM1, AM3, NtMATE1, NtMATE2, NtJAT1, NtJAT2, 
MtMATE1, MtMATE2, TT12, FRD3, EDS5, ALF5, DTX1) are shown in the phylogenetic tree (Figure 
3-3). 
The sequence and phylogeny analysis does not necessarily give us a good indication of substrate 
preference for the MATE transporters. As has been demonstrated for the nicotine MATE 
transporters, proteins with diverse sequences are able to transport the same substrate. 
However this analysis does demonstrate that C. roseus contains homologues that are expressed 
in leaf tissue, the major site of MIA biosynthesis, for all major clades of MATE proteins that have 
been characterised to date. 
There are two MATE proteins that are highly expressed in leaf tissue, and also cluster in 
expression profile with known biosynthetic genes in the MIA pathway (Figure 3-4), as discussed 
in Chapter II. These are annotated as CrMATE10740 and CrMATE1952, and were seen to be good 
candidates for further study. 
Moreover analysis of the C. roseus genome demonstrates that the CrMATE1952 protein is on 
the same genomic contig as two biosynthetic genes in the MIA pathway, tryptophan 
decarboxylase, the enzyme that catalyses the formation of tryptamine, as well as strictosidine 
synthase (Kellner et al., 2015b). 
There is precedent for secondary metabolic pathways to be clustered on the genome in a 
number of plant species, (Nützmann and Osbourn, 2014), however the presence of a transporter 
in these metabolic clusters is rare. It is debatable as to whether the putative cluster of 
tryptophan decarboxylase, strictosidine synthase and the CrMATE1952 is a true functional 
secondary metabolic cluster, as it only consists of three genes in a small part of the known 
alkaloid metabolic pathway, however it is known at the transcriptomic level that these genes 
are co-regulated. It is possible that the spatial proximity on the genome is involved in controlling 
transcriptional regulation. 
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Figure 3-3 Phylogenetic tree of MATE proteins.  
The 14 most abundantly expressed MATE proteins in C. roseus are highlighted as Cr_locus_contig no. 
The two Catharanthus MATE proteins that co-regulate with the early steps in the MIA biosynthetic 
pathway are highlighted as CrMATE10740 and CrMATE1952. The other sequences used in the tree are 
the functionally characterised MATE proteins from Arabidopsis; AtFRD3, AtDTX1, AtALF5 and AtTT12, 
Medicago: MtMATE1 and MtMATE2, Grapevine: VvAM1 and VvAM3, and N. tabaccum: NtMATE1, 
NtMATE2, NtJAT1 and NtJAT2. Highlighted sequences by red dots are Catharanthus loci which have 
been used for VIGS in this study. The evolutionary history was inferred by using the Maximum Likelihood 
method based on the JTT matrix-based model, and the bootstrap consensus tree was inferred from 500 
replicates. The percentage of replicate trees in which the associated taxa clustered together in the 
bootstrap test are shown next to the branches. Branches corresponding to partitions reproduced in less 
than 50% bootstrap replicates are collapsed. 
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Figure 3-4 Transcriptomic profile of CrMATE1952 and CrMATE10740. 
Analysis of the expression profile of CrMATE1952 and CrMATE10740 across 23 different tissues and 
experimental conditions, which have previously been presented in Table 1, demonstrates that they have 
a similar expression pattern as known genes in the MIA biosynthetic pathway. 
 
3.3.2 MATE protein localisation and overexpression in N. benthamiana 
 
Transient overexpression under the control of the CaMV35S promoter, of the CrMATE1952-YFP 
and CrMATE10740-YFP fusions in C. roseus cell suspension cultures resulted in their localisation 
to the tonoplastic membrane as well as other smaller vacuole like compartments (Figure 3-5). 
Both of these proteins co-localised with a known tonoplastic marker protein, the potassium 
channel TPK1 from Arabidopsis (Bertl et al., 2008; Gomez et al., 2009; Marinova et al., 2007). 
 
Figure 3-5 Overexpression of CrMATE10740-YFP and CrMATE1952-YFP in C. roseus cell suspension 
cultures 
A.) Co-localisation of CrMATE10740 with the Arabidopsis potassium channel TPK1 i.) CrMATE10740-YFP 
ii.) Arabidopsis TPK-CFP iii.) Merge iv.) Differential interference contrast B.) Co-localisation of CrMATE1952 
with the Arabidopsis potassium channel TPK1 i.) CrMATE1952-YFP ii.) Arabidopsis TPK-CFP iii.) Merge iv.) 
Differential interference contrast. Scale bar = 10 µm. Cloning of the C. roseus CrMATE genes and 
Arabidopsis TPK1 gene into pEAQ-HT DEST1 was performed by R. Payne, subcloning of the genes, 
transformation by particle bombardment into C. roseus cell suspension cultures and visualisation was 
performed by Vincent Courdavault, University of Tours. 
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For CrMATE1952-GFP, this localisation is also observed with overexpression in N. benthamiana 
epidermal cells (Figure 3-6). A CrMATE1952-GFP C-terminal GFP fusion of the protein was cloned 
into the pEAQ-HT DEST1 vector for transient overexpression in N. benthamiana using 
Agrobacterium tumefaciens (Sainsbury et al., 2009). This resulted in localisation of CrMATE1952-
GFP to the tonoplast membrane, as well as to other small vacuole compartments when 
visualised by confocal microscopy (Figure 3-6). 
 
Figure 3-6 Expression of CrMATE1952-GFP in Nicotiana benthamiana epidermal cells. 
Overexpression of CrMATE1952-GFP using the pEAQ-HTDEST1 expression vector coupled with 
Agrobacterium tumefaciens infiltration of N. benthamiana and visualisation by confocal microscopy. A.) 
MES buffer infiltrated N. benthamiana leaf tissue B.) Overexpression pf CrMATE1952-GFP using the 
pEAQ-HTDEST1 expression vector. White arrows indicate the localisation of CrMATE1952-GFP to smaller 
vacuoles in N. benthamania epidermal cells. Scale bar = 20 µm. 
 
 
These smaller vacuoles have also been observed when transiently overexpressing other 
tonoplast localised transport proteins in N. benthamiana, such as the ABCC1, an ATP binding 
cassette protein that is involved in anthocyanidin 3-O-glycoside transport (Francisco et al., 
2013). The localisation in N. benthamiana epidermal cells is also reminiscent of the tonoplastic 
MATE1 and MATE2 from Medicago (Zhao and Dixon, 2009; Zhao et al., 2011). 
The localisation of CrMATE10740-GFP in Nicotiana benthamiana epidermal cells was not 
feasible due to the toxicity of overexpressing this protein and this will be discussed in more detail 
in Section 3.3.11. 
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3.3.2.1 Hypothetical roles of MATE proteins at the tonoplast in C. roseus 
 
To date all MATE proteins that have been characterised direct the transport of the substrate 
away from the cytoplasm. Therefore if they are expressed at the plasma membrane they export 
the substrate from the cell, whilst expression at the tonoplast membrane results in vacuolar 
import from the cytosol. Therefore the localisation of these transporters, CrMATE1952 and 
CrMATE10740, to the tonoplast membrane limits the potential substrates that these 
transporters might be involved in transporting.  
As discussed in Chapter I, the MIA pathway in C. roseus is subcellularly compartmented, with the 
pathway occurring in multiple organelles, and there are multiple points in the pathway in which 
the vacuole is known to be involved. 
The vacuole is thought to be the site of storage of many of the downstream alkaloids in MIA 
metabolism in C. roseus such as vindoline, serpentine, and catharanthine in mesophyll and 
idioblasts cells (Figure 3-7). These compounds are transported into the vacuole using a proton 
dependent secondary transport system in C. roseus cells (Carqueijeiro et al., 2013). A member 
of the MATE protein family could potentially function as an importer of the downstream 
alkaloids into the vacuole. This family has been hypothesised to function in this storage role 
(Carqueijeiro et al., 2013), however to date no gene has been identified via either in vitro activity 
or through reverse genetics that substantiates this view (Carqueijeiro et al., 2013; Roytrakul and 
Verpoorte, 2007). 
Alternatively, the vacuole is also known to be the site of biosynthesis of strictosidine in the 
epidermis, which is an earlier step in the pathway, and a key branchpoint step in the biosynthesis 
of MIAs.  Strictosidine synthase, which is localised to the vacuole, catalyses the Pictet Spengler 
condensation of tryptamine and secologanin to form strictosidine. This therefore requires the 
transport of the two substrates for strictosidine synthesis, tryptamine and secologanin into the 
vacuole (Figure 3-7). Although there is debate in the literature with regards to whether 
tryptamine is able to be transported across the tonoplast membrane through an ion-trap 
mechanism, and whether a transport step is needed to facilitate transport (Deus-Neumann and 
Zenk, 1984; Deus-Neumann and Zenk, 1986), secologanin is a glycosylated iridoid, and is 
therefore likely to be impermeable to the lipid bilayer and requires a transporter to be moved 
into the vacuole (Courdavault et al., 2014). 
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As has been discussed in Chapter II, the transcriptional co-regulation of the genes involved in 
MIA biosynthesis has centred on the early steps in the pathway, namely the formation of 
tryptamine, secologanin and strictosidine. Enzymes downstream that are involved in different 
branches of MIA biosynthesis, such as the steps between tabersonine and vindoline, have not 
been shown to be strongly co-regulated. 
The fact that the two MATE transporters co-regulate with the genes involved in secologanin, 
tryptamine and strictosidine biosynthesis, as well as the fact that CrMATE1952 is clustered on 
the genome with tryptophan decarboxylase and strictosidine synthase is strongly indicative that 
these transporters are likely to be involved in the early steps in the pathway.  
 
Figure 3-7 Potential role of MATES at the tonoplast membrane. 
MATES are secondary transporters that move substrates away from the cytoplasm and therefore at the 
tonoplast membrane are vacuolar importers. There are two main hypothesised roles for the MATES in 
MIA transport. A.) These transporters could be transporting the final products of MIA biosynthesis, such 
as serpentine, vindoline and catharanthine into the vacuole for storage or B.) These transporters are 
involved in the transport of secologanin or tryptamine into the vacuole in order for the biosynthesis of 
strictosidine 
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Furthermore, CrMATE1952 gene expression has been shown to be preferentially enriched in 
epidermal tissue by qPCR (Vincent Courdavault; personal communication). This epidermal 
enrichment is consistent with the MATEs involvement in the early steps of the pathway as 
opposed to transporting the downstream MIAs into the vacuole in mesophyll and laticifer cells. 
 
 
3.3.3 Virus Induced Gene Silencing 
 
VIGS is a reverse genetic approach that can be used in C. roseus to assess whether a gene has a 
functional role in MIA metabolism by screening for a metabolic phenotype. For individual 
silencing of the genes CrMATE1952 and CrMATE10740 as well as another MATE gene, locus_ 
2720, in C. roseus, 500 bp regions of the genes were cloned into the pTRV2u vector for 
transformation into A. tumefaciens strain GV3101 and transient gene silencing. 
3.3.3.1 VIGS CrMATE10740 and locus_2720 
 
VIGS for CrMATE10740 and locus_2720 did not result in a statistically significant difference in 
any of the major alkaloid peaks vindoline, catharanthine, serpentine/alstonine, strictosidine or 
the iridoid glycoside secologanin and therefore to date, there is no evidence that these 
transporters are functionally relevant in MIA biosynthesis in C. roseus (Figure 3-8). 
 
 
 
 
 
 
 
 
 
 
88 
 
 
 
 
Figure 3-8 Metabolite profile upon VIGS of CrMATE10740 and locus_2720  
A.) Alkaloid profile for VIGS of locus_2720 relative to empty vector control tissue in Sunstorm Apricot 
VIGS-CrMATE1952 (n=12) VIGS-EV (n=12) ** p<0.01 B.) Alkaloid profile for VIGS of CrMATE10740 
relative to empty vector control tissue in Little Bright Eyes VIGS-CrMATE10740 (n=12) VIGS-EV (n=12) ** 
p<0.01. All data shown are mean + SEM. 
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3.3.3.2 VIGS CrMATE1952 
 
VIGS for the CrMATE1952 resulted in the reproducible accumulation of a new compound with 
m/z 391 (H+ adduct) and m/z 413 (Na+ adduct) (Figure 3-9, Figure 3-10). This peak is not observed 
in VIGS-EV controls, and is also not present in any VIGS experiments attempting to transiently 
silence other genes from C. roseus. The accumulation of this peak is reproducible across multiple 
VIGS experiments for silencing CrMATE1952 (Figure 3-11 and Appendix). Through qPCR we also 
observed that there is a decrease in the expression of CrMATE1952 in the VIGS-CrMATE1952 
silenced lines relative to the VIGS-EV controls, confirming the knockdown of the gene by VIGS 
(Figure 3-11). 
 
Figure 3-9 Representative Total Ion Chromatogram for VIGS-EV and VIGS-CrMATE1952 leaf tissue. 
Methanol extracts of leaf tissue from A.) VIGS-CrMATE1952 and B.) VIGS-EV were analysed by LC-MS. 
Presented are the total ion chromatograms. Highlighted is the new peak m/z 413 that reproducibly 
accumulates in VIGS-CrMATE1952 silenced tissue. It is necessary to note that secologanin elutes as m/z 
411 (Na+ adduct) on the Shimadzu-IT-TOF mass spectrometer and m/z 389 (H+ adduct) on the Thermo-
Finnigan instrument with a Deca XP ion trap detector. Similarly the phenotype observed in VIGS-
CrMATE1952 silenced tissue runs as m/z 413 (Na+ adduct) on the Shimadzu-IT-TOF mass spectrometer 
and m/z 391 (H+ adduct) on the Thermo-Finnigan instrument with a Deca XP ion trap detector. 
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Figure 3-10 Representative Extracted Ion Chromatogram of m/z 413 for VIGS-EV and VIGS-
CrMATE1952 leaf tissue. 
Methanol extracts of leaf tissue from A.) VIGS-CrMATE1952 and B.) VIGS-EV leaf tissue were analysed by 
LC-MS. Presented are the extracted ion chromatograms for the m/z 413 that accumulates in the VIGS-
CrMATE1952 silenced tissue. Although there are multiple m/z 413 peaks it is only the peak highlighted in 
red that reproducibly accumulates relative to VIGS-EV control. 
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Figure 3-11 Metabolite and qPCR profile upon VIGS of CrMATE1952 
A.) Alkaloid profile for VIGS of CrMATE1952 relative to empty vector control tissue in Little Bright Eyes 
VIGS-CrMATE1952 (n=12) VIGS-EV (n=8) ** p<0.01 B.) m/z 391 profile for VIGS of CrMATE1952 relative to 
empty vector control tissue in Little Bright Eyes, VIGS- CrMATE1952 (n=12) VIGS-EV (n=8) ** p<0.01 C.) 
qPCR normalised expression of the CrMATE1952 gene in VIGS-EV and VIGS-CrMATE1952 silenced plants 
VIGS-CrMATE1952 (n=8) VIGS-EV (n=8).  All data shown are mean + SEM. 
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3.3.4 Secologanin feeding to wild type C. roseus leaf tissue 
 
The new peak m/z 391 (H+ adduct) and m/z 413 (Na+ adduct) that is accumulating in 
CrMATE1952 silenced tissue is likely to be an iridoid glycoside derived from secologanin. 
Feeding wild type C. roseus leaf tissue with secologanin can recapitulate the metabolic 
phenotype observed upon CrMATE1952 silencing, namely the formation of a peak of m/z 391 
(H+ adduct) and m/z 413 (Na+ adduct). This peak is at the same retention time as the peak that 
accumulates in VIGS-CrMATE1952 silenced tissue. Therefore, it is reasonable to assume that 
these compounds are derived from secologanin. Since secologanin has an m/z 389 (H+ adduct) 
and m/z 411 (Na+ adduct) the new compound that accumulates is likely to be the reduced form 
of secologanin in which the aldehyde is reduced to the alcohol, forming secologanol (Figure 
3-12). 
 
Figure 3-12 Representative Extracted Ion Chromatogram of m/z 413 for Wild Type C. roseus leaf tissue 
fed with secologanin or water.   
Methanol extracts of leaf tissue from A.) Secologanin fed and B.) H2O fed wild type C. roseus leaf tissue 
were analysed by LC-MS. Presented are the extracted ion chromatograms for the m/z 413 that 
accumulates upon secologanin feeding, and co-elutes with the peak that accumulates in CrMATE1952 
silenced leaf tissue. 
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Figure 3-13 Metabolite profile upon feeding wild type C. roseus leaf tissue secologanin 
A.) Alkaloid profile of C. roseus Little Bright Eyes leaf tissue fed either H2O (n=4) or secologanin (n=4) ** 
p<0.01 B.) m/z 391 profile C. roseus Little Bright Eyes leaf tissue fed either H2O (n=4) or secologanin (n=4) 
** p<0.01. All data shown are mean + SEM. 
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3.3.5 Sodium borohydride reduction of secologanin 
 
To assess whether the peak of m/z 391 (H+ adduct) and m/z 413 (Na+ adduct) is the reduced 
product of secologanin, this iridoid glycoside can be chemically reduced to the alcohol, and the 
product analysed by LC-MS. Chemical reduction of secologanin to secologanol is feasible using 
sodium borohydride (NaBH4) in aqueous methanol. Treatment of a standard of 1 mM 
secologanin with NaBH4 resulted in the chemical reduction to the alcohol (Figure 3-14, Figure 
3-15). This compound has the same retention time and m/z 413 as the peak that is accumulating 
in CrMATE1952 silenced plant tissue, and that is accumulating in wild type C. roseus leaf tissue 
upon exogenous secologanin feeding (Figure 3-16). 
 
 
Figure 3-14 Conversion of secologanin to secologanol 
Secologanin can be converted to its alcohol derivative secologanol by chemical reduction using sodium 
borohydride (NaBH4). This reaction may also proceed enzymatically through an as of yet undiscovered 
reductase enzyme as is observed upon feeding secologanin to wild type leaf tissue 
 
Furthermore treatment of the methanolic extract of an EV control tissue with sodium 
borohydride, supports this hypothesis. Sodium borohydride treated methanolic extract of VIGS-
EV resulted in the accumulation of a peak of m/z 413 that has the same retention time as the 
peak accumulating in VIGS-CrMATE1952 tissue (Figure 3-15, Figure 3-16). 
 
95 
 
 
Figure 3-15 Representative Extracted Ion Chromatogram of m/z 413 and m/z 411 for VIGS-EV reduced 
with NaBH4, and a secologanin standard reduced with NaBH4.    
Aqueous Methanol extracts of VIGS-EV leaf tissue treated A.) with NaBH4 and B.) without NaBH4. Aqueous 
Methanol extracts of a 1 mM secologanin standard treated C.) with NaBH4 and B.) without NaBH4. E.) 
Chemical structures of secologanin and secologanol.   
 
 
Figure 3-16 Extracted Ion Chromatograms m/z 413  
Overlay of the extracted ion chromatograms of m/z 413 from the secologanin feeding experiments to 
wild-type leaf tissue (black), reduction of a VIGS-EV leaf tissue with NaBH4 (red), and the VIGS-
CrMATE1952 leaf tissue (blue). The green box indicates these compounds elute at the same retention 
time. 
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3.3.6 Proposed role of CrMATE1952 in MIA metabolism 
 
Due to the localisation of the CrMATE1952 protein to the tonoplast membrane and the fact that 
a derivative of secologanin is accumulating in VIGS-CrMATE1952 silenced tissue, our current 
hypothesis is that CrMATE1952 could be acting as the secologanin importer into the vacuole. 
The reason a derivative of secologanin is observed upon silencing is likely to be due to the effect 
silencing the CrMATE1952 transporter has on the spatial localisation of secologanin (Figure 
3-17). Silencing of the transporter does not necessarily affect the secologanin concentration, but 
instead it would directly affect the relative ratio of secologanin in the cytoplasm and the vacuole, 
with the CrMATE1952 silenced leaves having a higher concentration of secologanin in the 
cytoplasm due to inhibition of vacuolar import. 
Plants, and other living organisms, do not accumulate aldehydes as these are reactive species 
and potentially toxic (Kunjapur et al., 2014; LoPachin and Gavin, 2014). As mentioned previously, 
secologanin has an aldehyde moiety, and it is possible that the response of the plant to the 
accumulation of secologanin in the cytoplasm is its detoxification through reduction to the 
alcohol. Similarly it is also conceivable that this is not a direct plant response, but instead, if 
there is a promiscuous reductase in the cytoplasm, mislocalisation of secologanin to the cytosol, 
increases the relative chance that secologanin can act as the substrate for reduction. The 
phenotype observed is therefore likely to be due to the relative mislocalisation of secologanin, 
due to inhibition of vacuolar import, and its subsequent derivitisation to an alcohol. 
This result is supported by the secologanin feeding experiments. Upon feeding secologanin to 
wild-type leaf tissue an accumulation of m/z 391 and m/z 413 is observed, and this peak that 
accumulates co-elutes with the compound observed upon CrMATE1952 silencing, as well as the 
m/z 391 and m/z 413 peak that is seen upon treatment of secologanin with NaBH4. The reason 
for the observation of this peak can be explained in the same way as CrMATE1952 silencing. 
Feeding a large quantity of secologanin, that exceeds the concentration present in leaf tissue, 
potentially saturates the potential for secologanin import into the vacuole, and therefore again 
affects the relative distribution of secologanin in the vacuole and cytoplasm. Accumulation of 
secologanin in the cytoplasm upon secologanin feeding thereby recapitulates the metabolic 
phenotype observed upon CrMATE1952 silencing, and leads to secologanin reduction to 
secologanol (Figure 3-17). 
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Figure 3-17 Proposed scheme for secologanol formation in C. roseus.  
A.) Secologanin is an aldehyde that is usually stored in the vacuole B.) Silencing of the transporter (red 
arrow) results in differential localisation of secologanin and its subsequent reduction C.) Feeding 
secologanin also results in an increased cytoplasmic concentration of secologanin and its conversion to 
secologanol due to saturating the pathway. 
 
This result highlights the importance of subcellular compartmentation in metabolic pathways 
when the substrate is potentially toxic or has the potential to be derivatised by enzymes from 
other metabolic pathways. Secologanin is an aldehyde that accumulates in leaf tissue, and its 
localisation to the vacuole may be necessary to prevent its derivatisation. The data we present 
here provides evidence for the involvement of a tonoplastic transporter that directly affects 
secologanin metabolism. 
There is a disparate effect on the downstream alkaloids in the replicates of the VIGS experiments 
upon CrMATE1952 silencing. Although the accumulation of m/z 391 and m/z 413 is always 
observed upon CrMATE1952 silencing, there is variability between VIGS experiments with 
regards to the affect silencing this transporter has on the downstream alkaloids strictosidine, 
catharanthine, serpentine and vindoline (Figure 3-11 and Appendix). The fact that a decrease in 
these alkaloids is not always observed is indicative that there is enough flux through the pathway 
to maintain MIA biosynthesis, and therefore enough secologanin is able to enter the vacuole for 
strictosidine synthesis to maintain MIA biosynthesis in the CrMATE1952 silenced leaf tissue. 
There are two main hypotheses that can account for the maintenance of MIA biosynthesis 
despite inhibiting the secologanin importer, CrMATE1952. Firstly it is possible that there is 
functional redundancy in secologanin transport activity and it is possible that multiple 
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transporters could also be transporting secologanin into the vacuole. The phenotype we observe 
upon CrMATE1952 silencing is therefore due to the fact that CrMATE1952 contributes enough 
towards secologanin import into the vacuole to result in the relative mislocalisation of 
secologanin, however there is enough transport activity of secologanin into the vacuole to 
maintain MIA biosynthesis due to the activity of other transporters. 
Alternatively it is possible that CrMATE1952 is the only transporter involved, and despite 80-
90% silencing at the transcript level by qPCR, there is still enough basal activity of secologanin 
import by CrMATE1952 to maintain flux to downstream alkaloids.  
The pathway to MIA biosynthesis is through a convergent metabolic pathway between primary 
amino acid metabolism derived from tryptophan, and the monoterpene iridoid glycoside 
pathway. If there is a relative discrepancy in the relative flux between these two branches, and 
the flux through the terpene metabolism to secologanin is greater than the flux through to 
tryptamine, it is possible that the basal activity of CrMATE1952 that is present despite silencing 
has enough capacity to maintain flux to downstream alkaloids.  
 
Figure 3-18 Monoterpene indole alkaloid biosynthesis is a convergent metabolic pathway.  
MIA biosynthesis is a convergent metabolic pathway centred on the formation of the key branchpoint 
strictosidine in the vacuole. If rate of formation of secologanin (Vsec) greatly exceeds the formation of 
tryptamine (VTryp) it is possible that despite silencing transport of secologanin into the vacuole by VIGS 
there is enough residual basal activity of the transporter CrMATE1952 to maintain flux to the 
downstream alkaloids such as catharanthine or vindoline. 
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3.3.7 Isotopic labelling of the strictosidine pool  
 
Given that strictosidine biosynthesis requires both secologanin and tryptamine substrates, we 
hypothesised that one substrate could be rate limiting in the leaf tissue. Isotopic labelling studies 
were used to explore whether tryptamine supply to the MIA pathway is potentially limiting. 
Wild type leaf tissue was cut at the petiole and fed with 5 mM d4-tryptamine over a period of 
four days. Feeding studies with isotopically labelled tryptamine demonstrated that feeding the 
substrate led to higher strictosidine accumulation relative to wild type controls. This resulted in 
a ~ 10 fold increase in the amount of strictosidine in the leaf tissue (Figure 3-19). 
 
 
Figure 3-19 Feeding d4-tryptamine resulted in an increase in the total strictosidine pool.  
Wild type C. roseus leaves were cut at the petiole and fed 100 µl 5 mM d4-tryptamine for four days. The 
total strictosidine pool is the combined peak area of the endogenous strictosidine m/z 531 and the 
labelled strictosidine m/z 535. A and B represent separate replicates of the feeding experiment  A.) d4-
tryptamine fed leaves (n=5), H2O fed leaves (n=5) B.) d4-tryptamine fed leaves (n=3) H2O fed leaves (n=3). 
p < 0.05 * p < 0.01 **.  C.) Structure of d4-strictosidine. All data presented is the mean + SEM. 
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Additionally, the strictosidine pool in these d4-tryptamine feeding experiments was reproducibly 
enriched in label to >90% demonstrating that the pool of strictosidine is effectively turned over 
in this time period (Table 3). This demonstrated that feeding the substrate for strictosidine 
biosynthesis, tryptamine, is able to alter the steady state of the metabolic pathway and result in 
the accumulation of strictosidine. 
 
Table 3 Enrichment of d4-strictosidine 
The average enrichment of the d4- strictosidine relative to unlabelled strictosidine is presented. 
Enrichment values were calculated as a percentage of the combined peak area of m/z 531 and m/z 535; 
(peak area m/z 535)/(∑(peak area m/z 535 + peak area m/z 531)) A.) d4-tryptamine fed leaves (n=5), H2O 
fed leaves (n=5) presented is the mean enrichment value + SEM B.) d4-tryptamine fed leaves (n=3) H2O 
fed leaves (n=3) mean enrichment value + SEM. The presence of d4-strictosidine in the water fed controls 
can be explained by baseline noise and natural isotope abundance. 
 
Replicate  strictosidine d4-strictosidine 
A WT-H2O fed leaf 0.983 + 0.004 0.017 + 0.004 
 WT-d4-tryptamine fed leaf 0.013 + 0.004 0.987 + 0.004 
B WT-H2O fed leaf 0.989 + 0.004 0.01 + 0.004 
 WT-d4-tryptamine fed leaf 0.012 + 0.006 0.988 + 0.006 
 
The accumulation of strictosidine suggests that its utilisation, either due to inefficiency in export 
from the vacuole or inefficiency in its utilisation by the enzymes downstream in the pathway, is 
a potential bottleneck in the MIA pathway under conditions where substrate is supplied 
exogenously. 
 The fact that the steady state of strictosidine is altered upon supply of tryptamine suggests that 
tryptophan decarboxylation to tryptamine may be limiting in the strictosidine biosynthesis, and 
by bypassing this enzyme by supplying tryptamine, it is possible to increase flux through the MIA 
pathway. The alteration in the steady state levels of strictosidine indicates the utilisation of 
strictosidine subsequently becomes a metabolic bottleneck.  
For a linear pathway it could be unsurprising that exogenous supply of millimolar concentrations 
of substrate result in product increase, however the MIA metabolic pathway is a convergent 
metabolic network between seco-iridoid biosynthesis and tryptamine biosynthesis which merge 
at the branchpoint of strictosidine. 
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The fact that strictosidine is able to accumulate upon exogenous supply of tryptamine, is 
indicative that the seco-iridoid branch of the metabolic pathway is not limiting strictosidine 
biosynthesis. If the seco-iridoid branch of the pathway is not the limiting reagent in strictosidine 
biosynthesis, this further supports the argument that secologanin needs to be partitioned into 
the vacuole to protect it from derivatisation to its alcohol product in the cytoplasm. 
To further assess the labelling of the strictosidine pool and the potential for tryptophan 
decarboxylase to be limiting, a series of labelling experiments were performed in which wild 
type C. roseus leaf tissue was fed d4-tryptamine, d5-tryptophan and H2O. In all cases the size of 
the strictosidine pool, as well as the enrichment of the pool m/z 535 was monitored. m/z 535 is 
monitored for the d5-tryptophan experiments as well, as the labelling of strictosidine with d5-
tryptophan results in the production of d4-strictosidine (Figure 3-20). 
Notably while feeding isoptopically labelled d4-tryptamine resulted in an increase in the total 
pool size of strictosidine, feeding d5-tryptophan did not lead to a statistically significant increase 
in the strictosidine pool relative to H2O fed controls (Figure 3-20). 
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Figure 3-20 Isotopic labelling of strictosidine.  
Wild type C. roseus leaves were cut at the petiole and fed either 100 µl 5 mM d4-tryptamine, or 5 mM d5-
tryptophan daily for four days. The total strictosidine pool is the combined peak area of the endogenous 
strictosidine m/z 531 and the labelled strictosidine m/z 535. A and B represent separate replicates of the 
feeding experiment. A.) d4-tryptamine fed leaves (n=5), d5-tryptophan fed leaves (n=5),    H2O fed leaves 
(n=5) B.) d4-tryptamine fed leaves (n=5), d5-tryptophan fed leaves (n=5), H2O fed leaves (n=5). p < 0.05*. 
All data represent the mean + SEM. C.) Feeding both d4-tryptamine and d5-tryptopahn leads to the 
formation of d4-strictosidine. 
 
 
 
 
Feeding both isoptopically labelled d4-tryptamine and d5-tryptophan resulted in the labelling of 
the strictosidine pool with, as previously demonstrated, in excess of >90% labelling for d4-
tryptamine fed leaf tissue, and >65% labelling of the strictosidine pool for d5-tryptophan fed leaf 
tissue in both experimental replicates (Table 4). Representative MS spectra for the strictosidine 
pool for d4-tryptamine, d5-tryptophan and H2O-fed leaf tissue is presented in Figure 3-21. 
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Table 4 Enrichment of d4-strictosidine 
The average enrichment of the d4-strictosidine relative to unlabelled strictosidine is presented. 
Enrichment values were calculated as a percentage of the combined peak area of m/z 531 and m/z 535. 
(peak area m/z 535)/(∑(peak area m/z 535 + peak area m/z 531)). A.) d4-tryptamine fed leaves (n=5), d5-
tryptophan fed leaves (n=5), H2O fed leaves (n=5) presented is the mean enrichment value + SEM B.) d4-
tryptamine fed leaves (n=5), d5-tryptophan fed leaves (n=5),  H2O fed leaves (n=5) mean enrichment value 
+ SEM. The presence of d4-strictosidine in the water fed controls can be explained by baseline noise and 
natural isotope abundance. 
 
  strictosidine d4-strictosidine 
A WT-H2O fed leaf 0.997 + 0.001 0.001 + 0.001 
 WT-d4-tryptamine fed leaf 0.057 + 0.03 0.943 + 0.003 
 WT-d5-tryptophan fed leaf 0.216 + 0.029 0.784 + 0.029 
B WT-H2O fed leaf 0.981 + 0.005 0.019 + 0.005 
 WT-d4-tryptamine fed leaf 0.049 + 0.02 0.951 + 0.02 
 WT-d5-tryptophan fed leaf 0.324 + 0.03 0.676 + 0.03 
 
 
 
 
 
 
 
 
Figure 3-21 Representative mass spectra for strictosidine for H2O fed, d5-tryptophan fed and d4-
tryptamine fed C. roseus leaf tissue 
Mass spectra for strictosidine A.) H2O fed C. roseus leaf tissue, B.) d5-tryptophan fed C. roseus leaf tissue 
and C.) d4-tryptamine fed C. roseus leaf tissue. 
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This set of feeding experiments is further supportive of the hypothesis that tryptophan 
decarboxylase may be limiting MIA biosynthesis in C. roseus, and bypassing this enzyme by 
exogenous supply of tryptamine can result in the accumulation of strictosidine. Furthermore, 
the fact that exogenous tryptamine has such as substantial impact on the levels of strictosidine 
suggests that the seco-iridoid substrate is not the limiting one. 
 
 
Figure 3-22 Exogenous supply of tryptamine results in an increase in strictosidine production 
A.) Strictosidine biosynthesis is a convergent metabolic pathway between secoiridoid biosynthesis and 
tryptamine B.) Exogenous supply of tryptamine and bypassing tryptophan decarboxylase (TDC) can 
increase strictosidine, indicating secologanin biosynthesis is not a limiting factor in strictosidine 
synthesis as highlighted by red arrows 
 
There is debate in the literature about whether tryptamine or the secoiridoid branch of MIA 
metabolism is limiting, with conflicting results about the increases in alkaloid accumulation 
upon exogenous feeding of different substrates (Canel et al., 1998; Contin et al., 1999b; 
Morgan and Shanks, 2000; Peebles et al., 2006; Whitmer et al., 1998). These previous studies 
have all been performed in cell suspension cultures which have a different alkaloid profile to 
leaf tissue, and the work presented in this thesis is the first demonstration that in the leaf 
tissue the tryptamine branch appears to be limiting. It is therefore possible that the limiting 
nature of either branch of the convergent metabolic branchpoint is dependent on the 
particular tissue or system under investigation. 
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3.3.8 Virus Induced Gene Silencing Fusions 
 
Two sets of VIGS fusion pTRV2u vectors were generated to combinatorially silence multiple 
MATE genes, and assess whether there are functionally redundant transporters involved in 
secologanin import into the vacuole in C. roseus.  
3.3.8.1 Combinatorial silencing of CrMATE1952 and CrMATE10740 
 
A double fusion silencing vector between CrMATE1952 and CrMATE10740, pTRV2u-
CrMATE1952_CrMATE10740, was generated by uracil specific excision reagent (USER) fusion 
cloning (Geu-Flores et al., 2007; Nour-Eldin et al., 2010), to transiently silence both MATE 
proteins CrMATE1952 and CrMATE10740.  
As demonstrated previously, CrMATE10740 is tightly co-regulated with the MIA pathway, 
however individual silencing did not lead to a metabolic phenotype. Although CrMATE1952 and 
CrMATE10740 are not homologous, and occur on different clades in the phylogenetic tree 
(Figure 3-3), as has been demonstrated by the nicotine MATE transporters, MATEs with diverse 
sequences are able to transport the same metabolite, and therefore it is possible that both 
CrMATE1952 and CrMATE10740 might both be involved in secologanin import into the vacuole. 
Silencing using the double vector for VIGS-CrMATE1952_CrMATE10740 resulted in the same 
result as individually silencing the CrMATE1952, Figure 3-23. Both sets of plants accumulated a 
metabolite with an m/z 391, and in this particular VIGS experiment both individually silencing 
CrMATE1952 and using the double vector for silencing both CrMATE1952 and CrMATE10740, 
also resulted in a decrease in the downstream alkaloids vindoline and catharanthine. qPCR 
confirmed silencing of the gene CrMATE1952 in both the CrMATE1952 individually silenced 
plants and CrMATE1952-CrMATE10740 double silenced plants (Figure 3-23), as well as silencing 
of the CrMATE10740 gene in the double fusion CrMATE1952-CrMATE10740 silenced plants 
(Figure 3-23). 
The fact that there is not a statistically significant difference in the peak of m/z 391 between the 
individually silenced CrMATE1952 and the double silenced CrMATE1952_CrMATE10740 plants 
is indicative that the CrMATE10740 is unlikely to be involved in secologanin import, as there is 
no cumulative effect upon silencing both transporters. 
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Figure 3-23 Metabolite and qPCR profile upon VIGS of CrMATE1952 and the double fusion 
CrMATE1952_CrMATE10740.  
A.) Alkaloid profile for VIGS of CrMATE1952, and the double construct CrMATE1952_CrMATE10740, 
relative to empty vector control tissue in Little Bright Eyes VIGS-CrMATE1952 (n=12), VIGS-
CrMATE1952_CrMATE10740 (n=12), VIGS-EV (n=12) ** p<0.01 B.) m/z 391 profile for VIGS of 
CrMATE1952 and the double construct  CrMATE1952_CrMATE10740,  relative to empty vector control 
tissue in Little Bright Eyes VIGS- CrMATE1952 (n=12), VIGS-CrMATE1952_CrMATE10740 (n=12), VIGS-EV 
(n=12) ** p<0.01 C.) qPCR normalised expression of the CrMATE1952 gene in empty vector, and 
CrMATE1952 and CrMATE1952_10740 silenced plants; VIGS-CrMATE1952 (n=8), VIGS-
CrMATE1952_10740 (n=8), VIGS-EV (n=8). D.) qPCR normalised expression of the CrMATE10740 gene in 
empty vector and CrMATE1952_10740 silenced plants; VIGS-CrMATE1952_10740 (n=8), VIGS-EV (n=8). 
All data shown are mean + SEM. 
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3.3.8.2 Combinatorial silencing of CrMATE1952 homologues. 
 
As shown by the phylogenetic tree (Figure 3-3), CrMATE1952 has a number of homologues 
present in the transcriptome of C. roseus, namely locus_10550, locus_3327, locus_8527. 
Although the locus_10550 is closest in sequence alignment to CrMATE1952, it is not highly 
expressed in leaf tissue and was therefore excluded from further consideration. A triple silencing 
vector for the transient silencing of CrMATE1952, locus_3327 and locus_8527 in C. roseus by 
VIGS was generated. The genes at locus_3327 and locus_8527 do not co-regulate with the genes 
in the MIA pathway, however they are expressed in leaf tissue. It is therefore feasible that they 
may contribute basal activity towards secologanin import into the vacuole that can compensate 
for CrMATE1952 silencing. 
Silencing utilising this triple silencing vector resulted in the same metabolic phenotype as that 
found by singly silencing CrMATE1952 relative to EV controls with the emergence of a peak of 
m/z  413 (Na+ adduct). 
There was no significant difference between the triple silencing vector and singly silenced 
CrMATE1952 with regards to effects on downstream alkaloids or secologanol accumulation, 
suggesting there was no major effect on phenotype as a result of cumulatively silencing the 
genes as opposed to singly silencing CrMATE1952 (Figure 3-24). 
qPCR confirmed that in both the CrMATE1952 and the CrMATE_locus_3327_locus_8527 triple 
silencing plants the gene CrMATE1952 was silenced relative to VIGS-EV controls (Figure 3-24). 
Further silencing experiments are therefore potentially needed to exacerbate this metabolic 
phenotype if more transporters are involved in secologanin import.  
This work demonstrates that combinatorial VIGS vectors can be generated by stacking ~500 bp 
regions of genes onto the pTRV2u vector and cloned by a USER fusion cloning strategy, as 
highlighted by the CrMATE-CrMATE10740 double silenced plants. Further combinatorial 
silencing experiments could therefore utilise this approach to stack genes from disparate 
transporter classes and assess their effect on secologanol formation together with the effect on 
downstream MIAs.  
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Figure 3-24 Metabolite and qPCR profile upon VIGS of CrMATE1952 and the triple fusion 
CrMATE1952_locus3327_locus8527  
A.) Alkaloid profile for VIGS of CrMATE1952, and the triple construct CrMATE1952-Triple, relative to 
empty vector control tissue in Little Bright Eyes VIGS-CrMATE1952 (n=9), VIGS-CrMATE1952-Triple 
(n=14), VIGS-EV (n=9) ** p<0.01 B.) m/z 413 profile for VIGS of CrMATE1952 and the triple construct  
CrMATE1952-Triple,  relative to empty vector control tissue in Little Bright Eyes VIGS- CrMATE1952 
(n=9), VIGS-CrMATE1952-Triple (n=14), VIGS-EV (n=9) ** p<0.01 C.) qPCR normalised expression of the 
CrMATE1952 gene in empty vector, CrMATE1952 and CrMATE1952-Triple silenced plants VIGS-
CrMATE1952 (n=8), VIGS-CrMATE1952-Triple (n=8), VIGS-EV (n=8).  All data shown are mean + SEM. 
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3.3.9 Heterologous expression of MATE proteins in S. cerevisiae 
 
The function of a transporter also needs to be assessed by heterologous expression and in vitro 
biochemical assays. S. cerevisiae is a good host for the expression of eukaryotic membrane 
proteins and for the characterisation of substrate transport (Newstead et al., 2007). This system 
was used for the expression of CrMATE1952 and CrMATE10740 to assess whether they have the 
capacity to transport secologanin. 
C-terminal tagging with green fluorescent protein, GFP, facilitates in the identification of 
whether a membrane protein is correctly folded. For an integral membrane protein fused to 
GFP, the GFP folds and becomes fluorescent only if the N-terminal membrane protein is 
integrated into the membrane (Newstead et al., 2007). Screening of C-terminally tagged GFP 
fusions of membrane proteins, together with analysing the localisation of expression in the yeast 
strain can therefore be used to assess whether S. cerevisiae is a suitable host for heterologous 
expression and transport assays (Drew et al., 2008; Newstead et al., 2007). 
As discussed previously there are a number of plant MATEs that have been characterised for 
transport of secondary metabolites in S. cerevisiae; the four tonoplast localised nicotine 
transporters NtMATE1/2, NtJAT1, NtJAT2 (Morita et al., 2009; Shitan et al., 2014; Shoji et al., 
2009) as well as the flavonoid transporters AtTT12, MtMATE1, MtMATE2, AM1 and AM3, 
(Gomez et al., 2009; Marinova et al., 2007; Zhao and Dixon, 2009; Zhao et al., 2011). The 
localisation of the membrane protein in the yeast dictates the type of transport assay that is 
amenable.  
For the MATEs, transport universally occurs in the direction away from the cytoplasm. 
Therefore, if the MATE transporter is expressed at the plasma membrane, a whole yeast assay 
approach is necessary.  Although the nicotine transporters are localised to the tonoplast in 
plants, overexpression of these proteins as C-terminal GFP fusions in S. cerevisiae, under control 
of a constitutive promoter, resulted in localisation to the plasma membrane (Morita et al., 2009; 
Shitan et al., 2014; Shoji et al., 2009). 
In this whole cell assay, the yeast culture expressing the MATE is incubated with the substrate, 
relying on endogenous yeast transporters to pump the potential substrate from the media into 
the cell. The yeast expressing the MATE, which selectively pumps the substrate out, would be 
expected to have a lower intracellular concentration of the substrate than a negative control 
not expressing the transporter. This type of assay has been used in the assessment of transport 
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for the NtJAT1, NtJAT2, NtMATE1 and NtMATE2 (Morita et al., 2009; Shitan et al., 2014; Shoji et 
al., 2009).  
In comparison, over-expression of the tonoplast flavonoid transporters, AtTT12 (Marinova et al., 
2007), MtMATE1 and MtMATE2 (Zhao and Dixon, 2009; Zhao et al., 2011) in S. cerevisiae as C-
terminal GFP fusions, resulted in the localisation of each protein to a defined internal membrane 
in the yeast. The assay for flavonoid uptake was therefore designed to measure uptake of 
flavonoids from purified yeast vesicles expressing each MATE protein. AtTT12 has been shown 
to be expressed in an active form from both a constitutive and inducible promoter system 
(Marinova et al., 2007; Zhao and Dixon, 2009; Zhao et al., 2011), whilst MtMATE1 and MtMATE2 
have been characterised utilising a galactose inducible promoter. 
 
Figure 3-25 Transport assays in yeast  
For the MATEs, if the proteins are expressed at the plasma membrane a whole yeast assay approach is 
needed. A.) The yeast culture is incubated in substrate and the yeast expressing the MATE would be 
expected to have a lower intracellular concentration due to export from the cell. B.) If the proteins are 
localised to internal membranes, the yeast microsomes can be extracted for an import assay. 
 
3.3.9.1 Overexpression of CrMATE1952 and CrMATE10740 in yeast 
 
CrMATE1952 and CrMATE10740 were cloned as C-terminal GFP fusions into the gateway 
compatible yeast expression vector pYES-DEST52. This plasmid is used for inducible protein 
expression under control of the galactose inducible promoter GAL1 and has been used in the 
characterisation of MtMATE2, AtTT12 and MtMATE1 (Zhao and Dixon, 2009; Zhao et al., 2011). 
The use of an inducible GAL1 promoter was chosen as it has been shown to increase the amount 
of protein expressed for eukaryotic membrane proteins, relative to using constitutive promoters 
(Newstead et al., 2007). The CrMATE1952-GFP and CrMATE10740-GFP fusions were expressed 
in three different yeast strains, InvSCI, WATII, and ybtI. 
Whole cell 
export assay
Microsomal 
extraction and 
import assay
S. cerevisiae S. cerevisiae S. cerevisiae
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Unfortunately overexpression of CrMATE1952-GFP and CrMATE10740-GFP proteins as C-
terminal GFP fusions in S. cerevisiae, upon induction by galactose, did not result in the defined 
membrane localisation of these proteins to either the plasma membrane, or an internal 
membrane, as has been observed with the other functionally characterised MATE proteins; 
NtMATE1/2, NtJAT1, NtJAT2, AtTT12, MtMATE1, MtMATE2, AM1 and AM3 (Gomez et al., 2009; 
Marinova et al., 2007; Morita et al., 2009; Shitan et al., 2014; Shoji et al., 2009; Zhao and Dixon, 
2009; Zhao et al., 2011). 
Expression of CrMATE10740-GFP or CrMATE1952-GFP resulted in localisation primarily to the 
lytic vacuole lumen in S. cerevisiae when visualised using confocal microscopy in the three 
different yeast strains, InvSCI, WAT11 and ybt1 (Figure 3-26). 
This mislocalisation has also been observed for the nicotine transporting MATE protein NtJAT2 
(Shitan et al., 2014).  The NtJAT2-GFP fusion has a dual targeting to the plasma membrane, as 
well as the vacuolar lumen. The localisation of the GFP signal to the vacuolar lumen was 
hypothesised to be due to membrane protein mistargeting and the subsequent digestion of the 
protein by yeast proteases. As GFP is stable to proteolytic degradation it therefore localised to 
the vacuolar lumen. This was confirmed by a western blot with a GFP antibody which 
demonstrated the presence of two bands for the size of the NtJAT2-GFP fusion and free soluble 
GFP (Shitan et al., 2014). 
A western blot of crude membranes from CrMATE10740-GFP in InvSC1 and WAT11 only resulted 
in a band with the same size as GFP when targeted with an anti-GFP antibody. For the 
CrMATE1952-GFP expressing yeast strains InvSCI or WATII no band was detectable with this anti-
GFP antibody (Figure 3-27). 
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Figure 3-26 Heterologous expression of CrMATE1952-GFP and CrMATE10740-GFP in S. cerevisiae. 
A.) Expression of CrMATE1952-GFP in two different strains of S. cerevisiae WATII and InvSCI and 
visualisation by confocal microscopy. B.) Expression of CrMATE10740-GFP in three different strains of S. 
cerevisiae WATII, InvSCI and ybtI and visualisation by confocal microscopy. (l-r) Brightfield, GFP-
fluorescence, Merge. Scale bar = 5 µm. 
 
 
Figure 3-27 Western blot of microsomal membranes from GFP, CrMATE1952-GFP and CrMATE10740-
GFP expressing yeast strains.  
Western blot of yeast microsomal membranes extracted from 1. Untransformed yeast 2. GFP expressing 
WATII 3. CrMATE10740-GFP InvSCI colony1 4. CrMATE10740-GFP InvSCI colony2 5. CrMATE10740-GFP 
WATII colony1 6. CrMATE1952-GFP InvSCI colony1 7.) CrMATE1952-GFP InvSCI colony2 8.) CrMATE1952-
GFP WATII colony1. Each lane was loaded with 10 µg/µl of protein.Membrane was labelled with an anti-
GFP antibody. 
 
A GFP expressing yeast strain showed that the localisation of the GFP signal from free GFP, and 
GFP derived from expressing the CrMATE-GFP fusions was different (Figure 3-28). This is 
indicative that the GFP derived from the CrMATE-GFP constructs are likely to be due to the 
transporter protein products being degraded in the lytic vacuole, with the GFP from the fusion 
accumulating in the vacuolar lumen. 
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In order to assess whether the cloning strategy and yeast strains utilised in this study are suitable 
for C. roseus membrane transporter expression, a putative purine permease CrPUP_1443 that 
is expressed in C. roseus leaf tissue, was cloned and expressed as a C-terminal GFP fusion in all 
yeast strains using the vector pYES-DEST52 (Figure 3-28).  
In all yeast strains, the CrPUP_1443-GFP fusion localised to a different subcellular compartment 
to either CrMATE10740-GFP or CrMATE1952-GFP, namely both the plasma membrane as well 
as internal vesicles. This is reminiscent of the MATE transporters NtJAT1, NtJAT2, NtMATE1, and 
is indicative that the cloning strategy we have used is suitable for membrane protein expression, 
and that CrMATE1952 and CrMATE10740 may not be amenable to heterologous expression in 
S. cerevisiae. 
 
 
Figure 3-28 Heterologous expression of GFP and CrPUP_1443-GFP in S. cerevisiae. 
A.) Expression of GFP in three different strains of S. cerevisiae WATII, InvSCI and ybtI and visualisation by 
confocal microscopy. B.) Expression of CrPUP_1443-GFP in three different strains of S. cerevisiae WATII, 
InvSCI and ybtI and visualisation by confocal microscopy. Highlighted by white arrows is the plasma 
membrane of the yeast to which CrPUP_1443-GFP localised. (l-r) Brightfield, GFP-fluorescence, Merge. 
Scale bar = 5µm. 
 
Furthermore expression of CrMATE10740-GFP by the group of Vincent Courdavault, University 
of Tours, in a different yeast strain AD12345678 resulted in the same localisation as that of 
CrMATE10740-GFP in WAT11 (unpublished results; personal communication) and the group of 
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Marianna Sottomayer were also unsuccessful in stably expressing CrMATE1952-GFP in S. 
cerevisiae (unpublished results; personal communication). 
3.3.10 Heterologous expression in Xenopus laevis oocytes. 
 
An alternative system to test for transport is the Xenopus oocyte expression system. In this 
system, linear cRNA derived from in vitro transcription, encoding the transporter to be 
expressed, is microinjected into the Xenopus oocyte for protein expression. The protein is likely 
expressed at the plasma membrane of the oocyte and transport assays can then be performed 
relative to water injected controls, to assess whether the transporter can move the substrate 
(Figure 3-29). 
 
Figure 3-29 Scheme for Xenopus oocyte expression.  
Xenopus laevis oocytes can be utilised for the heterologous expression of membrane proteins through 
the microinjection of linear cRNA containing the gene of interest. Depending on the directionality of 
transport, an import assay or export assay can be performed, and LC-MS utilised to detect the transport 
of the substrate. The export assay is technically more challenging as it requires either the co-injection of 
the substrate with the cRNA or the separate injection of substrate. 
 
 
For the MATE proteins that have been characterised to date, the general directionality of 
transport is away from the cytoplasm. Therefore, in planta, if these transporters are expressed 
at the tonoplastic membrane, they move substrates into the vacuole, whilst expression at the 
plasma membrane would result in the movement of the substrate out of the cell.  
For the Xenopus oocyte based assay in which the MATEs are expressed at the plasma membrane 
an export assay is required. In this scheme the transport assay requires the microinjection of the 
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substrate into the oocyte, as well as the cRNA, and subsequent measurement of substrate levels 
in the oocyte. The assumption is that the oocytes expressing the correct transporter will contain 
less substrate than the negative controls. This methodology has previously been employed for 
MATE proteins in the characterisation of organic acid export (Durrett et al., 2007; Furukawa et 
al., 2007). 
3.3.10.1 Microinjection of secologanin into Xenopus oocytes 
 
To assess whether the substrate secologanin is compatible with the Xenopus assay system, and 
whether there are any endogenous transport systems for the substrate that may affect the 
transport assay, 50 nl of a secologanin stock solution at concentrations of 1 mM, 5 mM and 10 
mM was injected into untransformed Xenopus laevis oocytes, and incubated in MBS buffered 
saline for two days. The oocytes were subsequently homogenised and extracted in methanol for 
2 hr at 60 oC, and the methanolic extract monitored by LC-MS. 
As can be seen in Figure 3-30 and Figure 3-31 after two days there is no detectable secologanin 
in the oocytes injected with 1 mM or 5 mM, whilst there is some residual secologanin detected 
when oocytes were injected with 10 mM.  
It appears that the oocytes reduce secologanin to secologanol, since a peak of m/z 413 that co-
elutes with the secologanol product of VIGS-CrMATE1952 silencing is observed (Figure 3-31). 
This suggests that the oocyte expresses a non-specific reductase that can convert the aldehyde 
of secologanin to the alcohol, perhaps as a detoxification mechanism.  
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Figure 3-30 Metabolite profile upon microinjection of Xenopus laevis oocytes with secologanin. 
For each concentration of secologanin 20 Xenopus laevis oocytes were microinjected with either 50 nl 1 
mM secologanin, 5 mM secologanin and 10 mM secologanin. For each datapoint 5 oocytes were pooled, 
extracted in methanol and analysed by LC-MS. This therefore resulted in 4 replicates for each injected 
concentration. No secologanin or secologanol was identified upon injection of 50 nl 1 mM secologanin. 
All data shown are mean + SEM. 
 
 
Figure 3-31 Representative Extracted Ion Chromatogram of m/z 413 and m/z 411 Xenopus laevis 
oocytes injected with secologanin. 
Xenopus laevis oocytes were microinjected with either 50 nl 1 mM secologanin, 5 mM secologanin and 10 
mM secologanin. For each concentration, 5 oocytes were pooled, extracted in MeOH and run by LC-MS. 
A.) Extracted ion chromatogram of m/z 411 (secologanin) and m/z 413 (secologanol) for oocytes injected 
with 10 mM secologanin. B.) Extracted ion chromatogram of m/z 411 (secologanin) and m/z 413 
(secologanol) for oocytes injected with 5 mM secologanin. 
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The derivatisation of secologanin will complicate characterisation of CrMATE1952 in this 
heterologous host.  
This provides further evidence for the importance of subcellular compartmentation of this 
substrate in C. roseus, and indicates that its storage and localisation to the plant vacuole may be 
an integral mechanism to prevent secologanin reduction. An alternative approach to this 
methodology would be to microinject the Xenopus oocytes with substrate immediately prior to 
performing the oocyte assay. This method, however, would be more technically challenging as 
it would require two injections of the oocytes. 
3.3.11 Overexpression in N. benthamiana 
 
An alternative expression system to S. cerevisiae or X. laevis oocytes, is through the use of N. 
benthamiana expression. Transient over expression of the two MATE transport proteins 
CrMATE10740 and CrMATE1952 in N. benthamiana, utilising agroinfiltration, together with the 
purification of vacuoles from this leaf tissue, can be used for transport assays across the 
tonoplast membrane. 
Due to the proposed directionality of transport, in which the CrMATE1952 is hypothesised to 
result in the import of secologanin into the vacuole, a transport assay for secologanin can be 
conducted across the tonoplast membrane with the contents of the vacuoles expressing the 
CrMATE1952 transporter and negative control vacuoles assessed for secologanin uptake by LC-
MS. 
The full length CrMATE10740 and CrMATE1952 genes were cloned into the pEAQ-HT DEST1 
expression vector and transformed into A. tumefaciens strain LBA4404 for transient 
overexpression by agroinfiltration in N. benthamiana. 
Overexpression of CrMATE10740 for harvesting of vacuoles was not feasible as the expression 
of the native protein resulted in the cell death of the infiltrated leaves. This phenomenon 
occurred irrespective of the optical density used to infiltrate the leaf tissue (Figure 3-32). 
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Figure 3-32 Overexpression of CrMATE10740 in N. benthamiana leaf tissue 
Agroinfiltration of N. benthamiana leaves for expression of the CrMATE10740 protein using the pEAQ-HT 
system resulted in cell death of the leaf tissue. A.) Expression of pEAQ-HT-CrMATE10740. B.) Expression 
of pEAQ-HT GFP. Infiltrated leaves are highlighted by white arrows. 
 
In contrast, over expression of the CrMATE1952 leaf tissue did not result in cell death, and, as 
has been shown previously in this chapter, expression of a C-terminal GFP fusion of CrMATE1952 
in N. benthamiana epidermal cells resulted in fluorescence in membrane vesicle compartments 
(Figure 3-6). We have been able to isolate protoplasts and generate vacuoles from N. 
benthamiana plant tissue (Figure 3-33). Therefore, the stage is now set to utilise this expression 
system to functionally characterise the CrMATE1952 protein. 
 
 
Figure 3-33 Purification of plant vacuoles from N. benthamiana.  
A.) Brightfield image of N. benthamiana mesophyll protoplasts. Scale bar = 100 µm B.) Brightfield image 
of vacuoles purified from N. benthamiana mesophyll protoplasts by osmostic lysis and ultracentrifugation 
on a Ficoll gradient. Neutral red stain was used for visualisation of the vacuoles. Scale bar = 60 µm. Both 
images were AF6000 stereo brightfield microscope.  
 
 
119 
 
3.4 Conclusion 
 
This chapter presents the first example of a MATE transporter directly affecting iridoid glycoside 
formation in C. roseus. Silencing of the CrMATE1952 transporter resulted in a clear metabolic 
phenotype, with the accumulation of a new compound that, based upon co-elution with known 
standards, is likely to be the reduced product of the iridoid glycoside secologanin, secologanol. 
The localisation of the transporter to the tonoplast membrane, together with the metabolic 
phenotype observed, suggests that this transporter is likely to be a secologanin importer into 
the vacuole, and the observed metabolic phenotype occurs because the redistribution of 
secologanin in the cytoplasm leads to its reduction.  
Although silencing of this transporter led to a reproducible metabolic phenotype involved in 
iridoid glycoside biosynthesis, the effect on the downstream alkaloids is minimal, suggesting that 
other transporters might also be involved in secologanin import. 
Individually silencing other MATE transporters in C. roseus, as well as combinatorially silencing 
these transporters, did not lead to a phenotype that is greater than singly silencing CrMATE1952. 
Therefore, to date, we only have evidence to suggest that CrMATE1952 is involved in iridoid 
glycoside transport.  
It is possible that other transporter families other than the MATEs are also involved in 
secologanin import, and therefore the combinatorial silencing of disparate transporter classes 
may provide a method for generating novel metabolic phenotypes in C. roseus. 
The work described in this chapter highlights the importance of subcellular compartmentation 
involved in aldehyde metabolism. Secologanin accumulates in C. roseus leaf tissue, and it is 
possible that its import into the vacuole prevents its derivatisation to the less reactive alcohol 
secologanol. As has been observed, silencing this tonoplast localised transporter, as well as over-
feeding secologanin to wild type plants, is likely to lead to the subcellular redistribution of 
secologanin. This subsequently results in the accumulation of the reduced product of 
secologanin, secologanol (m/z 391 (H+ adduct) and m/z 413 (Na+ adduct)). 
The importance of subcellular localisation is further emphasised by the fact that other non-plant 
organisms also possess mechanisms for the reduction of secologanin. Microinjection of 
secologanin into Xenopus laevis oocytes resulted in the reduction of secologanin to a peak of 
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m/z 413, indicating that an unrelated species possesses a promiscuous reductase for 
detoxification of this aldehyde.  
The localisation of secologanin to the vacuole thereby provides a mechanism by which this 
substrate is able to accumulate in the plant without its derivatisation, and highlights the 
importance of the subcellular localisation of this metabolic pathway in controlling the 
accumulation of reactive intermediates, which are needed as substrates for alkaloid 
biosynthesis.  
Sequestration of intermediates might be especially important in the context of a convergent 
metabolic network. The formation of strictosidine, the key metabolic branchpoint in the MIA 
pathway, occurs as a result of condensation of the product of tryptophan, tryptamine and the 
iridoid glycoside secologanin. If there is a discrepancy in the rate of formation of tryptamine and 
secologanin, and tryptamine formation becomes limiting relative to secologanin, the storage of 
secologanin in the vacuole prevents its derivatisation to the alcohol secologanol. 
With regards to this, it is interesting that CrMATE1952 is the gene that is both co-regulated at 
the transcriptional level with known genes in the biosynthetic pathway, as well as being 
clustered on the genome with tryptophan decarboxylase and strictosidine synthase. It is possible 
that this spatial proximity on the genome is integral for co-regulation of these genes. The co-
regulation and genomic location hints that the two branches of the convergent metabolic 
pathway to strictosidine synthesis via iridoid glycoside metabolism and the decarboxylation of 
tryptophan are intricately connected. Further work to pick apart how the pathways of 
tryptamine synthesis and iridoid glycoside transport are related is still needed. 
In the context of metabolite damage, it is known that small molecules are often damaged by 
side reactions from promiscuous enzymes or through spontaneous chemical reaction, and repair 
pathways are needed to mitigate the effect of this. Key examples of this include the repair of 
hydrated NAD(P)H back to NAD(P)H through the action of a fused dehydratase-epimerase 
(Niehaus et al., 2014) or the repair of 5-formyltetrahydrofolate back to 5,10-
methenyltetrahydrofolate by the 5-formyltetrahydrofolate cycloligase (Linster et al., 2013). The 
transport of secologanin into the vacuole therefore potentially represents a pre-emptive 
mechanism to prevent the inappropriate reduction to the non-useful side product secologanol. 
In vitro evidence for transport of secologanin by CrMATE1952 has not been possible in S. 
cerevisiae, as the protein is not appropriately expressed, or Xenopus oocytes, as the endogenous 
metabolism of secologanin by the oocytes prevents analysis of export. Preliminary evidence 
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suggests we are able to extract vacuoles from N. benthamiana expressing CrMATE1952 and we 
are now in the position to attempt transport assays for this protein across the tonoplast 
membrane. 
3.5 Future directions  
 
There are a number of future directions and alternative experiments that can be proposed for 
the characterisation of the MATEs involved in secologanin transport. 
1.) As has been described previously, further VIGS experiments are necessary to assess whether 
other transporters are involved in secologanin vacuolar import. This would utilise the 
combinatorial VIGS stacking approach that has been developed in this study, and would allow 
for the silencing of multiple transporter families in one VIGS experiment. 
2.) VIGS is a reverse engineering approach that allows relatively fast screening for metabolic 
phenotypes when compared to other reverse genetic engineering approaches such as RNAi and 
genetic knock out. Now that a metabolic phenotype has been identified for the MATE 
transporter CrMATE1952 it could be feasible to knock out the gene in C. roseus. A genetic knock 
out would confirm whether the lack of a phenotype on the downstream alkaloids for this 
transporter is due to the functional redundancy of this transporter. If the transporter is 
functionally redundant, we would expect the same metabolic phenotype that we observe by 
VIGS. If however, the lack of a phenotype for downstream alkaloids is due to the fact that there 
is enough basal activity of the CrMATE1952 transporter upon VIGS silencing to maintain flux for 
MIA biosynthesis, a genetic knock out of this transporter should have a greater cumulative effect 
on the MIA levels. 
3.) We need to utilise the N. benthamiana vacuole preparation method, coupled to 
overexpression of CrMATE1952 in this heterologous host, to assess whether these vacuoles can 
transport secologanin to a greater extent than endogenous N. benthamiana vacuoles, to provide 
further definitive proof that this transporter is involved in the translocation of secologanin. 
Iridoid biosynthesis is a crucial part of the biosynthetic pathway for high value anti-cancer agents 
produced by this plant, and we have uncovered a transporter for this pathway. Altogether this 
work highlights the importance of a MATE transporter in the distribution of secologanin in C. 
roseus leaf tissue, and how the subcellular distribution of reactive intermediates is integral to 
prevent their derivatisation in metabolic pathways. This appears to be especially important in 
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the context of a convergent metabolic pathway where the two convergent branches may not be 
occurring at the same rate. 
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4 Characterisation of C. roseus NPF transporters 
 
4.1 Introduction to NPF transporters 
4.1.1 Background to MFS transporters and the POT/PTR/NPF family of transporters. 
 
The major facilitator superfamily (MFS) is a transporter family that occurs ubiquitously in all 
living organisms (Pao et al., 1998). Unlike the ABC transporters, which utilize the energy of ATP 
hydrolysis for movement of small molecules and macromolecules across biological membranes, 
the MFS transporters are secondary transporters that utilize the chemiosmotic ion gradient for 
the movement of small molecules, and are involved in the transport of a wide spectrum of 
substrates (Pao et al., 1998). The MFS proteins encompass both facilitators, which transport a 
substrate down its concentration gradient, as well as secondary active transporters which utilise 
the energy of chemiosmotic ion gradients to couple the movement of a solute against its 
concentration gradient (Reddy et al., 2012).   
The major facilitator superfamily is divided into 91 subfamilies, in accordance with the 
transporter classification database (Saier et al., 2009). This superfamily is broadly characterised 
as having 12 transmembrane helices with a common structural fold comprising two discretely 
folded domains, each containing 6 α-helices with pseudo two fold symmetry, and with the N- 
and C-termini located on the cytoplasmic side of the membrane (Yan, 2015). To date, these 
transporters are thought to mechanistically transport the substrate across the membrane by an 
alternating access model. In this mechanism the substrate binding site is alternately exposed to 
either side of the membrane, allowing for solute movement across the lipid bilayer (Yan, 2013; 
Yan, 2015). 
The proton oligopeptide cotransporter family (POT/PTR/SLCA15) is a subfamily of the MFS 
proteins with four distinct homologues in humans, PepT1, PepT2, Pht1 and Pht2 (SLC15A1-A4) 
(Daniel and Kottra, 2004; Smith et al., 2013). This subfamily is present in all kingdoms of life. The 
bacterial, yeast and human homologues that have been characterised to date demonstrate 
transport of a range of substrates, including di- and tri-peptides, as well as the β-lactam 
antibiotics (Newstead et al., 2011). As transport of the di- and tri-peptides show no dependence 
on substrate sequence, this family therefore displays broad substrate specificity for in excess of 
8500 different substrates derived from the 20 proteinogenic L-α-amino acids (Daniel and Kottra, 
2004; Smith et al., 2013). The physiological role of these human proteins are dependent on their 
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tissue specific localisation, with PepT1 primarily localised to the intestine and kidney, and PepT2 
localised to the kidney, brain and lung (Daniel and Kottra, 2004; Smith et al., 2013). 
In planta the homologues of the bacterial, fungi and mammalian, POT/PTR/ SLC15 family 
members are known as the Nitrate and Peptide family (NPF) transporters, all of which display a 
conserved membrane topology with 12 predicted transmembrane helices. In comparison to 
bacteria, yeast and mammals, the functionality and size of this transporter family is considerably 
expanded in planta, with more than 50 members of this family in Arabidopsis.  
 In bacteria and mammals, the primary function of this transporter family appears to be in 
nitrogen assimilation from di and tri peptides (Daniel and Kottra, 2004; Newstead et al., 2011; 
Smith et al., 2013), whilst in planta this family has the capacity to transport a wide variety of 
substrates, and is therefore involved in a diverse array of physiological plant functions, however 
to date this family has primarily been associated with low affinity nitrate transport (Leran et al., 
2014). 
 A rigorous phylogenetic relationship of the plant NPF transporter family was performed utilising 
2398 protein sequences from 33 different plant genomes, and demonstrated that there are 
eight unambiguous clades in this family in plants, resulting in the characterisation of eight 
subfamilies NPF1-NPF8 (Leran et al., 2014). It is necessary to note that sequence homologies do 
not necessarily correlate with substrate specificity, with multiple families being able to transport 
the same substrates. Additionally some NPF transporters have the capacity to transport more 
than one substrate, and also act as metabolic sensors. 
 An overview of the known substrate specificities of the characterised NPF transporters from 
Arabidopsis to date is highlighted in Table 5 (Leran et al., 2014). 
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Table 5 NPF transporters in Arabidopsis thaliana 
Table adapted from (Leran et al., 2014). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Previous Name NPF nomenclature Substrate 
NRT1.11 AtNPF1.2 Unknown 
NAXT1 AtNPF2.7 Nitrate 
NRT1.9 AtNPF2.9 Nitrate/glucosinolates 
GTR1 AtNPF2.10 Nitrate/glucosinolates 
GTR2 AtNPF2.11 Nitrate/glucosinolates 
NRT1.6 AtNPF2.12 Nitrate 
NRT1.7 AtNPF2.13 Nitrate/glucosinolates 
Nitr AtNPF3.1 Nitrate/nitrite 
AIT3 AtNPF4.1 Abscisic acid 
AIT4 AtNPF4.2 Unknown 
NRT1.14 AtNPF4.3 Unknown 
NRT1.13 AtNPF4.4 Unknown 
AIT2 AtNPF4.5 Unknown 
NRT1.2/AIT1 AtNPF4.6 Nitrate/Abscisic acid 
PTR3 AtNPF5.2 Dipeptides 
NRT1.16 AtNPF5.13 Nitrate 
NRT1.15 AtNPF5.14 Nitrate 
NRT1.4 AtNPF6.2 Nitrate 
NRT1.1 AtNPF6.3 Nitrate/Auxin 
NRT1.3 AtNPF6.4 Nitrate 
NRT1.8 AtNPF7.2 Nitrate 
NRT1.5 AtNPF7.3 Nitrate 
PTR1 AtNPF8.1 Dipeptides 
PTR5 AtNPF8.2 Dipeptides 
PTR2/NTR1 AtNPF8.3 Dipeptides 
PTR4 AtNPF8.4 Unknown 
PTR6 AtNPF8.5 Unknown 
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In Arabidopsis, the low affinity nitrate transporter family, the NPF transporters, is a large gene 
family with ~53 members (Leran et al., 2014).  The expanded gene family of the NPF transporters 
suggests that there may be more diverse functional roles of these transporters, other than low 
affinity nitrate transport, that have not yet been elucidated.  
With the exception of the NPF8 subfamily, the majority of the NPF families contain members 
that have been shown to have at least low affinity nitrate transport (Chiang et al., 2004). An in 
depth analysis of the role NPF transporters play in nitrogen utilisation in planta is beyond the 
scope of this thesis, this discussion will focus on the diversity in substrate specificity that has 
been elucidated for this transporter class and the effect this specificity has on plant physiology. 
 
4.1.2 Characterisation of NRT1.1/AtNPF6.3 
 
The first described, and the best characterised, NPF transporter to date is 
NRT1.1/CHL1/AtNPF6.3. This transporter was first identified using a T-DNA tagged mutant of the 
low affinity uptake mutant chl1 (Tsay et al., 1993). Chlorate is a nitrate analogue that is toxic to 
plants due to its conversion to chlorite by nitrate reductase. Mutants in the NRT1.1 gene are 
resistant to chlorate and therefore deficient in nitrate uptake (Tsay et al., 1993). 
This transporter is primarily localised to the root, and is involved in both low and high affinity 
supply of nitrate to the plant from its external environment (Huang et al., 1996; Tsay et al., 1993; 
Wang et al., 1998). Uniquely this transporter displays both high and low affinity to external 
nitrate concentration when expressed in Xenopus oocytes, displaying biphasic kinetics for 
nitrate uptake (Huang et al., 1996; Liu et al., 1999; Wang et al., 1998). This biphasic kinetics is 
due to the specific phosphorylation of threonine residue 101 by a kinase CIPK23. Expression of 
a T101A mutant version of NRT1.1 in Xenopus oocytes displayed only low affinity kinetics, whilst 
expression of T101D, a phosphomimetic exhibits only high affinity nitrate uptake (Tsay et al., 
1993). This transporter, as will be discussed, also has substrate specificity for the plant hormone 
auxin (Krouk et al., 2010), however is not able to transport nitrite, alanine, sulphate, phosphate 
or dipeptides (Parker and Newstead, 2014). To date this is the only plant NPF transporter whose 
structure has been solved by X-ray crystallography (Parker and Newstead, 2014; Sun et al., 
2014). Crystal structures for both the wild type protein and the T101D phosphomimetic have 
been generated to assess the structural difference that allow for low affinity versus high affinity 
transport. As would be predicted the NRT1.1 adopts a classical major facilitator superfamily fold, 
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with 12 transmembrane α-helices centred on a pseudo two-fold axis between the two N-
terminal and C-terminal domains (Parker and Newstead, 2014; Sun et al., 2014). The central 
substrate binding site is very similar to the peptide transporters present in bacteria, such as the 
PepTSo from Shewanella oneidensis (Newstead et al., 2011). It is known that NRT1.1 utilises a 
proton gradient for the electrogenic transport of nitrate across cellular membranes, and an 
EXXER motif that has been shown to be integral for coupling proton movement in bacterial 
PepTSO is conserved in the Arabidopsis NRT1.1. This indicates that the mechanism for coupling 
proton movement is likely to be conserved irrespective of substrate specificity in these two 
related transporter classes (Parker and Newstead, 2014).  
 
4.1.3 Role of NPF transporters in transport of nitrate 
 
Although NRT1.1 displays dual affinity for nitrate, the majority of NPF transporters that have 
been characterised to date are solely low affinity nitrate transporters. As mentioned, 
NRT1.1/ATNPF6.3 is primarily expressed in the roots. The expression of this gene is inducible by 
the application of nitrate (Tsay et al., 1993). As well as an inducible system for nitrate uptake in 
the roots, Arabidopsis also has a constitutive low affinity nitrate uptake system, encoded by 
AtNRT1.2/AtNPF4.6 (Huang et al., 1999). 
In Arabidopsis, the role of the NPF transporters have primarily been shown to be involved in 
nitrogen mobilisation and assimilation in different plant tissues, with NPFs from different 
subfamilies, yet with low affinity nitrate activity, preferentially expressed in different tissues. 
Upon uptake of nitrate to the root there is a need to redistribute this nutrient in the plant 
through root to shoot nitrate translocation, which is achieved through loading of nitrate into the 
xylem. Mutation in the transporter AtNPF7.3 resulted in a decrease in the nitrate content of 
xylem sap, indicating this transporters role in nitrate xylem loading (Chen et al., 2012; Lin et al., 
2008). In contrast, mutations in transporters AtNPF7.2 and AtNPF2.9 result in an increase in the 
root to shoot translocation of nitrate, indicating that these transporters play a role in retaining 
nitrate in the root (Li et al., 2010; Wang and Tsay, 2011). The specific localisation of AtNPF7.2 to 
xylem parenchyma and AtNPF2.9 to the companion cells of root phloem support this hypothesis 
(Li et al., 2010; Wang and Tsay, 2011). 
Leaf specific expression of NPF genes is essential for nitrogen allocation and sequestration. 
AtNPF2.13 is involved in the remobilization of nitrate from older to younger leaves, and is 
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expressed in the phloem of older leaf tissue (Fan et al., 2009). The petiole has a unique function 
in nitrate homeostasis, and is a site of nitrate storage. The low affinity AtNRT1.4/AtNPF6.2 is 
only expressed in the petiole, and its mutation reduces the nitrate content of the petiole (Chiu 
et al., 2004) demonstrating the role of this transporter in localised nitrate sequestration. 
Similarly, nitrate transport is integral to the correct development of seeds, and the transporter 
AtNPF2.12 is specifically localised to the vascular bundle of siliques, and is required for correct 
embryo development (Almagro et al., 2008). Correct nitrate allocation in the embryo may also 
require the protein AtNPF5.5 (Léran et al., 2015). 
As shown, the distinct cellular localisation of these low affinity nitrate transporters directly 
impacts nitrogen metabolism in the plant, affecting nitrate reallocation that is integral to plant 
development, as well as in response to environmental fluctuations in nutrient availability. 
4.1.4 The NAXT transporter in Arabidopsis 
 
The AtNPF2.7(NAXT) is unique in its role as a nitrate efflux transporter, as all other characterised 
nitrate transporters are importers (Segonzac et al., 2007). NAXT1/AtNPF2.7 is localised at the 
plasma membrane, as has been determined by overexpression of a NAXT1-GFP fusion, together 
with immunoblotting of plasma membrane purified fractions from Arabidopsis root, and is 
primarily expressed in the mature root cortex. RNAi of the NAXT family did not result in a growth 
phenotype, however the roots from these plants contained 30% higher nitrate content relative 
to wild type plants (Segonzac et al., 2007). The naxt1 T-DNA insertion did not display a strong 
phenotype, however upon acid load, and acidification of the medium in which the plants were 
grown, the naxt1 T-DNA insertion plants displayed lower nitrate efflux activity relative to wild 
type controls. This efflux capacity is thought to be passive, and therefore thermodynamically 
downhill (Segonzac et al., 2007). Interestingly the NAXT1 protein does not contain the conserved 
EXXER motif which in bacterial peptide transporters, and also in the Arabidopsis NRT1.1, is 
conserved and thought to be involved in coupling transport to the proton gradient (Segonzac et 
al., 2007). 
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4.1.5 Role of NPF transporters in hormonal transport and plant development 
 
Although the low affinity nitrate activity of this transporter class is the best defined, there is a 
growing appreciation that the NPF transporters may have other substrate specificities, and be 
involved in hormone transport. 
As well as its role in nitrate transport, the NRT1.1/AtNPF6.3 transporter has an integral role in 
nitrate sensing, and is the first transceptor identified in plants. Nutrient sensing is critical for the 
development of a proper lateral root network (Krouk et al., 2010). Nitrate is the main nitrogen 
source for plants, however is also a key signal molecule for development of lateral roots, which 
occurs under high nitrogen concentration. In particular NRT1.1 is key for the formation of a 
nitrate regulated root system by stimulating lateral root growth in response to a local supply of 
nitrate. This regulation of lateral root growth is achieved by nitrate dependent control of auxin 
accumulation. In three heterologous expression systems, Xenopus laevis oocytes, tobacco BY2 
cells and yeast, NRT1.1 was shown to transport auxin (Krouk et al., 2010).  In a knockout mutant 
of NRT1.1 crossed with an Arabidopsis line that contains an auxin inducible GUS reporter system, 
auxin accumulated in lateral root primordia when grown in a range of nitrate concentrations, 
which was not observed in wild type, where auxin only accumulated in lateral roots at high 
nitrate concentration. This is indicative that NRT1.1 represses auxin accumulation at low 
external nitrate concentration, whilst high external nitrate competes with auxin as a substrate 
for NRT1.1, consequently leading to auxin accumulation in lateral roots (Krouk et al., 2010). 
This demonstrates how transport and nutrient sensing are elegantly intertwined with roles in 
plant development. 
As well as controlling local auxin concentrations, the NPF transporter family has been implicated 
in the transport of other plant hormones, such as abscisic acid.  
As has been mentioned previously abscisic acid is a key hormone involved in the response to 
abiotc and biotic stresses (Hetherington and Woodward, 2003). Through a yeast functional 
screen for ABA uptake, a number of NPF transporters were identified as being capable of 
transporting ABA (Kanno et al., 2012). The yeast screen effectively monitored the internal 
cellular accumulation of ABA through a yeast two hybrid system. PYR/PYL/RCAR ABA receptors 
interact with PP2C type protein phosphatases in the presence of abscisic acid. This interaction 
can be assessed by a yeast two hybrid system utilising a HIS3 selection marker. cDNA libraries in 
this yeast strain can be screened for survival on -HIS media, with the assumption that sequences 
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that allow the yeast to survive, increase the concentration of ABA inside the cell, allowing for 
expression of HIS3, and therefore the cDNA clone is likely to encode for an ABA importer (Kanno 
et al., 2012). Utilising this screening approach four NPF transporters were identified (AIT 1,2,3,4 
or AtNPF4.6, AtNPF4.5, AtNPF4.1 and AtNPF4.2) that had ABA import activity, with AIT1 and 
AIT3 having highest affinity. As should be noted AIT1/AtNPF4.6 is also the previously identified 
constitutive low affinity nitrate transporter present in roots. The transport activity was also 
tested independently by LC-MS and detection of ABA inside the yeast. AIT1 was specific for ABA 
and could not transport the other plant hormones gibberellin, auxin or jasmonic acid, whilst AIT3 
also had gibberellin uptake activity (Kanno et al., 2012). This uptake activity was also observed 
when the proteins were expressed in Spodoptera frugiperda (Sf9) insect cells. A GFP fusion of 
AIT1 preferentially localised to the plasma membrane, and loss of function of this protein 
resulted in a decrease in temperature of inflorescence stems, and more open stomata, 
suggesting a physiologically relevant role for the NPF transporter in ABA transport in planta 
(Kanno et al., 2012). As has been described previously for NRT1.1/CHL1/AtNPF6.3, the 
competition of transport between nitrate and auxin allows for NRT1.1 to act as a sensor that is 
crucial for correct plant development. In comparison, although interactions between ABA signals 
and nitrate have been speculated, nitrate does not compete with ABA as a substrate for 
AtNPF4.6 (Kanno et al., 2013). 
In Medicago truncatula abscisic acid is also transported by members of the NPF family, through 
a member of the NPF6 subfamily, annotated as MtNPF6.8 (Pellizzaro et al., 2014). 
Overexpression in N. benthamiana as a C-terminal GFP fusion resulted in localisation to the 
plasma membrane, with this gene expressed in both roots and shoots. The RNAi lines of 
MtNPF6.8 did not display any changes in the nitrogen status of the root, however, the 
knockdown lines were no longer sensitive to nitrate dependent inhibition of primary root length 
(Pellizzaro et al., 2014). Supplementation with exogenous ABA could restore this inhibition, and 
expression of MtNPF6.8 in Xenopus laevis oocytes demonstrated ABA uptake activity. This is 
indicative that MtNPF6.8 is a dual affinity transporter for both nitrate and ABA, and is likely to 
be involved in ABA dependent nutrient sensing in plant development (Pellizzaro et al., 2014). 
Similarly another Medicago truncatula NPF transporter, MtNPF1.7 has also been implicated in 
root architecture, with defects in lateral root organ development in npf1.7 mutants, whose 
phenotype could be rescued by exogenous application of abscisic acid (Yendrek et al., 2010). 
This demonstrates that multiple NPF transporter subfamilies may be co-ordinately involved in 
plant development, and hormone transport. 
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4.1.6 Alternative substrate specificities for NPF transporters 
 
In Arabidopsis the NPF subfamily 8 is unique in that it preferentially transports di- and tri-
peptides, like the human SLC15 transporters, and does not transport nitrate (Chiang et al., 2004). 
The first amino acid and peptide transporter belonging to the NPF 8 class was identified by a 
heterologous complementation approach in yeast mutants defective for histidine biosynthesis 
(Frommer et al., 1994). NTR1/AtNPF8.3 was identified as a histidine transporter, however has 
lower affinity for this amino acid in comparison to amino acid permeases. Furthermore 
NTR1/AtNPF8.3 was able to complement a yeast strain deficient in oligopeptide transport, and 
demonstrated high affinity, yet broad specificity, for di- and tri-peptide substrates (Frommer et 
al., 1994; Rentsch et al., 1995). AtNPF8.1 (AtPTR1), AtNPF8.2 (AtPTR5) and AtNPF8.3 
(AtPTR2/NTR1) have also been shown to be specific transporters for di- and tri-peptides through 
complementation in yeast. AtNPF8.1 and AtNPF8.2 proteins are localised to the plasma 
membrane in plants, whilst AtNPF8.3 is localised to the tonoplast (Dietrich et al., 2004; 
Komarova et al., 2008). 
Two members of the NPF8 family in Arabidopsis AtNPF8.4 (AtPTR4) and AtNPF8.5 (AtPTR6) have 
been shown to localize to the tonoplast membrane as opposed to the plasma membrane in 
planta, however their functional characterization has not been achieved in Xenopus laevis 
oocytes or in yeast (Weichert et al., 2012) and therefore the function of these transporters 
remains unclear. 
As well as the NPF8 subfamily, one member of the NPF5 subfamily from Arabidopsis, AtNPF5.2 
(PTR3) has been characterised as a dipeptide transporter through complementation in a yeast 
mutant defective in oligopeptide transport, and is upregulated in response to salicylic acid 
(Karim et al., 2007). In comparison, other members of the AtNPF5 family transport nitrate with 
no affinity for peptides (Léran et al., 2015). This again demonstrates that sequence homology is 
not necessarily a reliable predictor of substrate specificity (Karim et al., 2007). 
NPF transporters have also been implicated in organic acid transport. Alder is a plant species 
that is able to form a symbiotic relationship with the actinomycete Frankia. A nodule specific 
plant mRNA encoding a NPF transporter was identified, the protein product of which localises 
to the plasma membrane at the interface between the plant cell and the bacteria. Heterologous 
expression of the transporter in Xenopus laevis oocytes, yeast and E. coli demonstrated that this 
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transporter is specific for dicarboxylates, such as malate and succinate, and is likely to be 
involved in carbon supply to the bacterium (Jeong et al., 2004). 
4.1.7 Role of NPF transporters in secondary metabolism. 
 
The NPF transporter family has been implicated in the transport of secondary metabolites in 
Arabidopsis. The major defence compounds in Arabidopsis are a class of secondary metabolites 
known as glucosinolates (Nour-Eldin et al., 2012). These compounds are present ubiquitously in 
the plant, however upon senescence, there is a translocation of glucosinolates from leaf to 
seeds, as has been determined by monitoring 14C-labelled glucosinolates in planta. Two NPF 
transporters, GTR1 and GTR2 (AtNPF2.10 and AtNPF2.11), were identified in a screen of 
Arabidopsis transporters to have uptake activity in Xenopus oocytes for the model glucosinolate 
substrate 4-methylthiobutyl glucosinolate (4MTB) (Nour-Eldin et al., 2012). Biophysical 
characterisation of these transporters using two voltage electrode clamp in Xenopus laevis 
oocytes demonstrated that transport was dependent on the proton gradient, and that these 
transporters are capable of utilising a variety of glucosinolates as substrates, however there was 
no activity towards di- and tri- peptides. The gtr1/gtr2 double Arabidopsis mutant abolishes 
glucosinolate accumulation in the seeds, with a concomitant increase in methionine derived 
glucosinolates in leaf tissue, indicating a key role of these transporters in source to sink 
translocation. Complementation with GTR1 and GTR2 resulted in the re-establishment of seed 
glucosinolate content (Nour-Eldin et al., 2012). Both GTR1 and GTR2 localised to the plasma 
membrane, and whilst GTR1 is primarily associated with the mesophyll, GTR2 is localised to the 
vasculature of the plant, indicating a potential role in apoplasmic phloem loading of 
glucosinolates (Nour-Eldin et al., 2012). 
4.1.8 Summary to Introduction 
 
As has been demonstrated, the distinct subcellular and intercellular localisation of NPF 
transporters, which to date have been primarily shown to be low affinity nitrate transporters, is 
crucial for both nutrient sensing, and nitrogen allocation throughout the plant, and required for 
correct plant development. 
The recent discovery that the NPF class of transporters is involved in the transport of multiple 
substrates in Arabidopsis, including auxin, glucosinolates, abscisic acid, dicarboxylates, di- and 
tri-peptides, as well as low affinity nitrate transport, together with the fact that there are ~53 
members in the Arabidopsis genome, suggests this transporter class may have as of yet 
133 
 
unidentified substrate specificities, and could be involved in the transport of a wide variety of 
other compounds. As such it would be appealing to assess whether these transporters have any 
physiological role in MIA transport in C. roseus. This would be the first identification that the 
NPF transporters play a physiological role in secondary specialised metabolism, outside of 
Arabidopsis. 
To date, many approaches for the elucidation of NPF transporter function have centred on the 
in vitro characterisation of the transporter, through testing the transporters ability to 
complement defective yeast strains in oligopeptide or amino acid transport, or overexpression 
in Xenopus oocytes and testing transport on a range of substrates. I would argue to further 
assess the functionality of these transporters, it is necessary to test these transporters on a 
wider substrate repertoire, as was demonstrated in the elucidation of glucosinolate transporters 
(Nour-Eldin et al., 2012) or utilise a strategy whereby knocking down the transporter in a given 
tissue can be used to screen for a metabolic phenotype that could be indicative of substrate 
transport, as will be demonstrated in this chapter. 
4.2 Aims of this Chapter 
 
1.) To assess whether there are any NPF transport proteins that are involved in MIA metabolism 
in C. roseus using VIGS 
2.) Functionally characterise the NPF transporters that display a metabolic phenotype after 
transient silencing in planta. 
 
 
 
 
 
 
 
 
134 
 
4.3 Results and Discussion 
 
4.3.1 NPF transporters in C. roseus 
 
There are ~46 genes in C. roseus that are annotated as NTR/PTR family members in the 
transcriptomic databases of C. roseus from the MPGR C. roseus transcriptome. This is in good 
agreement with the number found in the Cathacyc transcriptomic resource (Van Moerkercke et 
al., 2013). 
The focus of this chapter will centre on the NPF2 subfamily of transporters present in C. roseus. 
The reason for focusing on this subfamily is two-fold. Firstly the NPF2 subfamily has been 
demonstrated to be involved in secondary metabolism in Arabidopsis, in transporting 
glucosinolates (Nour-Eldin et al., 2012), and secondly, as will be demonstrated, a homologue of 
the NPF2 family transcriptionally co-regulates with the biosynthetic genes in the MIA pathway. 
There are 10 homologues of the NPF2 subfamily in C. roseus that are present in the 
transcriptome for which full length sequences could be obtained. These homologues are 
annotated as CrNPF2.1-CrNPF2.10. 
The functionally characterised members of the NPF2 subfamily in Arabidopsis include the two 
glucosinolate transporters GTR1 and GTR2 (AtNPF2.10 and AtNPF2.11) (Nour-Eldin et al., 2012), 
a low affinity nitrate transporter involved in phloem loading for root to shoot nitrate 
translocation, NRT1.9 (AtNPF2.9) (Wang and Tsay, 2011) and in the reallocation of nitrate from 
old to young leaves, NRT1.7 (AtNPF2.13) (Fan et al., 2009), a low affinity nitrate transporter for 
nitrate transport into the developing embryo, NRT1.6 (AtNPF2.12) (Almagro et al., 2008), as well 
as the NAXT (AtNPF2.7) nitrate efflux transporter (Segonzac et al., 2007). 
A phylogenetic analysis of the C. roseus homologues (Figure 4-1) demonstrated, as would be 
expected, the candidates CrNPF2.1-CrNPF2.8 are most similar to the AtNPF2 family members, 
forming a clade. In comparison, CrNPF2.9 and CrNPF2.10 are in turn most similar to the 
Arabidopsis NAXT/AtNPF2.7 protein, whilst the other characterised proteins from Arabidopsis 
that are present in other subfamilies, NRT1.1 (AtNPF6.3), NRT1.2 (AtNPF4.6), as well as the di- 
and tri- peptide transporters, AtNPF8.1-AtNPF8.5, form a distinct clade (Figure 4-1). 
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Figure 4-1 Phylogenetic tree of C. roseus NPF2 family homologues. 
The CrNPF2 homologues are highlighted in this phylogenetic tree together with the AtNPF2 family 
members, AtNPF2.7, AtNPF2.9, AtNPF2.10, AtNPF2.11, AtNPF2.12, AtNPF2.13, as well as the AtNPF 
family members AtNPF4.6, AtNPF6.3 and AtNPF8.1-AtNPF8.5. The evolutionary history was inferred by 
using the Maximum Likelihood method based on the JTT matrix-based model, and the bootstrap 
consensus tree was inferred from 500 replicates. The percentage of replicate trees in which the 
associated taxa clustered together in the bootstrap test are shown next to the branches. Branches 
corresponding to partitions reproduced in less than 50% bootstrap replicates are collapsed. 
 
 
4.3.2 Transcriptomic profiling and candidate selection 
 
Hierarchical clustering and self-organising maps (Chapter II) were utilised to identify candidate 
transport proteins and enzymes that were co-regulated with the monoterpene indole alkaloid 
biosynthetic pathway. Together with the two CrMATES that have been described in Chapter III, 
the other transport protein that was tightly co-expressed with the pathway was the candidate 
CrNPF2.9, one of the CrNPF2 subfamily members that is closest to the NAXT homologue in 
Arabidopsis. A representative expression profile of the CrNPF2.9 transcript, together with the 
three biosynthetic genes in MIA metabolism, secologanin synthase, tryptophan synthase and 
strictosidine synthase, as well as the two MATE proteins identified, is shown in Figure 4-2. 
CrNPF2.9 is the fourth highest expressed NPF transporter in leaf tissue suggesting that as well 
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as its strong co-regulation with genes in the MIA pathway, it is also highly expressed in leaf 
tissue, the major site of MIA metabolism in C. roseus. 
The full length candidate gene of CrNPF2.9 was cloned from C. roseus leaf cDNA into a pCR8GW 
entry vector and sequenced, confirming the correct assembly of this gene in the transcriptome. 
 
 
Figure 4-2 Co-regulation of CrNPF2.9 with known genes in the biosynthetic pathway. 
Expression profile of CrNPF2.9 measured as the log2(FPKM) in the 23 different experimental conditions 
highlighted in Table1. The expression profile of the known co-regulated genes that are involved in MIA 
biosynthesis; secologanin synthase, tryptophan synthase and strictosidine synthase as well as the two 
CrMATE1952 and CrMATE10740 are also shown for comparison. 
 
4.3.3 Localisation of CrNPF2.9 to the tonoplast membrane 
 
4.3.3.1 Prediction of tonoplast localisation 
 
CrNPF2.9 is predicted to localise to the tonoplast membrane. The CrNPF2.9 contains an acidic 
di-leucine motif at its N-terminus, (D/E)X3-5L(L/I), which is known to be involved in the subcellular 
localisation of NPF transporter proteins to the tonoplast membrane (Komarova et al., 2012). This 
paper demonstrated that AtPTR2, AtPTR4 and AtPTR6 are localised to the tonoplast whilst 
AtPTR1 and AtPTR5 are localised to the plasma membrane, and that this acidic di-leucine motif 
is critical for the correct localisation of AtPTR2, 4 and 6 to the tonoplast membrane. The 
CrNPF2.9 transporter is the only CrNPF2 subfamily member to contain this motif at its N-
terminus (Figure 4-3).  
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Figure 4-3 The first 40 amino acids for the CrNPF2 family. 
Highlighted in yellow is the (D/E)X3-5L(L/I) present in CrNPF2.9 which does not occur in the other CrNPF2 
family members 
 
 
 
 
Additionally it has been reported that vacuolar localised proteins often contain more acidic 
residues throughout the protein sequence, and therefore have a considerably lower isoelectric 
point (pI) (Carter et al., 2004). 
For membrane proteins localised to the tonoplast there have also been reports that these 
proteins have a more acidic pI. This has been best described for the plant aquaporin family. The 
plasma membrane, PIP subfamily, of aquaporins have an isolectric point of ~9 whilst the 
tonoplast localised aquaporins, TIP subfamily, have an isoelectric point of ~6.0 (Gomes et al., 
2009). 
Similarly this phenomenon has also been observed for the NPF transporters. The tonoplast 
localised AtPTR2, 4, 6 have a pI in the range of 5.34-6.57, whilst the NPF transporters localised 
to the plasma membrane,  AtPTR1 and 5, have a pI of 8.3 and 7.87 respectively. Interestingly 
CrNPF2.9 has a considerably lower pI than the other 9 CrNPF2 transporters in C. roseus, with a 
predicted pI of 6.1, whilst the other CrNPF2 transporters have a pI in the range of 7.53-9.25 
(Table 6). 
 
 
 
 
 
Gene  N-terminal sequence 40 aa 
CrNPF2.1 MELEENKMKKQLSSTWFLCCSKCLPVNSSSSSSKVSSPNS 
CrNPF2.2 MDSKKTSSSWVSCCTKCLPTKPSNSKQNNGRHDEENQDMV 
CrNPF2.3 MESKNEHQMGKSSPWFNICSTKCLPINSSSKVSSPTSSSM 
CrNPF2.4 MAEKSSSIDATENGFVKIKEPNHRGVKAMPFIVGNETFEK 
CrNPF2.5 MEENQEHKAIKNHEPNYRGIKAMPFVIGNETFEKLGTIGT 
CrNPF2.6 MEKNEKLVPNGTKEDGKVAAKNEPNYRGIKAMPFVLGNET 
CrNPF2.7 MEKKETMDTKPKEEEEEEPQINYRGIKAMPYIIGNETFEK 
CrNPF2.8 MEKNQQKEGAMEEEPVLDVQEKPQIINYKGIKAMPYIIGN 
CrNPF2.9 MGDTEAQLLQPGHKQKGGWITFPFILATRTLLTLAVAGFS 
CrNPF2.10 MDDAENPKSSSASTKQGGWITFPFIIGTMAGMSLAAGGWV 
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Table 6 Isoelectric points for the CrNPF2 subfamily. 
The isoelectric point (pI) of the CrNPF2 subfamily members was performed utilising the ExPASY 
isoelectric point calculator 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.3.2 NPF transporter localisation and overexpression in N. benthamiana 
 
Overexpression of the CrNPF2.9 gene in C. roseus cell suspension culture as a C-terminal YFP 
fusion resulted in its localisation to the tonoplast membrane, and is consistent with our 
prediction of tonoplast localisation. This protein co-localised with the tonoplastic marker 
protein, a potassium channel from Arabidopsis, AtTPK1 (Figure 4-4). 
 
 
Figure 4-4 Overexpression of CrNPF2.9-YFP in C. roseus cell suspension cultures  
Co-localisation of CrNPF2.9 with the Arabidopsis potassium channel TPK1 i.) CrNPF2.9-YFP ii.) Arabidopsis 
TPK-CFP iii.) Merge iv.) Differential Interference Contrast. Scale bar = 10 µm  Cloning of the C. roseus 
CrNPF2.9 gene and Arabidopsis TPK1 gene into pEAQ-HT DEST1 was performed by R.Payne, subcloning 
and transformation by particle bombardment into C. roseus cell suspension cultures and visualisation by 
confocal microscopy was performed by Vincent Courdavault, University of Tours. 
 
Gene Name Isoelectric point (pI) 
CrNPF2.1 7.53 
CrNPF2.2 8.74 
CrNPF2.3 8.76 
CrNPF2.4 9.25 
CrNPF2.5 8.95 
CrNPF2.6 9.16 
CrNPF2.7 9.1 
CrNPF2.8 8.81 
CrNPF2.9 6.1 
CrNPF2.10 9.18 
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Additionally, overexpression of a CrNPF2.9-GFP fusion using the pEAQ-HT system and 
agroinfiltration in N. benthamiana resulted in the localisation to a membrane in N. benthamiana 
epidermal cells, which is likely to be the tonoplast due to the presence of trans-vacuolar strands 
(Figure 4-5). 
 
 
Figure 4-5 Expression of CrMATE1952-GFP in Nicotiana benthamiana epidermal cells. 
Overexpression of CrNPF2.9-GFP using Agrobacterium tumefaciens infiltration of N. benthamiana in the 
pEAQ-HTDEST1 expression vector and visualisation by confocal microscopy. A.) MES buffer infiltrated N. 
benthamiana leaf tissue B.) Overexpression pf CrNPF2.9-GFP using the pEAQ-HTDEST1 expression 
vector. White arrows indicate the localisation of CrNPF2.9-GFP to trans-vacuolar strands in N. 
benthamania epidermal cells. Scale bar = 20 µm. 
 
 
4.3.4 VIGS CrNPF2.9 
 
To assess the physiological relevance of CrNPF2.9 in C. roseus, a VIGS pTRV2u silencing vector 
containing ~500 bp of the gene for the NPF-transporter CrNPF2.9 was generated. As can be seen 
from the phylogenetic tree, the closest homologue of CrNPF2.9 in C. roseus is the protein 
CrNPF2.10.  
Although this transporter is the closest homologue to CrNPF2.9, it has less than 50% sequence 
identity at the nucleotide level and there is no region that has a contiguous sequence of more 
than 20 bp that would allow for cross-silencing in the VIGS experiment. Similarly a BLAST search 
of the ~500 bp region of the gene used for VIGS against the C. roseus transcriptome did not 
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result in the identification of other genes with a contiguous stretch of 20 bp indicating a low 
chance of cross-silencing. 
 VIGS of this transporter led to a significant metabolic phenotype, resulting in the ~20 fold 
greater accumulation of the intermediate strictosidine compared to empty vector controls. A 
significant decrease in the downstream alkaloids, vindoline and catharanthine, was also 
observed (Figure 4-6). As will be discussed in section 4.3.4.4, silencing also led to a physiological 
blackening of the leaf tissue. 
The VIGS experiment has been independently replicated multiple times, and each time the same 
metabolic phenotype was observed. Three independent replicates of this silencing experiment 
are presented in Figure 4-7. 
 
Figure 4-6 Representative Total Ion Chromatogram for VIGS-EV and VIGS-CrNPF2.9  
Methanol extracts of leaf tissue from A.) VIGS-CrNPF2.9 and B.) VIGS-EV were analysed by LC-MS. 
Presented are the total ion chromatograms. Highlighted in the red box is the peak corresponding to 
strictosidine. 
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Figure 4-7 Metabolite profile upon VIGS of CrNPF2.9 from three independent VIGS experiments. 
A.) Alkaloid profile for VIGS of CrNPF2.9 relative to empty vector control tissue in Little Bright Eyes VIGS 
CrNPF2.9 (n=8) VIGS-EV (n=14) ** p<0.01 B.) Alkaloid profile for VIGS of CrNPF2.9 relative to empty 
vector control tissue in Little Bright Eyes VIGS CrNPF2.9 (n=12) VIGS-EV (n=10) ** p<0.01 C.)Alkaloid 
profile for VIGS of CrNPF2.9 relative to empty vector control tissue in Little Bright Eyes VIGS CrNPF2.9 
(n=8) VIGS-EV (n=12) ** p<0.01. All data shown is mean + SEM. 
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4.3.4.1 Proposed role of CrNPF2.9 in MIA metabolism 
 
The metabolic phenotype observed upon silencing the CrNPF2.9 gene is consistent with the 
CrNPF2.9 protein being responsible for the transport of strictosidine out of the vacuole. As has 
been mentioned in Chapter I, strictosidine synthase is localised to the vacuole, whilst the next 
enzyme in the pathway, strictosidine β-glucosidase, is localised to the nucleus (Guirimand et al., 
2010). This therefore requires the transport of strictosidine out of the vacuole for subsequent 
downstream processing to other MIAs.  
The fact that CrNPF2.9 is localised to the tonoplast membrane, and when silenced leads to the 
accumulation of strictosidine, together with the concomitant decrease in downstream MIAs, 
vindoline and catharanthine, is indicative that this protein is likely to be the strictosidine 
exporter from the vacuole. 
 
 
Figure 4-8 Strictosidine is exported from the vacuole after synthesis  
A.) Strictosidine is synthesised in the vacuole by strictosidine synthase and exported for production of 
downstream alkaloids such as vindoline. B.) Silencing of CrNPF2.9 resulted in the accumulation of 
strictosidine and the decrease in vindoline (highlighted by a red arrow), which is consistent with it being 
the strictosidine exporter from the vacuole. 
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This is the first in vivo indication that the NPF transporter family is involved in MIA metabolism 
and is physiologically relevant in planta. This is also the first time, outside of Arabidopsis that 
this transporter family has been shown to be involved in secondary metabolism. 
4.3.4.2 Untargeted metabolomics VIGS-CrNPF2.9 leaf tissue 
 
As well as the accumulation of strictosidine, a compound with m/z 499 also accumulated upon 
CrNPF2.9 silencing. This compound is present at a low level in the VIGS-EV tissue and this 
phenotype is reproducible across all VIGS-CrNPF2.9 experiments (Figure 4-9). 
 
 
Figure 4-9 Accumulation of m/z 499 upon CrNPF2.9 silencing 
This data is from the same three independent VIGS experiments presented in Figure 4-7 A.) m/z 499 profile 
for VIGS of CrNPF2.9 relative to empty vector control tissue in Little Bright Eyes VIGS CrNPF2.9 (n=8) VIGS-
EV (n=14) ** p<0.01 B.) m/z 499 profile for VIGS of CrNPF2.9 relative to empty vector control tissue in 
Little Bright Eyes VIGS CrNPF2.9 (n=12) VIGS-EV (n=10) ** p<0.01 C.) m/z 499 profile for VIGS of CrNPF2.9 
relative to empty vector control tissue in Little Bright Eyes VIGS CrNPF2.9 (n=8) VIGS-EV (n=12) ** p<0.01. 
All data is mean + SEM. 
 
 
The identity of this compound is unknown, however the m/z value is consistent with a derivative 
of strictosidine, strictosamide. Additionally, the MS2 fragmentation pattern of this compound is 
also consistent with this compound (Figure 4-10). 
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Figure 4-10 Analysis of m/z 499 accumulating in VIGS-CrNPF2.9 leaf tissue. 
A.) Representative extracted ion chromatograms for m/z 499 in methanolic extracts of VIGS-CrNPF2.9 
(blue) and VIGS-EV (black) leaf tissue analysed by LC-MS. B.) MS and MS2 spectra of m/z 499 
accumulating in VIGS-CrNPF2.9 leaf tissue C.) Proposed structures corresponding to the fragmentations 
in the MS2 spectra. 
 
 
The accumulation of strictosamide would be consistent with the hypothesis that the 
accumulation of strictosidine in the vacuole could subsequently lead to its derivatisation and 
intramolecular cyclisation, which is known to happen under non-enzymatic conditions. 
Alternatively, it is also feasible that the accumulation of this compound is an artefact of the 
extraction procedure of VIGS-CrNPF2.9 tissue and this cyclisation is promoted due to the higher 
concentration of strictosidine in the sample. 
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4.3.4.3 VIGS of CrNPF2.9 stem tissue 
 
Metabolite analysis of the stem tissue from C. roseus NPF silenced plants taken from around the 
wound site from VIGS pinching, indicated that the silencing also affects the stem alkaloid 
pathway. Unlike in leaf tissue, the dominant alkaloid in stem is the peak with m/z 349, which 
represents a mixture of serpentine and alstonine, as opposed to vindoline m/z 457 (Figure 4-11). 
 As would be expected, in CrNPF2.9 silenced plants there is an increase in the amount of 
strictosidine present in stem tissue. This indicates biosynthesis of MIAs is not leaf specific, and 
that this metabolic pathway is active in stem tissue. This also indicates that the CrNPF2.9 
transporter is also likely to be involved in MIA metabolism in multiple tissues. 
 
 
 
Figure 4-11 Metabolite analysis of stem tissue upon CrNPF2.9 silencing 
A.) Alkaloid profile of stem tissue taken from around VIGS wound site for empty vector control (n=4) and 
CrNPF2.9 silenced plants (n=4) and uninfected stem (n=4) ** p < 0.01. All data is mean + SEM. B.) 
Representative photos of stem tissue from I.) VIGS-CrNPF2.9 plants II.) VIGS-EV stem 
 
4.3.4.4 Blackening leaf tissue upon CrNPF2.9 VIGS 
 
The metabolic phenotype observed upon CrNPF2.9 silencing is accompanied by a blackening of 
the leaf and stem tissue (Figure 4-11, Figure 4-12). This observed phenotype is likely to be caused 
as a result of cell death, which we think is due to the high levels of strictosidine accumulating in 
the leaf tissue, which may be toxic. 
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Figure 4-12 Blackening of VIGS-CrNPF2.9 leaf tissue. 
Silencing CrNPF2.9 results in blackening leaves. A.) Three leaves from  three separate VIGS-EV plants B.) 
Three leaves from three separate VIGS-CrNPF2.9 plants displaying the black phenotype. Highlighted by 
white arrows are the black regions. 
 
 
Staining the black leaf with 4',6-diamidino-2-phenylindole (DAPI) and propidium iodide and 
analysis by confocal microscopy indicated that the black tissue is necrotic tissue (Sikorskaite et 
al., 2013; Truernit and Haseloff, 2008). Propidium iodide staining of the leaf tissue stains the 
extracellular spaces and the plant cell wall, as is seen in the VIGS-EV control leaves (Figure 4-13). 
The uptake of the propidium iodide stain internally is indicative of cell death, as is seen with the 
black leaf upon silencing of the CrNPF2.9 transporter (Figure 4-13). Conversely DAPI staining 
specifically stains nuclei and double stranded DNA. As is shown for the VIGS-EV control tissue, 
DAPI staining results in staining of plant nuclei, whilst in the black leaf tissue from CrNPF2.9 
silenced plants the dye is diffuse, and does not stain nuclear structures, again indicating that the 
cells in the blackened area have undergone cell death (Figure 4-13).  
 
Figure 4-13 Confocal microscopy of VIGS-EV leaf tissue and VIGS-CrNPF2.9 leaf tissue displaying the 
black phenotype  
A.) DAPI and propidium iodide staining of VIGS-EV leaf tissue B.) DAPI and propidium iodide staining of 
VIGS-CrNPF2.9 leaf tissue. Scale bar = 30 µm. 
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4.3.4.5 Trypan blue staining VIGS-CrNPF2.9 black leaf tissue 
 
There are a number of potential reasons for the cause of this cell death. Firstly, the accumulation 
of strictosidine could be toxic to leaf tissue. Secondly, depletion of secondary metabolites upon 
CrNPF2.9 silencing may make the plant more susceptible to disease. To assess whether the black 
leaf tissue was due to the presence of a fungal pathogen, leaves from EV C. roseus and CrNPF2.9 
silenced black leaf tissue were stained with trypan blue, in order to detect fungal hyphae. As can 
be seen in Figure 4-14 trypan blue staining did not lead to the observation of fungal hyphae in 
CrNPF2.9 silenced or EV leaf tissue. However, interestingly visualisation of this cleared tissue 
under UV light resulted in yellow fluorescence which appears to be centred on the regions 
undergoing cell death.  
 
 
Figure 4-14 UV fluorescence of VIGS-CrNPF2.9 C. roseus leaf tissue 
A. Trypan blue stained VIGS-EV and VIGS-CrNPF2.9 leaf visualised under standard white light, after 
removal of chlorophyll. B. Trypan blue stained VIGS-EV and VIGS-CrNPF2.9 leaf visualised under UV light. 
2 leaves for VIGS-EV and VIGS-CrNPF2.9 are shown respectively. 
 
 
Additionally, when the methanolic extract from VIGS-CrNPF2.9 leaf samples is analysed by Thin 
Layer Chromatography (TLC), additional yellow fluorescence compounds are observed on the 
TLC plate relative to VIGS-EV controls (Figure 4-15). 
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Figure 4-15 UV fluorescence of VIGS-EV and VIGS-CrNPF2.9 leaf tissue methanol extracts from two 
different cultivars of C. roseus 
Methanol extracts of VIGS-EV and VIGS-CrNPF2.9 leaf tissue were run by silica TLC in 7:3 
Chloroform:MeOH and visualised by 365 nm UV A.) Methanol extracts from cultivar Little Bright Eyes I.) 
VIGS-EV plant 1 II.) VIGS EV plant 2 III.) VIGS-CrNPF2.9 B.) Methanol extracts Sunstorm Apricot I.) VIGS-
EV II.) VIGS-NPF2.9. Yellow fluorescent spots in VIGS-CrNPF2.9 leaf tissue is highlighted by a white 
dotted circle. 
 
 
The yellow fluorescent compounds could not be identified after extraction from the TLC silica 
and analysis by LC-MS, indicating these compounds may not ionise well in either positive or 
negative ionisation mode by electrospray ionisation. 
The reason for this yellow fluorescence specifically in VIGS-CrNPF2.9 leaf tissue, together with 
the visualisation of yellow fluorescent compounds upon visualisation of the methanolic extract 
of VIGS-CrPNF2.9 leaf tissue by silica TLC is interesting and requires further investigation. 
Yellow autofluorescence of leaf tissue under UV light (365 nm) is used as an indicator of cell 
stress, and this autofluorescence is often attributable to the accumulation of phenolic 
compounds (Klement et al., 1990). In the example we present here, the yellow autofluorescence 
is unlikely to be due to the accumulation of phenolic compounds, as these should be detectable 
by LC-MS in the methanolic extract of VIGS-CrNPF2.9 tissue. 
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4.3.4.6 Proposed causes of cell death 
 
Our current hypothesis as to the cause of cell death in VIGS-CrNPF2.9 silenced leaf tissue, is that 
the accumulation of strictosidine is toxic to the cell. The reason for this toxicity is unclear since 
strictosidine itself does not contain reactive functional groups, and the accumulation of 
strictosidine in this VIGS-CrNPF2.9 tissue would be localised to the vacuole and subsequently 
compartmented away from the cytoplasm.  
However the accumulation of strictosidine in the vacuole, an acidic microenvironment, may lead 
to its spontaneous deglycosylation through acid hydrolysis, or through the action of a non-
specific vacuolar glycosidase.  
The deglycosylation of strictosidine results in the formation of a reactive dialdehyde species 
(Figure 4-16). This dialdehyde is unstable and very reactive and has been shown to lead to the 
crosslinking of proteins and any group with a free amine (Guirimand et al., 2010), thereby having 
the potential to crosslink proteins, DNA and lipid head groups such as ethanolamine.  
As such, accumulation and deglycosylation of strictosidine in the vacuole could potentially result 
in disruption of vacuole function, resulting in cell death. 
 
 
Figure 4-16 Potential mechanism for cell death in strictosidine accumulating plants. 
Deglycosylation of strictosidine results in the formation of a reactive dialdehyde that has the potential 
to crosslink free amines 
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4.3.4.7 Characterisation of the spatial distribution of metabolism in VIGS tissue 
 
Analysis of methanol extracts of VIGS-CrNPF2.9 leaf tissue by LC-MS demonstrated that there is 
an accumulation of strictosidine in this silenced tissue relative to VIGS-EV control plants, 
however it does not provide spatial information as to where the strictosidine is accumulating in 
the leaf.  
To further assess whether the strictosidine accumulation is directly associated with certain areas 
of the leaf, the VIGS tissue was analysed by Mass Spectrometry Imaging (MSI). There are a 
number of MSI methods that can be applied to plant tissue utilising a variety of ionisation 
sources including: secondary ion mass spectrometry (SIMS), laser ablation electrospray 
ionisation (LAESI), matrix assisted laser desorption ionisation (MALDI) and desorption 
electrospray ionisation (DESI) (Matros and Mock, 2013).  SIMS-MSI and MALDI-MSI have the 
best spatial resolution for imaging (between 1 µm-10 µm) and have been used on a variety of 
plant tissues. The MALDI-MSI approach requires application of a matrix to the biological tissue, 
which assists ionisation of compounds on the surface. Ionisation of the molecular ions then takes 
place under vacuum. One of the limitations of MALDI-MSI is that only the surface is imaged. If 
other parts of the tissue need to imaged, the sample needs to be cryosectioned (Brown and He, 
2015; Matros and Mock, 2013).  
Although DESI-MSI has a lower spatial resolution of ~100 µm the ionisation occurs under 
atmospheric conditions without the application of a matrix, and therefore sample preparation 
is less technically intensive (Li et al., 2013). DESI-MSI has been utilised for both the direct and 
indirect imaging of plant tissues (Müller et al., 2011). Direct imaging results in the electrospray 
scanned directly over the leaf surface, whilst indirect imaging, by comparison, requires the 
imprinting of the metabolites from the plant tissue onto either filter paper or microporous 
Teflon, under high pressure (1 ton), with this imprint subsequently scanned by DESI. Both are 
able to provide spatial information with regards to the metabolite distribution in leaf tissue, and 
have been successfully applied to the analysis of the spatial distribution of secondary 
metabolites in Hordeum vulgare (Li et al., 2011), Hypericum perforatum (Thunig et al., 2011), 
Myristica malabrica (Ifa et al., 2011), as well as Catharanthus roseus (Hemalatha and Pradeep, 
2013).  
In this study, indirect DESI-MSI of VIGS-EV and VIGS-CrNPF2.9 imprinted leaf tissue was utilised 
to assess the spatial distribution of metabolites in this leaf tissue. MALDI-MSI was not used for 
the assessment of the metabolite distribution in VIGS-CrNPF2.9 leaf tissue because the target 
151 
 
compound, strictosidine m/z 531, did not ionise well with the standard matrix (α-cyano-4-
hydroxy-cinnamic acid). Further optimisation of the matrix for ionisation of this compound is 
therefore required (Data not shown). 
Preliminary analysis of the indirect DESI-MSI of the leaf imprints from VIGS-EV and VIGS-
CRNPF2.9 leaf tissue displayed a distinctly different localisation of metabolites. As observed in 
Figure 4-17 both the downstream alkaloids m/z 457 (vindoline) and m/z 337 showed a uniform 
distribution in the VIGS-EV leaf tissue imprint. In comparison in the VIGS-CrNPF2.9 leaf tissue 
imprints these molecular ions are localised to the tip of the leaf tissue (Figure 4-17). 
Strictosidine, m/z 531 is not detectable in the VIGS-EV leaf imprint (data not shown), whilst in 
comparison the strictosidine accumulated in VIGS-CrNPF2.9 in the regions which have lowest 
m/z 457 and m/z 337, nearer the leaf petiole (Figure 4-17). This therefore indicates that there is 
a different localisation of strictosidine and vindoline in the VIGS-CrNPF2.9 leaf tissue, with the 
highest accumulation of vindoline in the region with the lowest accumulation of strictosidine 
(Figure 4-17). This is consistent with the standard metabolite profile of the VIGS-CrNPF2.9 leaf 
tissue, and also demonstrates that the transporter is likely to be involved in the MIA pathway, 
as it appears silencing the transporter blocks formation of vindoline and leads to the 
accumulation of strictosidine. 
 
Figure 4-17 DESI-MSI of VIGS-EV and VIGS-CrNPF2.9 leaf tissue 
A.) DESI-MSI of VIGS-CrNPF2.9 leaf tissue. (l-r) strictosidine, m/z 531, green; m/z 337, blue; vindoline, m/z 
457, red. B.) DESI-MSI of VIGS-EV leaf tissue. (l-r) strictosidine, m/z 531, data not shown; m/z 337, blue; 
vindoline, m/z 457, red. Scale bar is intensity of ion counts. 
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Further work and optimisation of this methodology is needed to provide more information 
about the spatial distribution of metabolism upon silencing other genes in the MIA pathway, 
however preliminarily it appears that it is a useful tool for assessment of the spatial distribution 
of metabolites in VIGS tissue, and this is the first example of DESI being applied to VIGS samples 
in C. roseus. 
 
4.3.4.8 Combinatorial silencing of transporters by VIGS 
 
In Chapter III a transporter, CrMATE1952, was identified that produced a VIGS phenotype 
resulting in the accumulation of a new peak with m/z 391 (H+ adduct) and m/z 413 (Na+ adduct). 
It was assumed that this phenotype was due to the mislocalisation of secologanin in the cytosol 
leading to the accumulation of the reduced product secologanol. To further assess whether both 
CrMATE1952 and CrNPF2.9 are involved in the MIA pathway, and occur sequentially in the 
pathway, it is necessary to combinatorially silence these two transporters. 
Two VIGS fusion pTRV2 vectors were generated, a double fusion that contains ~500 bp of both 
CrMATE1952 and CrNPF2.9 in the pTRV2u vector, and a triple silencing vector that contains ~500 
bp each of CrMATE1952, CrMATE10740, and CrNPF2.9. CrMATE10740 is the other MATE protein 
apart from CrMATE1952 that also co-regulates with the MIA pathway. These vectors were 
generated by USER fusion cloning. 
Both the double fusion and triple fusion vectors resulted in the same metabolic phenotype. Each 
of the combinatorial VIGS experiments was performed in parallel with a set of empty vector 
control plants, as well as individually silenced CrNPF2.9 as a positive control (Figure 4-18, Figure 
4-19). 
As would be expected, only in vectors containing sequence for silencing CrMATE1952 do we see 
the accumulation of secologanol, m/z 391, and this was observed for both the double and triple 
silencing vector (Figure 4-18, Figure 4-19). This compound was not present in either the 
individually silenced VIGS-CrNPF2.9 or VIGS-EV control plants (Figure 4-18, Figure 4-19). 
In both the individually silenced CrNPF2.9 plants, as well as in the double and triple VIGS fusions, 
there was an accumulation of strictosidine relative to empty vector control plants. However the 
extent of strictosidine accumulation was attenuated in the double and triple silenced plants 
relative to the individually silenced CrNPF2.9 tissue (Figure 4-18, Figure 4-19).  
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The fact that both the double and triple silenced plants also show a comparable decrease in the 
downstream MIAs, vindoline and catharanthine, like the individually silenced CrNPF2.9 plants, 
is indicative that the two transporters CrMATE1952 and CrNPF2.9 may be working sequentially 
in the same metabolic pathway.  
CrMATE1952 silencing results in the mislocalisation of secologanin leading to the accumulation 
of m/z 391 (H+ adduct). This decreases the amount of secologanin entering the vacuole, and 
therefore limits strictosidine synthesis. Any strictosidine that is formed in the vacuole, in turn, 
accumulates because it cannot exit due to the silencing of CrNPF2.9. The combined effect of 
silencing both CrMATE1952 and CrNPF2.9 therefore has a comparable effect on vindoline and 
catharanthine as individually silencing CrNPF2.9 (Figure 4-18, Figure 4-19). 
The double and triple silencing plants did not result in the cell death phenotype that is seen upon 
individually silencing the CrNPF2.9. This correlates with the fact that the strictosidine 
accumulation in these double and triple silencing sets of plants is attenuated relative to the 
individually silenced CrNPF2.9 plants. 
qPCR analysis on the VIGS tissue for the double silencing and triple silencing sets of plant tissue 
demonstrated that in both sets, both the CrNPF2.9 gene and the CrMATE1952 are silenced 
relative to the empty vector control plants (Figure 4-18, Figure 4-19), and that in the triple 
silenced plants CrMATE10740 is also silenced (Figure 4-19). 
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Figure 4-18 Metabolite and qPCR profile for VIGS double fusion vector CrNPF2.9_CrMATE1952 
A.) Alkaloid profile for VIGS of empty vector control tissue, individually silenced CrNPF2.9 and the 
double fusion vector CrNPF2.9_CrMATE1952 in Little Bright Eyes;  VIGS CrNPF2.9 (n=10), VIGS-
CrNPF2.9_CrMATE1952 (n=15),  VIGS-EV (n=9) ** p<0.01 B.) m/z 391, secologanol (H+ adduct) 
accumulation for VIGS of empty vector control tissue, individually silenced CrNPF2.9 and the double 
fusion vector CrNPF2.9_CrMATE1952 in Little Bright Eyes;  VIGS CrNPF2.9 (n=10), VIGS-
CrNPF2.9_CrMATE1952 (n=15),  VIGS-EV (n=9) ** p<0.01 C.) qPCR normalised expression of the 
CrMATE1952 gene in empty vector control tissue and the double silenced CrNPF2.9_CrMATE1952 
silenced tissue; VIGS-CrNPF2.9_CrMATE1952 (n=8) VIGS-EV (n=8). D.) qPCR normalised expression of the 
CrNPF2.9 gene in empty vector control tissue and the double silenced CrNPF2.9_CrMATE1952 silenced 
tissue; VIGS-CrNPF2.9_CrMATE1952 (n=8) VIGS-EV (n=8). All data shown is mean + SEM. 
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Figure 4-19 Metabolite and qPCR profile for VIGS triple fusion vector 
CrNPF2.9_CrMATE1952_CrMATE10740 
A.) Alkaloid profile for VIGS of empty vector control tissue, individually silenced CrNPF2.9 and the triple 
fusion vector CrNPF2.9_CrMATE1952_CrMATE10740 in Little Bright Eyes;  VIGS CrNPF2.9 (n=12), VIGS-
CrNPF2.9_CrMATE1952_CrMATE10740 (n=15),  VIGS-EV (n=11) ** p<0.01 B.) m/z 391, secologanol (H+ 
adduct), accumulation for VIGS of empty vector control tissue, individually silenced CrNPF2.9 and the 
triple fusion vector CrNPF2.9_CrMATE1952_CrMATE10740 in Little Bright Eyes;  VIGS CrNPF2.9 (n=12), 
VIGS-CrNPF2.9_CrMATE1952_CrMATE10740 (n=15),  VIGS-EV (n=11) ** p<0.01 C.) qPCR normalised 
expression of the CrMATE1952 gene in empty vector and the triple silenced 
CrNPF2.9_CrMATE1952_CrMATE10740 silenced tissue; VIGS-CrNPF2.9_CrMATE1952_CrMATE10740  
(n=8) VIGS-EV (n=8). D.) qPCR normalised expression of the CrNPF2.9 gene in empty vector and the 
triple silenced CrNPF2.9_CrMATE1952_CrMATE10740 silenced tissue; VIGS 
CrNPF2.9_CrMATE1952_CrMATE10740  (n=8) VIGS-EV (n=8). E.) qPCR normalised expression of the 
CrMATE10740 gene in empty vector and the triple silenced CrNPF2.9_CrMATE1952_CrMATE10740 
silenced tissue; VIGS CrNPF2.9_CrMATE1952_CrMATE10740  (n=8) VIGS-EV (n=8). All data shown is the 
mean + SEM. 
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4.3.4.9 qPCR analysis of VIGS-CrNPF2.9 silenced tissue 
 
As has been discussed in Chapter III, qPCR is utilised to assess the relative silencing of genes in a 
VIGS experiment between the VIGS -EV control plant tissue and the VIGS silenced tissue.  
qPCR analysis to assess the level of CrNPF2.9 silencing in the individually silenced CrNPF2.9 VIGS 
tissue was not possible due to significant variation in the reference housekeeping genes used 
for normalisation between VIGS-EV and VIGS-CrNPF2.9. The three most commonly utilised 
reference genes used for qPCR VIGS tissue in C. roseus are EIF4α, RPS9 and 60SRPPO (Asada et 
al., 2013; Geu-Flores et al., 2012; Liscombe and O’Connor, 2011; Salim et al., 2013). Although 
there have been reports for the selection and validation of other reporter genes for qPCR in C. 
roseus (Pollier et al., 2014) in our hands these genes proved highly variable, and appear to be 
lowly expressed in leaf tissue (Appendix), in relation to the established standards, EIF4α, RPS9 
and 60SRPPO. 
The reference genes are used as a method for normalisation of gene expression in qPCR data, 
and act as internal controls for the qPCR experiment. These genes should be stably expressed in 
the tissues under consideration in the silencing experiment.  VIGS tissue for individually silencing 
CrNPF2.9 resulted in a twofold lower expression of the reporter genes EIF4α, RPS9 and 60SRPPO 
relative to VIGS-EV tissue (Figure 4-20). This is reproducible from two separate independent 
VIGS experiments (Figure 4-20) and is despite RNA quality being comparable between VIGS-EV 
and VIGS-CrNPF2.9 (Figure 4-20). As shown previously for the double and triple pTRV2 vectors 
(CrNPF2.9_CrMATE1952 and CRNPF2.9_CrMATE1952_CrMATE10740) the silencing of the 
CrNPF2.9 gene can be measured in these plants. For plants silenced using the fusion vectors 
there is no significant difference in the reporter genes for the VIGS-EV and VIGS-fusion 
expression levels. 
The potential reason for this disparity in housekeeping gene expression in VIGS-CrNPF2.9 leaf 
tissue is likely due to the influence of the cell death VIGS phenotype seen upon CrNPF2.9 
silencing.  
As cell death is not a usual phenotype that occurs with most VIGS studies, this might explain why 
this discrepancy in housekeeping gene profile has not been observed before.  Cell death is not 
observed in the CrNPF2.9_CrMATE1952 double silenced plants, or the 
CrNPF2.9_CrMATE1952_CrMATE10740 triple silenced plants. This may be because, although 
strictosidine does accumulate, it does not accumulate as highly as in the CrNPF2.9 individually 
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silenced plants. qPCR was therefore able to be performed on the double silenced, 
VIGS_CrNPF2.9_CrMATE1952, and triple silenced, 
VIGS_CrNPF2.9_CrMATE1952_CrMATE10740,  as presented in Figure 4-18 and Figure 4-19. 
 
 
 
 
Figure 4-20 Relative expression of housekeeping genes in VIGS-CrNPF2.9 silenced plant tissues. 
A.) Relative expression of EIF4α, RPS9 and 60SRPPO in VIGS-CrNPF2.9 silenced leaf tissue to VIGS-EV leaf 
tissue VIGS-CrNPF2.9 (n=8), VIGS-EV (n=8). RNA extracted from VIGS-EV leaf tissue (n=8) and VIGS-
CrNPF2.9 (n=8) used for cDNA synthesis in the qPCR study. B.) Relative expression of EIF4α, RPS9 and 
60SRPPO in VIGS-CrNPF2.9 silenced leaf tissue to VIGS-EV leaf tissue VIGS-CrNPF2.9 (n=8), VIGS-EV 
(n=8). RNA extracted from VIGS-EV leaf tissue (n=8) and VIGS-CrNPF2.9 (n=8) used for cDNA synthesis in 
the qPCR study. All data shown is the mean + SEM. 
 
 
4.3.4.10 VIGS of the CrNPF2 subfamily 
 
As has been shown in this chapter, CrNPF2.9 resulted in a metabolic phenotype upon silencing 
that is consistent with it being the exporter of strictosidine from the vacuole. There are nine 
other orthologs of this transporter family in C. roseus. The orthologs CrNPF2.4 and CrNPF2.6 are 
localised to the plasma membrane, and have been shown to have transport activity towards the 
iridoid glycosides, 7-deoxyloganic acid, loganic acid, loganin and secologanin, when expressed 
in Xenopus laevis oocytes (Larsen et al; submitted). The secoiridoid pathway for the generation 
of secologanin is inter-cellulary compartmented, and there is a need for the transport of a 
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mobile intermediate between the IPAP cells and the epidermis. To date this intermediate has 
been hypothesised to be loganic acid (Miettinen et al., 2014). 
To assess whether the in vitro activity of CrNPF2.4 and CrNPF2.6 is physiologically relevant these 
transporters were targeted by VIGS. VIGS of the NPF transporters CrNPF2.4 and CrNPF2.6 did 
not result in a statistically significant difference in the downstream alkaloids vindoline, 
catharanthine, strictosidine or serpentine, and there was no reproducible accumulation of any 
new peaks, when compared to EV control plants. There was also no change in the peak area of 
secologanin relative to EV control plant tissues. The VIGS experiment was repeated twice in two 
different cultivars of C. roseus, Little Bright Eyes and Sunstorm Apricot (Figure 4-21). 
Although the transporters CrNPF2.4 and CrNPF2.6 have the capacity to transport a range of 
iridoid glycosides in vitro, and the work presented in (Larsen et al; submitted) elegantly 
demonstrates that the NPF transporter family is capable of transporting this class of compounds, 
thereby expanding the known substrate repertoire of this transporter family, the physiological 
relevance of these transporters and the role they play in MIA metabolism in planta is debatable. 
It is possible at the plasma membrane that these transporters are functionally redundant, and 
multiple transporters and transporter families, may be involved in the transport of the iridoid 
glycosides in planta. One way of addressing this is through the use of combinatorial silencing of 
multiple transporter classes by VIGS and analysing for a metabolic phenotype that results in the 
accumulation of the iridoid glycosides to be transported. 
159 
 
 
Figure 4-21 Metabolite profile for VIGS for CrNPF2.4 and CrNPF2.6. 
A.) VIGS in C. roseus cultivar Sunstorm Apricot pTRV2-EV (n=11), pTRV2-CrNPF2.4 (n=11), pTRV2-CrNPF2.6 
(n=11), p<0.01**B.) VIGS in C. roseus cultivar Little Bright Eyes ; pTRV2-EV (n=8), pTRV2-CrNPF2.4 (n=8), 
pTRV2-CrNPF2.6 (n=8). p<0.01 **. Untargeted metabolomics using the XCMS software package was 
performed for both VIGS experiments and did not identify the accumulation of new peaks in the CrNPF 
silenced lines relative to empty vector control. All data shown is the mean + SEM. 
 
4.3.5 Heterologous expression of CrNPF2.9 in S. cerevisiae 
 
Due to the predicted directionality of transport for the CrNPF2.9 transporter, in which 
movement of solute is predicted to occur into the cytoplasm from the vacuole, for a compatible 
transport assay in S. cerevisiae, the CrNPF2.9 transporter would need to be located in the plasma 
membrane of the yeast. If the CrNPF2.9 transporter localises to the yeast plasma membrane it 
would be possible to perform an import assay with strictosidine into yeast cells. This whole yeast 
cell assay has been utilised for the characterisation of the purine permease transporter that 
transports nicotine in Arabidopsis, NUP1 (Hildreth et al., 2011). 
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Figure 4-22 Whole cell yeast cell assay 
Due to the predicted directionality of the NPF transporter a whole cell yeast import assay would be 
feasible if the transporter is expressed at the plasma membrane 
 
If the CrNPF2.9 localises to internal membranes, such as the yeast vacuolar membrane, the assay 
becomes technically challenging as it then becomes necessary to pre-load the yeast vacuole with 
substrate prior to the assay and detect export from the vacuole. 
To assess whether the CrNPF2.9 transporter is expressed at the plasma membrane, it was over 
expressed as a C-terminal GFP fusion in S. cerevisiae under control of a galactose inducible 
promoter in the yeast expression vector pYES-DEST52. 
Over expression of CrNPF2.9 in S. cerevisiae as a C-terminal GFP fusion resulted in a similar 
localisation in the yeast as the two MATE proteins expressed in Chapter III, with localisation to 
internal membranes in the yeast strains InvSCI and ybtI or the yeast lytic vacuole for WATII 
(Figure 4-23). Although there is localisation to what appears to be the yeast plasma membrane 
when expressing the protein in the ybt1 strain, this localisation is not consistent between 
individual yeast cells.  
This is in contrast to the C. roseus purine permease, CrPUP_1443, whose expression resulted in 
localisation to the yeast plasma membrane, as well as in internal membranes for all three yeast 
strains, or soluble GFP that localises to the yeast cytoplasm (Chapter III). 
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Figure 4-23 Expression of CrNPF2.9-GFP in S. cerevisiae. 
CrNPF2.9-GFP was cloned into the yeast expression vector pYES-DEST52, expressed in three separate 
yeast strains WATII, InVScI and ybt1, and imaged by confocal microscopy. (l-r) Brightfield, GFP-
fluorescence, Merge. Scale bar = 5 µm. 
 
4.3.5.1 Site directed mutagenesis of the CrNPF2.9 
 
A variant of the CrNPF2.9-GFP construct was made to assess whether the length of the linker 
between the membrane protein and GFP affects protein stability and localisation. The linker 
between the C-terminus of the membrane protein utilised a three amino acid glycine-serine-
glycine linker, and this was extended to an eight amino acid linker GSGMGGSG. 
Additionally, it was postulated that the ubiquitination state of the membrane transporter might 
affect its turnover rate at the plasma or vacuolar yeast membrane. The CrNPF2.9 transporter 
has a predicted C-terminal yeast ubiquitination site (Figure 4-24), whilst the C. roseus putative 
purine permease, CrPUP_1443, which was shown to express at the yeast plasma membrane as 
a C-terminal GFP fusion in Chapter III does not (Figure 4-24).  
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Figure 4-24 Ubiquitination site prediction for the C. roseus purine permease and CrNPF2.9 
A.) The CrNPF2.9 contains a predicted yeast ubiquitination site at the C-terminus of the protein, 
highlighted by a red arrow in accordance with the CKSAAP_UBsite prediction server. B.) The purine 
permease CrPUP_1443 does not contain a predicted ubiquitination sequence C.) The C-terminal 20 amino 
acids of the CrNPF2.9 protein showing the lysine to arginine mutation generated, highlighted in yellow, to 
prevent putative monoubiquitination of the transporter. 
 
Ubiquitin is a 76-amino acid protein that is expressed in all eukaryotic cells and is used as a post-
translational modification for a diverse array of physiological functions; including signalling for 
proteolytic degradation by the proteasome, and altering cellular localisation (Horák, 2003; 
MacGurn et al., 2012). Ubiquitination occurs on lysine residues via the formation of an 
isopeptide bond. In yeast ubiquitination is a key modification for the promotion of plasma 
membrane protein turnover and ubiquitin mediated endocytosis. The ubiquitin modification 
acts as a targeting signal for endocytosis of plasma membrane proteins and their subsequent 
degradation in the lytic vacuole (Horák, 2003; MacGurn et al., 2012).  
This mechanism has been shown for the endogenous yeast uracil permease (Fur4p) (Galan et 
al., 1996), the ABC transporter Ste6p (Kölling and Hollenberg, 1994), the yeast general amino 
acid permease (Gap1p) (Springael et al., 1999), the yeast multidrug transporter Pdr5p (Egner 
and Kuchler, 1996), as well as for the other membrane spanning receptors such as the G-protein 
163 
 
coupled receptor Ste2p (Hicke and Riezman, 1996). An overview of this protein degradation 
pathway is presented in Figure 4-25. 
 
Figure 4-25 Overview of ubiquitin mediated endocytosis and vacuolar degradation of plasma membrane 
proteins in yeast 
I.) Ubiquitination of the membrane protein II.) Ubiquitination mediated endocytosis III.) Degradation in 
the vacuole IV.) Golgi to endosome traffic V.) exocytosis VI.) Endosomal recycling to cell surface. Figure 
adapted from (MacGurn et al., 2012).  
 
The CrNPF2.9 putative ubiquitination site was mutated from a lysine to an arginine (CrNPF2.9 
K>R) utilising a reverse primer that contained the point mutation, and cloned into the pYES-
DEST52 yeast expression vector. Both the short and extended C-terminal GFP linker versions of 
the CrNPF2.9 K>R protein were generated and expressed in the S. cerevisiae yeast strain WAT11.  
WAT11 was selected as the yeast strain, as previous GFP fusion proteins showed distinct 
localisation to the lytic vacuole in this strain, and it would be easier to monitor redistribution of 
the protein to a different membrane compartment.  
 
Overexpression of the CrNPF2.9 with the extended linker to GFP, or with the mutated 
ubiquitination site, led to a minor relocalisation, however not to the plasma membrane (Figure 
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4-26). As such, S. cerevisiae as a platform for heterologous expression of this transporter was 
abandoned.  
 
 
 
Figure 4-26 Localisation of CrNPF2.9-GFP in S. cerevisiae 
Extension of the GFP linker between CrNPF2.9 and GFP in the fusion protein, together with mutation of a 
predicted ubiquitination site was performed to assess whether there is a change in subcellular localisation 
of the protein when heterologously expressed in S. cerevisiae. In all cases the CrNPF2.9-GFP fusions 
resulted in localisation to the lytic vacuole of the yeast (l-r) Brightfield, GFP-fluorescence, Merge. Scale 
bar = 5 µm. 
 
4.3.6 Heterologous expression of CrNPF2.9 in Xenopus laevis oocytes 
 
An alternative expression system for CrNPF2.9 is the Xenopus oocyte expression system. In this 
system, linear cRNA derived from in vitro transcription, encoding the CrNPF2.9 to be expressed, 
is microinjected into the Xenopus oocyte for protein expression. The protein is likely to be 
expressed at the plasma membrane of the oocyte and transport assays can then be performed 
relative to water injected controls, to assess whether the transporter can uptake the substrate 
(Figure 4-27).  
Due to the predicted directionality of transport, if the CrNPF2.9 is localised to the plasma 
membrane of the Xenopus laevis oocyte, it is feasible to perform an import assay into the 
Xenopus laevis oocyte, and detect uptake of the substrate by LC-MS (Figure 4-27). 
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Figure 4-27 Overview of the Xenopus laevis oocyte uptake assay 
cRNA generated by in vitro transcription is microinjected into the oocyte for expression of the protein. 
After 3 days incubation in MBS buffer the oocytes are incubated at pH 5 containing the substrate 
strictosidine for 1 h. The oocytes are subsequently washed and extracted in MeOH for analysis of 
strictosidine uptake by LC-MS. 
 
 
The full length CrNPF2.9 transporter was cloned into two separate Xenopus laevis oocyte 
expression vectors pT7TS and pLIFE0016, and complementary cRNA was generated by in vitro 
transcription. This cRNA was used for the microinjection of Xenopus laevis oocytes, which were 
utilised to assess strictosidine uptake relative to water injected controls. The strictosidine used 
in this study was produced enzymatically and purified by preparative HPLC. 
 
Although there are some clear examples where import is greater in the CrNPF2.9 injected 
Xenopus oocytes relative to water injected controls, as can be seen from Figure 4-28 there is 
batch to batch variability in the oocytes when the assay is replicated between different weeks. 
As such it is not possible to definitively state that we are observing transport of strictosidine into 
the oocyte. 
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Figure 4-28 Strictosidine uptake assays in Xenopus laevis oocytes 
To assess uptake of strictosidine in Xenopus laevis oocytes, ~20 oocytes were microinjected with 50 nl 1 
µM cRNA, and ~20 oocytes microinjected with H2O. Each batch of oocytes was incubated in 750 µl of 100 
µM strictosidine. For each batch of 20 oocytes, oocytes were pooled in batches of 4 for extraction in 
MeOH and analysis by LC-MS, resulting in 5 replicates per batch. A.) Microinjection with cRNA derived 
from CrNPF2.9-pT7TS. Roman numerals I-VII represent separate weeks. B.) Microinjection with cRNA 
derived from CrNPF2.9-pLIFE0016. Roman numerals VIII-XI represent separate weeks on which the assay 
was performed. For uptake the CrNPF2.9 injected bars should be higher than water injected and 
uninjected controls p<0.01**. All data shown is mean + SEM. 
 
There are a number of potential limitations in this Xenopus oocyte uptake study. Firstly, as has 
been highlighted in Colman and Drummond, 1986, batch to batch variation in oocyte quality can 
greatly affect the experiment. As can be seen in the data in Figure 4-28 repetition of the 
experiment varies between weeks, indicating that different batches of oocytes may have 
different transport capacity for the substrate strictosidine. Sourcing oocytes from a commercial 
supplier may eliminate this problem. 
 
A second limitation of the study in oocytes is the fact that CrNPF2.9 is predicted to be a 
facilitative transporter, and not an active transporter, of strictosidine. 
 
The structure of the Arabidopsis nitrate transporter NRT1.1 (Parker and Newstead, 2014) 
implicates a conserved motif that is integral for coupling of solute to the proton gradient. It has 
been shown that an EXXER motif in the structure of the peptide transporter Shewanella 
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oneidensis PepTSo is necessary for proton binding to the transporter for peptide transport 
(Newstead et al., 2011). This motif, EXXE(R/K), is conserved in the related NPF transporter family 
and is present in the glucosinolate transporters AtGTR1/AtGTR2, and suggests that the coupling 
of proton movement for structural changes in this class of transporters is conserved and 
substrate independent, for the active transport of solute (Nour-Eldin et al., 2012). 
 
Interestingly, the Arabidopsis NAXT transport protein, which has been thought to lead to nitrate 
export (Segonzac et al., 2007), is a passive transporter that is not thought to utilise the proton 
gradient for transport, but instead transports nitrate down its concentration gradient. This 
transporter does not contain the conserved EXXE(R/K) motif for proton coupling (Figure 4-29). 
 
CrNPF2.9 has the closest sequence identity to the NAXT transporter from Arabidopsis and also 
does not contain the conserved EXXE(R/K) sequence (Figure 4-29). 
 
 
 
 
Figure 4-29 N-terminal alignment of the NPF transporters 
As can be seen a conserved EXXE(R/K) motif is present in the AtGTR1 and AtNRT1.1 transporters 
highlighted in yellow 
 
 
 
 
 
Based on this we would predict that therefore CrNPF2.9 is a facilitative transporter, that moves 
strictosidine down its concentration gradient, but does not couple this movement to the proton 
gradient (Figure 4-30). 
 
 
 
 
 
 
AtNAXT          ---------------------------------------MASSVTGDAETAISADSSTKR 21 
CrNPF2.9        --------------------------------------------MGDTEAQLLQPGHKQK 16 
AtGTR1          MKSRVILNHRDRRDKNHNNNNTNHYTQVDTMERKPLEVEPSTTTTNTDVVDSFEEEQRKI 60 
AtNRT1.1        ----------------------------------MSLPETKSDDILLDAWDFQGRPADRS 26 
                                                                          :  
 
AtNAXT          RGGGWITFPFMIATLLGLTIAAWGWLLNLIVYLIEEFNVKSIAAAQIANIVSGCICMVPA 81 
CrNPF2.9        --GGWITFPFILATRTLLTLAVAGFSSNLIVYLINEFNVNRIDSAQIYNVVNGCMALFPL 74 
AtGTR1          VYRGWKVMPFIIGNETFEKLGIIGTLSNLLVYLTSVFNLKSYTAATIINAFSGTINFGTF 120 
AtNRT1.1        KTGGWASAAMILCIEAVERLTTLGIGVNLVTYLTGTMHLGNATAANTVTNFLGTSFMLCL 86 
                   **   .:::       :   *   **:.**   :::    :*   . . *   :    
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Figure 4-30 Overview of the predicted transport of NPF transporters 
AtNRT1.1 couples the movement of nitrate against its concentration gradient utilising the electrochemical 
potential of the proton gradient. Similarly AtGTR1/AtGTR2 utilise the proton gradient for coupling of 
glucosinolate transport into the cytoplasm. Based on sequence identity and the absence of an EXXE(R/K) 
motif in both AtNAXT and CrNPF2.9 both transporters are thought to be facilitative transporters. AtNAXT 
has been shown to passively transport nitrate, whilst CrNPF2.9 is predicted to be a facilitative strictosidine 
exporter. 
 
 
For the NPF transporters characterised to date, that have utilised an LC-MS approach for 
detection of transport, such as for the glucosinolate/H+ co-transporters AtGTR1 and AtGTR2, the 
transporters are active transporters, which utilise the electrochemical gradient of across the 
tonoplast membrane to move the substrate against the concentration gradient (Nour-Eldin et 
al., 2012). 
This makes the assay potentially easier to interpret, as the nature of active transport means the 
concentration of substrate can significantly build up in the oocyte relative to the external 
medium.  
Secondly, the AtGTR1 and AtGTR2 are amenable for analysis by electrophysiology (Nour-Eldin et 
al., 2012). It was shown that AtGTR1 and AtGTR2 result in negative currents when incubated in 
the substrate glucosinolates. As the glucosinolate is negatively charged, yet a negative current 
is seen upon incubation of the oocyte in the substrate, this suggests that the transporters couple 
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the charge across the tonoplast membrane with a stoichiometric ratio of nH+ > nglucosinolate (Nour-
Eldin et al., 2012). 
Similarly, the canonical nitrate transporter from Arabidopsis NRT1.1 results in the electrogenic 
transport, coupling the symport of NO3- to the proton gradient, and therefore the ratio of 
proton: solute movement across the membrane is at least 2:1 (Parker and Newstead, 2014). 
At the pH of the vacuole (ca. pH 5), strictosidine is likely to be positively charged, and therefore 
movement of strictosidine into the cytoplasm by CrNPF2.9 would be energetically downhill and 
dissipate the electrochemical potential across the membrane. However the theoretical 
concentrative capacity of the transporter is likely to be dependent on the concentration gradient 
of strictosidine across the tonoplast membrane.  Therefore it would not be possible to detect 
transport into the oocyte, greater than the concentration of the external medium, which may 
also limit detection of transport in our assay system. Therefore further experiments are needed 
with higher quality oocytes in order to definitively assess in vitro transport for CrNPF2.9. 
 
4.4 Conclusion 
 
This chapter highlights the identification of an NPF transport protein that is directly involved in 
MIA metabolism in C. roseus. There are ten homologues of the CrNPF2 subfamily in C. roseus. It 
has been shown in (Larsen et al; submitted), that two of these proteins, CrNPF2.4 and CrNPF2.6 
are able to transport a range of iridoid glycosides when expressed in Xenopus laevis oocytes.  
VIGS of these transporters, however, did not result in a metabolic phenotype, indicating that 
these two proteins might be functionally redundant. Future work would be to combinatorially 
silence these transporters and assess whether they compensate for each other’s activity. It is 
also possible at the plasma membrane that there might be other transporter families that could 
be contributing to transport of the iridoid glycosides as well, and a combinatorial reverse 
genetics screen with other transport families should be employed to pick apart this potential 
functional redundancy. 
To date, despite the in vitro characterisation of the two NPF transporters, CrNPF2.4 and 
CrNPF2.6 as iridoid glycoside transporters, which further expands the substrate repertoire of 
this transporter family as presented in (Larsen et al; submitted), the physiological importance of 
these transporters in MIA metabolism is still open for debate. 
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CrNPF2.9 is a transport protein whose closest homologue is the NAXT transporter in Arabidopsis.  
CrNPF2.9 strongly co-regulates with known genes in the MIA biosynthetic pathway, and this 
protein has been shown to localise to the tonoplast membrane when overexpressed in two 
heterologous systems, C. roseus cell suspension cultures, and N. benthamiana.  
Silencing of this transporter resulted in a strong metabolic phenotype, resulting in the over 
accumulation of strictosidine, the central metabolic branch point in MIA metabolism, suggesting 
this transporter is the exporter of strictosidine from the vacuole.  
This is the first demonstration that an NPF transporter is physiologically relevant to MIA 
metabolism. Co-silencing of CrNPF2.9 with the MATE proteins identified in Chapter III further 
indicate that both proteins are likely to be involved in MIA biosynthesis. 
The metabolic phenotype is accompanied by cell death, which is attributable to the toxic 
accumulation of strictosidine in the tissue, as determined by confocal microscopy and 
preliminary analysis by DESI mass spectrometry imaging which indicated that strictosidine is 
accumulating in the region surrounding the dying tissue. 
To date, heterologous expression of CrNPF2.9 has proven elusive for characterisation of 
strictosidine transport in both S. cerevisiae as well as Xenopus oocytes. Based on sequence 
analysis of the transporter, as with the NAXT protein from Arabidopsis, the CrNPF2.9 lacks the 
EXXE(R/K) motif present in NPF transporters that is thought to couple transport to proton 
gradient and allow for active transport, therefore it is predicted that CrNPF2.9 is likely to act as 
a facilitative transporter. 
The strong metabolic phenotype, resulting in the over accumulation of strictosidine, poses a 
number of intriguing questions over the regulation of the MIA metabolic pathway and the fact 
that this accumulation of strictosidine can result in cell death of the plant tissue is indicative that 
there is a need to limit the accumulation of strictosidine in plant tissue. 
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4.5 Future directions  
 
There are a number of experiments that are needed to further assess the involvement of the 
NPF transporter class in MIA metabolism.  
1.) As has been highlighted, although CrNPF2.4 and CrNPF2.6 are capable of transporting iridoid 
glycosides in vitro, there is a need to assess whether this is physiologically relevant to MIA 
metabolism. Individually silencing these two transporters did not result in a metabolic 
phenotype, and therefore combinatorially silencing these transporters is needed to assess 
physiological involvement in the pathway. 
2.) There are seven other NPF homologues present in the C. roseus transcriptome, and 
individually silencing these other transporters may highlight an involvement in the MIA pathway. 
These other transporters do not co-regulate transcriptionally and are predicted to localise to the 
plasma membrane, therefore if they are involved in the MIA pathway it would be predicted that 
they are involved in the later stages of MIA biosynthesis. 
3.) To date CrNPF2.9, despite resulting in a strong VIGS phenotype, has proven recalcitrant to 
assessment of transport in a heterologous system. Further work is needed to demonstrate that 
this transporter is able to transport strictosidine, and assess the mechanistic detail concerning 
whether this transport is a facilitative transporter, as is predicted form the sequence. 
Altogether the work in this chapter has identified a tonoplast transporter, CrNF2.9, that, when 
silenced, leads to the accumulation of strictosidine. This phenotype is consistent with it being 
the exporter of strictosidine from the vacuole. Furthermore, this metabolic phenotype is 
accompanied by cell death, indicating that the export of strictosidine from the vacuole, and 
maintenance of a low level of strictosidine in the cell is likely to be fundamental for control of 
the MIA pathway. 
 
 
 
 
 
172 
 
5 Characterisation of Reticuline Oxidase Like enzymes in C. 
roseus 
 
5.1 Introduction to the Reticuline Oxidase family 
5.1.1 Flavoproteins 
 
Flavin dependent enzymes are characterised by the binding of the cofactors flavin adenine 
dinucleotide (FAD) or flavin mononucleotide (FMN) (Heuts et al., 2009). These cofactors can be 
associated with the apoprotein either non-covalently or by covalent attachment, and use the 
redox-active isoalloxazine ring system for catalysis. More than 90% of the FAD-dependent 
enzymes are oxidoreductases, however a few FAD-dependent proteins are also able to catalyse 
non-redox based reactions (Heuts et al., 2009). 
FAD is a cofactor derived from riboflavin (Vitamin B2), and can be synthesised de novo by plants, 
bacteria and fungi (Figure 5-1) (De Colibus and Mattevi, 2006). Because of the chemical 
properties of the isoalloxazine ring, FAD can exist in a number of different redox states, with 
both the one-electron reduced semiquinone and two-electron reduced dihydroflavin, being 
catalytically relevant entities (Walsh and Wencewicz, 2013) (Figure 5-1). The tight binding of FAD 
to the enzyme prevents its dissociation and subsequent uncontrolled autoxidation outside of 
the enzyme. This means that during catalysis of the oxidation reduction reaction, the FAD in the 
enzyme undergoes a catalytic cycle through two half reactions, to allow FAD to be regenerated 
(Walsh and Wencewicz, 2013).  
The first reductive half reaction of FAD results in the oxidation of the substrate with concomitant 
reduction of the FAD, whilst the second re-oxidative half reaction results in the reoxidation of 
the reduced flavin (Figure 5-1) (Walsh and Wencewicz, 2013). The redox potential of free 
riboflavin is ~-200 mV, though the enzyme microenvironment in which the FAD is situated is able 
to tune this redox potential. The redox potential of the FAD in different flavoproteins has been 
measured at values ranging from -400 mV to +200 mV (Heuts et al., 2009). 
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Figure 5-1 Flavin Adenine Dinucleotide  
A.) Structure of Flavin Adenine Dinucleotide (FAD) B.) The three biologically accessible redox states of the 
isoalloxazine ring of FAD are oxidised Flavin, reduced Flavin and the semiquinone. Figure adapted from 
(Walsh and Wencewicz, 2013) 
 
Flavin dependent enzymes can react with molecular oxygen in different ways. Flavin dependent 
oxidases utilise molecular oxygen as the final electron acceptor to reoxidise the reduced FAD, 
subsequently releasing hydrogen peroxide (Mattevi, 2006). Flavin dependent mono-oxygenases 
form a C4 α-(hydro)peroxide adduct of the flavin that allows insertion of an oxygen atom into 
the substrate, with release of H2O (Mattevi, 2006). Flavin dependent dehydrogenases, do not 
react readily with oxygen, and utilise an alternative molecule, such as a quinone or redox 
protein, as the final electron acceptor to reoxidise FAD (Mattevi, 2006). 
 The diversity in the redox states of the isoalloxazine moiety of FAD, the fact the redox potential 
can be tuned, together with the differential nature by which FAD can interact with molecular 
oxygen, has ensured that flavoproteins are ubiquitous in nature and their chemical versatility 
has meant they are involved in a wide range of biological processes, act on a wide variety of 
substrates, and catalyse novel chemistry (Mattevi, 2006; Walsh and Wencewicz, 2013). 
Sequence structure analysis of FAD-containing proteins suggests that there are four main 
structural folds; the glutathione reductase (GR) fold, ferredoxin reductase (FR) fold, the pyruvate 
oxidase (PO) fold, and the p-cresol methylhydroxylase (PCMH) or vanillyl alcohol oxidase (VAO) 
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fold (Dym and Eisenberg, 2001). Reticuline oxidases, the subject of this chapter, are part of the 
VAO family. 
 The VAO fold is characterised by two subdomains consisting of both α helices and β sheets. The 
members of the VAO family share a conserved FAD binding domain, in which the FAD cofactor 
is accommodated between the two sub domains, adopting an elongated conformation, with the 
enzyme active site at this interface (Dym and Eisenberg, 2001). Members of the VAO superfamily 
have been identified in all kingdoms of life and are involved in a diverse range of metabolic 
processes, although these enzymes primarily act as either oxidases or dehydrogenases. 
Although 90% of FAD associated proteins bind FAD in a non-covalent manner, the VAO 
flavoprotein family has a relatively higher propensity for covalent binding, with one in four 
VAO family members predicted, based upon genome mining, to contain a conserved histidine 
residue that allows for histidyl-FAD attachment (Heuts et al., 2009). There are four main types 
of covalent attachment characterised in this enzyme family, monocovalent FAD linkage via 
either a histidine or tyrosine residue generating an 8α-N3-histidyl-FAD, 8α-N1-histidyl-FAD or 
8α-O-tyrosyl-FAD attachment, as well as bicovalent linkage through attachment to a histidine 
and cysteine resulting in an 8α-N1-histidyl-6-S-cysteinyl-FAD linkage (Figure 5-2). In plant 
enzymes, covalent attachment has only been shown via the monocovalent, 8α-N1-histidyl-FAD 
and bicovalent 8α-N1-histidyl-6-S-cysteinyl-FAD attachments, with the linking histidine present 
in the N-terminal part of the protein (Heuts et al., 2009). 
 
Figure 5-2 Types of covalent linkage for FAD 
There are four main types of covalent linkage in FAD dependent enzymes A.) 8α-N1-histidyl-6-S-cysteinyl-
FAD B.) 8α-N1-histidyl-FAD C.) 8α-N3-histidyl-FAD D.) 8α-O-tyrosyl-FAD. Only 8α-N1-histidyl-6-S-cysteinyl-
FAD and 8α-N1-histidyl-FAD have been seen in planta. (Conventional numbering has been used in this 
scheme). 
 
 
 
175 
 
5.1.1.1 The role of the Vanillyl Alcohol Oxidase Superfamily in planta 
 
In planta the VAO superfamily is involved in a wide variety of biological processes, including 
catalysing novel oxidative reactions that lead to structural heterogeneity in secondary 
metabolites, developmental processes through controlling the catabolism and anabolism of 
plant hormones, and in plant defence through the production of hydrogen peroxide (Leferink et 
al., 2008a). There are three primary sub families of VAO protein in planta that have been 
characterised and shown to have both a physiological function and/or catalytic activity in vitro; 
the aldonolactone oxidoreductase family, the cytokinin dehydrogenase family, and the 
berberine bridge enzyme family (Leferink et al., 2008a). 
The only plant VAO type enzyme to be characterised that does not contain a covalent linkage to 
FAD is L-galactono-1,4-lactone dehydrogenase (GALDH), which is involved in the biosynthesis of 
ascorbic acid in plants, oxidising L-galactono-1,4-lactone to L-ascorbate, with the concomitant 
reduction of cytochrome c (Figure 5-3) (Leferink et al., 2008b).  This enzyme is an example of an 
aldonolactone dehydrogenase. Recombinant GALDH is also able to catalyse the conversion of 
gulono-1,4-lactone to L-ascorbate, however at a lower catalytic efficiency  than what is thought 
to be its natural substrate L-galactono-1,4-lactone (Leferink et al., 2008b). This enzyme is 
integral to plant metabolism and its silencing by RNAi in tomato results in numerous plant and 
fruit developmental defects thought to be related to changes in ascorbate redox state, and 
mitochondrial function (Alhagdow et al., 2007).   
Cytokinin dehydrogenase is an enzyme that contains a monocovalent histidyl-FAD and is 
involved in the degradation of the plant hormone family, the cytokinins, to adenine or adenosine 
by the oxidative cleavage of their sidechains (Werner et al., 2003).  There are multiple families 
of cytokinin dehydrogenases that have different subcellular localisation, are expressed at 
different times in development, and have different substrate specificities for the cytokinin side 
chain. Since cytokinin dehydrogenases control cytokinin catabolism, these enzymes are integral 
in controlling the local cytokinin level in plant tissue and, consequently, the action of the 
hormone (Schmülling et al., 2003; Werner et al., 2003). Transgenic Arabidopsis overexpressing 
cytokinin dehydrogenases have a decreased cytokinin content, and display the associated 
deficiencies in shoot and flower development, coupled with deficiencies in leaf vasculature, and 
enhanced root growth and formation (Werner et al., 2003). The best studied of these enzymes 
is CKX1 from maize for which a crystal structure has been elucidated, revealing the VAO protein 
architecture (Malito et al., 2004). 
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Figure 5-3 Role of VAO enzymes in plant metabolism  
A.) GALDH catalyses the oxidation of L-galactono-1,4-lactone to L-ascorbic acid with reduction of 
cytochrome c B.) The cytokinin dehydrogenase family catalyses the degradation of cytokinins to adenine 
with concomitant reduction of an electron acceptor that is thought to be a quinone. 
 
5.1.2 The Berberine Bridge Enzyme (BBE)-like family  
 
The berberine bridge enzyme (BBE)-like family is a large subfamily of the VAO superfamily of 
FAD dependent oxidoreductases and these enzymes have been shown to have a diverse array 
of metabolic functions in planta. 
 
The first role to be discovered for a member of the BBE enzyme family was the oxidation of 
reticuline to a berberine precursor in benzoisoquinoline alkaloid (BIA) biosynthesis (Dittrich and 
Kutchan, 1991). This class of alkaloids are present in species of the Papaveraceae, 
Ranunculaceae, Berberidaceae, Fumariaceae, and Menispermaceae and all are derived from 
two molecules of L-tyrosine (Figure 5-4) (Beaudoin and Facchini, 2014). This alkaloid family is 
diverse, with more than 2,500 structures described and contains a number of pharmaceutically 
relevant compounds, including the antimicrobial agent, sanguinarine, the cough suppressant, 
noscapine, as well as the narcotic analgesics, morphine and codeine (Beaudoin and Facchini, 
2014). (S)-reticuline is a central metabolic intermediate that acts as a branchpoint towards the 
morphinan, protoberberine, phthalideisoquinoline and benzo[c]phenanthridine structural 
scaffolds found in the BIA family.  
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Figure 5-4 Overview of benzylisoquinoline alkaloid biosynthesis 
Figure adapted from Beaudoin and Facchini, 2014. 
 
The berberine bridge enzyme, also called reticuline oxidase, converts (S)-reticuline to the 
berberine precursor (S)-scoulerine by catalysing the oxidative cyclisation between the N-methyl 
moiety of (S)-reticuline into the berberine bridge carbon C-8 of (S)-scoulerine with concomitant 
release of H2O2 (Figure 5-5). This is the first step in the pathway towards the protoberberine, 
phthalideisoquinoline and benzo[c]phenanthridine alkaloids (Beaudoin and Facchini, 2014). The 
berberine bridge enzyme was originally discovered and purified to homogeneity from the cell 
culture of Berberis beania and was shown to turnover (S)-reticuline, (S)-protosinomenine and 
(S)-laudanosaline with stoichiometric release of H2O2 (Steffens et al., 1985). The gene for BBE 
was first cloned from Eschscholtzia californica cell suspension cultures, where it was shown that 
the level of the gene in the cell culture was induced by treatment with a fungal elicitor, 
suggesting that upregulation of this pathway enzyme, is integral to plant defence (Dittrich and 
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Kutchan, 1991). In this study the gene was cloned and heterologously expressed in S. cerevisiae 
where the enzyme resulted in the stereospecific conversion of (S)-reticuline to (S)-scoulerine 
(Dittrich and Kutchan, 1991).  In vitro the enzyme has been tested with 23 isoquinoline alkaloids, 
and the enzyme was able to form the berberine bridge carbon with five compounds: (S)-
reticuline, (S)-protosinomenine, (R,S)-crassifoline, (R,S)-laudanosoline and (R,S)-6-O-
methyllaudanosoline (Figure 5-5) (Kutchan and Dittrich, 1995). As well as C-C bond formation to 
form the berberine bridge in tetrahydrobenzylisoquinoline alkaloids, BBE also catalyses the N-
demethylation of N-methylcoclaurine, implicating a likely methylene imminium intermediate in 
the reaction mechanism (Figure 5-5). This is further highlighted by the fact BBE was shown to 
have oxidative activity against some tetrahydroprotoberberine alkaloids, namely (S)-coreximine 
and (S)-norseponine, forming a double bond between the nitrogen and the berberine bridge C-
8 carbon (Kutchan and Dittrich, 1995). This activity has also been observed for the 
tetrahydroprotoberberine alkaloid (S)-scoulerine which is thought to be the natural product of 
BBE (Winkler et al., 2009b) (Figure 5-5). 
 
Figure 5-5 Reactions catalysed by the canonical BBE from E. californica and P. somniferum 
A.) The canonical formation of the carbon carbon bond for formation of the berberine bridge B.) BBE 
catalyses the N-demethylation of N-methylcoclaurine, implicating a likely methylene iminium 
intermediate in the reaction mechanism C.) Oxidation of tetrahydroprotoberberine alkaloids 
 
The homologue of BBE from opium poppy (Papaver somniferum) has also been cloned (Facchini 
et al., 1996), and it has 70% identity to that found in E. californica. As in E. californica cell 
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suspension cultures, this gene was upregulated by treatment of Papaver somniferum cell 
suspension cultures with a fungal elicitor. The BBE gene also showed a distinct spatial 
distribution, being primarily localised to the root and stems of mature opium poppy, which is 
consistent with its involvement in sanguinarine biosynthesis, which is primarily localised to the 
root (Facchini et al., 1996). The BBE from P. somniferum has been shown to contain an N-
terminal signal sequence that targets BBE to the endoplasmic reticulum, as well as an adjacent 
vacuolar targeting sequence that leads to its subsequent translocation to this compartment 
(Bird and Facchini, 2001). BBE from opium poppy has been shown to have the same activity 
against (S)-reticuline as the homologue found in E. californica (Hagel et al., 2012). There are five 
other full length BBE like proteins present in the transcriptome of opium poppy, one of which 
has 94% identity to the opium poppy BBE and is assumed to have the same biological activity, 
as it can catalyse the same reactions in vitro (Hagel et al., 2012). 
There have been a number of reports of the role of the BBE in planta and whether it’s silencing 
leads to an altered metabolic phenotype (Frick et al., 2004; Hagel et al., 2012; Park et al., 2002; 
Park et al., 2003). In cell suspension cultures of E. californica, cell lines expressing antisense BBE 
mRNA transcripts resulted in a reduction in BBE mRNA levels, together with a decrease in BBE 
activity. This decrease in BBE activity was accompanied by a decrease in benzophenanthridine 
alkaloids, an alteration in the free amino acid pools in the cell culture, together with a reduction 
in the growth rate of the cell culture, however there is no concomitant increase in pathway 
intermediates preceding BBE in the antisense lines for this enzyme (Park et al., 2002). A similar 
phenomenon was seen in transgenic root cultures of E. californica. Antisense BBE expression 
again led to a decrease in BBE activity, together with a decrease in benzylphenanthridine 
alkaloids, a change in the size of the free amino acid pool and altered growth rate of the culture. 
In comparison overexpression of BBE resulted in a two fold increase in BBE activity, together 
with a five fold increase in benzylphenanthridine alklaoids (Park et al., 2003). In whole plants of 
opium poppy, the stable transformation of antisense BBE results in an increase in reticuline, 
laudanine, laudasonine, dehydroreticuline, salutaridine, and (S)-scoulerine and altered the ratio 
of morphinan and tetrahydrobenzylisoquinonline alkaloids in latex, however no change in 
benzophenanthridine alkaloids, such as sanguinarine, occurred in roots (Frick et al., 2004). This 
is interesting, as a decrease in sanguinarine might be expected as BBE catalyses the branchpoint 
reaction to (S)-scoulerine. VIGS of BBE in opium poppy using a silencing construct that targets 
both BBE homologues resulted in a decrease in sanguinarine 
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and dihydrosanguinarine, together with an increase in the substrate reticuline (Hagel et al., 
2012). The combined evidence from cell suspension cultures and whole plants is indicative that 
BBE plays a role in benzylisoquinoline biosynthesis in both California and opium poppy.  
In comparison overexpression of BBE resulted in a two fold increase in BBE activity, together 
with a five fold increase in benzylphenanthridine alklaoids (Park et al., 2003). 
As well as in the conversion of (S)-reticuline to (S)-scoulerine and the unusual formation of the 
berberine bridge carbon, BBE-like enzymes have also been found to be involved in other aspects 
of benzylisoquinoline alkaloid biosynthesis.  
There are six full length homologues of BBE present in opium poppy. Two are thought to be 
involved in performing the canonical BBE reaction, conversion of (S)-reticuline to (S)-scoulerine 
(Hagel et al., 2012).  Three of the remaining homologues could not be expressed in Pichia 
pastoris, and when silenced in opium poppy no change in the metabolic phenotype was 
observed.  The remaining homologue displayed novel enzymatic activity in the 
benzylisoquinoline pathway, catalysing the oxidation of dihydrosanguinarine to sanguinarine, 
and was therefore named dihydrobenzophenanthridine oxidase (DBOX) (Figure 5-6) (Hagel et 
al., 2012). This enzyme also similarly oxidised a number of protoberberine and 
benzylisoquinoline alkaloids, including scoulerine, tetrahydropapaverine 
tetrahydrocolumbamine, tetrahydropalmitine, canadine and stylopine, and therefore displayed 
(S)-tetrahydroprotoberberine oxidase (STOX) activity, suggesting this enzyme is a 
multifunctional oxidase. VIGS of this enzyme resulted in a decrease in sanguinarine, 
dihydrosanguinarine and papaverine, suggesting it is an integral enzyme in BIA metabolism 
(Hagel et al., 2012).   
Other BIA producing plants also contain a third type of BBE-like protein that has protoberberine 
dehydrogenase activity, (S)-tetrahydroprotoberberine oxidase, (STOX). This enzyme activity was 
originally identified in suspension cultures of Berberis (Amann et al., 1984). The gene was cloned 
and expressed in Sf9 insect cell cultures, together with a homologue from Argemone mexicana 
(Gesell et al., 2011). Both BwSTOX and AmSTOX were able to act as oxidases on a number of 
different protoberberine scaffolds, and showed differential substrate specificity. Both acted on 
(S)-tetrahydropalmatine, generating two double bonds to form palmatine, whilst BwSTOX 
showed activity towards (S)-scoulerine, and converted (S)-canadine to berberine, and AmSTOX 
demonstrated in vitro activity towards (S)-corexime generating a new alkaloid product that does 
not have a conjugated ring system (Figure 5-6). It has been shown that BBE enzyme from E. 
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californica also has STOX activity towards its end product (S)-scoulerine, forming 
dehydroscoulerine, however this reaction occurs at a rate around 3000 times lower than that of 
its primary reaction (Winkler et al., 2009b). 
 
Figure 5-6 Proposed roles of Berberine Bridge Like enzymes in benzylisoquinoline alkaloid biosynthesis 
Each reaction involves the oxidation of a carbon-nitrogen bond 
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5.1.2.1 The role of berberine bridge enzyme family in pyridine alkaloid metabolism 
 
BBE-like genes have also been implicated in the biosynthesis of the pyridine alkaloid, nicotine, 
in tobacco (Nicotiana tabacum) (Kajikawa et al., 2011). Four full length BBE-like genes were 
identified in the tobacco genome (BBLa, b, c, d), and their expression was shown to be under 
the transcriptional control of the NIC regulatory locus, induced by MeJA and highly expressed in 
roots, which is similar to the known enzymes involved in nicotine biosynthesis. Silencing these 
BBL genes either constitutively or inducibly, by RNA interference in tobacco hairy roots resulted 
in decreased nicotine levels, together with the accumulation of a novel metabolite identified as 
dihydrometanicotine (DMN) (Kajikawa et al., 2011). In transgenic tobacco plants in which the 
BBL genes were silenced, nicotine levels were lower in the leaves and roots compared to wild 
type controls, whilst DMN was the most abundant alkaloid in roots in silenced lines. Silencing of 
the BBL genes in tobacco BY2 cell suspension cultures resulted in a decrease in the accumulation 
of the pyridine alkaloids anatabine, anabasine, though DMN did not accumulate (Kajikawa et al., 
2011).  
This work was further validated in field grown tobacco in which transgenic tobacco carrying an 
RNAi construct to reduce BBL expression, also resulted in a decrease in nicotine levels (Lewis et 
al., 2015). Additionally, an EMS mutant screen for disruption of each of the BBL homologues, 
BBLa, b and c, combined with sexual crossing to generate all possible homozygous combinations 
demonstrated that BBLa had the biggest single effect on alkaloid content, however the greatest 
decrease in nicotine and total alkaloid levels occurred in the homozygous line that disrupted all 
three BBLa, b, c genes (Lewis et al., 2015). 
Collectively, these data strongly implicate the BBL-genes in nicotine biosynthesis in Nicotiana 
tabacum. The data suggest that the BBL proteins oxidise DMN to form nicotine (Figure 5-7). As 
with BBE from E. californica, the tobacco BBL proteins contain an N-terminal signal peptide that 
targets the enzymes for localisation to the vacuole. Recombinant expression of BBLa in Pichia 
pastoris resulted in the expression of a heavily glycosylated protein that was shown to bind FAD, 
though incubation of the enzyme with DMN did not lead to the predicted conversion to nicotine, 
and therefore the exact enzymatic reaction catalysed by these tobacco BBL proteins is still not 
known (Kajikawa et al., 2011). 
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5.1.2.2 The role of berberine bridge enzyme family in terpenophenolic metabolism 
 
BBE-like proteins have also been implicated in the formation of both Δ9-tetrahydrocannabinolic 
acid (THCA) and cannabidiolic acid (CBDA) synthesis in Cannabis sativa (Sirikantaramas et al., 
2004; Taura et al., 2007). Marijuana contains unique terpenophenolics called cannabinoids that 
are psychoactive, however also possess analgesic and anti-inflammatory properties. 
Psychoactive C. sativa contains a higher level of THCA, whilst fiber-type Cannabis has a higher 
proportion of CBDA. These molecules are derived from the same precursor, cannabigerolic acid 
(CBGA), and therefore the relative activity of THCA synthase to CBDA synthase is important in 
determining the psychoactivity of the Cannabis strain (Onofri et al., 2015; Taura et al., 2007). 
THCA synthase, a BBE-like enzyme, was shown to be a flavinylated oxidase that could catalyse 
the oxidative cyclisation of CBGA to THCA (Figure 5-7) forming a carbon oxygen bond and 
releasing H2O2, when expressed recombinantly in tobacco hairy roots or insect cell culture 
(Sirikantaramas et al., 2004; Taura et al., 1996; Taura et al., 1995). It contains a 28 amino acid 
signal peptide that likely targets it to the secretory pathway.   
Recombinant THCA synthase expressed in insect cells or tobacco BY2 cells is secreted to the 
culture medium, whilst overexpression of THCA synthase as a GFP fusion in transgenic N. 
tabacum resulted in its localisation to the storage cavity of glandular trichomes. THCA synthase 
activity was detected in endogenous Cannabis sativa trichomes, and suggested that the storage 
cavity is both the site of cannabinoid accumulation and biosynthesis (Sirikantaramas et al., 
2005). Interestingly CBDA synthase is also a BBE-like enzyme that has 84% identity to THCA 
synthase. Both of these enzymes catalyse the oxidative cyclisation of CBGA to either THCA or 
CBDA respectively, and are thought to proceed through a similar mechanism (Taura et al., 1996; 
Taura et al., 2007). The distinct catalytic activity of THCA synthase or CBDA synthase therefore 
plays a role in controlling the chemotype of the C. sativa variety (Taura et al., 2007). Sequence 
heterogeneity of CBDA and THCA synthases in C. sativa is a key determinant of chemical 
phenotype and determining whether a strain is psychoactive. With increasing availability of 
sequences for C. sativa transcriptomes and genomes, there is a growing appreciation that there 
are multiple CBDA- and THCA like synthases expressed (Onofri et al., 2015). Analysis of different 
C. sativa lines with different mutations in CBDA and THCA homologues, along with analysis of 
the corresponding chemical phenotype, suggested that many mutations that impair 
functionality of these enzymes in C. sativa led to an increase in the precursor CBGA as would be 
expected (Onofri et al., 2015; Shoyama et al., 2012). 
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Figure 5-7 The role of BBE like enzymes in specialised plant metabolism 
Outside of benzylisoquinoline biosynthesis BBE like enzymes are involved in pyridine and terpenophenolic 
metabolism. A.) Based on silencing experiments in tobacco, BBLa is thought to lead to the conversion of 
dihydrometanicotine (DMN) to nicotine, however this has not yet been shown in vitro B.) The enzyme 
CBDA synthase catalyses the conversion of cannaigeriolic acid (CBGA) to cannabidiolic acid (CBDA) C.) The 
enzyme THCA synthase catalyses the conversion of cannabigeriolic acid (CBGA) to tetrahydrocannabinolic 
acid (THCA). 
 
5.1.2.3 The role of the berberine bridge enzyme family in primary metabolism 
 
BBE-like enzymes are also involved in a diverse range of metabolic processes outside of 
secondary metabolism. In Arabidopsis, a plant that does not contain benzylisoquinoline, pyridine 
alkaloids, or cannabinoids, there are 28 different members of this enzyme family (Daniel et al., 
2015).  This family of enzymes has been shown to be expressed during certain developmental 
stages as well as in response to environmental stresses. Two of these genes AtBBE-like 13 and 
15, have been functionally characterised. AtBBE-like 15 is located in the cell wall and gene 
disruption of this enzyme resulted in defects in female gametophytic development. 
Heterologous expression in Pichia pastoris, and screening against a targeted library of 
compounds demonstrated that both AtBBE-like 15  and AtBBE-like 13, showed  catalytic activity 
in which cinnamyl-, p-coumaryl, -coniferul and sinapyl alcohol, are converted  to the 
corresponding aldehydes, and suggested that these enzymes may act as monolignol 
oxidoreductases (Daniel et al., 2015). The localisation of the AtBBE-like 15 to the apoplastic 
space is consistent with a physiological role for this activity, as monolignols are thought to be 
exported in their alcohol forms to the apoplast, where they act as substrates for cell wall 
polymerization (Daniel et al., 2015). Furthermore, this enzyme co-expressed with known genes 
involved in monolignol biosynthesis, including phenylalanine ammonia lyase, an enzyme 
involved in entry into the phenylpropanoid pathway, as well as monolignol glucoside hydrolases. 
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Structural analysis of the active site residues in the AtBBE-like 13 and 15 enzymes, identified 
important structural sequences that are involved in substrate recognition, and based on 
alignments to the other 28 members of this family implicated a further 12 of the AtBBE-like 
proteins as acting as alcohol oxidases, however this needs to be experimentally verified (Daniel 
et al., 2015).  
BBE-like proteins in Helianthus annus (Ha-CHOX), and Lactuca sativa (Ls-CHOX) were shown to 
be carbohydrate oxidases, with the ability to oxidise a range of monosaccharide and 
disaccharide substrates and led to the formation of H2O2 (Custers et al., 2004). With glucose as 
a substrate, Ha-CHOX forms δ-glucono-1,5-lactone. Despite homology to BBE-like enzymes, it is 
unable to catalyse the conversion of (S)-reticuline to (S)-scoulerine and form the berberine 
bridge carbon. Transcription of the Ha-CHOX gene from sunflower was shown to be upregulated 
in response to salicylic acid, as well as in response to the plant pathogens Sclerotinia 
sclerotiorum, Botyrtis cinerea and Diaporthe helianthi and transgenic tobacco overexpressing 
Ha-CHOX was shown to be more resistant to Pectobacterium carotovorum (Custers et al., 2004). 
It is thought therefore that Ha-CHOX is an active part of the plant defence response, as it is 
upregulated under pathogen attack, and contributes to formation of H2O2 as a result of 
carbohydrate oxidation (Custers et al., 2004). 
Similarly in ornamental tobacco, a BBE-like protein called Nectarin V is also thought to be 
involved in plant defence (Carter and Thornburg, 2004). Nectarin V was purified from the nectar 
of ornamental tobacco, subjected to N-terminal sequencing, and the cDNA encoding the full 
length protein was elucidated. The temporal expression of Nec5 suggested it was only expressed 
during maturation of the nectary, and spatially is only localised to this organ. Plant nectar in 
tobacco does not contain alkaloids, however does contain a range of other mono- and di-
saccharides, amino acids, organic acid vitamins and oils. Nectarin V was shown to display 
carbohydrate oxidase activity, and in particular was active against glucose. This carbohydrate 
oxidase activity is again thought to lead to the high concentration of H2O2 found in nectar, 
together with the action of Nectarin I which is a superoxide dismutase (Carter and Thornburg, 
2004). 
The timothy grass pollen allergen Phlp4, protein has been shown to be homologous to BBE and 
is a contributory factor in respiratory allergies (DeWitt et al., 2006). Enzymatically it catalyses 
the oxidation of D-glucose, however unusually for a bicovalently linked FAD BBE-like protein, it 
acts as a dehydrogenase as opposed to an oxidase (Zafred et al., 2015). 
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Figure 5-8 The role of BBE-Like enzymes in primary metabolism 
A.) AtBBE-like proteins have been shown to be involved in the generation of monolignol aldehydes 
involved in cell wall biosynthesis. B.) Nectarin V and Ha-CHOX catalysed the oxidation of D-glucose to 
glucono 1,5-lactone, with the release of H2O2 which is thought to contribute to plant defence. C.) Similarly 
the pollen allergen Phlp4 catalyses the same reaction, however is a dehydrogenase and doesn’t use 
oxygen as a final electron acceptor. The identity of the endogenous electron acceptor is not known. 
 
The fact that BBE-like proteins are ubiquitous in the plant kingdom, and that many species 
contain multiple BBE-like homologues, is suggestive that this class of enzymes has a general role 
in plant metabolism. The aforementioned specialised roles of BBE-like enzymes in alkaloid and 
cannabinoid biosynthesis may have arisen by gene duplication and mutational diversification 
from primitive oxidoreductases (Daniel et al., 2015). 
 
5.1.3 The process of autoflavinylation and the role of covalent flavinylation 
 
With the exception of GALDH, all VAO family proteins from plants have been shown to contain 
either monocovalent or bicovalent attachment of FAD and there has been debate as to the role 
covalent attachment plays in catalysis.  
In all VAO proteins studied to date, flavinylation occurs autocatalytically, and for bi-covalently 
associated FAD, the 8α-N1-histidyl and 6-S-cysteinyl-FAD covalent attachment in the enzyme 
occurs independently. This has been shown for BBE from E. californica, THCA synthase from C. 
sativa as well as in glucooligosaccharide oxidase (GOOX) from Acremonium strictum and 
chitooligosaccharide oxidase (ChitO) from Fusarium graminearum. In all cases single mutations 
of either the histidine or cysteine FAD linkages in the enzymes still resulted in FAD covalently 
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linked to the enzyme, suggesting each covalent attachment is formed independently (Heuts et 
al., 2008; Huang et al., 2008; Sirikantaramas et al., 2004; Winkler et al., 2007). 
There are a number of sequence determinants for FAD covalently binding to VAO type enzymes. 
GALDH, a VAO protein from A. thaliana that binds FAD non-covalently, has a leucine in the 
position that is usually a conserved histidine for covalent attachment. Mutagenesis of the 
leucine to an isoleucine, phenylalanine or histidine destabilised the protein, and all mutants 
bound FAD non-covalently. This therefore suggested that despite the presence of histidine in 
the L56H mutant, other residues are required for autoflavinylation (Leferink et al., 2008b). This 
has been further shown for the VAO protein from Penicillium simplicissimum. The mutation 
H61T prevented the formation of a covalent link between H422 and FAD, suggesting this H61 is 
important for activating H422 to covalently react with FAD (Tahallah et al., 2002). 
The redox potential of flavins can be influenced by the surrounding chemical environment, and 
therefore the protein environment of the enzymatic active site may have a direct effect on its 
redox potential (Heuts et al., 2009). It has been shown that covalent coupling of flavin increases 
the midpoint potential of FAD, with bicovalent attachment having the greatest effect (Heuts et 
al., 2009). An increase in the midpoint potential of the FAD allows the enzyme to oxidise the 
substrate more efficiently. This has been elegantly shown for the BBE from E. californica. This 
enzyme has a bicovalent attachment to FAD at H104 and C166 (Winkler et al., 2006; Winkler et 
al., 2008; Winkler et al., 2009a). The wild type protein has a high midpoint potential of +132 mV. 
Mutagenesis of the amino acids H104 and C166 demonstrated that covalent attachment is 
integral to achieving this high midpoint potential (Winkler et al., 2007). Mutation of the histidine 
to alanine or threonine resulted in low yields of protein, suggesting the histidyl-FAD covalent 
attachment might be integral to the stability of the protein. In comparison mutating the C166 to 
an alanine resulted in good yield of protein as it still had a single covalent link to H104, however 
it resulted in a decrease in the redox potential to +53 mV (Winkler et al., 2007). Additionally, the 
steady state turnover of the enzyme decreased, with a switch in the rate limiting step in catalysis 
from re-oxidation of the FAD, to the oxidation of the (Winkler et al., 2007). This suggested the 
bicovalent attachment fine tunes the FAD redox potential for improved catalytic efficiency. In 
comparison, for THCA synthase, the mutation of the H114 still resulted in soluble protein, 
however this mutation abolished enzyme activity suggesting the histidyl-FAD is integral to 
catalysis (Sirikantaramas et al., 2004). This has also been shown for bicovalent VAO proteins 
outside of plants. Glucooligosaccharide oxidase from Acremonium strictum, has been 
crystallised and was the first enzyme identified to show bicovalent attachment of FAD (Huang 
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et al., 2005). In each of the single mutants H70A and C130A, there was a decrease in the 
midpoint potential of the FAD from +126 mV to +69 mV and +61 mV respectively, which 
correlated with a decrease in the activity of the enzyme. The double mutant H70A/C130A, which 
did not contain FAD, was inactive even upon supplementation of the assay with exogenous FAD 
(Huang et al., 2008). In the context of GOOX, the covalent attachment appears to be essential 
for the structural integrity of a well ordered FAD binding cavity in the enzyme active site (Huang 
et al., 2008). Conversely in Chito-oligosaccahride oxidase (ChitO) from Fusarium graminearum, 
another bicovalent VAO type protein, mutagenesis of C154A reduced the redox potential from 
+131 mV to +70 mV, whilst mutation of H94A resulted in an increased redox potential, though 
both mutations resulted in a decrease in enzymatic activity (Heuts et al., 2008). This suggests 
that although C154A is likely involved in tuning the redox potential of the FAD, the bicovalent 
nature of the FAD linkage may be important for the correct positioning of the cofactor in the 
active site of the enzyme (Heuts et al., 2008). 
A key proposed role of covalent flavinylation, as well as its impact on redox potential, has been 
its implied involvement in the structural integrity of the protein. In many bicovalently linked 
proteins, mutations that led to the mono-covalent attachment of FAD were still viable and 
soluble but had lower catalytic efficiency. Mutations that completely abolish FAD binding usually 
cannot be expressed, as has been shown for BBE from E. californica (Winkler et al., 2007) and 
ChitO from F. graminearum (Heuts et al., 2008). For GOOX, from Acremonium strictum, although 
the double mutant H70A/C130A, was expressed, it did not contain FAD, suggesting that removal 
of both covalent linkages to FAD from the protein alters the structure of the protein and 
prevents FAD binding non-covalently, demonstrating that the bicovalent linkage is required for 
correct FAD positioning as well as in catalysis (Huang et al., 2008). However for VAO, as 
mentioned, mutagenesis of the histidyl-FAD covalent link leads to a reduction in catalytic 
efficiency, though the mutants are all able to tightly bind FAD non-covalently, demonstrating 
that the covalent linkage is not needed to form a suitable FAD binding site (Tahallah et al., 2002). 
Similarly in the bicovalently linked protein GilR, an oxidoreductase involved in gilovarcin 
biosynthesis the double mutant H65A/C125A, despite having no enzymatic activity, was 
appropriately folded and bound FAD non-covalently (Noinaj et al., 2011). This therefore suggests 
that the role of covalent flavinylation on protein structural integrity is protein dependent.  
The majority of covalently linked VAO proteins are oxidases, both in planta and in other 
kingdoms of life, and are able to utilise molecular oxygen as the final electron acceptor. One of 
the postulated reasons for this is that covalent flavinylation increases the redox potential of the 
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FAD and therefore limits the redox partners that can be used in electron transfer (Heuts et al., 
2009).  However there are exceptions where proteins that have a covalent-FAD linkage act as 
dehydrogenases. The archetypal example of this is the cytokinin dehydrogenase family of 
enzymes, which have been shown to react sluggishly with molecular oxygen and instead have a 
preference for a range of quinones that act as the final electron acceptor to oxidise FAD 
(Frébortová et al., 2004; Frébortová et al., 2010). Additionally, it has been shown that bicovalent 
plant allergen Phlp 4, despite a very high redox potential of +200 mV, does not react well with 
oxygen, and therefore likely utilises an alternative electron acceptor for re-oxidation of FAD. 
Mutagenesis studies of the BBE, Phlp4 and GALDH enzymes have identified two key residues 
termed ‘the gatekeeper’ (Leferink et al., 2009) and ‘alternative gatekeeper’ (Zafred et al., 2015). 
These residues are involved in forming an oxygen pocket that influences the reactivity of the 
enzyme towards molecular oxygen. In particular, through mutagenesis, it was shown that it is 
possible to increase the oxygen reactivity of the dehydrogenase Phlp4 (Zafred et al., 2015), to 
convert the dehydrogenase GALDH, that binds FAD non-covalently, into an oxidase (Leferink et 
al., 2009), and to decrease the reactivity of BBE towards molecular oxygen (Zafred et al., 2015). 
This work increases the predictive power through sequence analysis, of whether a VAO enzyme 
is likely to react with molecular oxygen as the final electron acceptor. However it should be 
noted that, to date, all VAO type enzymes that bind FAD non-covalently act as dehydrogenases.  
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5.1.4 Summary for Introduction 
 
The BBE family, which is conserved throughout the plant kingdom, has been shown to catalyse 
varied and unique oxidation reactions on a plethora of structurally diverse substrates. Members 
of this protein family have been implicated in the metabolism of three different families of 
natural products, the benzylisoquinoine alkaloids, pyridine alkaloids and terpenophenolics. 
Therefore, this family is an attractive target to search for biosynthetic gene candidates in MIA 
metabolism in C. roseus.   
5.2 Aims of this Chapter 
 
1.) Assess whether any VAO enzymes are involved in MIA biosynthesis in C. roseus using an in 
planta loss of function screen. 
2.) Functionally characterise the VAO enzymes that display a metabolic phenotype. 
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5.3 Results 
 
5.3.1 The reticuline oxidase family in Catharanthus roseus 
 
As discussed in Chapter II the reticuline oxidase like protein annotated as locus_5608 in the C. 
roseus transcriptome, co-expresses with a number of genes that have previously been shown to 
be involved in MIA metabolism in C. roseus, including strictosidine synthase, secologanin 
synthase, tryptophan decarboxylase, tryptophan synthase as well as the transporters 
characterised in Chapter III and Chapter IV (Figure 5-9). Due to this co-expression it was 
therefore assessed to be a good candidate for its potential involvement in MIA metabolism, and 
will hereafter be referred to as CrRO. 
 
Figure 5-9 Transcriptomic profile of CrRO  
Analysis of the expression profile of CrRO across 23 different tissues and experimental conditions, which 
have previously been described in Chapter II demonstrates that it has a similar expression pattern as 
known genes in the MIA biosynthetic pathway, as well as a similar expression pattern to the transporters 
CrNPF2.9, CrMATE1952 and CrMATE10740 that have been demonstrated to result in a VIGS phenotype 
earlier in this thesis. 
 
CrRO encodes for a protein 530 amino acids in length and the full length gene was cloned from 
C. roseus leaf cDNA into a pCR8GW gateway compatible entry vector and sequenced. The 
sequence was consistent with that found in the MPGR C. roseus transcriptome, and genome, 
demonstrating that the gene is real, is expressed in leaf tissue and that the gene was correctly 
assembled in the transcriptome. 
The C. roseus genome shows that CrRO does not contain any introns and exists as one contiguous 
exon, which is consistent with reticuline oxidases from other plant species (Facchini et al., 1996). 
There is one homologue of CrRO present on the C. roseus genome that has a greater than 70% 
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identity at the amino acid level and encodes for a 550 amino acid protein. Interestingly these 
proteins are spatially close on the genome and are both present on the same 23,195 bp genomic 
contig. This is suggestive that these two genes could have arisen from a gene duplication event. 
The homologue of CrRO has the same genomic organisation as CrRO, and again occurs as one 
contiguous exon (Figure 5-10). 
 
Figure 5-10 Genomic organisation of the CrRO  
There are two reticuline oxidases, CrRO and CrRO homologue, spatially close on a genomic contig ~23,000 
bp in length. Open reading frames are highlighted by orange arrows.  As with other characterised 
reticuline oxidases each gene occurs as one contiguous exon. The CrRO is highlighted by a blue box, and 
the CrRO homologue highlighted by a red box. 
 
A basic local alignment using BLAST of the CrRO homologue against the C. roseus transcriptome 
did not identify a transcript that had a complete open reading frame, unlike CrRO, but instead 
had greatest sequence identity to a transcript annotated as locus_15353 that was 
misassembled. This misassembled transcript was expressed at low levels in the C. roseus 
transcriptome in all tissues. A BLAST of the CrRO homologue against two other openly available 
C. roseus transcriptomes, Cathacyc (Van Moerkercke et al., 2013), and Phytometasyn (Xiao et 
al., 2013) also failed to retrieve a full length transcript of the CrRO homologue. 
To assess whether the CrRO homologue gene is actually expressed in leaf tissue, primers were 
designed to amplify the full length gene of the CrRO homologue from C. roseus leaf cDNA using 
the sequence from the genome, to amplify a truncation of the CrRO homologue that aligns 
better with the start codon of the CrRO, and to amplify two internal regions of the CrRO 
homologue gene 100 bp in length. As a positive control the full length CrRO and 100 bp of the 
CrRO were amplified.  
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 In all cases no band of the correct size could be amplified from leaf cDNA for the CrRO 
homologue (Figure 5-11) indicating that despite having significant sequence identity to CrRO, 
the CrRO homologue does not appear to be expressed in leaf tissue and therefore is unlikely to 
have a role in leaf MIA metabolism, and may be a pseudogene. 
 
 
Figure 5-11 PCR amplification of CrRO and CrRO Homologue from C. roseus cDNA 
A.) Full length PCR amplification of the CrRO homologue from C. roseus leaf cDNA. 1.) Amplification full 
length CrRO homologue 2.) Amplification N-terminal truncation of CrRO homologue 3.) Amplification 
CrRO gene. B.) Amplification of 100 bp regions of CrRO homologue 1.) Amplification section1 100 bp CrRO 
homologue 2.) Amplification section 2 100 bp CrRO homologue 3.) Amplification 100bp of CrRO 
 
 
5.3.1.1 Assessment of the CrRO sequence 
 
CrRO does not contain the conserved sequence required for the bicovalent attachment of FAD. 
The conserved histidine residue that ordinarily coordinates attachment to FAD, as has been 
found in all BBE-like enzymes in planta, is not present, and instead has an alanine at this position. 
Additionally the cysteine that is conserved and allows for bicovalent attachment of FAD is also 
not present and is substituted with a serine (Figure 5-12, Figure 5-13). This suggests that FAD is 
likely to bind non-covalently in CrRO. Although more than 90% of enzymes that bind FAD have 
a non-covalent attachment, the enzymes that have been characterised to date in the BBE like 
enzyme subfamily all contain a conserved motif that allows for at least monocovalent 
attachment to FAD. 
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It is therefore the first protein to my knowledge that has sequence identity to the berberine 
bridge enzyme scaffold, but is predicted to bind non-covalently to FAD (Figure 5-12). 
 
 
Figure 5-12 The predicted residues for covalent FAD binding in CrRO are not present. 
A.) BBE contains a histidine and cysteine that allows for bicovalent attachment of FAD by an 8α-N1-histidyl-
6-S-cysteinyl-FAD attachment B.) In CrRO the equivalent residues are an alanine and a serine.  
 
 
 
As has been mentioned previously, all VAO type proteins identified to date that do not bind FAD 
covalently act as dehydrogenases (Leferink et al., 2008a). It is therefore tempting to speculate 
that the CrRO would not use molecular oxygen, but another electron acceptor instead in its 
catalytic cycle for re-oxidation of FAD. 
However based on the work in (Leferink et al., 2009; Leferink et al., 2008b; Zafred et al., 2015) 
this CrRO enzyme is predicted to be able to bind molecular oxygen. CrRO has a glycine at the 
‘gatekeeper’ residue and a valine at the ‘alternative gatekeeper’, (Figure 5-13, Figure 5-14), 
which is consistent with the oxidases such as BBE, as opposed to the dehydrogenases such as 
Phlp4 or GALDH. Whether this enzyme acts as an oxidase or dehydrogenase is therefore still an 
open question that requires experimental validation, and cannot be determined by analysis of 
the sequence alone. 
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Figure 5-13 Protein alignment of CrRO. 
Alignment of CrRO against the CrRO homologue present on the C. roseus genome, the Cannabis sativa 
THCA synthase and the canonical BBE from Papaver somniferum. Highlighted in yellow are the histidine 
and cysteine that are involved in bicovalent attachment of FAD in C. sativa THCA synthase and P. 
somniferum BBE, which are in turn an alanine, serine or tyrosine in CrRO and CrRO homologue. 
Highlighted in green is the gatekeeper residue that is a glycine in all sequences, and highlighted in red is 
the alternative gatekeeper residue, which is valine in all sequences indicating that all have the predicted 
capacity to bind molecular oxygen. 
 
Figure 5-14 Active site of E. californica BBE and Phl p 4 
Aligned structures of the wild type E. californica BBE (green) and Phl p 4 (light pink) with the FAD 
highlighted in yellow. A pocket of space (blue) allows for oxygen binding in the oxidase BBE. Phl p 4 has a 
residue I153 (alternative gatekeeper) that prevents oxygen binding, whilst when G164 (the gatekeeper) 
of the BBE is mutated to A164 (dark pink) this also prevents oxygen binding. CrRO has a glycine at the 
gatekeeper residue and a valine at the alternative gatekeeper and is therefore predicted to bind 
molecular oxygen. Figure sourced from Zafred et al., 2015. 
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The Apocynaceae family of plants produces a wide variety of MIAs that have the aspidosperma, 
iboga and corynanthe alkaloid scaffolds. If the CrRO is integral to MIA biosynthesis, in a part of 
the metabolic pathway that is common between different plant species, we may expect other 
species to contain a homologous protein to CrRO. 
A BLAST search of this protein against the transcriptomes of other members of the Catharanthus 
genus, Catharanthus ovalis and Catharanthus longifolius, using the Phytometasyn server, 
demonstrated that this CrRO is conserved with 99.3% sequence identity in these species. A 
homologous protein was also conserved in more distant family members, such as Vinca minor 
and Tabernaemontana elegans each protein having 72% identity and 67.9% identity 
respectively. In comparison, Rauwolfia serpentina and Camptotheca acuminata, despite also 
producing MIAs, do not contain a homologue that is mutated for bicovalent attachment. 
Interestingly the homologues from Catharanthus ovalis, Catharanthus longifolius, Vinca minor 
and Tabernaemontana elegans, like the CrRO from C. roseus, do not contain the histidine or 
cysteine that allows for bicovalent attachment of FAD, with the histidine replaced by an alanine 
in C. ovalis and C. longifolius, whilst replaced by a serine in V. minor and T. elegans, and the 
cysteine replaced by a either a tyrosine or serine in each of these plant species.  
This demonstrated that although the CrRO protein is unusual in having a berberine bridge 
scaffold, but is predicted to bind FAD non-covalently, this reticuline oxidase like protein is 
conserved in a number of species of MIA producing plants. 
The alkaloid content of the different plant species may provide clues as to which specific MIA 
metabolic pathway CrRO might be involved in. The fact that Rauwolfia serpentina and 
Camptotheca acuminata contain a homologue that has lower sequence identity and also 
appears to bind FAD differently, suggests the CrRO from C. roseus may have a unique function 
that is not is involved in ajmalan, yohimbine, ajmalicine or quinoline type alkaloid biosynthesis 
which are the predominant alkaloid families found in Rauwolfia serpentina and Camptotheca 
acuminata. As well as ajmalicine type indole alkaloids, C. roseus also contains aspidosperma and 
iboga type alkaloids, which are highlighted by the MIAs, vindoline and catharanthine. The iboga 
and aspidosperma alkaloid families are thought to be synthesised from a common chemical 
intermediate, preakuammicine. Similarly Tabernaemontana elegans contains iboga based 
alkaloids, whilst Vinca minor produces vincamine, a hunteria type alkaloid that based on feeding 
studies (Ahmad et al., 1983), has been shown to be derived from the aspidosperma alkaloid 
tabersonine. The conservation of a reticuline oxidase like protein that is predicted to bind FAD 
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non-covalently in the Catharanthus genus, Tabernaemontana elegans and Vinca minor, whilst 
such a protein is absent in Rauwolfia serpentina or Camptotheca acuminata, may suggest that 
this protein is involved in the biosynthesis of iboga and aspidosperma based MIAs.  
As more transcriptomic and genomic data becomes available for plant species that produce 
MIAs it will be interesting to ascertain whether this particular reticuline oxidase like protein is 
conserved in these plant species, as has been shown so far in C. roseus, V. minor and T. elegans. 
There are nine contigs in the C. roseus transcriptome that are annotated as either berberine 
bridge enzymes or reticuline oxidases that are also expressed in leaf tissue. Furthermore a BLAST 
search of the P. somniferum BBE against the C. roseus transcriptome identified a further seven 
genes that are annotated as either an FAD-dependent oxidoreductase, a CPRD2 protein, 
carbohydrate oxidase, lactate dehydrogenase, or misannotated as a gene of unknown function, 
resulting in a gene family of ~16 genes. With the exception of CrRO and the CrRO homologue, 
all of these proteins have the predicted conserved histidine present for monocovalent 
attachment of FAD, and 10/16 are predicted to also bind in a bicovalent manner due to the 
presence of a conserved cysteine residue. All of the BBE-like enzymes contain a glycine residue 
at the ‘gatekeeper’ position, however 3 out of the 16 have an isoleucine or leucine instead of a 
valine at the ‘alternative gatekeeper’ residue suggesting three of the proteins may act as 
dehydrogenases. 
Only CrRO was shown to cluster with regards to its expression profile with genes shown to be 
involved in the MIA pathway (Figure 5-9). Additionally this CrRO is also highly expressed in leaf 
tissue and has the third highest expression of this class of enzyme in leaf tissue in C. roseus. 
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Figure 5-15 Phylogenetic tree of BBE-like enzymes 
A phylogenetic tree showing sequences for all of the BBE-like enzymes present in C. roseus, the 
homologues of CrRO present in C. longifoilus, C. ovalis, V. minor, T. elegans, as well as the characterised 
BBE like enzymes, BBE from P. somniferum and E. californica, NtBBLa-d from N. tabacum, THCA synthase 
and CBDA synthase from C. sativa, AmSTOX from A. mexicana, BwSTOX from B. wilsoniae, Ha-CHOX from 
H. annus, Nectarin V from ornamental tobacco and Phlp4 from P. pratense are presented. Highlighted by 
the red circles are the C. roseus reticuline oxidase like enzymes silenced in this thesis. The evolutionary 
history was inferred by using the Maximum Likelihood method based on the JTT matrix-based model, and 
the bootstrap consensus tree was inferred from 500 replicates. The percentage of replicate trees in which 
the associated taxa clustered together in the bootstrap test are shown next to the branches. Branches 
corresponding to partitions reproduced in less than 50% bootstrap replicates are collapsed. 
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5.3.2 VIGS of Reticuline Oxidase-Like Enzymes in C. roseus 
 
5.3.2.1 VIGS of CrRO 
 
To assess whether CrRO is involved in MIA metabolism, it was silenced by VIGS. Two regions of 
the reticuline oxidase like gene (CrRO) from the N-terminus (500 bp in length) and C-terminus 
(281 bp in length) were selected for the construction of two pTRV2u silencing vectors. An N- and 
C-terminal region of the gene were selected for silencing to ensure that any phenotype observed 
was due to silencing of this specific RO and not as a result of cross-silencing other members of 
the reticuline oxidase like family in C. roseus. A BLAST against the transcriptome for each of the 
regions from the N- and C-terminus suggested that the VIGS fragments selected do not contain 
regions of homology that has significant overlap to other genes in the transcriptome that could 
cause potential cross-silencing.  
VIGS of the CrRO using both either the N-terminal or C-terminal fragment in the VIGS vector 
resulted in a novel metabolic phenotype, showing the accumulation of two new peaks with m/z 
values of 355 and 397, relative to the empty vector control VIGS tissue (Figure 5-18). These peaks 
are not found, or found at very low levels in the EV control, in comparison to the CrRO silenced 
leaf tissue (Figure 5-18). The fact both N-terminal and C-terminal VIGS vectors generated the 
same metabolic phenotype is indicative that silencing of this gene, CrRO, is the likely cause of 
the accumulation of these peaks.  
The whole VIGS experiment has been replicated multiple times, generating the same metabolic 
phenotype. The results from the whole VIGS experiment are presented in (Figure 5-16) utilising 
the N-terminal VIGS vector, as well as the VIGS experiment in which silencing of the CrRO with 
the N-terminal and C-terminal VIGS vector are performed in parallel (Figure 5-17). Further 
replicates are presented in the Appendix. This is the first evidence that the reticuline oxidase 
(and more broadly the VAO family of enzymes) is fundamentally involved in metabolism in C. 
roseus. qPCR to confirm the silencing of the CrRO gene was performed for multiple replicates of 
the VIGS experiments (Figure 5-16, Figure 5-17). 
The qPCR demonstrated that use of both the N- and C terminally targeted VIGS vector results in 
efficient CrRO silencing (Figure 5-17). 
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Figure 5-16 Metabolite and qPCR profile upon VIGS of CrRO using the N-terminal VIGS vector 
A.) Alkaloid profile for VIGS of CrRO relative to empty vector control tissue in Little Bright Eyes; VIGS-CrRO 
(n=8) VIGS-EV (n=8) ** p<0.01 B.) m/z 355 and m/z 397 profile for VIGS of CrRO relative to empty vector 
control tissue in Little Bright Eyes; VIGS- CrRO(n=8) VIGS-EV (n=8) ** p<0.01 C.) qPCR normalised 
expression of the CrRO gene in empty vector and CrRO silenced plants; VIGS- CrRO (n=8) VIGS-EV (n=8). 
All data presented is the mean + SEM. 
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Figure 5-17 Metabolite and qPCR profile upon VIGS of CrRO using the N- and C-terminal VIGS vector 
A.) Alkaloid profile for VIGS of CrRO and CrRO_Cterm relative to empty vector control tissue in Little Bright 
Eyes VIGS-CrRO (n=10), VIGS-CrRO_Cterm (n=8), VIGS-EV (n=10) ** p<0.01 B.) m/z 355 and m/z 397 profile 
for VIGS of CrRO and CrRO_Cterm relative to empty vector control tissue in Little Bright Eyes; VIG-
CrRO(n=10), VIGS-CrRO_Cterm (n=8), VIGS-EV (n=10) ** p<0.01 C.) qPCR normalised expression of the 
CrRO gene in empty vector and CrRO silenced plant;  CrRO (n=8), VIGS-CrRO_Cterm (n=8), VIGS-EV (n=8). 
All data presented is the mean + SEM. 
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Figure 5-18 Representative Total Ion Chromatogram and Extracted Ion Chromatograms for VIGS-EV, 
VIGS-CrRO and VIGS-CrRO Cterm leaf tissue. 
Methanol extracts of leaf tissue from VIGS-CrRO_Cterm, VIGS-CrRO and VIGS-EV leaf tissue were analysed 
by LC-MS. Total ion chromatograms of A.) VIGS-CrRO_Cterm B.) VIGS-CrRO C.) VIGS-EV as well as Extracted 
ion chromatograms of m/z 355 and m/z 397 for D.) VIGS-CrRO_Cterm, E.) VIGS-CrRO and F.) VIGS-EV are 
presented. The m/z 355 and m/z 397 do not accumulate in VIGS-EV leaf tissue. 
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5.3.2.2 VIGS of RO homologues 
 
As mentioned, there are multiple reticuline oxidase like genes in the C. roseus transcriptome. 
CrRO is the third most abundantly expressed in leaf tissue and the only one whose expression 
profile clusters with known genes in the MIA metabolic pathway. The most abundant RO-like 
protein (locus_2957) present in leaf tissue was silenced using VIGS by a colleague in the 
O’Connor group and did not result in a metabolic phenotype (Franziska Kellner; personal 
communication). Two other reticuline oxidases from C. roseus were selected for silencing from 
disparate regions of the phylogenetic tree, locus_5372 and locus_2174. These genes were the 
most highly expressed in leaf tissue on their respective branches of the phylogenetic tree, 
however did not co-regulate with the MIA pathway. 
pTRV2u silencing constructs were generated to individually silence the locus_5372 and 
locus_2174. The individual silencing constructs did not lead to a metabolic phenotype in C. 
roseus. There was no accumulation of new compounds and there was no statistically significant 
change in the peak area of vindoline, catharanthine, secologanin or strictosidine (Figure 5-19). 
Furthermore plants in which the locus_5372 or locus_2174 is silenced do not accumulate 
compounds with an m/z value of 355 or 397. This suggested that the role of CrRO in the plant is 
unique to this enzyme (Figure 5-19, Figure 5-20). 
A triple silencing vector to allow for the combinatorial silencing of CrRO, locus_5372 and 
locus_2174 was generated by USER fusion cloning. If CrRO is functionally redundant and 
compensating for the activity of locus_5372 and locus_2174 then combinatorial silencing of all 
three genes should lead to either a novel metabolic phenotype or an enhanced metabolic 
phenotypic greater than that observed through individual silencing.  
VIGS using this triple silencing construct resulted in the same metabolic phenotype as 
individually silencing the CrRO gene (Figure 5-19, Figure 5-20). This suggested that there was no 
cumulative silencing effect upon silencing all three RO genes at the same time, and therefore 
the evidence to date only implicates CrRO as being physiologically relevant to C. roseus 
metabolism.  
qPCR confirmed that all three genes CrRO, locus_5372 and locus_2174 in the triple silenced lines 
are silenced in these experiments. Additionally, in CrRO individually silenced plants there 
appeared to be a minor amount of cross-silencing of locus_5372 and no cross-silencing with 
locus_2174. The fact that the locus_5372 individually silenced plants do not show a phenotype 
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suggested that the cross-silencing observed is unlikely to be contributory to the metabolic 
phenotype (Figure 5-19, Figure 5-20). 
 
 
 
Figure 5-19 Metabolite and qPCR profile upon VIGS of CrRO, locus_5372, locus_2174 and the 
CrRO_Triple silencing fusion vector. 
A.) Alkaloid profile for VIGS of CrRO, locus_5372, locus_2174 and a triple silencing vector of all three, 
relative to empty vector control tissue in Little Bright Eyes: VIGS-CrRO (n=11), VIGS-2174 (n=11), VIGS-
5372 (n=9), VIGS-CrRO-Triple (n=10),  VIGS-EV (n=12) ** p<0.01 B.) m/z 355 and m/z 397 profile for VIGS 
of CrRO , locus_5372, locus_2174 and a triple silencing vector of all three relative to empty vector control 
tissue in Little Bright Eyes VIGS-CrRO (n=11), VIGS-2174 (n=11), VIGS-5372 (n=9), VIGS-CrRO-Triple (n=10),  
VIGS-EV (n=12) ** p<0.01. All data presented is the mean + SEM. C.) Normalised expression of the gene 
CrRO in VIGS-EV (n=8), VIGS-CrRO (n=8) and VIGS-CrRO_Triple tissue (n=8) D.) Normalised expression of 
the gene locus_2174 in VIGS-EV (n=8), VIGS-CrRO (n=8) and VIGS-CrRO_Triple tissue (n=8) E.) Normalised 
expression of the gene locus_5372 in VIGS-EV (n=8), VIGS-CrRO (n=8) and VIGS-CrRO_Triple tissue (n=8). 
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Figure 5-20 Representative Extracted Ion Chromatogram of m/z 355 and m/z 397 for VIGS-EV, VIGS-
2174, VIGS-5372, VIGS-CrRO and VIGS-CrRO-Triple leaf tissue. 
Methanol extracts of leaf tissue from A.) VIGS-EV B.) VIGS-2174 C.) VIGS-5372 D.) VIGS-CrRO E.) VIGS-
CrRO-Triple leaf tissue were analysed by LC-MS. Presented are the extracted ion chromatograms for the 
m/z 355 and m/z 397 which accumulated in the VIGS-CrRO and VIGS-CrRO-Triple tissue but not in the 
other tissue samples. 
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5.3.2.3 Analysis of Stem Tissue for CrRO silenced plants 
 
Silencing of the CrNPF2.9 transporter in Chapter IV demonstrated that the VIGS can affect the 
metabolic phenotype occurring in both leaf and stem. Metabolite analysis of VIGS-EV stem and 
stem from VIGS-CrRO silenced plants demonstrated that there was no significant difference in 
the peaks present in these tissues and that the compounds represented by m/z 355 and 397 did 
not accumulate in stem (Figure 5-21). This may be indicative that the physiological role of CrRO 
is leaf specific. As demonstrated previously (Chapter IV), the peak with value m/z 349 is the 
dominant peak in stem as opposed to vindoline in leaves. 
 
 
Figure 5-21 Metabolite analysis of stem tissue upon CrRO silencing  
Alkaloid profile of stem tissue taken from around VIGS wound site for Empty vector control (n=8) and 
CrRO silenced plants (n=8) ** p < 0.01. All data presented is the mean + SEM 
 
5.3.2.4 Isotopic labelling of MIAs  in VIGS-CrRO leaf tissue 
 
We do not know the identity of the compounds with m/z 355 and m/z 397 that are accumulating 
in the CrRO silenced VIGS experiments. An exact mass for the m/z 397 peak was obtained, with 
a value of 396.2048 (Gerhard Saalbach, John Innes Centre). The best molecular formula for this 
exact monoisotopic mass is C23H28N2O4. This is consistent with this compound being a MIA, due 
to the presence of two nitrogen atoms in the molecular formula. 
To further demonstrate that these compounds of m/z 355 and m/z 397 are MIAs, and that the 
CrRO is involved directly in MIA biosynthesis, CrRO VIGS tissue was fed with deuterated (d4)-
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tryptamine. As MIAs are derived from tryptamine we predict we would observe m/z increase by 
4 for all MIA compounds. Individual leaves from CrRO plants were cut at the petiole and fed 
5mM d4-tryptamine over the course of 4 days.  
Label was incorporated into the known alkaloids, strictosidine and vindoline (Figure 5-23, Figure 
5-24). As has been observed in other feeding experiments (Chapter III), there is an accumulation 
of labelled strictosidine, with the strictosidine pool in leaf tissue labelled to ~ 75% (Table 7). This 
is in contrast to the label incorporation into downstream alkaloids, potentially implicating that 
either the export of strictosidine from the vacuole or its downstream utilisation is a metabolic 
bottleneck.  
For CrRO VIGS tissue the label was also incorporated into the peaks with m/z value of 355 and 
397, resulting in peaks of m/z 359 and 401 respectively. This is indicative that these peaks are 
derived from tryptamine, and therefore likely to be MIAs (Figure 5-23, Figure 5-24). The amount 
of label incorporation into the m/z 355 and m/z 397 peak is not as great as the label incorporated 
into strictosidine, however comparable to that observed in the downstream MIAs vindoline. 
Vindoline results in a ~2% label enrichment, whilst the label enrichment for m/z 355 and m/z 
397 is between 8-11% (Table 7). 
Although we do not know the role of CrRO, this labelling data is indicative that the two peaks 
that are accumulating do not have an oxidised β-carboline ring (Figure 5-22).  The fact that 
labelling results in m/z + 4 for both m/z 355 and m/z 397 is indicative that there is no loss of 
deuterium. Therefore although we do not know the specific catalytic role of CrRO, this labelling 
data is indicative that the two peaks that are accumulating do not have an oxidised β-carboline 
ring (Figure 5-22). 
 
Figure 5-22 d4-Tryptamine feeding results in deuteration of β-carboline ring. 
Tryptamine labelling results in the deuteration of the β-carboline ring. The fact deuterated label is 
incorporated into the m/z 359 and m/z 397 peaks is indicative that these compounds contain a non-
oxidised β-carboline ring system as the label is still present.  
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Figure 5-23 Mass Spectra for H2O fed C. roseus leaf tissue upon VIGS-CrRO silencing 
Mass spectra of m/z 355, m/z 397, strictosidine and vindolinefor two separate replicates of C. roseus VIGS-
CrRO leaf tissue fed H2O;H2O fed A and H2O fed B. As would be expected no label is present in the mass 
spectra for H2Ofed tissue. 
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Figure 5-24 Mass Spectra for d4-tryptamine fed C. roseus leaf tissue upon VIGS-CrRO silencing 
Mass spectra of m/z 355, m/z 397, strictosidine and vindoline for two separate replicates, A and B, of C. 
roseus VIGS-CrRO leaf tissue fed d4-tryptamine. Label incorporation m + 4 as a result of d4-tryptamine 
feeding is highlighted by a black arrow. 
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Table 7 Enrichment of labelling upon d4-tryptamine feeding to VIGS-CrRO leaf tissue 
The relative enrichment of the m/z +4 relative to m/z is presented for each compound. Enrichment 
values were calculated as a percentage of the combined peak area of m/z and m/z + 4; (peak area (m/z + 
4))/(∑(peak area (m/z + 4) + peak area (m/z)). The presence of deuterated compounds in the water fed 
controls can be explained by baseline noise and natural isotope abundance. 
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5.3.2.5 Deacetylation of VIGS-CrRO leaf extracts 
 
The fact that two new peaks, m/z 355 and m/z 397, accumulated in the VIGS tissue is indicative 
that either two separate metabolic pathways are being affected by silencing of the CrRO, or that 
the two compounds are related. It is possible that silencing of the CrRO results in the 
accumulation of one compound in the plant, which in turn is then detoxified or derivatised by 
the endogenous metabolism of C. roseus.  
The mass difference of 42 between 397 and 355 suggests that m/z 397 might be the acetylated 
derivative of m/z 355.  
Potassium carbonate (K2CO3) can be used for the deacetylation of compounds in aqueous 
methanol (Wuts and Greene, 2006). Treatment of a methanolic extract of VIGS-CrRO tissue with 
K2CO3 resulted in the depletion of the m/z 397 and the accumulation of m/z 355, relative to its 
non-treated control (Figure 5-25).  
In comparison treatment of a VIGS-EV methanolic extract with potassium carbonate did not lead 
to the significant accumulation of a compound with m/z 355 relative to untreated controls, 
indicating that the increase in m/z 355 upon treatment with K2CO3 in the VIGS-CrRO tissue is 
likely to be due to its conversion as a result of the deactylation of m/z 397 (Figure 5-25). 
The base-dependent conversion of the compound m/z 397 to m/z 355, strongly suggested that 
the m/z 397 compound is likely to be the acetylated derivative of m/z 355. Therefore these 
compounds are directly related to each other, and CrRO is acting on one branch of the metabolic 
pathway. 
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Figure 5-25 Extracted ion chromatograms for VIGS-CrRO and VIGS-EV extract treated with K2CO3 in 
aqueous MeOH for m/z 355 and m/z 397. 
Methanolic extracts of the VIGS-CrRO treated A.) with and B.) without potassium carbonate and 
methanolic extracts of the VIGS-EV treated C.) with and D.) without potassium carbonate. Plotted are the 
extracted ion chromatograms for m/z 355 and m/z 397 
 
 
It is likely that the m/z 355 that is accumulating in VIGS-CrRO leaf tissue is acetylated on a free 
hydroxyl group, since the deacetylation reaction (K2CO3, 1 hour at room temperature in MeOH) 
was performed under conditions too mild to effect the hydrolysis of an amide. 
Additionally, vindoline and catharanthine were still present in the sample upon treatment with 
K2CO3 indicating that the reaction conditions were not strong enough for the liberation of the 
methoxy group from methyl-esters (Figure 5-26). 
 
 
Figure 5-26 Reactivity of acetylated groups to deacetylation by K2CO3 
Esters are more reactive towards cleavage of the acetyl group with K2CO3 than either methyl esters, which 
would liberate a methoxy group or amides, which would liberate the amine. 
 
 
 
Acylation of oxygen- and nitrogen containing secondary metabolites in plants is a common 
reaction resulting in the formation of esters and amides respectively (Schmidt et al., 2015). This 
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reaction is often catalysed by the BAHD acyltransferase superfamily. In C.roseus, the terminal 
step in vindoline biosynthesis is catalysed by deactylvindoline acetyltransferase (DAT), resulting 
in the addition of an acetyl group to a hydroxyl moiety, forming vindoline (St‐Pierre et al., 1998). 
This family of enzymes also catalyses the transfer of the acyl donors of malonate, 
hydroxycinnamate, tiglate, anthranilate and benzoate moieties to various alcohol substrates. A 
key recent example is the esterification of benzoyl-CoA and methylecgonine in the biosynthesis 
of cocaine (Schmidt et al., 2015). As well as the formation of esters there a number of examples 
of BAHD acyltransferases involved in the formation of amides, a key example of this is agmatine 
coumaroyltransferase, which results in the formation of N-(4-guanidinobutyl)-4-
hydroxycinnamamide (Burhenne et al., 2003). 
 
5.3.2.6 Proposed MIA structures for the m/z 355 and m/z 397 
 
There are a number of MIAs that have an m/z ratio of 355, with a predicted molecular formula 
of C21H26N2O3, together with a non-substituted β-carboline ring and a free hydroxyl group. These 
include the compounds vincamine and yohimbine, two MIAs of the eburnamine and 
corynanthine classes respectively, as well as the early pathway intermediates isositsirikine, 
together with its isomer sitsirikine, and stemmadenine. 
Although not present in C. roseus, vincamine is found in a number of related species such as 
Vinca minor. It has recently been shown that vincamine can be formed from the structural 
rearrangement of tabersonine (Kellner et al., 2015a), a key intermediate in the formation of 
vindoline. It is hypothetically feasible that if tabersonine is inappropriately rearranged to 
vincamine in C. roseus, a repair pathway back to tabersonine might be necessary, which would 
encompass a series of oxidation and reduction reactions (Figure 5-27). If CrRO is involved in this 
repair pathway, vincamine (m/z 355) might be expected to accumulate upon CrRO silencing. 
Although feasible, this scenario is unlikely, however, as V. minor also contains a homologue of 
CrRO. 
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Figure 5-27 Tabersonine can rearrange to vincamine 
The rearrangement of tabersonine to vincamine encompasses a number of oxidation and reduction 
reactions. Figure adapted from (Kellner et al., 2015a). 
 
 
The yohimbine class of alkaloids are a group of corynanthine alkaloids that are structurally 
related to the C. roseus heteroyohimbine alkaloids ajmalicine, epi-ajmalicine and 
tetrahydroalstonine. The yohimbine alkaloids yohimbine, rauwolscine, and corynanthine all 
have an m/z 355. These compounds have not been found in C. roseus leaf tissue, however are 
present in the related plant species Rauwolfia serpentina (Figure 5-28). These compounds fit the 
criteria for the m/z 355 for the compound accumulating in the VIGS-CrRO silenced tissue, 
however the hypothetical reason for their accumulation upon VIGS-CrRO silencing and the role 
CrRO plays in their metabolism is unknown. 
 
 
Figure 5-28 Diastereoisomers of the yohimban alkaloids.  
Three known diasteroisomers of yohimban alkaloids accumulate in Rauwolfia serpentina, yohimbine, 
corynanthine and rauwolscine 
 
Isositsirikine is a compound that is derived from the deglycosylated product of strictosidine and 
is the reduced form of geissoschizine (Figure 5-29). It could be envisaged that if geissoschizine is 
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inappropriately reduced to isositsirikine, it would need to be reoxidized to its enol form. If CrRO 
was the oxidase responsible for this, its silencing would result in the accumulation of m/z 355, 
and then this molecule could then be acetylated to m/z 397.  
If this is the case, then CrRO would be acting on an off-pathway intermediate, effectively acting 
to recycle isositsirikine back to geissoschizine and this might explain why CrRO silencing does 
not lead to a reproducible statistically significant decrease in vindoline or catharanthine, as it is 
not a direct pathway enzyme, but is instead involved in metabolite repair (Figure 5-29). 
 
Figure 5-29 Proposed Scheme for regeneration of geissoschizine from isositsirikine utilising CrRO 
Similarly stemmadenine, a molecule that also has an m/z 355, is thought to be an integral 
intermediate in the metabolic pathway to vindoline and catharanthine biosynthesis, however 
could be converted back to the substrate preakuammicine by a hypothetical oxidation reaction 
catalysed by CrRO. This would result in the formation of a carbon-nitrogen bond, as has been 
observed in many reactions catalysed by the BBE-like enzymes in benzylisoquinoline alkaloid 
biosynthesis (Figure 5-30). 
 
Figure 5-30  Proposed generation of preakuammicine from stemmadenine 
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5.3.3 LC-MS Analysis of plant extracts and known standards 
 
To assess whether there are any compounds that could account for either the m/z 355 and m/z 
397 peaks that accumulated upon CrRO silencing, methanolic extracts of known MIA producing 
plants, as well as known standards that have an m/z 355 were analysed by LC-MS to see if any 
compounds co-elute with the new compounds that occur in VIGS-CrRO leaf tissue. 
5.3.3.1 LC-MS Analysis of plant extracts 
 
For the crude methanolic extracts of plant tissue, C. roseus root, as well as V. minor and V. major 
leaf was extracted in methanol. C. roseus root has a different alkaloid profile to the leaf tissue. 
It does not contain the aspidosperma or iboga alkaloids that occur in leaf, and primarily 
accumulates serpentine. In comparison V. minor and V. major are known to accumulate 
vincamine as well as a number of other MIAs. 
Methanolic extracts of V. minor, V. major, as well as extracts from other C. roseus tissues such 
as roots, contain compounds that have m/z values of 355 and 397. However none of these 
compounds co-eluted with the m/z 355 and m/z 397 present in the C. roseus CrRO VIGS tissue 
(Figure 5-31). 
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Figure 5-31 Mass Chromatogram for VIGS-CrRO, V. minor, V. major, and C. roseus root EIC m/z 355 and 
m/z 397 
Methanolic extracts of VIGS-CrRO leaf tissue as well as C. roseus root, V. minor and V. major were run by 
LC-MS and the extracted ion chromatogram (EIC) with m/z 355 and m/z 397 plotted for each sample. C. 
roseus root m/z 355 (A) m/z 397 (B). V. minor m/z 355 (C) m/z 397 (D), V. major m/z 355 (E) m/z 397 (F). 
Highlighted in the green box is the m/z 397 that accumulated in the VIGS-CrRO leaf tissue. 
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5.3.3.2 LC-MS standards of known monoterpene indole alkaloids 
 
The MIAs isositsirikine, sitsirikine and stemmadenine are not commercially available and 
therefore could not be analysed in this study. Vincamine, rauwolscine, corynanthine and 
yohimbine are commercially available and have been run as standards to compare the retention 
time of the m/z 355 from VIGS-CrRO extracts (Figure 5-32). Yohimbine, corynanthine, and 
vincamine do not co-elute with the m/z 355 that accumulated in VIGS-CrRO tissue, indicating 
that they are different compounds. In comparison, the yohimban alkaloid rauwolscine co-eluted 
with the same retention time as that of m/z 355 that accumulated in VIGS-CrRO leaf tissue 
(Figure 5-32). 
 
Figure 5-32 Mass Chromatogram for VIGS-CrRO, yohimbine, vincamine, rauwolscine and corynanthine 
EIC m/z 355 
Methanolic extracts of the VIGS-CrRO, yohimbine, corynanthine, rauwolscine and vincamine were 
analysed by LC-MS and the extracted ion chromatogram (EIC) with m/z 355 plotted for each sample. 
Vincamine, yohimbine, corynanthine and the m/z 355 peak from VIGS-CrRO tissue do not co-elute and 
are therefore different compounds, whilst rauwolscine and the m/z 355 peak from VIGS-CrRO co-elute. 
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The co-elution of the m/z 355 from VIGS-CrRO leaf tissue and rauwolscine, however, appeared 
to be an artefact of the chromatography used in the LC-MS. Despite co-elution and the fact the 
molecule has an m/z 355, these two compounds are likely to be different. MS/MS fragmentation 
of the yohimban alkaloids yohimbine, corynanthine and rauwolscine resulted in the dominant 
ions on the MS2 spectra of 144, 212 and 224 (Figure 5-33). 
 
In comparison the m/z 355 and m/z 397 compounds accumulating in VIGS-CrRO tissue 
preferentially fragment with ions of 337 and 230 (Figure 5-33). Therefore the m/z 355 from VIGS-
CrRO and rauwolscine are different compounds.  
 
 
 
Figure 5-33 MSn fragmentation of Rauwolscine and the m/z 355 and m/z 397 compounds from VIGS-
CrRO 
A.) MS and MS2 fragmentation of rauwolscine m/z 355 B.) MS and MS2 fragmentation of VIGS-CrRO m/z 
355 C.) MS and MS2 fragmentation of VIGS-CrRO m/z 397. 
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In summary, we know that the two compounds that accumulated upon silencing of the CrRO are 
MIAs and that these two compounds are related to each other, with the m/z 397 the acetylated 
derivative of m/z 355. 
 
To date we have not identified a compound that co-elutes with either the m/z 355 or m/z 397 
present in VIGS-CrRO tissue and that also has the same MSn fragmentation pattern, from analysis 
of known standards or plant tissues known to contain MIAs. 
  
Altogether, further VIGS experiments are therefore needed to obtain enough silenced leaf tissue 
so that the compounds m/z 355 and m/z 397 can be isolated for structural elucidation by NMR, 
in order to confirm the identity of these compounds. 
 
5.3.4 Heterologous expression of CrRO 
 
Our assumption is that the compounds of m/z 355 and m/z 397 are accumulating because they 
are the substrate or are a derivatised version of the substrate for CrRO.  
To test this hypothesis, it is necessary to heterologously express CrRO and incubate it with a 
protein free extract of the silenced tissue that contains the alkaloid products. Consumption of 
the m/z 355 and m/z 397 compounds will demonstrate that one or both of these compounds is 
a substrate for CrRO. 
Furthermore the identity of any new compound that accumulates will provide further 
information about the structure of m/z 355 and m/z 397.  
Three separate heterologous expression systems have been utilised in this study; S. cerevisiae, 
E. coli and Sf9 insect cells.  
To date the heterologous expression and characterisation of plant berberine bridge like enzymes 
has primarily utilised: E. coli, S. cerevisiae, Pichia pastoris, and Sf9 insect cells. The expression 
systems used for the characterisation of these known plant enzymes that has been published is 
summarised in Table 8. 
Of the results in the published literature for these enzymes, the most reproducible expression 
for this enzyme family is Sf9 insect cell culture and Pichia pastoris. 
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Table 8 Expression systems for RO proteins published 
Gene Plant 
species 
E. 
coli 
S. 
cerevisiae 
P. 
pastoris 
Sf9 
insect 
cells 
Reference 
Berberine Bridge Enzyme E. 
californica 
     Kutchan 1991, Kutchan 1995, Winkler 
2006, 2007, 2009, Wallner 2012  
Berberine Bridge Enzyme P. 
somniferum 
      Hawkins and Smolke2008, Hagel 2012 
Berberine Bridge Enzyme C. japonica        Minami 2008 
(S)-tetrahydroprotoberberine 
oxidase (STOX) 
B. wilsoniae        Gesell 2011 
(S)-tetrahydroprotoberberine 
oxidase (STOX) 
A. 
mexicana 
       Gesell 2011 
dihydrobenzophenanthridine 
oxidase (DBOX) 
P. 
somniferum 
       Hagel 2012 
tetrahydrocannabinolic acid 
synthase (THCA synthase) 
C. sativa      Taura 2007, Zirpel 2015, Sirikantaramas 
2004 
cannabidiolic acid synthase 
 (CBDA synthase) 
C. sativa        Taura 2007 
BBLa, b, c, d N. tabacum        Kajikawa 2011 
Phl p 4 P. pratense       DeWitt 2006, Zafred 2015 
Carbohydrate oxidase (Ha-
CHOX) 
H. annuus        Custers 2004 
AtBBE-like 13 A. thaliana        Daniel 2015 
AtBBE-like 15 A. thaliana        Daniel 2015 
 
 
5.3.4.1 Heterologous expression in S. cerevisiae 
 
There is literature precedent for successful expression of some reticuline oxidase like proteins 
in S. cerevisiae. The BBE from E. californica was first cloned and shown to be catalytically active 
when heterologously expressed in S. cerevisiae (Dittrich and Kutchan, 1991). Under a galactose 
inducible promoter system, utilising the pYES2 yeast expression vector, the BBE from both Coptis 
japonica or P. somniferum was also shown to be capable of converting (S)-reticuline to (S)-
scoulerine, when expressed in S. cerevisiae yeast culture (Hawkins and Smolke, 2008; Minami et 
al., 2008). However, attempts to reconstitute the berberine derived alkaloid 
dihydrosanguinarine, which utilises the product of the berberine bridge enzyme, (S)-scoulerine, 
as an intermediate, demonstrated that the BBE from P. somniferum was limiting flux to the 
downstream in S. cerevisiae (Fossati et al., 2014). 
CrRO was cloned into the inducible yeast expression vector pYES-DEST52, and transformed into 
the yeast strain ybt1.  
Liquid cultures started from two separate yeast colonies containing the CrRO pYESDEST52 vector 
were incubated with lyophilised CrRO silenced VIGS extract containing the compounds m/z 355 
and m/z 397. As a negative control, the uninduced CrRO yeast colonies, two GFP expressing ybt1 
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yeast strains, and two uninduced GFP expressing ybt1 yeast strains were also incubated with 
CrRO silenced VIGS extract. After 10 hours incubation there was no turnover of either the m/z 
355 or m/z 397, measured by LC-MS from either the yeast pellet or from the yeast media, and 
untargeted metabolomics by XCMS did not demonstrate the accumulation of any other new 
compounds (Figure 5-34). While there are several possible reasons why turnover was not 
observed, the most likely is that the protein is misfolded and non-functional. 
 
 
Figure 5-34 S. cerevisiae feeding study 
Two separate yeast colonies were induced for expression of CrRO, together with a GFP control, and the 
media supplemented with the aqueous fraction of the VIGS-CrRO extract, and incubated for 10 hours. The 
yeast media and yeast pellet were extracted in methanol and these samples run on the LC-MS to detect 
whether the peaks of m/z 355 and m/z 397 had been consumed. 
 
5.3.4.2 Heterologous expression of CrRO in E. coli 
 
For expression of CrRO in both E. coli (and Sf9 insect cells, in Section 5.3.4.3) a suite of vectors 
was generated utilising the pOPIN cloning series of vectors (Berrow et al., 2007) that 
encompassed a series of signal sequences and tags that may aid with solubility of the protein. 
This is summarised in Table 9. 
Additionally variants of CrRO lacking a putative N-terminal signal peptide as predicted by the 
SignalP 4.1 server (Petersen et al., 2011), or had a C-terminal truncation that aligned better with 
the consensus sequence of both C. sativa THCA synthase and P. somniferum BBE were cloned 
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(Figure 5-35). These variants were cloned into vectors that contained either an N- or C-terminal 
His tag, as well as a vector that contained an insect cell secretion signal and C-terminal His tag. 
Table 9 Variants of CrRO was cloned into a suite of pOPIN vectors that are compatible with expression 
in E. coli and Sf9 insect cells. 
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Figure 5-35 Protein sequence of CrRO   
A.) Using the secretion signal prediction software SignalP 4.1, a signal sequence was predicted at the N-
terminus of the CrRO protein B.) Amino acid sequence of CrRO. Highlighted in yellow at the N-terminus is 
the predicted signal sequence. The protein variants that were cloned include the full length protein, 
together with variants that have truncations at the N- and C-terminus of the protein. Amino acid residues 
removed in the truncated variants at the N- and C-terminus are highlighted in yellow. 
 
 
 
 
The full length CrRO, together with the N-terminal truncation that eliminated the putative  
secretion signal peptide, were expressed as N-terminal His tagged proteins in the E. coli strain 
SoluBL21 (Figure 5-36). A positive control for flavoprotein expression in E. coli from Pisum 
sativum was also expressed (Construct donated by Lorenzo Caputi, John Innes Centre). 
 
As can be seen in Figure 5-36, the flavoprotein from pea was expressed in soluble form, whilst 
the N-terminal truncated CrRO protein was insoluble. In comparison the full length protein of 
CrRO, from two separate colonies, did not lead to protein expression, indicating E. coli utilising 
an N-terminal histidine tag is not a suitable system for expression of this protein (Figure 5-36). 
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Figure 5-36 E. coli expression of CrRO and pea flavoprotein 
Expression test of CrRO in pOPINF with an N-terminal histidine tag in E. coli strain SoluBL21. 1.) 
Uninduced cell culture 2.) Insoluble pellet 3.) Flow through 4.) Elution from Ni-NTA resin. A.) Full length 
CrRO pOPINF colony 1 red circle shows no soluble protein expression B.) Full length CrRO pOPINF colony 
2 red circle shows no soluble protein expression C.) N-term truncation CrRO red circle shows insoluble 
protein expression D.) Flavoprotein from Pisum sativum red circle shows soluble protein expression. 
 
5.3.4.3 Expression Screen of CrRO Sf9 Insect Cells 
 
All twelve cloned variants of the CrRO were screened for expression in Sf9 insect cell culture 
(Figure 5-37). A summary of successful soluble expression from both the secreted and 
intracellular fraction of Sf9 insect cells is presented in Table 10. 
For the Sf9 insect cells, as with E.coli expression, an N-terminal histidine tagged variant of CrRO 
did not result in soluble protein, irrespective of N- or C-terminal truncation. 
However, the full length CrRO protein, along with the C-terminal truncated version of CrRO, 
which both contained a C-terminal histidine tagged expressed at good levels in soluble form. 
Additionally good expression was also obtained from the pOPING vectors that had either the N-
terminal truncation or both N- and C-terminal truncation (Figure 5-37). 
This result therefore emphasises that the secretory signal is required for the correct folding of 
the CrRO protein. An N-terminal histidine tag could likely interfere with the correct sorting of 
the CrRO protein, and no CrRO protein with an N-terminal tag is expressed in insect cells or E. 
coli. Only the full length and C-terminal truncations with a C-terminal His tag led to soluble 
protein production in insect cells. The N-terminal truncated variants of CrRO expressed as C-
terminal His-tagged proteins, and therefore do not contain the endogenous secretory signal, are 
lowly expressed in insect cells. 
Notably, the variants of CrRO in which the endogenous secretion signal is replaced by the insect 
cell secretion signal, are abundantly expressed. The CrRO variants that contain both the 
226 
 
endogenous secretion signal and the insect cell secretion signal in tandem are also expressed in 
insect cells though in lower levels than the variants containing only one secretion signal (Table 
10). 
 
Figure 5-37 Expression screening of pOPIN CrRO constructs in Sf9 Insect cells. 
All twelve variants of the CrRO gene were screened for expression in Sf9 insect cells A.) SDS-PAGE gel with 
coomassie staining for the intracellular protein fraction of the insect cells after purification by Ni-NTA. B.) 
Western blot of the intracellular insect cell fraction with an anti-His antibody. Lane numbers 1.)CrRO-
pOPINF full length 2.)CrRO-pOPINF N-terminal truncation 3.) CrRO-pOPINF C-terminal truncation 4.) CrRO-
pOPINF N- and C-terminal truncation 5.) CrRO-pOPINE full length 6.) CrRO-pOPINE N-terminal truncation 
7.) CrRO-pOPINE C-terminal truncation 8.) CrRO-pOPINE N- and C-terminal truncation 9.) CrRO-pOPING 
full length 10.) CrRO-pOPING N-terminal truncation 11.) CrRO-pOPING C-terminal truncation 12.) CrRO-
pOPING N- and C-terminal truncation. Screening of insect cell expression was performed by Joanne 
Nettleship at the Oxford Protein Production Facility. 
 
 
There is literature precedent for the requirement for a secretion signal for correct folding of 
BBE-like enzymes in both Sf9 insect cells and Pichia pastoris, with soluble protein expressed from 
either the full length variants of these enzymes or with the endogenous signal sequence 
replaced by an alternative targeting sequence. For the BBE from E. californica, active enzyme 
was generated in P. pastoris from both a construct expressing the native full length BBE 
sequence, or from a culture where the endogenous signal peptide from BBE was replaced by the 
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S. cerevisiae α-mating signal sequence (Winkler et al., 2006). Similarly, BBE from P. somniferum 
and DBOX , dihydrobenzophenanthridine oxidase (Hagel et al., 2012), AtBBE-like 15, AtBBE-like 
13 (Daniel et al., 2015) and the BBLa, b, c and d proteins from N. tabacum (Kajikawa et al., 2011) 
were functionally expressed in P. pastoris, by replacing the endogenous signal peptide with the 
S. cerevisiae α-mating prepro signal sequence. 
Protein that is secreted from the insect cells should be correctly folded as it has passed through 
the secretory pathway. Insect cell media culturing the pOPINE constructs as well as the two 
highest expressing pOPING constructs, were assessed for secreted protein (Figure 5-38). As 
would be expected the constructs that resulted in the secreted protein were the CrRO variants 
that contained either the endogenous signal sequence, or the endogenous signal sequence 
replaced by the insect cell secretion signal (Figure 5-38). Both the intracellular protein and 
secreted protein will be assessed for enzymatic activity. 
 
Figure 5-38 Expression screening of pOPIN CrRO constructs in Sf9 Insect cells for secreted expression 
All four pOPINE vectors v5.) CrRO-pOPINE full length 6.) CrRO-pOPINE N-terminal truncation 7.) CrRO-
pOPINE C-terminal truncation 8.) CrRO-pOPINE N- and C-terminal truncation, together with the best 
expressing pOPING vectors 10.) CrRO-pOPING N-terminal truncation 12.) CrRO-pOPING N- and C-terminal 
truncation were assessed for protein expression in both the secreted fraction. Presented is a western blot 
targeting the histidine tag of the secreted protein. Screening of insect cell expression was performed by 
Joanne Nettleship at the Oxford Protein Production Facility. 
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Table 10 Overview of soluble expression of CrRO enzyme variants in Sf9 insect cells.  
All twelve variants of the CrRO were screened for soluble expression in Sf9 insect cells. X- no expression, 
expression, good expression. 
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As has been discussed previously, CrRO is the first naturally occurring variant of the reticuline 
oxidase family that does not contain a putative covalent binding site for FAD utilising either a 
monocovalent histidine attachment, or a bicovalent 8-αN1-histidine and 6-S-cysteine linkage. 
For the BBE from E. californica, site directed mutagenesis of the covalent linkage between FAD 
and the enzyme at both the conserved histidine and cysteine residue resulted in very low 
expression in Pichia pastoris relative to wild type expression levels (Winkler et al., 2007). This 
implies that the covalent linkage of FAD to the enzyme is structurally important for proper 
protein folding. 
 
Similarly in other VAO type proteins the covalent attachment of FAD by the bicovalent linkage 
has been shown to be integral for protein stability. A H94A/C154A double mutant of the ChitO 
protein in Fusarium graminearum results in no expression of the enzyme (Heuts et al., 2008), 
and for the glucooligosaccharide oxidase from Acremonium strictum, the double mutant 
H70A/C130A, is expressed but does not bind FAD (Huang et al., 2008). In comparison the GilR 
oxidoreductase, the double mutant H65A/C125A binds FAD non-covalently, however this 
mutation abolishes enzymatic activity (Noinaj et al., 2011). 
 
As well as in analysis of the structural integrity of the protein, the potential for the enzyme to 
bind non-covalently with FAD is also interesting in the context of the redox potential of the FAD. 
It has been shown previously that covalent binding of FAD increases the redox potential of the 
enzyme, which in turn limits the final electron acceptor for regeneration of the FAD, hence most 
BBE enzymes utilise molecular oxygen (Heuts et al., 2009; Leferink et al., 2009; Zafred et al., 
2015). The fact that CrRO is predicted to bind non-covalently potentially suggests this enzyme 
may not utilise molecular oxygen as a final electron acceptor. 
 
We have been able to obtain soluble protein from insect cells of a naturally occurring variant of 
a BBE like enzyme that is predicted to bind FAD non-covalently, and utilising this expression 
system we now intend to functionally characterise the protein using the m/z 355 from VIGS-
CrRO tissue as its putative substrate.  
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5.4 Conclusion 
 
This chapter presents the first identification of an FAD dependent oxidase that has homology to 
the BBE family to be physiologically relevant to MIA biosynthesis in C.  roseus. 
 
Upon silencing of the CrRO gene with two separate pTRV2u vectors that target distinct regions 
of the gene, we observed the accumulation of two new compounds which have an m/z 355 and 
m/z 397. These compounds are not present in VIGS-EV control leaf tissue or in other C. roseus 
tissues such as stem or root. These compounds do not accumulate upon individually silencing 
other reticuline oxidase like genes from C. roseus indicating this CrRO is involved in the 
biosynthesis of these compounds. Isotopic labelling of these compounds suggested that the 
compounds with m/z 355 and m/z 397 are MIAs. Chemical derivatisation suggested that the two 
compounds are structurally related, with m/z 397 being the acetylated derivative of m/z 355. 
To date the structural elucidation of these alkaloids has not been determined, however we know 
that these compounds are not yohimban derived alkaloids, or known alkaloids that accumulate 
in C. roseus, V. minor or V. major, that the β-carboline ring is not substituted, and that the m/z 
355 is likely to contain a free hydroxyl group. A number of intermediates have been proposed, 
and to date the most likely candidates for m/z 355 are isositsirikine/sitsirikine and 
stemmadenine, with the m/z 397 being the acetylated derivative of these compounds.  
 
The protein is the first example of a BBE that is predicted to lack a covalent FAD binding site. 
There are homologues of this protein present in other MIA producing species that also have the 
putative covalent binding site mutated, including T. elegans and V. minor, indicating that this 
reticuline oxidase may work in a region of the MIA pathway that is conserved in these species. 
Similarly, based on the expression profile of this gene in the C. roseus transcriptome, the fact it 
co-expresses with secologanin synthase, strictosidine synthase, and the three transporters that 
have been characterised in Chapters III and IV indicates that it is likely to be working in an early 
to middle part of the MIA pathway.  
Three heterologous expression systems were utilised to obtain soluble protein of this CrRO. 
Enzymatic activity was not observed upon overexpression of the enzyme in S. cerevisiae, and 
soluble protein could not be produced in E. coli. This is consistent with the literature preference 
for characterisation of this family of proteins in Sf9 insect cells or P. pastoris. 
Soluble protein has been obtained through expression screening in Sf9 insect cells, with the best 
variants expressed being either the full length protein with a C-terminal histidine tag or a variant 
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of the enzyme that has the endogenous secretory signal replaced with an insect cell secretion 
signal with a C-terminal histidine tag. This is consistent with previous literature reports of the 
need for a secretion signal for correct protein folding. This enzyme is the first report of a 
naturally occurring variant of the berberine bridge like enzymes identified that is predicted to 
bind FAD non-covalently, and future work will assess the importance of this putative non-
covalent linkage for enzymatic activity. 
 
5.5 Future directions 
 
There are a number of future directions to continue the characterisation of this reticuline 
oxidase described in this chapter. 
 
1.) We have highlighted the importance of this enzyme in C. roseus metabolism by silencing 
using VIGS. Feeding studies with isotopically labelled tryptamine suggested that the compound 
is an MIA. It is necessary to increase the amount of VIGS material in order to obtain enough 
material for the structural characterisation of the MIA compounds that are accumulating in the 
plant by NMR. 
 
2.) We have silenced four homologues of the reticuline oxidase family in C. roseus that do not 
appear to impact the metabolism of C. roseus leaves. However silencing of additional members, 
as well as combinatorial silencing, of this protein family may identify novel enzymatic activity.  
 
3.) We hypothesise that the accumulating products of m/z 355 and m/z 397, that occur by 
silencing the CrRO are likely to be the substrate for the enzyme. We intend to assess whether 
the CrRO is able to turnover these compounds in vitro and further characterise this enzymatic 
reaction. Since we have demonstrated that the enzyme can be expressed in Sf9 insect cells the 
stage has been set to carry out these experiments. 
 
4.) The unique property of this enzyme, in that it does not contain a predicted covalent FAD 
binding site needs to be addressed. It is feasible that either this enzyme binds FAD non-
covalently or that it utilises a novel covalent linkage, and it will be interesting to address whether 
this is integral for enzymatic activity. The protein can be denatured to determine whether the 
flavin is in fact non-covalently bound, and further mutational analysis can provide insight into 
how this novel oxidase functions.  
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Altogether this study expands the substrate repertoire of the BBE-like enzyme family and 
provides the first evidence that this enzyme family is physiologically involved in MIA metabolism 
in C. roseus. 
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6 Conclusion 
 
Despite the intensive effort to elucidate the MIA pathway in C. roseus in the last decade, there 
are still a large number of unknown parts to this metabolic pathway. In particular the utilisation 
of the branchpoint intermediate strictosidine, and how its deglycosylated product is shuttled 
into different alkaloid structural scaffolds in C. roseus, together with how secondary metabolite 
transporters integrate the subcellular localisation of this metabolic pathway, has largely 
remained undiscovered. 
This thesis has aimed to emphasise the use of a reverse genetics strategy in the identification of 
a number of genes in the MIA pathway. Chapter II highlighted the use of a transcriptomic mining 
strategy to identify gene candidates involved in the MIA pathway utilising the assumption that 
genes involved in metabolic pathways are likely to be co-regulated. 
Chapter II further emphasised a number of the pitfalls of using a reverse genetics strategy. While 
a negative metabolic phenotype could be attributed to the fact the gene is not involved in the 
pathway, the lack of phenotype could be due to other reasons, for example functional 
redundancy in the gene of interest being silenced, whereby other homologous genes could 
compensate for activity, or inefficiency in the ability to silence the gene. As has been shown, a 
number of genes upon individual silencing do not lead to a phenotype. To date, we have 
assumed that this is indicative that there is no evidence that these genes are involved in the MIA 
pathway. However, further functional screening of these genes is necessary to assess with 
certainty whether the genes do not have a functional role in the MIA pathway. If further 
functional screening demonstrates activity towards MIA substrates, it potentially suggests that 
the lack of a physiological phenotype upon silencing could be due to functional redundancy, and 
therefore a combinatorial VIGS approach, in which multiple genes are silenced in the same 
experiment, is necessary to pick apart the complexity of this gene redundancy. Development of 
such a combinatorial silencing approach has been highlighted in Chapters III, IV and V. 
However, in comparison, a positive VIGS phenotype clearly provides evidence that the gene is 
involved in the C. roseus MIA pathway, and examples of such positive outcomes are highlighted 
in Chapters III, IV and V.  
Chapter III and IV demonstrated that the individual silencing of two genes encoding tonoplast 
localised transporters, a MATE protein, CrMATE1952, and an NPF transporter, CrNPF2.9 result 
in a metabolic phenotype that perturbs MIA metabolism in C. roseus. Silencing of CrMATE1952 
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resulted in the accumulation of an iridoid glycoside derivative, which is likely to be the reduced 
product of secologanin, secologanol. This product formation is likely to be due to the 
mislocalisation of secologanin to the cytosol as a result of its inability to enter the vacuole. This 
product is also produced upon feeding secologanin to wild type leaf tissue, as well as upon 
reducing secologanin with NaBH4. Despite a reproducible metabolic phenotype affecting iridoid 
glycoside formation upon silencing, the CrMATE1952 tissue does not lead to a consistent 
decrease in downstream MIAs. This could be because other transporters are also involved in the 
translocation of secologanin, or because secologanin formation is not the limiting step in MIA 
biosynthesis. The formation of strictosidine is a convergent metabolic pathway between 
secologanin and tryptamine biosynthesis. If there is enough secologanin flux into the vacuole, 
even despite an 80% knockdown in the VIGS experiment, relative to tryptamine production, then 
a decrease in downstream MIAs would not be expected.  
Silencing of the homologues of CrMATE1952 did not lead to a comparative decrease in MIAs, 
indicating, to date, there is only evidence that CrMATE1952 is involved in secologanin 
translocation. Furthermore feeding tryptamine to wild type leaf tissue resulted in the 
accumulation of strictosidine relative to water fed control tissue, indicating that it is likely that 
tryptamine biosynthesis, as opposed to secologanin biosynthesis, is limiting strictosidine 
formation in leaf tissue.  
The silencing of CrNPF2.9 resulted in the accumulation of strictosidine in leaf tissue. This 
phenotype is consistent with this transporter being the exporter of strictosidine from the 
vacuole, and was accompanied by a decrease in the downstream MIAs such as vindoline and 
catharanthine. Surprisingly this phenotype also resulted in cell death, which we currently believe 
is due to the strictosidine accumulation being toxic to the cell, however this requires further 
investigation. 
The combinatorial silencing of both CrNPF2.9 and CrMATE1952 resulted in a complementary 
phenotype to that observed upon individual silencing, with the accumulation of both 
secologanol, and strictosidine, together with the decrease in the MIAs vindoline and 
catharanthine. 
The current model for the tonoplastic transport of secologanin and strictosidine based on the 
work in this thesis is presented in Figure 6-1. 
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Figure 6-1 The tonoplast transport of secologanin and strictosidine. 
A.) VIGS of CrNPF2.9 and CrMATE1952 result in metabolic phenotypes that are consistent with them being 
the strictosidine exporter from the vacuole and the secologanin importer into the vacuole respectively.B.) 
Combinatorial silencing of both CrMATE1952 and CrNPF2.9 resulted in the accumulation of secologanol, 
the accumulation of strictosidine, and the decrease in the downstream alkaloids, vindoline and 
catharanthine. Red dashed arrows indicate accumulation or depletion of the compound upon VIGS of 
CrNPF2.9 and CrMATE1952. 
 
Further work on the heterologous expression of these transporters for functional 
characterisation in vitro is ongoing. The result from this reverse genetics approach allows for the 
targeted design for transport assays, with the predicted substrates for CrNPF2.9 and 
CrMATE1952, strictosidine and secologanin respectively. 
In Chapter V the silencing of a gene encoding a reticuline oxidase like protein, CrRO, resulted in 
a distinct, reproducible metabolic phenotype, with the accumulation of two new compounds, 
m/z 355 and m/z 397. These compounds are likely to be MIAs based upon isotopic labelling 
studies with d4-tryptamine, and it has also been demonstrated that the m/z 397 compound is 
likely to be the acetylated product of m/z 355. These compounds do not co-elute or have the 
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same MS2 fragmentation pattern as known alkaloid species that are commercially available and 
have the same mass-charge ratio. 
This is the first identification that a member of the reticuline oxidase family of proteins is 
involved in MIA metabolism. Moreover, it is an unusual protein as it has homology to the 
reticuline oxidases, yet is predicted to lack the conserved covalent linkages to FAD.  
Reverse genetics screens, coupled to untargeted metabolomics, has the advantage over the use 
of large scale screening for enzymatic activity, as it has the potential to discover novel aspects 
of metabolic pathways. Screening a particular substrate against enzyme libraries inherently 
biases the screen towards the identification of a preconceived reaction. Although this is 
incredibly useful for the identification of enzymes that have activity towards known substrates, 
such screening approaches are not useful for substrates that are expensive or not commercially 
available and therefore cannot be screened on a large scale, or for the identification of steps in 
the metabolic pathway that would not be inherently predictable.  
As demonstrated with the CrRO, it is unlikely that this enzyme would have been identified 
through a functional screen, as the substrate for the enzyme is unknown, however this reverse 
genetics approach allows us to interrogate the effect these genes have on MIA metabolism 
directly. 
Metabolism has the potential to be inherently complex, and for the elucidation of gene 
discovery in unknown metabolic pathways, it is not necessarily useful or justified to only focus 
on predicted steps in the metabolic pathway. Such predicted steps in metabolic pathways might 
be wrong, and it is highly possible that that the metabolic pathway may be non-linear and 
contain unforeseen reaction steps that significantly contribute to metabolic flux, that may be 
unpredictable. 
Chapter V, and the example of CrRO, therefore highlights the potential role of reverse genetic 
screens for uncovering non-predictable elements in pathways or for demonstrating the 
physiological relevance of genes whose substrates are not commercially available. It is through 
the use of this reverse genetics approach that we now have a platform to identify the 
compounds accumulating in the CrRO silenced lines, and functionally interrogate this enzyme to 
ascertain its relevance in MIA metabolism in C. roseus. 
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6.1 Perspectives and Outlook 
 
6.1.1 Novel mining strategies for genes of interest 
 
As has been presented in this thesis, there are a number of mining strategies available for gene 
discovery. The wealth of sequence information that is becoming available for medicinal plants 
(Góngora-Castillo et al., 2012; Kellner et al., 2015b; Van Moerkercke et al., 2013; Xiao et al., 
2013) allows for direct interrogation and identification of enzymes that could be involved in 
natural product metabolic pathways. The mining approaches demonstrated in this thesis use 
the concept that genes in a metabolic pathway are likely to be co-regulated at the transcriptional 
level, and clustering of the expression data by both hierarchical clustering and self-organising 
maps, has allowed for the identification of gene candidates that could be involved in the MIA 
pathway in C. roseus. These approaches offer the opportunity for the identification of large 
numbers of gene candidates. As has been shown in this thesis, however, it is necessary to 
experimentally verify their involvement in the pathway of interest by either functional 
characterisation or through reverse genetics to demonstrate their physiological relevance to the 
metabolic pathway. As demonstrated in Chapter II, while some genes have a highly similar 
expression profile to known genes in the MIA pathway, no evidence to date implicates these 
genes in the MIA pathway by the reverse genetics approach used in this thesis.  
As has also been presented in Chapter I, not all enzymes involved in the MIA pathway in C. roseus 
have been identified, with many of the downstream enzymes after strictosidine deglycosylation 
remaining unelucidated. To date all identified genes that act after the deglycosylation of 
strictosidine do not cluster at the expression level with each other or with other known genes 
in the pathway. This therefore suggests that alternative mining strategies that are not biased 
towards co-expression analysis are needed for the elucidation of these steps. 
There have been a number of methods proposed for the identification of new genes in this and 
other secondary metabolic pathways. As highlighted in Kellner et al., 2015b, the C. roseus 
genome has been published, which gives spatial information with regards to the proximity of 
genes on the genome. There is a growing body of evidence that in some secondary metabolic 
pathways, genes involved in the same pathway are clustered on the genome (Nützmann and 
Osbourn, 2014; Osbourn, 2010). This offers an alternative approach to novel gene identification, 
whereby genes spatially close to known genes in the pathway can be tested by either a reverse 
genetics approach to assess for physiological relevance to the MIA pathway in the plant, or 
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through a functional screen of enzymatic activity. This approach has been successful in the 
identification of tetrahydroalstonine synthase (THAS) (Stavrinides et al., 2015) and further work 
in this area is ongoing, as more clusters in the MIA pathway are elucidated.  
Alternatively it is possible to take genes with known predicted functionality, such as genes 
identified as glucosyltransferases of natural products, and functionally screen against substrates 
for which this activity is expected to take place.  
The limitations of this approach arise when the novel chemistry of the reactions in the pathway 
cannot be predicted, or for which the enzymology is novel. A key example was observed with 
the progesterone-5β reductase family, which has been shown to catalyse novel cyclisation of 8-
oxogeranial. From gene annotation alone this functionality could not be predicted, 
demonstrating that searches of natural product enzymes should not be limited to known 
families that have been previously shown to be involved in secondary metabolic pathways. 
Instead it is necessary to look into other gene families, which may not have previously been 
analysed for natural product enzymatic activity, or which may be annotated incorrectly. 
In particular this type of analysis is necessary for enzymatic reactions which are potentially 
unprecedented in planta. In the C. roseus pathway, the conversion of dehydrosecodine to either 
tabersonine or catharanthine, which is a main branchpoint in C. roseus to the aspidosperma and 
iboga classes of alkaloids, is predicted to be a net Diels-Alder reaction (Figure 6-2). In plants this 
type of enzyme has not yet been identified, and therefore prediction of the enzyme class that 
can perform this type of reaction is difficult. 
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Figure 6-2 Diels-Alder like enzymes in MIA biosynthesis 
Dehydrosecodine is the intermediate for both tabersonine and catharanthine and is predicted to form 
these molecules by a Diels-Alder like mechanism. To date this type of reaction has not been demonstrated 
to be catalysed by an enzyme in planta. 
 
As well as genes that are mis-annotated in terms of function, yet contain domains that can help 
to predict function, such as co-factor binding sites, there are also genes in plants that have no 
clear function at all. These genes of unknown function account for up to 40% of genes in plant 
genomes (de Crécy-Lagard and Hanson, 2007) (Bradbury et al., 2013) and could therefore also 
be the key source of novel enzymatic activity. Further work by both reverse genetics and 
functional screening for enzymatic activity is needed to analyse this potential untapped 
resource. 
In C. roseus, there are a number of methods by which it is possible to filter these unknown genes 
to enable more effective unbiased searches. Genes can be filtered on tissue level expression 
data, to filter genes based upon the localisation to the known biosynthetic site for metabolite 
synthesis. Other methods include comparative genomics to assess which genes are conserved 
between different plant species. With the current availability of transcriptomic resources in a 
number of MIA producing plant species, including Catharanthus longifolius, Catharanthus ovalis, 
Tabernaemontana elegans, Vinca minor, Vinca major, Rauwolfia serpentina and Camptotheca 
acuminata, it is possible that the enzymatic activity for the generation of the iboga and 
aspidosperma based alkaloids is conserved amongst these species. Homology based searches 
for genes of unknown function between species that produce similar MIA structural scaffolds 
may be a method for identifying this enzymatic activity, and this approach could also be utilised 
for other unknown metabolic pathways that involve novel biochemistry. 
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As has been observed in Chapter V, the CrRO that has been shown to be involved in MIA 
biosynthesis in C. roseus also has a homologue in both V. minor and T. elegans. In both of these 
species, as with the homologue for C. roseus, the putative FAD covalent binding site is mutated. 
Further dissection of these homologues is necessary to assess whether they are playing the same 
function in MIA metabolism in these species as in C. roseus, or whether they catalyse other 
functions. It is only through comparing this sequence data between species that produce similar 
compounds that we are able to predict that this reticuline oxidase like enzyme may have 
common functionality in these medicinal plants. 
Therefore the development of novel mining strategies, utilising both transcriptomic and 
comparative genomic tools, should be utilised for analysis of the genes of unknown function 
present in plants, to assess whether they are involved in secondary natural product formation, 
and able to catalyse novel chemistry. 
6.1.2 Elucidation of secondary metabolite transporters 
 
While the identification of new enzymes in metabolic pathways is essential, there is a growing 
precedence and need for the identification of transport steps that might also be involved in the 
MIA pathway. Despite the need for transport in the MIA pathway, to date only one transporter 
CrTPT2 has been functionally characterised, and is involved in catharanthine export (Yu and De 
Luca, 2013). 
This thesis has further identified two physiologically relevant tonoplast localised transport 
proteins, CrMATE1952 and CrNPF2.9 that give phenotypes upon silencing that perturb MIA 
biosynthesis, indicating that a reverse genetics screen can be successful in transporter 
identification.  
As with enzyme families, the functional annotation of current transporters in plant 
transcriptomic databases may not truly reflect the physiological substrate that they are 
transporting.  
As more natural product transporter classes are identified we will gain a better understanding 
of the potential diversity for secondary metabolite transport. The two largest classes of natural 
product transporters characterised in plants to date are the ABC transporters and the MATEs, 
however since 2012 there has been a growing appreciation that other transporter families are 
also involved in natural product transport (Jelesko, 2012; Nour-Eldin et al., 2012). 
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For example, the NPF transporters are a large class of the MFS proteins found in plants, and in 
Arabidopsis these have been shown to transport glucosinolates (Nour-Eldin et al., 2012).. 
Similarly the purine permeases from both Arabidopsis and N. tabacum, which are part of the 
DMT superfamily,  have been shown to transport other substrates such as the pyridine alkaloid 
nicotine (Jelesko, 2012). The work in this thesis further highlights that the MATE transporters 
are likely to have a role in the transport of glycosylated iridoids, and secondly that the NPF 
transporters have an expanded repertoire of substrates, as in C. roseus there is strong evidence 
that this transporter family is involved in strictosidine export from the vacuole. 
The fact that there are ~50 NPF transporters in many plant species, suggests that this family is a 
good starting point to assess novel transport functions for other secondary metabolites, in other 
medicinal plants. To date, evidence for the role of NPF transporters in secondary metabolism 
has been limited to Arabidopsis, and the work presented in this thesis further expands the 
physiological relevance of this transporter class to the medicinal plant C. roseus.  
This also highlights one of the key points in a recent review, addressing the difficulty in 
identifying the transporters for specialized metabolites (Nour-Eldin and Halkier, 2013) that there 
is a need to not limit homology searches for secondary metabolite transporters to the MATEs 
and ABCs, but instead to analyse other transporter families, by either a functional screen or 
reverse genetics approach, for their involvement in the movement of natural products. This is 
needed to address whether the neo-functionalisation of primary metabolite transporter 
families, for specific roles in natural product transport, is a common occurrence in plant 
metabolism.  
There is currently limited information on natural product transport in planta, and there is a 
burgeoning need for further elucidation of natural product transporters in medicinal plants. 
 
6.1.3 The role of spatial organisation in metabolic pathways and its applications to 
pathway engineering 
 
The role of transport in metabolic pathways in eukaryotic systems is still cryptic. The need for 
transport of metabolites between organelles in eukaryotic cells is likely to be due to a 
complicated mix of the evolutionary history of the organelle in which the metabolic pathway is 
localised, together with the physiological relevance and selection for that metabolic pathway to 
be localised to that subcellular compartment (Sweetlove and Fernie, 2013).  
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This study further highlights the role of spatial distribution of the metabolic pathway in the MIA 
pathway in C. roseus. As demonstrated with the silencing of the MATE protein CrMATE1952, 
there is an increase in the derivatised product of secologanin, secologanol, which is likely to be 
due to the mis-localisation of secologanin. The role of the spatial distribution of the metabolic 
pathway could therefore be to act as a pre-emptive mechanism to prevent the derivatisation of 
intermediates that are needed in the metabolic pathway that have the potential to be reactive. 
This is especially true in the context of convergent metabolic pathways where the flux to the 
branchpoint enzyme may not be equal, leading to the accumulation of one of the substrates 
along the branchpoint. 
In the context of the MIA pathway, the build-up of secologanin is likely to be due the fact that 
the synthesis of tryptamine is limiting relative to the synthesis of the iridoid secologanin. 
With the silencing of the NPF transporter CrNPF2.9 the accumulation of strictosidine in the 
vacuole is toxic to the cell, potentially indicating that there is a need to limit the accumulation 
of this intermediate in the cell. 
The spatial organisation of metabolism needs to be addressed in engineering efforts for the MIA 
pathway in heterologous systems. For the heterologous production of strictosidine in S. 
cerevisiae, enzymes that were targeted to different subcellular organelles in plants had the 
signal peptide removed (Brown et al., 2015). In the context of this heterologous pathway in yeast 
the titers of strictosidine are relatively low, and it was mentioned that the generation of the 
iridoid secologanin was the limiting step in this pathway (Brown et al., 2015). This is in contrast 
to the situation in plants in which the limiting step appears to be the supply of tryptamine to 
strictosidine biosynthesis.  
If such yeast strains are engineered to increase the yield of secologanin, whereby tryptamine 
becomes the limiting step as opposed to iridoid biosynthesis, it may be necessary to partition 
secologanin biosynthesis to prevent its derivitisation to secologanol.  
Secondly, as observed in planta upon VIGS of the CrNPF2.9 transporter, the accumulation of 
strictosidine appears to be toxic. It may therefore be necessary to limit the accumulation of 
strictosidine in such yeast strains, by ensuring that steady state concentrations of strictosidine 
remain low. This would require balancing flux from secologanin and tryptamine synthesis, and 
the downstream enzymes after strictosidine is generated. 
As observed in this thesis, the utilisation of plant transporters for engineering purposes in yeast 
is likely to be limited by the ability to express these transporters efficiently in the heterologous 
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host. Alternative methods for dealing with the spatial organisation of these metabolic pathways, 
such as the need to limit secologanin and strictosidine accumulation to prevent derivatisation 
and toxicity respectively are needed for the generation of higher titers of downstream alkaloids 
in heterologous systems. 
It may be possible that endogenous yeast transporters, or transporters from other species may 
also be capable of transporting strictosidine, and therefore the plant transporter CrNPF2.9 that 
has been identified as a strictosidine exporter may not be needed for engineering purposes. The 
use of transporter engineering in yeast has been successful in the production of high value 
alkanes, which have the potential for use as next-generation biofuels (Chen et al., 2013). These 
compounds are cytotoxic, however the expression of two ABC transporters ABC2 and ABC3 from 
Yarrowia lipolytica that have been demonstrated to export alkanes, increases the tolerance in 
this yeast strain to these products (Chen et al., 2013).  Additionally transporters could be evolved 
by directed evolution to select for alternative substrates, or for increased stability with regards 
to protein expression in the heterologous hosts. 
For the engineering of MIA biosynthesis, in planta, in a heterologous host such as N. 
benthamiana, the opportunity for transporter engineering may be easier. As demonstrated in 
the reconstitution of secologanin biosynthesis in N. benthamiana (Miettinen et al., 2014) 
although secologanin is generated, a number of the terpene intermediates in this pathway are 
derivatized and acetylated by endogenous metabolism. Although there are no reports that the 
secologanin is converted to secologanol in N. benthamiana, it will be necessary to assess 
whether the secologanin generated in this engineered system is also derivatised to other 
products, and whether partitioning biosynthesis to other sub-cellular compartments could 
increase efficiency to minimise secologanin derivatisation. The reconstitution of strictosidine 
biosynthesis in N. benthamiana resulted in the formation of strictosidine (Miettinen et al., 2014), 
indicating that N. benthamiana has an endogenous transport capacity for secologanin, as the 
strictosidine synthase utilised in this study would be localised to the vacuole. Expression of the 
CrMATE1952 may increase the efficiency with which secologanin can enter the vacuole in this 
hetereolgous host, however, and further heterologous expression of the other transport steps 
are necessary to assess whether they have any influence on the flux to engineered strictosidine 
or the downstream MIAs. 
Further work is therefore needed to firstly identify novel secondary metabolite transporters in 
C. roseus and other plant species to further expand our understanding of transporter substrate 
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specificity, and secondly to utilise these transport steps in engineering strategies to assess the 
relevance of the spatial organisation of metabolic pathways to carbon flux. 
6.2 Final Remarks 
 
Altogether this study has highlighted the benefits of utilising a reverse genetics strategy for the 
identification of physiologically relevant enzymes and transporters in MIA metabolism in C. 
roseus. The study has provided key new insights into the role the subcellular localisation of this 
metabolic pathway plays in metabolic organisation.  This work further expands the repertoire of 
MATE transporters in their involvement in secondary metabolic processes, and provides the first 
demonstration in C. roseus that NPF transporters are physiologically relevant to MIA 
metabolism. Moreover this reverse genetics screen has identified an enzyme CrRO that is 
involved in MIA metabolism, and provides the first evidence that the reticuline oxidase like 
enzyme family is involved in this metabolic pathway. 
In each of these three examples where a positive metabolic phenotype is observed upon 
silencing the gene, it is unlikely that these genes would have been identified without a reverse 
genetics method. The two transporters, CrMATE1952 and CrNPF2.9, have proven recalcitrant to 
efficient heterologous expression to test for in vitro activity, and may therefore not have been 
detected by a functional screen for transport. Secondly the enzyme CrRO, in all likelihood, 
utilises a substrate that is not commercially available and therefore screening for enzymatic 
activity would be potentially futile. This work therefore highlights the need for complementary 
approaches through both functional screening and reverse genetics for gene discovery in 
medicinal plants. 
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7 Materials and Methods 
 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich and all restriction 
enzymes from New England Biolabs. 
7.1 Methods for Bioinformatics 
7.1.1 MeV v4.7 software 
 
 The transcriptomic data for C. roseus was downloaded from   
http://medicinalplantgenomics.msu.edu  together with the expression data in the form of the 
log2(FPKM) value for each unigene across the different transcriptome libraries (Góngora-Castillo 
et al., 2012). This data was filtered based on the expression level in leaf tissue, and upon 
induction by MeJA. This filtered dataset was input into the MeV 4.7 software (Eisen et al., 1998; 
Saeed et al., 2003) for hierarchical clustering analysis. Multiple hierarchical clustering 
dendograms were generated using this dataset using different statistical distance metrics for 
the clustering algorithm. Known genes in the pathway were highlighted on the dendograms and 
this was used as a basis for candidate selection for VIGS experiments. 
7.1.2 Self-Organising Maps.  
 
This method for application to the C. roseus transcriptome was developed by Marc Jones (John 
Innes Centre) 
The data from the transcriptome dataset in the form of log2(FPKM) was mean centred and given 
a unit of variance. Self-organising maps were implemented and visualised in R  (Team, 2015) 
using the kohonen package (Wehrens and Buydens, 2007). The map sizes were chosen to give 
approximately forty contigs per node, with the map shape selected such that the ratio between 
the two edge lengths was the same as the ratio between the two largest eigenvalues of the data 
(Vesanto and Alhoniemi, 2000). A toroidal map was used so that every node had the same 
number of neighbours. This avoided boundary effects occurring when the neighbourhood 
distance metric was calculated. The known genes in the MIA pathway were mapped to the self-
organising maps, and the genes that were also present in the same and neighbouring nodes 
considered candidates for VIGS. These gene lists were compared to those generated by 
hierarchical clustering using the MeV v4.7 software. To assess how well the generated self-
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organising map fitted the data, two quality metrics were analysed. The first was the within-node 
distance, which is defined as the mean distance from the weight vector of a node to the samples 
mapped to it. Therefore, the smaller the within-node distance, the more accurately the node's 
weight vector represents the samples mapped to the node. The other quality metric used was 
the inter-nodal distance, defined as the sum of the distances from a node's weight vector to the 
weight vectors of its neighbouring nodes. The smaller the value, the more similar a node's weight 
vector is to its surrounding nodes' weight vectors. In order for a node to be classed as high 
quality in this analysis, both of the described quality metrics for that node had to be in the lowest 
quartile compared to all nodes. Quality nodes are highlighted green on the self organising map. 
7.1.3 Phylogenetic guide trees 
 
MEGA7 software (Tamura et al., 2011) and ClustalW (Larkin et al., 2007) were used for alignment 
and analysis of phylogenetic relationships. The evolutionary history was inferred by using the 
Maximum Likelihood method based on the JTT matrix-based model (Jones et al., 1992), and a 
bootstrap consensus tree was inferred from 500 replicates.  
7.1.4 Prediction Servers 
 
The protein isoelectric point (pI) was calculated using the ExPASy bioinformatics resource portal 
(Artimo et al., 2012). Signal peptide prediction was performed using the SignalP 4.1 server 
(Petersen et al., 2011). Prediction of membrane protein ubiquitination state was performed 
using the CKSAAP_UbSite predictor (Chen et al., 2011). 
7.1.5 Geneious 
 
All sequence data, including C. roseus transcriptome and genomic data, was analysed in 
Geneious (Kearse et al., 2012) and was also utilised for all alignments, sequence manipulation 
and basic local alignment search tool (BLAST) against publicly available sequence databases. 
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7.2 Methods for General Molecular Biology 
 
7.2.1 Sequencing 
 
All sequencing was performed by SourceBioscience, Cambridge using plasmid DNA as template 
and both vector specific and gene specific primers for the sequencing reaction. 
7.2.2 Primers 
 
All primers were supplied by either Sigma-Aldrich or Integrated DNA Technologies (IDT). 
7.2.3 Polymerase Chain Reaction (PCR) 
 
All PCR primers were designed to have a melting temperature of 58 oC. Unless otherwise stated, 
the conditions used for the PCR that utilised Uracil specific excision reagent (USER) compatible 
primers  per 25 µl reaction was 5 µl 10X HFBuffer, 2 µl dNTPs, 1 µl 10 µM forward primer, 1 µl 
10 µM reverse primer, 0.2 µl X7 polymerase, 0.2 µl template DNA and 15.3 µl water. For non-
USER based PCR the conditions for the PCR per 25 µl reaction was 2.5 µl 10X HFbuffer, 1.5 µl 
MgSO4, 2.5 µl dNTPs, 1 µl 10 µM forward primer, 1 µl 10 µM reverse primer, 1 µl KOD polymerase 
and 15 µl water. 
For the PCR, the stepwise gradient consisted of a melting temperature: 95 oC for 2 min, annealing 
temperature: 53 oC for 20 s, and extension temperature: 72 oC. If the PCR product <1 kbp the 
extension temperature was 1 min, whilst for PCR product >1 kbp the extension temperature was 
set at 1 min per kbp. This was repeated for between 28 and 31 cycles. 
7.2.4 Agarose Gel Electrophoresis 
 
Agarose gels (1% w/v) were made and run in TAE buffer (40mM 
Tris(hydroxymethyl)aminomethane (Tris), 20 mM acetic acid, and 1 mM 
Ethylenediaminetetraacetic acid (EDTA)). GelRed™(Biotium cat. no. 41010) and gel loading dye 
(NEB) were added to samples before loading and the gels were run at 100 V until the dye reached 
the lower portion of the gel. 
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7.2.5 Gel and PCR purification 
 
All PCR products used for downstream cloning were gel purified from the 1% agarose gel using 
a Nucleospin Gel and PCR clean-up kit (Machery-Nagel cat no. 740609.50) in accordance with 
the manufacturer’s instructions. All DNA was eluted from the column in 40 µl nuclease free H2O 
and stored at -20 oC. 
 
7.2.6 Common Media used for Molecular Biology 
 
Table 11 Media recipes for molecular biology 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
7.2.7 Antibiotic selection 
 
For the selection of E. coli and A. tumefaciens bacterial strains containing plasmids with a specific 
antibiotic resistance, LB liquid media and agar plates containing the specific antibiotic were used 
for bacterial growth. The antibiotics used in this study are presented in Table 12. 
Media Contents Microorganism cultivated 
Lysogeny Broth (LB) 1%(w/v) tryptone, 0.5% (w/v) yeast 
extract, 1% (w/v) NaCl, ddH2O 
E. coli, A. tumefaciens 
SOC 2% (w/v) tryptone, 0.5% (w/v) yeast 
extract, 10 mM NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 10 mM MgSO4, 20 mM glucose 
E. coli, A. tumefaciens 
YPD 1% yeast extract, 2% peptone, 2% D-
glucose 
S. cerevisiae 
SC-Uracil selection medium 0.67% yeast nitrogen base (without amino 
acids, with NH4SO4), Formedium complete 
synthetic dropout without uracil, 2% 
glucose 
S. cerevisiae 
SC-Uracil induction medium 0.67% yeast nitrogen base (without amino 
acids, with NH4SO4), Formedium complete 
synthetic dropout without uracil,  2% 
galactose, 2% raffinose. 
S. cerevisiae 
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Table 12 Antibiotics used for bacterial selection 
 
 
 
 
 
 
 
7.2.8 Extraction of RNA from plant tissue for cloning 
 
RNA from both mature and immature of C. roseus and A. thaliana leaves was extracted and 
purified with on column DNase digestion with the Qiagen RNeasy Plant Mini Kit (cat no: 74904) 
using the manufacturer’s protocol, for downstream cloning. <100 mg of leaf tissue was ground 
under liquid nitrogen and used for RNA extraction. The quality of the RNA was checked by gel 
electrophoresis on a 1% agarose gel and the RNA concentration determined on the nanodrop 
(NanoDrop ND-1000) 
7.2.9 cDNA synthesis from plant RNA for cloning 
 
cDNA was synthesised from the plant RNA extracted using Superscript III reverse transcriptase 
with RNaseH digestion (Invitrogen Superscript III reverse transcriptase cat no: 18080-044,  
Invitrogen RNaseOUT inhibitor cat no:10777-013 and Invitrogen oligod(T)12-18 primers cat no: 
18418-012 ) for first strand cDNA synthesis using the manufacturers protocol. Briefly up to 5 µg 
total RNA was incubated together with 5 µM oligod(T)20 primer and 1 mM dNTPs in a total 
volume of 10 µl and incubated at 65 oC for 5 min, and placed on ice. To the RNA, oligodT primer, 
dNTP solution, 10 µl of cDNA synthesis mix (consisting of RT buffer, 10 mM MgCl2, 20 mM 
dithiothreitol (DTT), 40 units RNaseOUT and 200 units Superscript III reverse transcriptase) was 
added. To instigate first strand cDNA synthesis, the mixture was incubated at 50 oC for 50 min 
and the reaction was terminated by incubation at 85 oC for 5 min. To each reaction 1 µl RNaseH 
was added and incubated at 37 oC for 20 min. The resulting cDNA was stored at -20 oC. 
OligodT primers were used for cDNA generation as they hybridise to the 3’ poly(A) tail of 
eukaryotic mRNAs. The oligod(T) primers are therefore a more specific priming method, and 
Antibiotic Final concentration (µg/ml) 
Carbenicillin 100 
Kanamycin 50 
Rifampicin 100 
Gentamycin 50 
Streptomycin 100 
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decrease the complexity of the cDNA generated, as it only consists of cDNA from expressed 
mRNA, which is representative of only 1-2% total RNA. 
7.3 General Methods for Escherichia coli 
 
Table 13 E. coli strains used in this thesis 
E. coli strain Source Function 
One Shot® TOP10 Invitrogen Plasmid propogation 
SoluBL21™ Amsbio Protein expression 
 
7.3.1 Preparation of chemically competent E. coli 
 
A 5 ml culture of the appropriate E. coli strain was grown in LB overnight at 37 oC. This was used 
as a starter culture, added to 500 ml SOC medium and incubated at 30 oC until the absorbance 
at 600 nm (OD600) was between 0.4-0.6. This culture was chilled on ice for 10 min and all 
remaining steps were kept on ice. The 500 ml cell suspension was centrifuged at 6,000 x g at 4 
oC, this pellet  was resuspended in 100 ml ice cold TB buffer (10 mM HEPES pH 6.7, 15 mM CaCl2, 
55 mM MnCl2, 250 mM KCl), and this suspension incubated on ice for 10 min before 
centrifugation at 4000 x g at 4 oC. The pellet was resupsended in 18.6 ml ice cold TB buffer and 
1.4 ml dimethyl sulfoxide (DMSO). The suspension was aliquoted into an appropriate volume, 
snap frozen in liquid N2 and stored at -80 oC until further use. 
7.3.2 Chemical transformation of E. coli 
 
2 µl of plasmid was added to 50 µl chemically competent E. coli cells, mixed gently and placed 
on ice. Chemical transformation of the plasmid into the E. coli cells was induced by heat-shock 
by incubating the mixture at 42 oC for 45 s. After heat shock the cells were placed on ice. The 
cells were incubated in 150 µl SOC medium immediately following transformation, at 37 oC for 
1 h, before being spread on agar plates containing the appropriate antibiotic selection, and 
grown overnight at 37 oC. 
7.3.3 Plasmid extraction 
 
Bacterial colonies were grown in 5 ml of LB + appropriate antibiotic selection and the plasmid 
extracted using a Qiagen Miniprep kit (cat no: 27104) in accordance with the manufacturer’s 
instructions. This procedure utilises alkaline lysis together with adsorption of the DNA on a silica 
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membrane. DNA was eluted from the silica membrane using 40 µl ddH2O and stored at -20 oC 
for future use. 
7.4 General Methods for Agrobacterium tumefaciens 
 
Table 14 A. tumefaciens strains used in this thesis 
A. tumefaciens  strain Function 
GV3101 Virus Induced Gene Silencing 
LBA4404 Protein expression in N. benthamiana 
 
7.4.1 Generation of electrocompetent A. tumefaciens 
 
Electrocompetent A. tumefaciens strains GV3101 and LBA4404 were generated using the 
protocol for the Biorad Micropulser electroporation apparatus (Catalog no 165-2100). Briefly a 
5 ml overnight culture of A. tumefaciens was used to inoculate 1 litre of LB broth, and this was 
grown at 30 oC with shaking to an OD of ~5x107 cells/ml. All subsequent steps were kept at 4 oC. 
The culture was centrifuged at 3000 x g, the supernatant discarded, and the cell pellet washed 
with 500 ml ice cold 10% glycerol. This wash step was repeated twice with a volume of 500 ml 
10% glycerol and once with a volume of 5 ml 10% glycerol. The final cell pellet was resuspended 
in 0.5 ml sterile ice cold 1 M sorbitol, and dispensed in 200 µl aliquots for long term storage at -
80 oC. 
7.4.2 Transformation into A. tumefaciens 
 
100-300 ng of plasmid DNA was mixed with 45 µl of electrocompetent A. tumefaciens GV3101 
or A. tumefaciens LBA4404, put into a 2 mm electroporation cuvette and placed on ice for 5 min. 
Using a Biorad micropulser (165-2100) this mixture was electroporated at 2.2 kV. Immediately 
after electroporation 150 µl of SOC was added to the cuvette, placed into a 1.5 ml eppendorf, 
and incubated at 28 oC for 2 h. This mixture was then spread onto agar plates containing 
rifampicin, gentamycin and the plasmid specific antibiotic selection marker for A. tumefaciens 
GV3101, and rifampicin, streptomycin and the plasmid specific antibiotic selection marker for A. 
tumefaciens LBA4404 . The plates were incubated for 2 days at 28 oC until individual colonies 
were visible. 
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Between 3-5 colonies were picked and grown in 5 ml liquid LB media containing antibiotic 
selection. Plasmid DNA was extracted and used as a template for PCR. Gene specific primers 
were used to test for the presence of the insert in the A. tumefaciens strain. For colonies testing 
positive for the insert, the liquid culture was mixed 1:1 with 25% glycerol and stored at -80 oC 
for future use. 
7.5 General Methods for Saccharomyces cerevisiae 
 
Table 15 S. cerevisiae strains used in this thesis 
S. cerevisiae strain Function 
InvSC1 Protein expression 
Ybt1 Protein expression 
WAT11 Protein expression 
 
7.5.1 Generation of electrocompetent yeast 
 
Electrocompetent S. cerevisiae was generated using the protocol for the Biorad Micropulser 
electroporation apparatus (Catalog no 165-2100). Briefly, 500 ml YPD media was inoculated with 
an overnight culture of S. cerevisiae. The culture was incubated at 30 oC to a cell density of ~108 
cells/ml. The cells were chilled on ice to prevent further growth, and all subsequent steps were 
performed on ice or at 4 oC. The culture was centrifuged at 3000 x g for 10 min and the 
supernatant discarded. The pellet was washed twice with 250 ml ice cold water, and 
subsequently washed with 20 ml sterile ice cold 1 M sorbitol. The solution was centrifuged, the 
supernatant discarded and the cell pellet resuspended in 0.5 ml sterile ice cold 1 M sorbitol, 
which was then dispensed into 200 µl aliquots for storage at -80 oC. 
7.5.2 Transformation into yeast by electroporation 
 
100-300 ng of plasmid DNA was mixed with 45 µl of electrocompetent S. cerevisiae, put into a 2 
mm electroporation cuvette and placed on ice for 5 min. Using a Biorad micropulser this mixture 
was electroporated at 1.5 kV. Immediately after electroporation 1 ml of 1 M ice cold sorbitol 
was added to the cuvette, placed into a 1.5 ml eppendorf. This solution was spread onto SC agar 
plates without uracil (SC-URA) for selection, with colonies appearing after 2 days of growth at 
30 oC. 
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7.6 General Methods for Proteins 
 
7.6.1 SDS-PAGE 
 
Protein samples were run using sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE), using pre-cast 12 well RunBlue SDS-PAGE gels (Expedeon). Protein samples were 
incubated with LDS-loading dye and 4% β-mercaptoethanol, and heated for 5 min prior to gel 
loading. The gels were run at 180 V for 1 h in 1 x SDS running buffer (24.8 mM Tris, 192 mM 
glycine, 0.1% SDS). Protein gels were visualised using InstantBlue (Expedeon). 
7.6.2 Western blots 
 
For transfer of the proteins to a nitrocellulose membrane the SDS-PAGE gel was soaked in 
transfer buffer (25 mM Tris, 190 mM Glycine, 20% (v/v) MeOH, H2O), before being sandwiched 
between a nitrocellulose membrane, two pieces of filter paper and two sponges, and placed 
between a –ve and +ve electrode. The transfer was performed on ice or at 4 oC at 100 mA for 1-
2 hr, until the protein ladder was transferred to the nitrocellulose membrane. 
The nitrocellulose membrane was blocked overnight in a solution of TBS (50 mM Tris, 150 mM 
NaCl, pH 7.5) and 5% milk powder (Marvel dried milk powder). The primary antibody was diluted 
1:10,000 in TBS and 5% milk powder and the nitrocellulose membrane incubated in this solution 
for 2 h at room temperature with gentle agitation. The nitrocellulose membrane was then 
washed 5 times in TBS containing 0.05% Tween-20 over the course of 45 min. The secondary 
antibody was diluted 1:5,000 in TBS and 5% milk powder, before incubation with the 
nitrocellulose membrane for 1 h and then subsequently washed 5 times in TBS and 0.05% 
Tween-20. The secondary antibody is conjugated to horse radish peroxidase (HRP) and was 
visualised using a Pierce™ ECL Western Blotting Substrate (Thermo Scientific) using the 
manufacturer’s instructions. This is an enhanced luminol based chemiluminescent substrate for 
detection of HRP on western blots, and is non-radioactive. The western blot was imaged using 
the auto exposure on an ImageQuant LAS500. 
7.6.3 Bicinchoninic acid (BCA) assay 
 
Protein samples were quantified using a BCA assay, which is a colorimetric detection method for 
protein concentration. This method utilises the colorimetric detection of Cu1+ by BCA upon the 
reduction of Cu2+ to Cu1+ by protein in an alkaline medium, resulting in a purple coloured reaction 
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product with strong absorbance at 562 nm that is linear with protein concentration. A standard 
curve for absorbance relative to protein concentration was generated using known 
concentrations of bovine serum albumin (BSA) in the range of 62.5 µg/ml to 1 mg/ml, with each 
concentration measured in triplicate, and the R2=0.99 for the standard curve. Protein samples 
were measured for absorbance at 562 nm and the concentration determined by comparison to 
the standard curve. 
7.7 General Methods Analytical Chemistry 
7.7.1 Thin Layer Chromatography (TLC) 
 
Thin layer chromatography was performed using glass backed silica plates (Millipore TLC silica 
gel 60 F254) cut to 5 cm x 2.5 cm. Around 10 µl of substrate was spotted onto the TLC plate, and 
the development conditions for each TLC are specified in the text. 
7.7.2 Mass Spectrometry 
 
High resolution mass spectrometry using electrospray ionisation (ESI), was performed by 
Gerhard Saalbach (John Innes Centre) using a Synapt G2 HDMS (Waters). 
7.7.2.1 Liquid Chromatography Mass Spectrometry (LC-MS) 
 
All samples were run on either a Thermo-Finnigan instrument equipped with a Deca XP ion trap 
detector or a Shimadzu LCMS-IT-TOF Mass Spectrometer. 
For both instruments the column used for chromatographic separation was a Phenomenex 
Kinetix 5µ C18 100A (100 × 2.10 mm, 5 µm), and the binary solvent system consisted of 
acetonitrile (ACN) and 0.1% formic acid in water. The elution program was the following: 1 min 
isocratic at 12% ACN, 3.5 min gradient up to 25% ACN, 2.5 min gradient up to 50% ACN, 1 min 
gradient up to 100% ACN, 6 min isocratic at 100% ACN, 1 min gradient down to 12% ACN, and 
2.5 min isocratic at 12% ACN.  
For the Shimadzu LCMS-IT-TOF mass spectrometer MS/MS fragmentation was induced by 
collision induced dissociation (CID), with collision energy 50%, collision gas 50% and isolation 
width of m/z 3.0.  
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For the Thermo-Finnigan instrument peak areas were calculated using the ICIS algorithm in 
Finnigan’s Xcalibur, and for the Shimadzu LCMS-IT-TOF Mass Spectrometer peak areas were 
calculated using the Shimadzu Profiling Solution software. All representative mass 
chromatograms presented in this thesis are from samples analysed on the Shimadzu LCMS-IT-
TOF Mass Spectrometer. The chromatogram data was extracted and plotted using SigmaPlot 
version 12.5. 
 
7.8 Methods specific for Virus Induced Gene Silencing 
 
7.8.1 Cloning for VIGS pTRV2 Vectors 
 
7.8.1.1 USER cloning into pTRV2u for individual silencing vectors 
 
Uracil excision-based cloning is a ligation-independent cloning technique. It utilises PCR primers 
that contain a single deoxyuridine residue near the 5’ end. Treatment of the PCR products with 
USER enzyme leads to the generation of 8 nucleotide 3’ overhangs, which can complement the 
ends of a USER compatible linearised vector (Geu-Flores et al., 2007; Nour-Eldin et al., 2010).  
The stable hybridisation product that occurs due to the complementarity between the 
overhanging sequences and the linearised destination vector allows for transformation of E. coli 
without prior ligation (Figure 7-1). 
A pTRV2u plasmid containing a USER cassette in the multiple cloning site of pTRV2 vector was 
designed by Fernando Geu-Flores (Geu-Flores et al., 2012). For USER compatible cloning, the 
pTRV2u plasmid was linearised by incubation with the restriction enzymes AsisI and Nt.BbvC1 
overnight at 37 oC and the linearised plasmid subsequently gel purified from a 0.7% agarose gel. 
The linearised plasmid can be stored at -20 oC until further use. 
A 500 bp region of each gene to be transiently silenced was selected and cloned into a non-
structural ORF of the pTRV2u vector. In order for selective knockdown of the gene of interest 
the 500 bp region of the gene is selected to be that which minimises the potential for off target 
knockdown of homologous gene candidates from the same gene family, based upon a BLAST 
search of the region of interest against the C. roseus transcriptome. 
The 500 bp region of the gene of interest for silencing was amplified using PCR from C. roseus 
leaf cDNA with gene specific primers containing overhanging sequences that complement the 
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overhangs on the pTRV2u linearised vector. These overhanging sequences end in a single 
deoxyuridine residue upstream of the gene specific region of the primer, that upon treatment 
with USER enzyme result in long complementary overhangs that can anneal to the overhanging 
sequences of the pTRV2u linearised vector. The resulting PCR product was gel purified from a 
1% agarose gel.  
 
 
Figure 7-1 Overview of USER-cloning into the pTRV2u plasmid 
 
The 500 bp PCR products, linearised pTRV2u vector, and USER enzyme were incubated together 
in a reaction volume of 10 µl at 37 oC for 40 min, and subsequently kept on ice for 15 min. This 
reaction mixture was used to transform 40 µl TOP10 E. coli by heat shock without prior ligation. 
The E. coli was recovered and grown in 200 µl SOC media at 37 oC for 40 min, and this was then 
spread onto kanamycin selective agar plates and incubated at 37 oC overnight. Three colonies 
from each plate were grown up in 5 ml overnight cultures. Plasmid DNA was extracted by a 
Qiagen Miniprep kit and tested for the 500 bp insert by PCR using gene specific primers and 
positive plasmids were sent for sequencing. pTRV2u constructs of the correct sequence were 
subsequently used for transformation into Agrobacterium tumefaciens strain GV3101. 
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Table 16 pTRV2 Vectors for single gene silencing and primers for VIGS vectors Chapter II 
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Table 17 pTRV2 Vectors for single gene silencing and primers for VIGS vectors Chapter III 
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Table 18 pTRV2 Vectors for single gene silencing and primers for VIGS vectors Chapter IV 
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Table 19 pTRV2 Vectors for single gene silencing and primers for VIGS vectors Chapter V 
Additionally primers for the amplification of the CrRO homologue are also highlighted 
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7.8.1.2 USER fusion cloning for generation of combinatorial VIGS vectors 
 
USER fusion cloning is a versatile method that allows for the ligation independent fusion of 
multiple PCR products into a vector, and was used for the generation of multiple VIGS fusion 
constructs, allowing for the stacking of ~500 bp regions of genes into one pTRV2u plasmid to 
allow for the combinatorial silencing of multiple genes in one VIGS experiment.  
As with the standard USER cloning the versatility of this method is due to the ability to generate 
long custom designed complementary overhanging sequences that allow for the formation of a 
stable hybridisation product that can be transformed into E. coli without prior ligation (Figure 
7-2). Custom overhanging sequences can be designed to generate a series of PCR products that 
have complementary overhangs that upon treatment with USER enzyme will result in the 
formation of a stable hybridisation product that can be transformed into E. coli.  
 
Figure 7-2 Overview of USER-cloning into the pTRV2u plasmid for the generation of combinatorial fusion 
vectors 
The example presented in this schematic resulted in the generation of the triple silencing vector pTRV2u-
CrNPF2.9_CrMATE1952_CrMATE10740 which was used in Chapter IV. 
 
 
For the formation of the fusion vectors each of the 500 bp gel purified PCR products for 
formation of the fusion, linearised pTRV2u vector, and USER enzyme were incubated together 
in a reaction volume of 10 µl at 37 oC for 40 min, and subsequently kept on ice for 15 min. This 
reaction mixture was used to transform 40 µl TOP10 E.coli by heat shock without prior ligation. 
The E. coli was recovered and grown in 200 µl SOC media at 37 oC for 40 min, and this was then 
spread onto kanamycin selective agar plates and incubated at 37 oC overnight. Three colonies 
from each plate were grown up in 5 ml overnight cultures. Plasmid DNA was extracted by a 
Qiagen Miniprep kit and tested for the 1000-1500 bp insert by PCR using gene specific primers 
and positive plasmids were sent for sequencing. pTRV2u constructs of the correct sequence 
were subsequently used for transformation into Agrobacterium tumefaciens strain GV3101. 
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Table 20 Primers for the generation of VIGS fusion vectors 
Primer Name Primer Sequence (5'-3')  Primer ID  
CrNPF2.9_forward_VIGS GGCGCGAUCGCTTGCGGTAGCTGGATTTA 1 
CrNPF2.9_reverse_VIGS_fusion  ATTCCAAU GCCACTGATTACTGAAGCAGCATT 2 
CrNPF2.9_CrMATE1952_forward_VIGS_fusion ATTGGAAUCCAAACAAAACTATGAAATAAACCAACCACTG 3 
CrMATE1952_forward_VIGS GGCGCGAU CCAAACAAAACTATGAAATAAACCAACCACTGT 4 
CrMATE1952_reverse_VIGS GGTTGCGAU 
GTTTTGAGAATATGTAAACAAACATAATAACAATGCCTGTTA  
5 
CrMATE1952_reverse_VIGS_fusion ACAAACAU AAT AAC AAT GCC TGT TAG GGT TAG AAG AAT TG 6 
CrMATE1952_CrMATE10740_forward_VIGS_fusion ATGTTTGU TGG ACA GAC CTT GAA GCT GG 7 
CrMATE_10740_reverse_VIGS  GGTTGCGAU ATCCCCTGGCAACACCTG 8 
1952_3327_forward_VIGS_fusion ATGTTTGU GCT GCT TCC TCC CTT GGC AAT AAT  9 
3327_reverse_VIGS_fusion AGCTACU G ATA TAT ATG CAC TTG GAT TAA TAA TG CTC 10 
3327_8527_forward_VIGS_fusion AGTAGCU CTG CCT CCT TAG GCA ACC AG 11 
8527_reverse_VIGS GGTTGCGAU CAA TGA AAT GTA GGC ACT TGG CTT CAC TAT A 12 
5608_CrRO_forward_VIGS GGCGCGAU TCTCTTCCTCTGTTGGAATTGGC 13 
5608_CrRO_reverse_VIGS_fusion ATT CAT TTC UAA GCA ATC TTC CTT TTT CAA TCC AAG  14 
5608_2174_forward_VIGS_fusion AGAAATGAAU TCC CTC CTC TGT TTT TGC CTT CTA A 15 
2174_CrRO_reverse_VIGS_fusion AGC ACC AGA UTG GAC CCA AGC 16 
2174_5372_forward_VIGS_fusion ATCTGGTGCU TTG TGT TTC TTC TGT TAT CAT CTT CAT TTC TGA 
TGA 
17 
5372_CrRO_reverse_VIGS GGTTGCGAU CAG TGG CAC CGG CCT  18 
 
 
Presented in Table 21 are the combinations of primers used andPCR products used for the 
generation of the combinatorial VIGS vectors utilised in this thesis. 
An overview of all VIGS vectors utilised in this thesis is presented in Table 22. 
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Table 21 Combinations of primers and PCR products for the VIGS fusion vectors using primer ID in 
Table 20 
 
 
 
264 
 
Table 22 Overview of all VIGS vectors generate and used in this thesis  
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7.8.2 Virus Induced Gene Silencing 
 
7.8.2.1 C. roseus plant growth conditions 
 
Two cultivars of C. roseus have been used for VIGS in this study, cv. Little Bright Eyes (purchased 
from B and T world seeds) and cv. Sunstorm Apricot (Syngenta). All plants were grown in a walk 
in growth chamber at 25 oC under 12 h days using the John Innes compost mix No.2 (peat based). 
7.8.2.2 VIGS Experiment 
 
For any given VIGS experiment, Agrobacterium containing the plasmids pTRV1, pTRV2-Empty 
Vector, pTRV2-Magnesium chelatase, and the pTRV2 constructs generated containing the 500 
bp of the gene of interest to be transiently knocked down, were grown in 5 ml LB liquid media 
containing rifampicin, gentamycin and kanamycin overnight. The cultures were centrifuged, and 
resuspended in Agrobacterium infiltration buffer (10 mM MES, 10 mM MgCl2, 100 µM 
acetosyringone, pH 5.5) to an optical density of 0.7 at 600 nm, and incubated for 2 hr at room 
temperature. Each pTRV2 construct was then mixed 1:1 with the pTRV1 Agrobacterium strain, 
and this mixture was used for pinching.  
For each pTRV2 construct a minimum of eight eight week old C. roseus plants were pinched on 
the stem using a pair of bent forceps, just below the meristem, and a bubble of Agrobacterium 
was placed over the wound site. The pTRV2-MgChl construct, which silences magnesium 
chelatase, and therefore chlorophyll biosynthesis, was used as a positive visual control to ensure 
the silencing experiment has worked. Between 21-25 days post pinching the MgChl plants turn 
yellow as a result of downregulation of chlorophyll biosynthesis and the VIGS experiment was 
harvested. 
For each plant pinched with the pTRV2-EV construct and the pTRV2-gene of interest constructs, 
the newest leaves emerging after the wound site were harvested. The leaf tissue was ground 
using a retsch ball mill and stored at -80 oC. This tissue was used for both analysis by LC-MS to 
assess the metabolite profile upon gene silencing, as well as qPCR to detect the change in 
expression level of the gene being silenced.  
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7.8.2.3 LC-MS of C. roseus tissue 
 
Between 10-20 mg of ground tissue of each plant was weighed, collected into 200 µl methanol 
containing 40 µM caffeine as an internal standard and incubated at 60 oC for 2 h. After a 30-min 
centrifugation step at 5,000 x g, an aliquot of the supernatant (50 µl) was mixed with an equal 
volume of water and analysed by LC-MS. VIGS experiments that gave a positive metabolic 
phenotype were run and quantified on both the Thermo-Finnigan instrument and the Shimadzu-
IT-TOF to ensure reproducibility of the VIGS experiment. One difference that needs to be 
highlighted is that for the iridoid glycoside secologanin, the dominant ion is different between 
the two instruments. For the Thermo-Finnigan instrument it runs as the proton adduct m/z 389, 
whilst for the Shimadzu-IT-TOF it runs as the sodium adduct m/z 411. Additionally the new peak 
accumulating in VIGS-CrMATE1952 that we believe is secologanol runs as the proton adduct m/z 
391 on the Thermo-Finnigan instrument, and as the sodium adduct m/z 413 on the Shimadzu-
IT-TOF. 
7.8.2.4 Untargeted metabolomics using XCMS 
 
LC-MS metabolite data from VIGS samples was converted to mzXML files for analysis by the 
programme XCMS (Smith et al., 2006; Team, 2015). This can be downloaded from 
http://www.bioconductor.org/ and run in the statistical programme R by running the command 
library(xcms). The VIGS data in mzXML format consists of two treatments, VIGS-EV and 
VIGS-gene of interest, which are separated into subdirectories. A peak list for each individual file 
is generated by the function xcmsSet(). A grouping algorithm implemented by the 
command group()cross references the peaks in individual files and creates a common peak 
list with similar mass and retention time. Using peaks common to all samples, XCMS can 
estimate how the retention times have changed between runs, and re-calculate the retention 
time of the peaks using the retcor()method. This new dataset can subsequently be re-
grouped with higher stringency. Some peaks do not exist in all files and the command 
fillPeaks ()integrates the baseline in samples where no peak was found to prevent a peak 
list with 0 values. The peak list of individual files, which contains the peak area, together with 
retention time correction, was exported into Excel. The peak areas for each individual sample 
were corrected for the peak area of caffeine, and the weight of the leaf. This normalised peak 
area for each mass was used for comparison between VIGS-EV and VIGS-gene of interest 
treatments, with the average peak area for each treatment, the fold change between VIGS-gene 
of interest and VIGS-EV controls, as well as a t-test calculated between the two sets. To correct 
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the p-value for multiple testing, the peaks present in the XCMS dataset were ranked based on 
their p-value, and the Benjamini-Hochberg method for False Discovery Rate (FDR) used to 
correct the p-value for the occurrence of false positives (Benjamini and Hochberg, 1995). 
7.8.2.5 qPCR VIGS tissue 
 
7.8.2.5.1 RNA extraction 
 
RNA needs to be extracted for in order to address the expression level of the gene in the plant. 
Less than 100 mg of plant tissue was used for extraction of RNA from each replicate in a VIGS 
experiment using a Qiagen RNeasy plant mini kit in accordance with the manufacturer’s 
instructions. For each set of pTRV2u plants, a minimum of eight plants were selected, that gave 
the best metabolic phenotype, for RNA extraction and qPCR. RNA quality was assessed on a 1% 
agarose gel and the concentration was measured on the nanodrop (ND-1000). 
7.8.2.5.2 cDNA synthesis for qPCR 
 
cDNA for qPCR from each replicate was synthesised using the Biorad  iScript cDNA synthesis kit 
(catalog no 170-8891).  Briefly the 5x iScript reaction mix, iScript reverse transcriptase, nuclease 
free H2O and 1 µg RNA from each VIGS sample was mixed in a total volume of 20 µl and 
incubated for 5 min at 25 oC, 30 min at 42 oC, and 5 min 85 oC , resulting in the formation of the 
cDNA which was used for qPCR.  
7.8.2.5.3 qPCR conditions 
 
Real-time qPCR, to assess gene expression of the genes silenced by VIGS,  was performed on a 
CFX96 touch Real-Time PCR system (Biorad) using the SYBR Green I technology. Each reaction 
was performed in a reaction volume of 25 µl and consisted of a normalised concentration of 
cDNA, 0.2 mM forward and reverse primers and the SsoAdvanced SYBR Green Supermix (Biorad 
catalog no: 1725271), which contains dNTPs, Sso7d fusion polymerase, MgCl2, SYBR® Green I 
and ROX normalisation dyes. The qPCR reaction was initiated by a denaturation step at 95 oC for 
10 min followed by 40 cycles at 95 oC for 15 s and 60 oC for 1 min. 
 
For each qPCR experiment,  to assess the relative expression level of genes of interest that have 
been silenced by VIGS, cDNA made from eight replicates of pTRV2-EV and eight replicates of 
pTRV2-gene of interest were used, and the qPCR reaction performed in technical duplicate. The 
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relative quantification of gene expression was performed using the ΔΔCq cycle method using 
either the 40S ribosomal protein 9 (Rps9), 60S acidic ribosomal protein (RPP0C) or elongation 
initiation factor 4a (EIF4a) as reference genes for normalisation. These reference genes have 
previously been published for use in VIGS qPCR experiments in C. roseus (Asada et al., 2013; 
Geu-Flores et al., 2012; Liscombe and O’Connor, 2011; Salim et al., 2014). Although there are 
reports of other qPCR targets being validated for C. roseus (Pollier et al., 2014), the primers that 
were published for these genes, annotated as CrN227, in our hands, did not give reliable data 
(Appendix) and therefore we utilised the previously published primers for normalisation in the 
VIGS experiment.   
 
7.8.2.5.4 Primer optimisation 
 
Prior to performing the qPCR reaction on the VIGS experiment, the qPCR primers for each gene 
of interest to be measured were optimised. Each primer pair was used in a standard PCR reaction 
against C. roseus cDNA to ensure only one target was amplified. 
 
For each primer pair a standard curve was generated to ensure the primer pair amplification 
efficiency had a linear relationship with cDNA concentration. cDNA from the VIGS-EV and VIGS-
pTRV2 constructs was pooled, and a serial dilution of this pooled cDNA was generated at 
concentrations of  1:5, 1:10, 1:20, 1:80, 1:320. A qPCR reaction for each primer pair was 
performed in technical triplicate at each concentration, and the quantitation cycle (Cq) plotted 
against log[cDNA]. Only primer pairs that gave a linear regression (R2) value of 0.99 were used 
in this study. This standard curve was also used to assess the appropriate starting concentration 
of cDNA to use for the qPCR reaction and ensure the Cq value for each gene to be analysed in 
the experiment occurred between 20-30 cycles in the qPCR reaction.  
 
Together with this, the melting curves generated were used to ensure that the primer pair is 
specific in its amplification and that it has only one amplified target in the cDNA. The primer 
efficiency values generated in this study were between 99-101%. 
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Table 23 qPCR primers used in this study 
  Primer Name Target Sequence (5'-3') 
qPCR primers CrNPF2.9_qPCR_Forward NPF transporter AAG AAG CTC TCC TTG TCA AAC AAA GAA GAA G 
  CrNPF2.9_qPCR_Reverse NPF transporter CTT GAA ACT TTC ATC AGG TAC AGT AGC AGG  
  CrMATE1952_qPCR_Forward MATE CCG GTG TTG CTG TTG GAT GT 
  CrMATE1952_qPCR_Reverse MATE CAA GTT TGA AGT AGA ACC CAA GAA GTG CA 
 CrMATE10740_qPCR_Forward MATE CTT GAA CTT GCC GCT GCA AAT CTT 
 CrMATE10740_qPCR_Reverse MATE CCT TGT CCA CAC AAA CTT TCC AGT GC 
  CrRO_qPCR_Forward Reticuline oxidase like protein CCG AGA ATC TCA TCT TCC AAA GAC ATG  
  CrRO_qPCR_Forward Reticuline oxidase like protein GCG TTT CGA TCA AAT CAG ACT TTA TTC AAG AAC  
  locus_5372_qPCR_Forward Reticuline oxidase like protein GAT AAA ACA ATT GTA ACA GCC TAT AAC GCG TTG  
  locus_5372_qPCR_Reverse Reticuline oxidase like protein TAC AAT CTT TTC GAG TCA ATC CCA GTT CG 
  locus_2174_qPCR_Forward Reticuline oxidase like protein CTC GAT GCC CAA GTC GTT GAT G 
  locus_2174_qPCR_Reverse Reticuline oxidase like protein ATC CCA AAA TAA CAC CAA AAC TAG CAC C 
  Rps9_qCR_Forward 40S ribosomal protein 9 TTG AGC CGT ATC AGA AAT GC  
  Rps9_qCR_Reverse 40S ribosomal protein 9 CCC TCA TCA AGC AGA CCA TA  
  EIF4a_qPCR_Forward Elongation initiation factor 4A TCA GGA GGC TCT TCC TGG TGA  
  EIF4a_qPCR_Reverse Elongation initiation factor 4A AGC TCC CTT GGC AGG GTC AT  
  RPP0C_qPCR_Forward 60S acidic ribosomal protein-0C CAAGGTTGGAGCCCCTGCTCGTGTT 
  RPP0C_qPCR_Reverse 60S acidic ribosomal protein-0C TCTTAGTTGGAATGTTCAGCACCTG 
 
7.8.2.6 Confocal microscopy of VIGS leaf tissue 
 
7.8.2.6.1 DAPI staining 
 
C. roseus leaves were vacuum-infiltrated and fixed in a solution of ethanol/acetic acid (3:1 v/v) 
for 1-2 h and then washed in phosphate buffered saline (PBS) pH 7.0. 
Tissue was cut into small pieces (approx 3 mm x 3 mm) that included both blackened regions 
and normal looking tissue. Material was incubated in a 1 µg/ml solution of DAPI (4’, 6-diamidino-
2-phenyl-indole) in dH2O for  1h, then washed in dH2O and mounted in Vectashield (Vector 
laboratories) and imaged on a Zeiss LSM780 confocal microscope using a x40 oil immersion lens. 
For visualisation of DAPI staining, excitation was at 405 nm and detected at 410-585 nm. Z-stacks 
with 1 µm spacing were used to generate Maximum projection images using ImageJ software 
(http://rsb.info.nih.gov/ij/). This work was performed in collaboration with Alison Pendle (John 
Innes Centre). 
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7.8.2.6.2 Propidium iodide staining 
 
Fresh unfixed tissue was used for propidium iodide staining. Tissue pieces were mounted in a 10 
µg/ml solution of propidium iodide in dH2O and viewed on a Zeiss LSM780 confocal microscope 
using a x40 oil immersion lens. 
For visualisation of propidium iodide, excitation was at 488 nm and the signal detected at 
wavelengths of 535-660 nm. Z-stacks with 1 µm spacing were used to generate maximum 
projection images using ImageJ software (http://rsb.info.nih.gov/ij/). This work was performed 
in collaboration with Alison Pendle (John Innes Centre). 
7.8.2.6.3 Trypan blue staining and visualisation by UV 
 
C. roseus leaf tissue was placed in a clearing solution consisting of (300 ml 95% ethanol, 125 ml 
90% lactic acid, 800 g chloral hydrate in 1 l chloroform) until the leaves were cleared of 
chlorophyll, and stored in 2.5 g/ml chloral hydrate. The leaves were stained in a solution of 0.1% 
trypan blue and lactoglycerol (lactic acid:glycerol:H2O 1:1:1) for 24 hours, and subsequently 
destained in solution of 2.5 g/ml chloral hydrate. The stained C. roseus leaves were analysed by 
an AF6000 stereo brightfield microscope using a 1x/0.02 objective lens. 
Photos of trypan blue stained leaves under UV light were taken by Andrew Davies (JIC 
photography department). 
7.8.2.7 Desorption Electrospray Ionisation Mass Spectrometry Imaging (DESI-MS) 
 
The freshly collected silenced leaves were imprinted either on Whatman grade 1 paper (VIGS-
CrNPF2.9) or polytetrafluroethylene (PTFE) sheets (VIGS-EV). For imprinting on Whatman paper, 
the leaf was placed between two layers of paper and manually imprinted using a hydraulic press 
under 1 tonne pressure. For PTFE imprinting, the abaxial side of the leaf was laid on the PTFE 
sheet and the upper side of the leaf was then covered with filter paper. The leaf imprints were 
mounted onto a microscope glass slide using double-sided tape. 
DESI experiments were performed using a Synapt G2 HDMS mass spectrometer (Waters) 
operated in positive mode with a scan time of 1.5 s in the mass range of 50-1200 m/z. Capillary 
voltage was 1.5 kV, cone voltage 40 V, source temperature 150 oC. DESI-MSI experiments were 
carried out using a Prosolia Inc. DESI 2D source. The leaf imprints were scanned in horizontal 
rows separated by 200 μm vertical steps until the entire tissue sample had been analysed. The 
271 
 
lines were scanned at a constant velocity of 200 μm/s, and mass spectra were recorded over the 
m/z 50-1200 range. 
The spray voltage was set at 1.5 kV. Nitrogen gas (100 psi) was used for nebulisation. The spray 
solvent, 0.11% formic acid in acetonitrile/water (70:30), was sprayed at a constant flow rate of 
1.5 μl/min. Mass spectra were recorded for a few seconds during electrospray contact with the 
leaf surface. 
Non-commercial software designed by Waters was used to convert the MassLynx mass spectra 
files (.raw) into a format compatible with HDI, which was used to process the mass spectral data 
to generate two dimensional spatially accurate ion images. This work was performed in 
collaboration with Lorenzo Caputi and Gerhard Saalbach (John Innes Centre) 
7.8.2.8 Chemical derivitisation of VIGS samples 
 
7.8.2.8.1 Treatment with NaBH4 
 
The chemical reduction of methanolic extracts of VIGS-EV C. roseus leaf tissue was achieved by 
incubating a 600 µl methanol VIGS-EV extract with 1 mg NaBH4. 20 µl of this sample was mixed 
with 30 µl MeOH and 50 µl H2O, and analysed directly by LC-MS.  
7.8.2.8.2 Treatment with potassium carbonate 
 
Deacetylation of compounds in VIGS-EV and VIGS-CrRO leaf tissue was achieved by incubating a 
600 µl methanol extract of each leaf tissue in K2CO3 (250 mM). This solution was incubated for 
1 h at room temperature and analysed by LC-MS.  
7.8.2.9 In vivo C. roseus leaf feeding experiments 
 
7.8.2.9.1 Secologanin feeding experiments 
 
2-3 cm long C. roseus leaves of wild type C. roseus leaf tissue were cut at the petiole and placed 
in 100 µl of either 5 mM secologanin or water.  The leaves were then fed daily 100 µl of the same 
compound over the course of 4-5 days. After feeding, the leaves were blotted to remove excess 
liquid, and weighed. Each leaf was extracted in 200-400 µl methanol for 2 h at 65 oC. 100 µl of 
the methanolic extract was removed, and centrifuged at 14000 rpm for 40 min. The supernatant 
was mixed 1:1 with H2O and analysed by LC-MS.  
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7.8.2.9.2 Isotopic Labelling Experiments 
 
2-3 cm long C. roseus leaves of wild type C. roseus leaf tissue, VIGS-EV leaf tissue, or VIGS-CrRO 
leaf tissue were cut at the petiole and placed in 100 µl of either 5 mM d4-tryptamine, 5 mM d5-
tryptophan, or water. Unless otherwise stated the leaves were then fed daily 100 µl of the same 
compound over the course of 4-5 days. After feeding, the leaves were blotted to remove excess 
liquid, and weighed. Each leaf was extracted in 200-400 µl methanol for 2 h at 65 oC. 100 µl of 
the methanolic extract was removed, and centrifuged at 14000 rpm for 40 min. The supernatant 
was mixed 1:1 with H2O and analysed by LC-MS.  
 
7.9 Methods specific for heterologous expression 
 
7.9.1 USER cloning into pCR8-GW  
 
7.9.1.1 pCR8-GW 
 
The Multisite Gateway® technology allows for movement of genes of interest in an entry vector 
into multiple vector systems for functional characterisation of proteins of interest. It is a 
universal cloning method that utilises the site-specific recombination properties of 
bacteriophage lambda (Walhout et al., 1999). pCR8-GW is a Gateway® compatible entry vector 
that allows for the recombination based transfer of a gene of interest in the entry vector into a 
wide variety of downstream destination vectors through use of the LR clonase reaction. The 
entry clone contains an attL1 and attL2 sites in the vector between which the gene of interest is 
cloned. This allows for recombination mediated transfer into destination vectors that contain 
two attR sites which contain a ccdB gene between them for negative selection, with 
recombination between the attL and attR sites resulting in the replacement of the ccdB gene 
with the gene of interest in the destination vector. Full length C. roseus genes were therefore 
cloned into pCR8-GW, sequenced and then this entry vector was subsequently used for 
downstream cloning into plant, yeast and Xenopus oocyte specific destination vectors. 
A USER-compatible version of the pCR8-GW vector, pCR8-GWu, was generated by Fernando 
Geu-Flores, which as described previously, is a ligation independent cloning technique that is 
facilitated by the generation of custom designed overhanging sequences that, when treated 
with USER enzyme, allow for the generation of a stable hybridisation product that can be 
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transformed into E. coli without prior ligation. pCR8-GWu was linearised through treatment with 
the enzymes PacI and NtBbvcI overnight at 37 oC, and gel purified on a 0.7% agarose gel. 
7.9.1.2 Cloning of full length gene sequences into pCR8-GW 
 
The full length genes of interest in this thesis were PCR amplified from C. roseus cDNA using 
gene specific primers and the PCR product was gel purified on a 1% agarose gel. The PCR 
products, linearised pCR8-GWu vector, and USER enzyme were incubated together in a reaction 
volume of 10 µl at 37 oC for 40 min, and subsequently kept on ice for 15 min. This reaction 
mixture was used to transform 40 µl TOP10 E.coli by heat shock without prior ligation and grown 
on spectinomycin. Three colonies from each plate were grown up in 5 ml overnight cultures. 
Plasmid DNA was extracted by a Qiagen Miniprep kit and tested for the insert by PCR using gene 
specific primers and positive plasmids were sent for sequencing. 
7.9.1.3 Cloning of C-terminal GFP fusions into pCR8-GW 
 
C-terminal GFP fusions of the full length genes of interest were generated by USER fusion 
cloning, and contained a GSG linker or an extended GSGMGGSG linker between the C-terminus 
of the protein and the N-terminus of the GFP.  For the C-terminal GFP fusions the reverse primers 
for amplification of the gene of interest contained complementary overhanging sequences in 
the region of the GSG or GSGMGGSG linker. This is complementary to a region in the forward 
primer used for the amplification of GFP from a pCR8GWu-GFP vector. This meant that the GFP 
and extended GFP PCR product utilised for USER cloning of the C-terminal GFP fusions was 
compatible with all the genes of interest to be cloned. 
For the formation of the C-terminal GFP fusions: the PCR product of the gene of interest, either 
GFP or GFP-extended PCR product, linearised pCR8-GWu vector, and USER enzyme were 
incubated together in a reaction volume of 10 µl at 37 oC for 40 min, and subsequently kept on 
ice for 15 min. This reaction mixture was used to transform 40 µl TOP10 E. coli by heat shock 
without prior ligation. The E. coli was recovered and grown in 200 µl SOC media at 37 oC for 40 
min, and this was then spread onto spectinomycin selective agar plates and incubated at 37 oC 
overnight. Three colonies from each plate were grown up in 5 ml overnight cultures. Plasmid 
DNA was extracted by a Qiagen Miniprep kit and tested for the insert by PCR using gene specific 
primers and positive plasmids were sent for sequencing. 
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Table 24 Primers for the generation of pCR8-GW vectors 
 
 
Table 25 pCR8-GW vectors generated in this study 
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7.9.2 Heterologous Expression in S. cerevisiae 
 
7.9.2.1 Cloning into pYES-DEST52 
 
As mentioned pCR8-GW is an entry vector for Gateway® compatible technology and allows for 
the cloning into multiple downstream destination vectors through the use of LR clonase 
mediated recombination. Briefly, each entry clone that contains attL sites flanking the gene of 
interest, is incubated with the destination vector containing attR sites and the LR Clonase™ 
enzyme mix, with the resultant recombination reaction occurring resulting in the gene of 
interest localised to the destination vector, and this reaction is used for the transformation of 
TOP10 E. coli by heat shock and selection on the antibiotic marker specific for the destination 
vector. 
pYES-DEST52 is a Gateway® compatible destination vector that allows for the expression of the 
protein of interest in S. cerevisiae under control of a galactose inducible promoter. 
For the pCR8-GW entry vectors generated, 50-100 ng of the entry vector was incubated with 
150 ng of the pYESDEST52 destination vector, 1 µl LR-Clonase™ enzyme mix, and TE buffer pH 
8.0 to a final reaction volume of 5 µl at 25 oC for 1 h. To terminate the reaction 0.25 µl Proteinase 
K was added to each reaction and incubated at 37 oC for 10 min. 2.5 µl of each reaction was used 
to transform 50 µl chemically competent TOP10 E. coli by heat shock, and positive transformants 
were selected on carbenicillin agar plates. Transformants were grown in 5 ml culture overnight 
at 37 oC in LB + carbenicllin, plasmid extracted by Miniprep, and the plasmid tested for insertion 
of the gene of interest by PCR. pYES-DEST52 plasmids testing positive for the gene of interest 
were used for transformation of S. cerevisiae. 
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Table 26 Overview of pYES-DEST52 vectors generated in this study 
 
 
 
 
 
 
 
 
7.9.2.2 Overexpression of proteins in S. cerevisiae 
 
The pYES-DEST52 vector is an inducible expression system for protein expression in yeast under 
control of the GAL1 promoter. For most S. cerevisiae laboratory strains, the presence of glucose 
represses transcription from the plasmid, whilst adding galactose induces transcription. 
The glycerol stock of the yeast strain to test protein expression was used to inoculate a starter 
culture of 15 ml SC-uracil medium containing 2% glucose as a carbon source. This was grown 
overnight at 30 oC and used to inoculate 100 ml SC-uracil containing 2% glucose, which was then 
grown to an OD600 of between 1-2. The culture was centrifuged at 4000 x g and resuspended in 
induction medium; SC-uracil containing 2% galactose and 2% raffinose. The culture was then 
grown for between 4-10 h at 30 oC. 
7.9.2.3 Confocal microscopy of S. cerevisiae expressing proteins 
 
The induced culture was used directly for analysis of protein expression under confocal 
microscopy. 10 µl of culture was placed on a microscope slide under a cover slip, and visualised 
by a Leica SP5 confocal microscope using a HCX PL APO CS 63.0x1.20 water immersion lens. For 
visualisation of the GFP, the sample was excited at 488 nm and the emission detected at 500-
580 nm. 
 
Name Gene of interest Vector 
Green Fluorescent Protein GFP pYesDest52 
CrMATE1952_full_length_native MATE pYesDest52 
CrMATE10740_full_length_native MATE pYesDest52 
CrNPF2.9_full_length_native NPF transporter pYesDest52 
CrMATE1952_full_length_GFPfusion MATE pYesDest52 
CrMATE10740_full_length_GFPfusion MATE pYesDest52 
CrNPF2.9_full_length_GFPfusion NPF transporter pYesDest52 
CrNPF2.9_K>R_GFPfusion NPF transporter pYesDest52 
CrNPF2.9_GFPfusion_extended NPF transporter pYesDest52 
CrNPF2.9_K>R_GFPfusion_extended NPF transporter pYesDest52 
1443_CrPUP_full_length_GFPfusion Purine permease pYesDest52 
CrRO_full_length_native Reticuline oxidase like protein pYesDest52 
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7.9.2.4 Preparation of yeast membrane vesicles 
 
For preparation of yeast membrane vesicles, the induced culture was centrifuged at 5000 x g for 
5 min at room temperature, washed with 40 ml dH2O, and pelleted at 5000 x g for 5 min at room 
temperature. The yeast cell pellet was resuspended in softening medium (0.1 M Tris-HCl pH 9.4, 
50 mM β-mercaptoethanol and 0. 1 M glucose), and the mixture incubated for 30 min at room 
temperature, before centrifugation at 5000 x g. The yeast pellet was resuspended in 100 ml 
zymolyase medium (50 mM Tris-MES pH 7.6, 0.9 M sorbitol, 0. 1 M glucose, 5 mM DTT and 10 
U/ml). This solution was incubated with shaking at 30 oC for 3 h and the resulting spheroblasts 
collected at 5000 x g for 10 min and washed successively with 1 M sorbitol. For preparation of 
yeast membranes, the spheroblasts were resuspended in 20 ml lysis buffer (50 mM Tris-MES pH 
7.6, 1.1 M glycerol, 5 mM EDTA, 1 mM DTT, 0.2% (w/v) BSA, 1.5% (w/v) polyvinylpyrrolidone, 
and cOmplete™ protease cocktail inhibitor tablets). This suspension was homogenised with a 
hand held homogeniser, and centrifuged at 4000 x g, and the supernatant fraction was collected. 
The pellet was successively washed twice with lysis buffer and the supernatant upon 
centrifugation was pooled. This supernatant was centrifuged at 120,000 x g for 1 h, and the 
resulting membranes were resuspended in resuspension buffer (5 mM Tris-MES pH 7.6 or 5 mM 
MOPS pH 7.6, 0.3 M sorbitol, 1 mM DTT, 0.1 M KCl and cOmplete™ protease cocktail inhibitor 
tablets). The total protein concentration of the yeast microsomal fraction was assessed by a BCA 
assay, and adjusted to 10 µg/ml. The vesicles were run by SDS-PAGE and a western blot 
performed using a commercially available mouse-monoclonal anti-GFP antibody (Abcam, cat no 
9F9.F9 ab1218) as the primary anti-body and rabbit mono-clonal anti-mouse IgG and IgM 
monoclonal antibody. 
7.9.2.5 Feeding Studies with S. cerevisiae 
 
To assess whether the enzymes expressed in S. cerevisiae were able to utilise compounds 
accumulating in VIGS tissue as substrates, the enzymes were expressed in S. cerevisiae as 
described in the section above and incubated with the substrate. For each yeast liquid culture 
expressing the gene of interest, 1 ml of VIGS methanol extract was dried under vacuum using a 
Savant SC210A speed vac concentrator coupled to a Savant RVT4104 refrigerated vapour trap. 
1 ml of yeast culture was used to resuspend the lyophilised material, and the yeast culture 
containing the VIGS compounds was incubated for 10 h at 30 oC. After 10 h the culture was 
centrifuged at 10,000 x g. The supernatant was removed and mixed 1:1 with MeOH and analysed 
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directly by LC-MS. Additionally, the yeast pellet was extracted in 100 µl MeOH, centrifuged at 
10,000 x g, and the MeOH extraction mixed 1:1 with H2O for analysis by LC-MS. 
 
7.9.3 Heterologous Expression in N. benthamiana 
 
7.9.3.1 Cloning into pEAQ-HT vector 
 
pEAQ-HT DEST1 is a Gateway® compatible destination vector that allows for the expression of 
the protein of interest in plants that are conducive to Agrobacterium infiltration (Sainsbury et 
al., 2009). In particular we have been using this expression system for the overproduction of 
proteins in N. benthamiana. 
For the pCR8-GW entry vectors 50-100 ng of the entry vector was incubated with 150 ng of the 
pEAQ-HT DEST1 destination vector, 1 µl LR-Clonase™ enzyme mix, and TE buffer pH 8.0 to a final 
reaction volume of 5 µl at 25 oC for 1 h. To terminate the reaction 0.25 µl Proteinase K was added 
to each reaction and incubated at 37 oC for 10 min. 2.5 µl of each reaction was used to transform 
50 µl chemically competent TOP10 E. coli by heat shock, and positive transformants were 
selected on kanamycin agar plates. Transformants were grown in 5 ml culture overnight at 37 
oC in LB + kanamycin, plasmid extracted by miniprep, and the plasmid tested for insertion of the 
gene of interest by PCR. pEAQ-HT DEST1 plasmids testing positive for the gene of interest were 
used for transformation of Agrobacterium tumefaciens strain LBA4404.  
The liquid culture of colonies of the Agrobacterium tumefaciens strain LBA4404 testing positive 
for the insert by PCR were mixed 1:1 with 25% glycerol and stored at -80 oC for future use. 
 
 
 
 
 
 
279 
 
Table 27 Overview of pEAQ-HT DEST1 vectors generated in this study 
 
 
 
 
 
 
 
7.9.3.2 Agroinfiltration of N. benthamiana leaf tissue 
 
Eight week old N. benthamiana plants were selected for Agroinfiltration. Agrobacterium 
tumefaciens strain LBA4404 containing pEAQ-HT DEST1 expression vectors containing the gene 
of interest for overexpression were grown overnight in a 10 ml starter culture containing LB 
supplemented with rifampicin, streptomycin and kanamycin at 28 oC. The cells were centrifuged 
at 4000 x g, and resuspended in Agrobacterium infiltration buffer (10 mM MES, 10 mM MgCl2, 
100 µM acetosyringone, pH 5.5) to an optical density of 0.2-0.4 at 600 nm, and incubated for 2 
h at room temperature.  
This solution was used for the infiltration. Mid-sized N. benthamiana leaves were infiltrated by 
syringe infiltration. Pressure was applied to the leaf in order to force the agrobacterium through 
the stomatal pores of the underside of the leaf. ~5 ml of infiltration solution was applied to each 
leaf until the entire leaf was infiltrated. For each construct two plants were infiltrated utilising 
three leaves per plant. Agrobacterium containing a pEAQ-HT DEST1 construct for the expression 
of GFP was used as a positive control. The N. benthamiana plants were left for between 4 and 7 
days for protein expression before harvesting. 
7.9.3.3 Visualisation of protein expression in N. benthamiana by confocal microscopy 
 
Leaves expressing the protein of interest were cut into discs 1 cm in diameter, placed on a 
microscope slide and visualised by a Leica SP5 confocal microscope using a HCX PL APO CS 
63.0x1.20 water immersion lens. For visualisation of the GFP, the sample was excited at 488 nm 
and the emission detected at 500-580 nm. 
Name Gene of interest Vector 
Green Fluorescent Protein GFP pEAQ-DEST1 
CrMATE1952_full_length_native MATE pEAQ-DEST1 
CrMATE10740_full_length_native MATE pEAQ-DEST1 
CrNPF2.9_full_length_native NPF transporter pEAQ-DEST1 
CrMATE1952_full_length_GFPfusion MATE pEAQ-DEST1 
CrMATE10740_full_length_GFPfusion MATE pEAQ-DEST1 
CrNPF2.9_full_length_GFPfusion NPF transporter pEAQ-DEST1 
CrRO_full_length_native Reticuline oxidase like protein pEAQ-DEST1 
Arabidopsis AtTPK1 Arabidopsis TPK1 pEAQ-DEST1 
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7.9.3.4 Generation of protoplasts  
 
The tissue of three leaves was used per construct for the generation of protoplasts. 
Agroinfiltrated N. benthamiana leaf tissue was harvested after 4-7 days post agroinfiltration and 
the mid-vein, large veins and injection site removed from the tissue with a razor blade. On the 
remaining tissue the underside of the leaf was gently scored with a razor blade at ~2 mm 
intervals and the leaf tissue incubated in protoplasting solution (0.4 M mannitol, 10 mM CaCl2, 
20 mM KCl, 0.1% BSA, 20 mM MES, 0.25% cellulose R10 (Sigma; C1794 from Trichoderma viride) 
and 0.25% macerozyme R10 (Sigma; P2401 pectinase from Rhizopus spp) pH5.7) for 4 h with 
gentle shaking in the dark. The resulting solution was filtered through muslin, washed gently 
with the protoplasting buffer, and centrifuged at 50 x g to retain the protoplasts. The protoplasts 
were visualised under an AF6000 stereomicroscope. 
7.9.3.5 Generation of vacuoles from protoplasts 
 
Protoplasts were lysed by osmotic lysis by incubating the protoplasts in lysis buffer (0.2 M 
mannitol, 10% (w/v) Ficoll 400, 15 mM EDTA, 10 mM MOPS pH 8.0, 150 µg/ml BSA and 1 mM 
DTT). This mixture was stained with neutral red solution in order to visualise the vacuoles.  A 
200 x dilution of 0.1% neutral red solution (0.1 g neutral red, 200 µl 1% acetic acid, 50 µl 
chloroform in a total volume of 100 ml water) was added to the lysed protoplast solution. The 
vacuoles were subsequently purified by ultracentrifugation at 72,000 x g for 1 h using a stepwise 
Ficoll gradient.  The gradient consisted of a lower phase of one volume lysed protoplast solution, 
a middle phase of two volumes 1:1 mixture of lysis buffer and an upper phase of vacuole buffer.  
The vacuole buffer contained (0.4 M betaine, 20 mM HEPES-KOH, pH 7.5, 20 mM KCl, 15 mg/ml 
BSA and 1 mM DTT). Vacuoles were harvested at the interface between the upper and middle 
phases, and were visualised by an AF6000 stereomicroscope. 
7.9.3.6 Subcellular Localisation in C. roseus cell suspension culture (This work was 
performed by Vincent Courdavault) 
 
The pEAQ-DEST1 vectors containing CrMATE1952, CrMATE10740, CrNPF2.9, and AtTPK1 were 
used as a template to subclone the genes into the pSCA-cassette vector as either a YFP fusion 
(CrMATE1952, CrMATE10740, CrNPF2.9) or a CFP fusion AtTPK1. Transient transformation of C. 
roseus cells by particle bombardment and fluorescence imaging were performed following the 
procedures previously described (Guirimand et al., 2009; Guirimand et al., 2010). C. roseus cells 
were bombarded with DNA-coated gold particles (1 μm) and 1,100 psi rupture disc at a stopping-
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screen-to-target distance of 6 cm, using the Bio-Rad PDS1000/He system. Cells were cultivated 
for 16 h to 38 h before being harvested and observed. The subcellular localisation was 
determined using an Olympus BX-51 epifluorescence microscope equipped with an Olympus DP-
71 digital camera and a combination of YFP and CFP filters. 
 
7.9.4 Heterologous Expression in Xenopus oocytes 
 
7.9.4.1 Cloning of CrNPF2.9 transporter into Xenopus laevis oocyte expression vector 
 
7.9.4.1.1 Cloning into the pT7TS vector  
 
pT7TS is a Gateway® compatible destination vector, and was donated from the lab of Tony Miller 
(John Innes Centre). The pCR8-GW entry vector containing the full length CrNPF2.9 gene, 50-
100 ng of the entry vector was incubated with 150 ng of the pT7TS destination vector, 1 µl LR-
Clonase™ enzyme mix, and TE buffer pH 8.0 to a final reaction volume of 5 µl at 25 oC for 1 h. To 
terminate the reaction 0.25 µl Proteinase K was added to each reaction and incubated at 37 oC 
for 10 min. 2.5 µl of each reaction was used to transform 50µl chemically competent TOP10 E. 
coli by heat shock, and positive transformants were selected on carbenicillin agar plates. 
Transformants were grown in 5 ml culture overnight at 37 oC in LB+carbenicllin, plasmid 
extracted by miniprep, and the plasmid tested for insertion of the gene of interest by PCR. pT7TS 
plasmids testing positive for the gene of interest were used for in vitro transcription for the 
production of cRNA to be injected into the Xenopus laevis oocyte. 
7.9.4.1.2 Cloning into pLIFE0016 vector by USER cloning 
 
Full length CrNPF2.9 was amplified from C. roseus cDNA using the primers in Table 28. The 
pLIFE0016 vector is a USER compatible vector that can be used for the generation of cRNA 
compatible for microinjection into Xenopus laevis oocytes, and was donated by Hussam Hassan 
Nour-Eldin (University of Copenhagen). Linearised pLIFE0016 and the CrNPF2.9 PCR product was 
incubated with USER in a reaction volume of 10 µl at 37 oC for 40 min, and subsequently kept on 
ice for 15 min. This reaction mixture was used to transform 40 µl TOP10 E.coli by heat shock 
without prior ligation. The E. coli was recovered and grown in 200 µl SOC media at 37 oC for 40 
min, and this was then spread onto carbenicillin selective agar plates and incubated at 37 oC 
overnight. Plasmid from positive colonies was used for the generation of linear cRNA. 
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Table 28 Primers for CrNPF2.9 cloning into pLIFE0016 
Primer  Plasmid  Sequence (5’-3’) 
CrNPF2.9  fwrd pLIFE0016 GGCTTAAU ATG GGA GAC ACC GAA GCA C 
CrNPF2.9  rev pLIFE0016 GGTTTAAU TTA CAT ATA TAT TTT ATT ATC ATT TGT TTC ATC TTC ATC CTC CAT 
 
Table 29 Xenopus oocyte expression vectors generated in this thesis 
Gene Plasmid  Enzyme for linearisation 
CrNPF2.9  pT7TS SalI-HF 
CrNPF2.9   pLIFE0016 NdeI or NotI 
 
7.9.4.2 Generation of cRNA for microinjection 
7.9.4.2.1 Linearisation of pLIFE0016 and pT7TS plasmids 
 
Both the pT7TS or pLIFE0016 vectors were used for generation of linear RNA for microinjection 
into Xenopus laevis oocytes. For the formation of linear RNA that is compatible with over 
expression in Xenopus oocytes, the mMESSAGE mMACHINE® T7 Ultra kit (Ambion catalogue 
no:1345) was  used. This kit allows for the in vitro synthesis of capped RNA.  For the efficient 
formation of RNA for expression in Xenopus oocytes using this method the vector must have a 
T7 promoter, which is followed by a 5’ UTR of Xenopus β-Globin gene, the gene of interest, and 
then the 3’ UTR of the Xenopus β-Globin gene and a poly(A) tail.   
Generation of linear RNA using the T7 system requires a linear DNA template containing a T7 
promoter that does not contain 3’ overhanging ends. As such the pLIFE0016 and pT7TS vectors 
need to be linearised prior to subjection to in vitro transcription.  
For the pT7TS vector, 6000 µg of plasmid DNA was linearised using SalI-HF, whilst for the 
pLIFE0016 vector 6000 µg of plasmid DNA was linearised using NdeI or NotI, with the 
appropriate enzyme buffer, in a total volume of 20 µl. The restriction digest was assessed on a 
1% agarose gel. These restriction enzymes only cut once on the vector, do not cut internally on 
the cloned gene, and do not cut between the T7 promoter and poly(A) tail, thereby generating 
a linear template, compatible for linear RNA generation. 
The linearised plasmid DNA was treated with 0.4 µl Proteinase K (20 mg/ml) and 20 µl SDS and 
incubated for 30 min at 50 oC. RNase free H2O was added to a total volume of 100 µl, to which 
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100 µl of phenol:chloroform  (1:1) was added. This was vortexed and centrifuged at 10,000 x g 
for 3 min at room temperature, and the aqueous phase retained. To this aqueous phase 3 M 
sodium acetate (pH 5.3) at 1/10 (v/v) was added together with 2 volumes of 100% ethanol. This 
was incubated overnight at -20 oC. The solution was mixed well and centrifuged at 10,000 x g for 
30 min at 4 oC. The pellet was retained and washed twice with 200 µl 70% ethanol, dried and 
resuspended in RNase free H2O to a final concentration of ~0.5 µg/µl.    
7.9.4.2.2 Generation of cRNA 
 
1 µg of the linear plasmid was used for the in vitro transcription of cRNA using the mMESSAGE 
mMACHINE® T7 Ultra kit (Ambion catalogue no:1345) kit in accordance with the manufacturer’s 
instructions. Briefly, the 1 µg linear plasmid, 2 µl T7 enzyme mix, 10 µl T7 nucleotides and ARCA 
(Anti-reverse cap analogue, for efficient RNA capping) and H2O were combined in a reaction 
volume of 20 µl, and incubated for 2 hr at 37 oC. For removal of the template DNA, 1 µl of DNaseI 
was added and incubated at 37 oC for 15 min.  
The RNA formed was purified again by phenol:chloroform extraction. 115 µl RNase free H2O, 15 
µl 5M sodium acetate and 150 µl phenol:chloroform, was added to the reaction mixture. The 
solution was vortexed and then centrifuged for 3 min at 10,000 x g at room temperature, and 
the aqueous phase retained. This was repeated with 50 µl RNase free H2O and pooled. To the 
200 µl retained aqueous phase, 200 µl chloroform was added, which was again vortexed, 
centrifuged for 3 min at 10,000 x g and the aqueous phase retained. 200 µl isopropanol was 
added to the aqueous phase and incubated at -20 oC overnight for precipitation of the RNA. The 
RNA was centrifuged at 10,000 x g at 4 oC for 30 min, the pellet washed with 70% ethanol, 
centrifuged at 10,000 x g and dried. The RNA was resuspended in RNase free H2O to a 
concentration of 2 µg/µl.  
 
Figure 7-3 Representative cRNA generated from in vitro transcription using the linearised pT7TS-
CrNPF2.9 vector as template. 
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7.9.4.3 Preparation of Xenopus laevis oocytes 
 
Xenopus laevis oocytes were kindly donated from the Gurdon Institute, Cambridge, and stored 
in modified barths saline (MBS: 88 mM NaCl, 1 mM KCl, 0.82 mM MgSO4, 10 mM Hepes, 
0.33 mM Ca(NO3)2, 0.41 mM CaCl2, pH 7.5). The Xenopus laevis oocytes were defolliculated by 
collagenase treatment (5 mg/ml collagenase) in calcium-free MBS, and the defolliculated 
oocytes were stored in MBS solution at 18 oC until further use. 
7.9.4.3.1 Microinjection of linear RNA into Xenopus laevis oocytes 
 
Drummond microcaps (cat no 1-000-0500) were pulled using a Narishige PE-2 glass 
microelectrode puller to produce glass needles for microinjection into the Xenopus laevis 
oocyte. Each needle was normalised to inject 50 nl of liquid into each oocyte.  Injection into the 
oocyte was performed using a PLI-100 microinjector (Digitimer Ltd) utilising a micromanipulator 
(Prior Scientific). For each assay ~ 20 oocytes were microinjected with 50 nl 1 µg/µl cRNA and 
~20 oocytes microinjected with 50 nl H2O as a negative control. This same method was used for 
the microinjection of secologanin into oocytes. 
7.9.4.3.2 Xenopus laevis oocyte uptake assay 
 
Xenopus oocytes were incubated in pH 7.5 MBS buffer for three days to induce protein 
expression, with the buffer routinely changed twice daily. For the assay, the oocytes injected 
with H2O or cRNA were incubated in 100 µM strictosidine in Kulori buffer (90 mM NaCl, 1 mM 
KCl, 1 mM CaCl2, 1 mM MgCl2, 5 mM MES, pH 5) for 1h. The oocytes were washed four times in 
ice cold Kulori buffer to stop the assay, pooled into batches of five oocytes, flash frozen in liquid 
N2 and stored at -80 oC.  
Extraction of the metabolite content in the oocyte was performed by homogenising the oocytes 
in MeOH containing 40 µM caffeine as an internal standard, and extracted at 60 oC for 2 h. This 
suspension was centrifuged at 10,000 x g, the supernatant removed and evaporated to dryness. 
This dried material was resuspended in 80 µl 50% MeOH, centrifuged at 10,000 x g and the 
supernatant used directly for analysis by LC-MS. 
 
 
 
285 
 
7.9.5 Heterologous expression in E. coli and Sf9 Insect cells. 
 
The pOPIN vector suite designed by the Oxford Protein Production Facility (OPPF) was utilised 
for the cloning of the reticuline oxidase CrRO gene from C. roseus. This suite of vectors is 
compatible for screening of protein expression in multiple hosts, with many of the vectors 
compatible with E. coli, Sf9 Insect cells and mammalian HEK293T cells, and therefore allows for 
parallel screening in multiple expression systems (Berrow et al., 2007). 
7.9.5.1 Cloning into pOPIN vectors 
 
The three pOPIN vectors used in this study were pOPINF,pOPINE and pOPING. pOPINF and 
pOPINE allow for the introduction of an N- or C-terminal histidine tag respectively, whilst 
pOPING allows for the introduction of an insect cell secretion signal at the N-terminus of the 
cloned gene, together with a C-terminal histidine tag. For linearisation of the pOPINF, pOPINE 
and pOPIN G vectors, pOPINF was NcoI and MscI, pOPINE was incubated with NcoI and PmeI, 
and pOPING was incubated with KpnI and PmeI, all in CutSmart buffer in accordance with 
manufacturer’s guidelines, overnight at 37 oC. Each linearised plasmid was gel purified on a 0.7% 
(w/v) agarose gel using stored at -20 oC for future use. 
The full length CrRO, together with designed N- and C-terminal truncated variants of this gene 
were PCR amplified from C. roseus cDNA and gel purified on a 1% agarose gel. The pOPIN suite 
of vectors is compatible with the In-Fusion enzyme. Each PCR product was incubated with its 
compatible linearised pOPIN vector together with the In-Fusion enzyme in a reaction volume of 
10 µl for 15 min at 50 oC. 2 µl of this reaction mixture was used to transform 40 µl TOP10 E. coli, 
and transformants were selected on LB + carbenicillin agar plates. Three colonies were grown 
for plasmid extraction, with the resultant plasmid tested for insertion of the gene by PCR and 
positive colonies are confirmed by sequencing. The resultant plasmid was stored at -20 oC. A 
Table of the CrRO gene variants and the pOPIN vectors they were cloned into is presented in 
Table 9 and the primers used for cloning are presented in Table 30. 
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Table 30 Primers used for the cloning of CrRO into pOPIN vectors 
 
 
 
 
 
 
 
Vector Name Vector   Primer Sequence (5'-3') 
CrRO_full_length_pOPINF pOPINF Fwrd AAGTTCTGTTTCAGGGCCCG 
ATAAAAAAAGTCCCAATAGTTCTTTCAATTTTCTG 
    Rev ATGGTCTAGAAAGCTTTA 
AAGTTCGACTTGTAAATGGAGAGGGG 
CrRO_full_length_pOPINE pOPINE Fwrd AGGAGATATACCATG 
ATAAAAAAAGTCCCAATAGTTCTTTCAATTTTCTG 
    Rev GTGATGGTGATGTTT 
AAGTTCGACTTGTAAATGGAGAGGGG 
CrRO_full_length_pOPING pOPING Fwrd GCGTAGCTGAAACCGGC 
ATAAAAAAAGTCCCAATAGTTCTTTCAATTTTCTG 
    Rev GTGATGGTGATGTTT 
AAGTTCGACTTGTAAATGGAGAGGGG 
CrRO_Ntermtruncated_pOPINF pOPINF Fwrd AAG TTC TGT TTC AGG GCC CGT CAA TTC CTG AAG CTT 
TTC TCA ATT GTA TTT CC 
    Rev ATGGTCTAGAAAGCTTTA 
AAGTTCGACTTGTAAATGGAGAGGGG 
CrRO_Ntermtruncated_pOPINE pOPINE Fwrd AGGAGATATACCATG T CAA TTC CTG AAG CTT TTC TCA 
ATT GTA TTT CC 
    Rev GTGATGGTGATGTTT 
AAGTTCGACTTGTAAATGGAGAGGGG 
CrRO_Ntermtruncated_pOPING pOPING Fwrd GCGTAGCTGAAACCGGC T CAA TTC CTG AAG CTT TTC 
TCA ATT GTA TTT CC 
    Rev GTGATGGTGATGTTT 
AAGTTCGACTTGTAAATGGAGAGGGG 
CrRO_Ctermtruncated_pOPINF pOPINF Fwrd AAGTTCTGTTTCAGGGCCCG 
ATAAAAAAAGTCCCAATAGTTCTTTCAATTTTCTG 
    Rev ATGGTCTAGAAAGCTTTAATGGAGAGGGGGAATGCTTTGT 
CrRO_Ctermtruncated_pOPINE pOPINE Fwrd AGGAGATATACCATG 
ATAAAAAAAGTCCCAATAGTTCTTTCAATTTTCTG 
    Rev GTGATGGTGATGTTTATGGAGAGGGGGAATGCTTTGT 
CrRO_Ctermtruncated_pOPING pOPING Fwrd GCGTAGCTGAAACCGGC 
ATAAAAAAAGTCCCAATAGTTCTTTCAATTTTCTG 
    Rev GTGATGGTGATGTTTATGGAGAGGGGGAATGCTTTGT 
CrRO_NandCtermtruncated_pOPINF pOPINF Fwrd AAG TTC TGT TTC AGG GCC CGT CAA TTC CTG AAG CTT 
TTC TCA ATT GTA TTT CC 
    Rev ATGGTCTAGAAAGCTTTAATGGAGAGGGGGAATGCTTTGT 
CrRO_NandCtermtruncated_pOPINE pOPINE Fwrd AGGAGATATACCATG T CAA TTC CTG AAG CTT TTC TCA 
ATT GTA TTT CC 
    Rev GTGATGGTGATGTTTATGGAGAGGGGGAATGCTTTGT 
CrRO_NandCtermtruncated_pOPING pOPING Fwrd GCGTAGCTGAAACCGGC T CAA TTC CTG AAG CTT TTC 
TCA ATT GTA TTT CC 
    Rev GTGATGGTGATGTTTATGGAGAGGGGGAATGCTTTGT 
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7.9.5.2 Expression testing E. coli 
 
Expression testing of the CrRO protein was performed in the E. coli strain SoluBL21. The 
CrRO_full_length_pOPINF and CrRO_Ntermtruncated_pOPINF vectors that were confirmed by 
sequencing were transformed into the E. coli expression strain SoluBL21 by heat shock and 
positive transformants were checked by colony PCR.  
A single positive colony was used to grow an overnight 10 ml starter culture at 37 oC with shaking 
at 200 rpm in LB supplemented with carbenicillin. This culture was used to start a 100 ml culture 
grown at 37 oC in LB supplemented with carbenicillin until the optical density of the media 
reached an optical density at 600 nm (OD600) of 0.5-0.8. After reaching this optical density the 
cultures were chilled on ice for 1 h. 1 ml of the non-induced culture was removed to assess 
protein composition in the non-induced cells. This 1 ml of culture was centrifuged at 4000 x g 
and lysed with BugBuster™ (Millipore). To the remaining culture, the media was supplemented 
with isopropyl β-D-1-thiogalactopyranoside (IPTG) at a final concentration of 0.1 mg/ml to 
induce protein expression and was incubated with shaking overnight at 18 oC. 1 ml of the culture 
was removed to test for insoluble protein. This 1 ml of the culture was centrifuged at 4000 x g 
and the pellet dissolved in 50 µl 8M urea. 
The remaining 100 ml of culture was centrifuged at 4000 x g and the pellet resuspended in buffer 
A1 (50 mM Tris-HCl, 50 mM glycine, 500 mM NaCl, 20 mM imidazole, 5% (w/v) glycerol), and 
subjected to cell lysis using the cell disruptor at 25 KPsi. The lysed suspension was centrifuged 
at 35,000 x g for 30 min and the supernatant collected. The supernatant was incubated with 200 
µl Ni-NTA resin for 1 h at 4 oC. The Ni-NTA resin was washed 3 times with buffer A1, and the flow 
through was pooled. This represents proteins that do not bind to the Ni-NTA resin. The protein 
was eluted in 600 µl of elution buffer (50 mM Tris-HCl, 50 mM glycine, 500 mM NaCl, 500 mM 
imidazole, 5% (w/v) glycerol). Protein samples from the uninduced cell culture, insoluble cell 
pellet, flow through and eluted protein were run by SDS-PAGE to assess protein expression. 
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7.9.5.3 Expression testing in Sf9 Insect cells. 
 
This work was performed by Joanne Nettleship at the Oxford Protein Production Facility. 
7.9.5.3.1 Sf9 Insect cells 
 
Spodoptera frugiperda (Sf9) cells were used for the purpose of recombinant protein expression 
using insect-specific viruses called baculoviruses.  The number of cells in 10 µl of Sf9 cell stock 
from a shake flask was counted using 10 µl trypan blue staining. The ratio of cell stock to Sf900II 
media was calculated to give 4x105 cells/ml, and this media and cell stock was transferred to a 
sterile flask and incubated at 27 oC with shaking at 120 rpm. Every 3-4 days the cells were 
passaged to a cell density of 4x105 cells/ml. 
7.9.5.3.2 Bacmid Preparation. 
 
100 ml of LB supplemented with kanamycin and chloramphenicol was used to grow up an 
overnight culture of E. coli containing the bacmid, at 37 oC. This bacmid DNA was extracted using 
the BACMAX™ DNA extraction kit (Epicentre) in accordance with the manufacturer’s protocol, 
and normalised to ~100 ng/µl. The bacmid DNA was linearised using the restriction enzyme 
Bsu36I utilising; 1 µl Bsu36I per 6 µg DNA for 2 h at 37 oC and a second digestion step again using 
1 µl Bsu36I per 6 µg DNA for 2 h at 37 oC. The reaction was stopped at 72 oC for 20 min, and no 
further purification was needed. 
7.9.5.3.3 Sf9 Transfection 
 
Sf9 cells were cultured in 24 well culture plates. 500 µl of Sf9 cells, at a density of 5x105 cells/ml 
in Sf900II media, were attached to the plate for 1 h at room temperature. The transfection mix, 
consisting of; 250 ng of the bacmid DNA, 100-500 ng of pOPIN vector DNA, 50 µl Sf900II, 1.5 µl 
FuGeneHD was incubated at room temperature for 30 min, before being added to the 
appropriate well containing Sf9 cells. This was incubated for 6-7 days at 27 oC, and the resultant 
viral supernatant was stored at 4 oC in the dark. This is the P0 viral stock.  
The P0 viral stock was used to amplify the virus, resulting in a P1 virus which can then be used 
for small scale screening. 500 µl of Sf9 cells at a density of 1x106 cells/ml was used to generate 
a monolayer of Sf9 cells in a 24 well plate, and was attached to the plate for 1 h at room 
temperature. 5 µl of the P0 virus stock was added to each well and incubated for 6-7 days at 27 
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oC. The supernatant contains the P1 virus stock, which was stored at 4 oC in the dark. For long 
term storage BSA is added to a final concentration of 10% and stored at -80 oC.  
7.9.5.3.4 Expression Testing  
 
24 deep well culture plates were used for Sf9 cultivation with 3 ml of cells at a density of 1x106 
cells/ml added to each well. 3 µl or 30 µl of the P1 virus was added to each well and the cells 
incubated with shaking for 3 days at 27 oC at 250 rpm. 
To assess for intracellular protein expression, 1 ml of the Sf9 cells were placed in a 96-well plate, 
centrifuged for 15 min at 6,000 x g, the supernatant removed (to test for secreted protein) and 
the resultant cells frozen at -80 oC for at least 30 min. The defrosted pellet was resuspended in 
210 µl NPI-10-Tween buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 1% Tween-20, 
pH 8.0), containing cOmplete™ protease inhibitors and 400 U/ml DNaseI, and agitated for 30 
min at 1000 rpm. The resulting solution was centrifuged at 6000 x g for 30 min, and was used to 
test for intracellular protein expression. 200 µl of the supernatant for testing for secreted 
proteins, and 200 µl of the supernatant for testing intracellular protein expression, was 
incubated with 20 µl of NiNTA magnetic beads, and each solution agitated for 30 min at 600 rpm 
to bind the protein to the beads, before being placed on a Qiagen Magnet Type B for 2 min, and 
the supernatant removed.  The magnetic beads were washed twice with 200 µl NPI-20-Tween 
buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, 0.05% Tween-20, pH 8.0), before the 
protein was eluted off the beads by incubation in 50 µl NPI-250-Tween buffer (50 mM NaH2PO4, 
300 mM NaCl, 20 mM imidazole, 0.05% Tween-20, pH 8.0), with shaking for 10 min at 600 rpm 
for protein elution. The eluted samples were run by SDS-PAGE to assess for protein expression, 
and a western blot with a mouse-monoclonal anti-His antibody (Abcam, cat no 9F9.F9 ab1218) 
as the primary anti-body and rabbit mono-clonal anti-mouse IgG and IgM monoclonal antibody. 
7.10 Methods specific for the purification of substrates 
 
7.10.1 Purification of secologanin 
 
Secologanin accumulates in the fruit of snowberry (Symphoricarpos) as well as in the leaves of 
honeysuckle (Lonicera). This accumulation is to a higher extent than in the leaves of C. roseus, 
and therefore these plants are a good natural resource for the purification of secologanin for 
use as a substrate in downstream assays and as a substrate for strictosidine biosynthesis. 
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100 g of snowberry fruit was harvested and ground under liquid N2 using a mortar and pestle 
and transferred to a glass duran bottle.  The chemical content of the ground material was 
extracted in 100 ml methanol, in an ultrasonic waterbath for 15 min. The methanol extraction 
was centrifuged and subsequently filtered (using Whatmann filter paper) into a round bottomed 
flask. This extraction procedure was repeated three times and the resultant pooled methanolic 
fraction concentrated to between 50-100 ml on a rotary evaporator. The methanolic fraction 
was washed twice 1:1 (v/v) with the hexane fraction from petroleum for the removal of lipid 
soluble compounds, and collected using a separating funnel. The methanolic fraction was 
concentrated to 60 ml for solid phase extraction (SPE, Discovery® DSC18) and removal of 
hydrophilic sugars. The SPE columns were primed with 1 column volume of methanol and 3 
column volumes of water. The 60 ml methanolic fraction was layered on top of the C18 column 
and allowed to run through the column by gravity. The column was eluted with 1 column volume 
of water, this fraction was discarded, and 1 column volume of methanol, which was retained. 
The methanol fraction from the column was concentrated by rotary evaporation, and water 
removed by lyophilisation overnight. 
The lyophilised extract was redissolved in a minimum amount of methanol and eluted on a silica 
column using MeOH:CHCl3 (2:8 v/v) as the mobile phase. The fractions collected were monitored 
for secologanin content using thin layer chromatography on glass backed silica plates, again 
using MeOH:CHCl3 (2:8 v/v) as the mobile phase, and the TLC plates were visualised under UV 
light at 254 nm wavelength. An authentic standard of secologanin has an Rf-0.5, and visualised 
at 254 nm. 
The fractions containing secologanin were pooled, concentrated and lyophilised. The powder 
was resuspended in MeOH for purification by preparative high performance liquid 
chromatography (prepHPLC). The HPLC used was a Dionex Ultimate 3000 pump, with a variable 
wavelength UV detector. The column used for chromatographic separation was a Phenomenex 
Luna 5µ C18(2) 100 A (250 x 30 mm), with the binary solvent system consisting of 0.1% TFA and 
acetonitrile. The elution programme was the following: 1 min isocratic at 1% ACN, 11 min 
gradient up to 40% ACN, 2 min gradient up to 100% ACN, 2 min isocratic at 100% ACN, 1min 
gradient down to 1% ACN, and 6 min isocratic at 1% ACN. The compounds were monitored by 
UV 241nm, and the fractions collected at the retention time 12.9 min. The resulting fractions 
were lyophilised and stored at -20 oC until further use. 
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7.10.2 Generation of secologanol 
 
Secologanol is the alcohol produced by the reduction of the aldehyde of secologanin. It was 
generated by incubating 1 ml 1 mM secologanin suspended in MeOH with 1 mg NaBH4. 25 µl of 
this sample was mixed with 25 µl MeOH and 50 µl H2O and analysed by LC-MS.  
7.10.3 Expression and purification of strictosidine synthase 
 
E. coli expression vectors for expression of strictosidine synthase were generated by Nancy 
Yerkes, and cloned into the E. coli expression strain SoluBL21.  
A single positive colony for each construct was used to grow an overnight 10 ml starter culture 
at 37 oC with shaking at 200 rpm in LB supplemented with kanamycin. This culture was used to 
start a 500 ml culture grown at 37 oC in LB supplemented with kanamycin until the media 
reached an optical density at 600 nm (OD600) of 0.5-0.8. After reaching this optical density the 
cultures were chilled on ice for 1 h. 1 ml of the non-induced culture was removed to assess 
protein composition in the non-induced cells. This 1 ml of culture was centrifuged at 4000 x g 
and lysed with BugBuster. To the remaining culture, the media was supplemented with IPTG at 
a final concentration of 0.1 mg/ml to induce protein expression and was incubated with shaking 
overnight at 18 oC. 1 ml of the culture was removed to test for insoluble protein. This 1 ml of the 
culture was centrifuged at 4000 x g and the pellet dissolved in 50 µl 8 M urea. 
The remaining 500 ml of culture was centrifuged at 4000 x g and the pellet resuspended in 
binding buffer (50 mM phosphate buffer pH 7.4, 30 mM imidazole, 300 mM NaCl, cOmplete™ 
protease inhibitor tablets), and subjected to cell lysis using the cell disruptor in single shot mode 
at 25 KPsi. The lysed suspension was centrifuged at 35,000 x g for 30 min and the supernatant 
collected. The supernatant was incubated with 600 µl Ni-NTA resin for 1 h at 4oC. The Ni-NTA 
resin and supernatant was stacked into a column, and was washed with binding buffer 3 times 
resulting in a total wash volume of 30 ml. This flow through was pooled and represents proteins 
that do not bind to the Ni-NTA resin. The protein was eluted in a total 5 ml volume of elution 
buffer (50 mM phosphate buffer pH 7.4, 500 mM imidazole, 300 mM NaCl) in 1 ml fractions. 
Protein samples from the insoluble cell pellet, flow through and eluted protein were run by SDS-
PAGE to assess protein expression (Figure 7-4). Fractions from the elution containing a protein 
of the right size were concentrated using Millipore 10 kDa spin filters, and the protein was buffer 
exchanged into phosphate buffer pH 7. A BCA assay was used to measure protein concentration, 
and the final concentration of the strictosidine synthase and strictosidine glucosidase was 
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adjusted to ~0.3 mg/ml. Glycerol was added to the protein in phosphate buffer to 10% (v/v), and 
the protein samples aliquoted and stored at -20 oC.   
 
 
Figure 7-4 Purification of strictosidine synthase 
Pooled fractions were used for the enzymatic generation of strictosidine. 
 
 
7.10.4 Enzymatic generation of strictosidine  
 
4 mM tryptamine, 2 mM purified secologanin and 2 µM strictosidine synthase was incubated in 
50 mM Phosphate buffer pH 7.4 buffer in ~50 ml overnight at 37 oC. This assay was checked for 
strictosidine production and consumption of secologanin by LC-MS. The solution was purified by 
SPE, eluted in 100% MeOH, and dried under vacuum. The dried product was resuspended in 
H2O, filtered with 2 µm filters and purified by HPLC in 2 ml aliquots. 
7.10.5 Purification of strictosidine 
 
The strictosidine generated was purified by preparative HPLC. Again the HPLC used was a Dionex 
Ultimate 3000 pump, with a variable wavelength UV detector. The column used for 
chromatographic separation was a Phenomenex Luna 5µ C18(2) 100 A (250 x 30 mm), with the 
binary solvent system consisting of 0.1% TFA and acetonitrile. The elution programme was the 
following: 1 min isocratic at 10% ACN, 8 min gradient up to 30% ACN, 4 min gradient up to 100% 
ACN, 6 min isocratic at 100% ACN, 1 min gradient down to 10% ACN, and 6 min isocratic at 10% 
ACN. The compounds were monitored by UV 241 nm, and the fractions collected at the retention 
time 13.5 min. The resulting fractions were lyophilised and stored at -20 oC until further use.  
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7.10.6 Nuclear Magenetic Resonance (NMR) Spectroscopy 
 
NMR spectra (1H NMR) were acquired using a Bruker Avance III 400 NMR spectrometer, 
operating at 400 MHz for 1H. 2.8 mg strictosidine were disolved in 500 µl MeOH-d4, and 500 µm 
Trimethylsilyl propanoic acid (TMSP) has been used as internal standard for chemical shift 
reference (δ 0 ppm) and quantification. The purity of strictosidine was calculated according 
to the formula (Ianalyte/Istandard)=(nhanalyte/nhstandard)*(Canalyte/Cstandard), where I is the intensity of the 
peak, nh is the number of protons, and C is the concentration.  
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9.1 Gene List of 5 neighbouring nodes highlighted in the Self Organising Map 
Highlighted in green are known genes in the MIA pathway, highlighted in yellow are the 
candidates selected in this study. 
 
 
 
  
 
locus_ref contig function. neuron_number imp_contig transporter mature_leaf immature_leaf
50822 cra_locus_50822_iso_2_len_357_ver_3 Gene of unknown function 9 n n 2.034662966 1.814853901
17962 cra_locus_17962_iso_6_len_1181_ver_3 Kinesin 9 n n 2.203182359 2.266705598
107691 cra_locus_107691_iso_1_len_279_ver_3 Gene of unknown function 9 n n 2.426431158 2.521729197
21267 cra_locus_21267_iso_1_len_2314_ver_3 Pentatricopeptide repeat-containing protein 9 n n 2.637359845 3.054322344
4824 cra_locus_4824_iso_1_len_889_ver_3 Major latex protein 9 n n 2.718021806 3.647510233
10286 cra_locus_10286_iso_1_len_1071_ver_3 Aquaporin, MIP family, NIP subfamily 9 n n 3.026038682 3.481195593
8587 cra_locus_8587_iso_2_len_2384_ver_3 Wall-associated kinase 9 n n 3.20487002 2.714302675
14470 cra_locus_14470_iso_1_len_734_ver_3 Conserved gene of unknown function 9 n n 3.252663919 2.845875387
5848 cra_locus_5848_iso_1_len_1276_ver_3 Esterase/lipase/thioesterase family protein 9 n n 3.601506363 4.190282986
42757 cra_locus_42757_iso_2_len_1176_ver_3 Transportin 9 n y 3.923149181 4.391747102
3419 cra_locus_3419_iso_2_len_582_ver_3 Peroxidase 2a 9 n n 4.027065562 2.809498822
5706 cra_locus_5706_iso_3_len_1913_ver_3 Carboxypeptidase B2 9 n n 4.078481749 4.233121118
775 cra_locus_775_iso_7_len_1694_ver_3 Nodulin MtN21 9 n n 4.417393479 4.009329255
5555 cra_locus_5555_iso_2_len_3030_ver_3 Calcium-dependent protein kinase 9 n n 4.60847218 4.52990838
13640 cra_locus_13640_iso_3_len_1323_ver_3 RNA-binding protein 9 n n 4.69540927 5.220306735
1614 cra_locus_1614_iso_6_len_1191_ver_3 Ubiquitin-conjugating enzyme E2 C 9 n n 4.766022634 4.467449046
10099 cra_locus_10099_iso_3_len_1907_ver_3 CYP72A57 9 n n 4.816200325 4.026348593
679 cra_locus_679_iso_6_len_1771_ver_3 4-coumarate--CoA ligase 9 n n 4.897395338 4.267011359
5186 cra_locus_5186_iso_5_len_2851_ver_3 NBS-LRR type resistance protein 9 n n 5.187597533 5.709494672
3934 cra_locus_3934_iso_2_len_1257_ver_3 GTP binding protein 9 n n 5.496903297 3.735338038
18109 cra_locus_18109_iso_3_len_1194_ver_3 Conserved gene of unknown function 9 n n 5.500231617 5.910444862
21742 cra_locus_21742_iso_1_len_1132_ver_3 Annexin 11 10 n n 2.24652362 2.116697443
13905 cra_locus_13905_iso_2_len_1077_ver_3 Protein 2 10 n n 2.586596629 3.389621875
3676 cra_locus_3676_iso_2_len_1708_ver_3 Anthocyanidine rhamnosyl-transferase 10 n n 2.906634735 2.862625952
49421 cra_locus_49421_iso_1_len_435_ver_3 Gene of unknown function 10 n n 3.060841167 3.583579255
16069 cra_locus_16069_iso_2_len_1960_ver_3 Enolase 10 n n 3.062043978 4.299808787
4194 cra_locus_4194_iso_2_len_1818_ver_3 Iaa-amino acid hydrolase 11 10 n n 3.84317989 3.987693772
8319 cra_locus_8319_iso_4_len_2366_ver_3 Nitrate transporter 10 n y 4.049238678 4.271881302
4773 cra_locus_4773_iso_3_len_2437_ver_3 Amino acid binding protein 10 n n 4.112791862 4.883757651
26 cra_locus_26_iso_7_len_3347_ver_3 Carbonyl reductase 10 n n 4.115299644 4.113858827
2335 cra_locus_2335_iso_6_len_2732_ver_3 Enoyl-CoA hydratase, mitochondrial 10 n n 4.118982589 4.396426681
6504 cra_locus_6504_iso_8_len_3035_ver_3 Anthranilate synthase alpha subunit 10 y n 4.301463271 4.929506975
4873 cra_locus_4873_iso_8_len_1642_ver_3 Myricetin O-methyltransferase 10 n n 4.474598281 5.37834168
6672 cra_locus_6672_iso_4_len_1013_ver_3 Conserved gene of unknown function 10 n n 4.568092925 5.044350401
9393 cra_locus_9393_iso_1_len_941_ver_3 Cytochrome P450 10 n n 4.79469658 5.048746236
16283 cra_locus_16283_iso_1_len_809_ver_3 NADP specific isocitrate dehydrogenase 10 n n 4.907645409 4.980057299
4121 cra_locus_4121_iso_1_len_1649_ver_3 Oxidoreductase 10 n n 4.948077495 5.312498185
995 cra_locus_995_iso_1_len_1587_ver_3 Tobamovirus multiplication 1 10 n n 4.948199005 5.191886337
539 cra_locus_539_iso_3_len_1184_ver_3 Epoxide hydrolase 10 n n 5.184930868 5.152751297
6518 cra_locus_6518_iso_7_len_4746_ver_3 D-3-phosphoglycerate dehydrogenase 10 n n 5.193298651 5.457804391
489 cra_locus_489_iso_9_len_2848_ver_3 Glucose-6-phosphate 1-dehydrogenase, chloroplastic 10 n n 5.233105775 4.77119892
2046 cra_locus_2046_iso_8_len_2228_ver_3 Strictosidine-O-beta-D-glucosidase 10 y n 5.348855601 6.190936784
3591 cra_locus_3591_iso_3_len_1774_ver_3 Indole-3-glycerol phosphate lyase IGL1 10 n n 5.504560014 6.131328133
1726 cra_locus_1726_iso_4_len_1538_ver_3 DUF300 family protein 10 n n 5.530354832 5.085981197
1763 cra_locus_1763_iso_10_len_5663_ver_3 Multidrug resistance-associated protein 10 n y 5.563542554 5.634375454
10740 cra_locus_10740_iso_5_len_2322_ver_3 Mate efflux family protein 10 n y 5.694651794 5.760449843
6036 cra_locus_6036_iso_3_len_2256_ver_3 6-phosphogluconate dehydrogenase 10 n n 5.882158809 6.523692106
1952 cra_locus_1952_iso_7_len_1704_ver_3 Mate efflux family protein 10 n y 5.913109615 6.625469226
2478 cra_locus_2478_iso_5_len_2072_ver_3 Auxin-induced protein 5NG4 10 n n 5.971180248 5.796345966
23587 cra_locus_23587_iso_1_len_537_ver_3 Gene of unknown function 10 n n 6.086340073 5.622716624
2461 cra_locus_2461_iso_2_len_435_ver_3 Gene of unknown function 10 n n 6.223785495 6.545098846
7644 cra_locus_7644_iso_3_len_1034_ver_3 Ferredoxin-3, chloroplast 10 n n 6.331178511 6.590615492
2176 cra_locus_2176_iso_5_len_1213_ver_3_strictosidine synthaseStrictosidine ynthase 10 y n 6.344224881 6.975595797
580 cra_locus_580_iso_6_len_2366_ver_3 10-hydroxygeraniol oxidoreductase 10 y n 6.414739349 6.88381629
518 cra_locus_518_iso_8_len_1140_ver_3 Tryptophan synthase beta chain 2, chloroplastic 10 n n 6.486075572 7.417042353
11931 cra_locus_11931_iso_1_len_427_ver_3 Cytochrome P450 10 n n 6.767350232 7.721666583
17400 cra_locus_17400_iso_1_len_272_ver_3 Secologanin synthase 10 y n 6.841520319 7.959828103
5091 cra_locus_5091_iso_1_len_297_ver_3 Elicitor-inducible protein EIG-J7 10 n n 6.968447925 7.546346595
2442 cra_locus_2442_iso_7_len_1193_ver_3 Cytochrome P450 10 n n 7.194224978 8.004742945
2479 cra_locus_2479_iso_3_len_905_ver_3 Lemir 10 n n 7.519879957 7.559354145
1734 cra_locus_1734_iso_3_len_2168_ver_3 NADPH--cytochrome P450 reductase 10 y n 7.613178008 7.572306108
1389 cra_locus_1389_iso_2_len_318_ver_3 Secologanin synthase 10 y n 7.705722229 9.412709558
13307 cra_locus_13307_iso_1_len_1915_ver_3 Nitrate transporter 11 n y 2.031324613 3.109462531
10830 cra_locus_10830_iso_3_len_1683_ver_3 Calmodulin binding protein 11 n n 2.081902005 3.024748736
5465 cra_locus_5465_iso_1_len_2209_ver_3 Endonuclease/exonuclease/phosphatase 11 n n 2.282994239 3.392234981
14550 cra_locus_14550_iso_1_len_1120_ver_3 Sugar transporter 11 n y 2.300779745 3.597936335
59453 cra_locus_59453_iso_1_len_453_ver_3 Superoxide dismutase [Mn], mitochondrial 11 n n 2.323257647 3.313908991
88388 cra_locus_88388_iso_1_len_535_ver_3 Conserved gene of unknown function 11 n n 2.446695589 2.743458957
10356 cra_locus_10356_iso_1_len_1833_ver_3 Leucine-rich repeat/extensin 11 n n 2.526975221 4.579759427
5964 cra_locus_5964_iso_3_len_2202_ver_3 Conserved gene of unknown function 11 n n 2.590197189 3.020075437
15951 cra_locus_15951_iso_1_len_2216_ver_3 Kinase 11 n n 2.656880733 3.686085868
9952 cra_locus_9952_iso_1_len_1019_ver_3 Phosphoglycerate mutase 11 n n 2.762859038 3.188987949
18723 cra_locus_18723_iso_3_len_1416_ver_3 Ku70-binding family protein 11 n n 2.8254763 3.011887389
1926 cra_locus_1926_iso_3_len_1400_ver_3 Optic atrophy 3 protein 11 n n 2.831798215 2.776815683
14334 cra_locus_14334_iso_1_len_870_ver_3 PnFL-1 11 n n 2.871268032 2.933211919
7314 cra_locus_7314_iso_1_len_2533_ver_3 RNA binding protein 11 n n 3.185184671 3.319417064
19017 cra_locus_19017_iso_4_len_2003_ver_3 Ankyrin repeat family protein 11 n n 3.191734766 2.831490174
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8604 cra_locus_8604_iso_2_len_1310_ver_3 Pentatricopeptide repeat-containing protein 11 n n 3.213549478 3.446137103
10234 cra_locus_10234_iso_1_len_2183_ver_3 Fructan 1-exohydrolase I 11 n n 3.236391588 3.730139952
10319 cra_locus_10319_iso_6_len_1803_ver_3 Galactosyltransferase family protein 11 n n 3.270359995 3.676572076
4905 cra_locus_4905_iso_2_len_894_ver_3 CHCH domain containing protein 11 n n 3.270373452 4.189642728
5360 cra_locus_5360_iso_1_len_1168_ver_3 Mitochondrion protein 11 n n 3.321652514 3.443619912
7501 cra_locus_7501_iso_6_len_2278_ver_3 Integrin-linked protein kinase 11 n n 3.528858829 4.043921887
7263 cra_locus_7263_iso_2_len_2518_ver_3 Oxysterol-binding family protein 11 n n 3.621161028 4.301251076
6827 cra_locus_6827_iso_1_len_1237_ver_3 Phytol kinase 1, chloroplast 11 n n 3.626976397 3.569904204
5578 cra_locus_5578_iso_3_len_1371_ver_3 Pyridoxal kinase 11 n n 3.75411786 3.76544988
8590 cra_locus_8590_iso_5_len_1451_ver_3 Gene of unknown function 11 n n 3.820332161 4.454208801
2710 cra_locus_2710_iso_4_len_2087_ver_3 Bem46 11 n n 4.050153389 4.632460174
10281 cra_locus_10281_iso_2_len_1155_ver_3 DECOY 11 n n 4.301916824 4.717468057
11582 cra_locus_11582_iso_6_len_2036_ver_3 Isoform 2 of Probable beta-1,3-galactosyltransferase 2 11 n n 4.310456462 4.362455862
4536 cra_locus_4536_iso_4_len_1291_ver_3 Methionyl-tRNA synthetase 11 n n 4.435248537 4.837201526
17470 cra_locus_17470_iso_1_len_1823_ver_3 Arogenate dehydratase 11 n n 4.449066085 4.383441646
3481 cra_locus_3481_iso_5_len_2753_ver_3 Hydroxyproline-rich glycoprotein family protein 11 n n 4.606223083 5.614097305
8473 cra_locus_8473_iso_2_len_1124_ver_3 DH putative beta-hydroxyacyl-ACP dehydratase 11 n n 4.737567794 6.263073854
838 cra_locus_838_iso_3_len_2096_ver_3 Nuclear transport factor 11 n y 4.843491476 4.856622232
9664 cra_locus_9664_iso_1_len_1014_ver_3 Glutaredoxin-C4 11 n n 4.844164672 5.249650126
216 cra_locus_216_iso_7_len_1193_ver_3 Protein pof4 11 n n 4.857259467 5.471047607
4232 cra_locus_4232_iso_1_len_681_ver_3 Mitochondrial import inner membrane translocase subunit Tim911 n n 4.893590344 5.873576994
22285 cra_locus_22285_iso_1_len_722_ver_3 Ubiquinol-cytochrome c reductase complex 6.7 kDa protein 11 n n 4.897400178 4.728268837
4768 cra_locus_4768_iso_4_len_2787_ver_3 NADH-ubiquinone oxidoreductase 39 kD subunit 11 n n 5.010650062 5.164029984
4649 cra_locus_4649_iso_2_len_2141_ver_3 NAD-malate dehydrogenase 11 n n 5.072873261 5.253202677
10929 cra_locus_10929_iso_4_len_1221_ver_3 Gene of unknown function 11 n n 5.144287071 4.768824792
2085 cra_locus_2085_iso_1_len_927_ver_3 NADH dehydrogenase 11 n n 5.267404706 5.498445554
6855 cra_locus_6855_iso_4_len_1139_ver_3 Cytochrome P450 11 n n 5.268733801 6.515376575
4159 cra_locus_4159_iso_4_len_1417_ver_3 ATP synthase 24 kDa subunit, mitochondrial 11 n n 5.284810223 5.524016647
6335 cra_locus_6335_iso_1_len_1143_ver_3 Clathrin adaptor complex small chain family protein 11 n n 5.319668509 5.146712238
6962 cra_locus_6962_iso_3_len_1689_ver_3 Vinorine synthase 11 n n 5.367671596 6.210924554
14850 cra_locus_14850_iso_3_len_734_ver_3 Conserved gene of unknown function 11 n n 5.3953062 5.752748591
15222 cra_locus_15222_iso_1_len_911_ver_3 Multidrug resistance-associated protein 2, 6 (Mrp2, 6), abc-transoprter11 n y 5.397132103 5.234087398
635 cra_locus_635_iso_4_len_2478_ver_3 Monodehydroascorbate reductase 11 n n 5.482499826 5.608809243
7753 cra_locus_7753_iso_3_len_1253_ver_3 Conserved gene of unknown function 11 n n 5.545109661 6.001302346
8320 cra_locus_8320_iso_6_len_1679_ver_3 Negatively light-regulated protein 11 n n 5.558013487 5.610304377
30243 cra_locus_30243_iso_1_len_701_ver_3 Conserved gene of unknown function 11 n n 5.568953262 5.541291802
7376 cra_locus_7376_iso_2_len_889_ver_3 Mago nashi 1 11 n n 5.639266899 6.112224716
9318 cra_locus_9318_iso_4_len_587_ver_3 Peptidyl-prolyl cis-trans isomerase Pin1 11 n n 5.65316036 5.36447088
5549 cra_locus_5549_iso_8_len_1090_ver_3 ATP-dependent transporter YFL028C 11 n y 5.657188378 6.029225376
4216 cra_locus_4216_iso_8_len_3698_ver_3 Acetyl-CoA synthetase 11 n n 5.816351386 5.779425206
8318 cra_locus_8318_iso_3_len_1309_ver_3 Nucleoside diphosphate kinase 1 11 n n 5.917756349 5.534404052
351 cra_locus_351_iso_4_len_2032_ver_3 ATP-citrate synthase 11 n n 5.924532249 6.156627177
8420 cra_locus_8420_iso_4_len_1918_ver_3 Aromatic-L-amino-acid decarboxylase 11 y n 5.94035941 7.463540721
1737 cra_locus_1737_iso_4_len_735_ver_3 Chalcone reductase 11 n n 6.0579744 6.910133013
570 cra_locus_570_iso_3_len_957_ver_3 Constitutive plastid-lipid associated protein 11 n n 6.543693838 6.58369959
9037 cra_locus_9037_iso_5_len_1732_ver_3 AAA ATPase; 26S proteasome subunit P45 11 n n 6.587220954 6.616788477
12599 cra_locus_12599_iso_2_len_782_ver_3 CXE carboxylesterase 11 n n 6.604585845 8.278133471
2110 cra_locus_2110_iso_3_len_915_ver_3 Superoxide dismutase [Mn], mitochondrial 11 n n 6.641991023 6.969288659
24360 cra_locus_24360_iso_1_len_527_ver_3 ATP synthase epsilon chain, mitochondrial 11 n n 6.727321476 7.811779266
8396 cra_locus_8396_iso_1_len_873_ver_3 ATP synthase D chain, mitochondrial 11 n n 6.842061147 6.897905945
19251 cra_locus_19251_iso_1_len_303_ver_3 Isocitrate dehydrogenase (NADP+) 11 n n 6.875939753 5.969528122
2533 cra_locus_2533_iso_1_len_794_ver_3 Fiber protein Fb15 11 n n 6.965853532 7.402994975
2052 cra_locus_2052_iso_4_len_1346_ver_3 ATP synthase f1, gamma subunit 11 n n 7.019657441 7.166906212
3455 cra_locus_3455_iso_5_len_1570_ver_3 Phosphoglycerate kinase 11 n n 7.144984469 7.429766586
4203 cra_locus_4203_iso_1_len_1034_ver_3 Adenosine kinase isoform 2S 11 n n 7.201976853 7.70016225
11589 cra_locus_11589_iso_1_len_737_ver_3 Mitochondrial ATP synthase 6kDa subunit 11 n n 7.510360671 7.805859928
53790 cra_locus_53790_iso_1_len_338_ver_3 Gene of unknown function 11 n n 7.641011277 8.820612982
8885 cra_locus_8885_iso_1_len_264_ver_3 Gene of unknown function 11 n n 8.469894114 9.687225194
17498 cra_locus_17498_iso_1_len_289_ver_3 Gene of unknown function 11 n n 8.795227966 8.518464324
37409 cra_locus_37409_iso_1_len_301_ver_3 Gene of unknown function 35 n n 2.378752977 1.69723115
28574 cra_locus_28574_iso_1_len_370_ver_3 Gene of unknown function 35 n n 2.401136196 3.293988398
8512 cra_locus_8512_iso_1_len_1271_ver_3 UDP-glucose:glucosyltransferase 35 n n 2.647197063 3.343279893
6087 cra_locus_6087_iso_1_len_2353_ver_3 Gene of unknown function 35 n n 2.749795967 3.330185488
35985 cra_locus_35985_iso_1_len_295_ver_3 Gene of unknown function 35 n n 2.843891412 2.253583924
13958 cra_locus_13958_iso_1_len_444_ver_3 Gene of unknown function 35 n n 3.001908505 3.287902203
381 cra_locus_381_iso_2_len_2638_ver_3 1-deoxy-D-xylulose 5-phosphate synthase 2 35 y n 3.103344886 3.866739868
2215 cra_locus_2215_iso_4_len_3190_ver_3 Conserved gene of unknown function 35 n n 3.169173001 3.649741905
7219 cra_locus_7219_iso_6_len_1914_ver_3 Glutamate receptor 35 n n 3.643313634 3.963557354
722 cra_locus_722_iso_7_len_1164_ver_3 Strictosidine synthase 35 n n 3.723733291 4.095603786
1974 cra_locus_1974_iso_3_len_1196_ver_3 Sinapyl alcohol dehydrogenase 35 n n 4.114949983 4.335390355
1452 cra_locus_1452_iso_2_len_1656_ver_3 Geranylgeranyl pyrophosphate synthase, chloroplastic 35 n n 4.312338439 4.995235757
5739 cra_locus_5739_iso_2_len_1991_ver_3 UDP-glucosyltransferase family 1 protein 35 n n 4.600638469 5.557364136
758 cra_locus_758_iso_5_len_2527_ver_3 Methylmalonate-semialdehyde dehydrogenase 35 n n 4.807555855 4.533606952
891 cra_locus_891_iso_7_len_1738_ver_3 4-diphosphocytidyl-methylerythritol 2-phosphate synthase 35 n n 4.916094423 5.064818198
3880 cra_locus_3880_iso_5_len_1914_ver_3 TPR domain containing protein 35 n n 5.043659469 5.143507706
113 cra_locus_113_iso_6_len_1847_ver_3 Geraniol synthase 35 n n 5.166337853 5.275841423
618 cra_locus_618_iso_7_len_2657_ver_3 1-deoxyxylulose 5-phosphate synthase 35 y n 5.18328006 5.629143843
3243 cra_locus_3243_iso_4_len_2217_ver_3 Cytochrome P450 35 n n 5.494940364 5.96045379
2665 cra_locus_2665_iso_3_len_1362_ver_3 Progesterone 5beta-reductase 2 35 n n 5.74253715 5.694637867
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5743 cra_locus_5743_iso_7_len_900_ver_3 Alcohol dehydrogenase 35 n n 5.881583869 5.603332584
6991 cra_locus_6991_iso_4_len_2997_ver_3 Plastidic ATP/ADP-transporter 35 n y 5.924727008 6.308564747
5034 cra_locus_5034_iso_8_len_2450_ver_3 Beta-glucosidase 35 n n 6.101036498 6.318400002
5068 cra_locus_5068_iso_2_len_683_ver_3 Protein S 35 n n 6.206881518 6.013906613
4910 cra_locus_4910_iso_10_len_1394_ver_3 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase 35 n n 6.334155272 6.01564921
7966 cra_locus_7966_iso_3_len_1015_ver_3 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase, chloroplastic35 y n 6.470305833 6.35897816
605 cra_locus_605_iso_4_len_1576_ver_3 Cytochrome P450 35 n n 6.507582184 6.553742939
4962 cra_locus_4962_iso_5_len_2409_ver_3 1-deoxy-D-xylulose-5-phosphate reductoisomerase 35 y n 6.529311854 6.024248749
2708 cra_locus_2708_iso_3_len_941_ver_3 Geraniol 10-hydroxylase 35 y n 6.773350237 7.02103548
1424 cra_locus_1424_iso_6_len_1981_ver_3 GCPE protein 35 y n 7.331194637 7.166564822
11857 cra_locus_11857_iso_9_len_2980_ver_3 Lecithine cholesterol acyltransferase 36 n n 2.232009862 2.336674719
5665 cra_locus_5665_iso_4_len_1529_ver_3 Nudix hydrolase 20, chloroplastic 36 n n 2.293979572 2.743381399
58436 cra_locus_58436_iso_1_len_586_ver_3 Gene of unknown function 36 n n 2.308156975 2.603601422
14634 cra_locus_14634_iso_1_len_1053_ver_3 Basic helix-loop-helix (bHLH) family protein 36 n n 2.636139678 2.519879014
45073 cra_locus_45073_iso_1_len_491_ver_3 Conserved gene of unknown function 36 n n 2.81609995 2.348141752
40681 cra_locus_40681_iso_3_len_1541_ver_3 CBS 36 n n 2.921895193 3.329755086
10710 cra_locus_10710_iso_5_len_2155_ver_3 Conserved gene of unknown function 36 n n 3.015174611 3.543446391
1113 cra_locus_1113_iso_2_len_1414_ver_3 ABC-transporter 36 n y 3.083655897 3.210119191
54804 cra_locus_54804_iso_4_len_802_ver_3 Serine hydroxymethyltransferase 36 n n 3.134925684 1.079859356
10262 cra_locus_10262_iso_1_len_3510_ver_3 Glycosyltransferase 36 n n 3.142209191 2.840199345
9522 cra_locus_9522_iso_6_len_3467_ver_3 Ion channel DMI1 36 n n 3.145126355 3.327831052
4190 cra_locus_4190_iso_3_len_1505_ver_3 Protein phosphatase 2c 36 n n 3.148192235 3.136214359
56545 cra_locus_56545_iso_1_len_469_ver_3 Gene of unknown function 36 n n 3.245570199 3.122339751
6540 cra_locus_6540_iso_3_len_1219_ver_3 Conserved gene of unknown function 36 n n 3.39514508 3.367440962
12417 cra_locus_12417_iso_4_len_2573_ver_3 Acyl-activating enzyme 18 36 n n 3.412605411 3.85939315
8977 cra_locus_8977_iso_2_len_2623_ver_3 Gd2b 36 n n 3.439955518 3.643752312
24210 cra_locus_24210_iso_1_len_1044_ver_3 Auxin-induced protein 5NG4 36 n n 3.469912018 3.362750405
70054 cra_locus_70054_iso_1_len_292_ver_3 14-3-3 family protein 36 n n 3.497689001 3.172965881
11693 cra_locus_11693_iso_4_len_3176_ver_3 ATP-binding cassette transporter 36 n y 3.590613995 3.50021568
36563 cra_locus_36563_iso_1_len_945_ver_3 Isopentenyl pyrophosphate: dimethyllallyl pyrophosphate isomerase36 y n 3.67746314 4.563823179
6670 cra_locus_6670_iso_2_len_1585_ver_3 Diphosphonucleoside phosphohydrolase 36 n n 3.754983679 3.784650548
5608 cra_locus_5608_iso_2_len_1934_ver_3 Reticuline oxidase 36 n n 3.931683057 4.348919321
3978 cra_locus_3978_iso_3_len_1482_ver_3 Mitochondrial carnitine/acylcarnitine carrier protein 36 n n 4.061534288 4.068653615
18184 cra_locus_18184_iso_1_len_922_ver_3 Chaperone protein DNAj 36 n n 4.089964172 2.718401084
3640 cra_locus_3640_iso_3_len_1136_ver_3 ZIP transporter 36 n y 4.097939411 4.281379264
9771 cra_locus_9771_iso_4_len_1760_ver_3 Hydrolase, alpha/beta fold family protein 36 n n 4.141784266 3.821700012
4144 cra_locus_4144_iso_2_len_2457_ver_3 3-ketoacyl-CoA synthase 36 n n 4.19105724 4.268569135
14176 cra_locus_14176_iso_4_len_1284_ver_3 Pentatricopeptide repeat-containing protein 36 n n 4.209656109 5.287745619
5019 cra_locus_5019_iso_5_len_2123_ver_3 Minovincinine 19-hydroxy-O-acetyltransferase 36 y n 4.369627007 4.747532414
7015 cra_locus_7015_iso_3_len_2535_ver_3 LEC14B protein 36 n n 4.469664607 4.737594833
818 cra_locus_818_iso_4_len_1965_ver_3 Serine/threonine-protein kinase PBS1 36 n n 4.49922085 4.061966241
56804 cra_locus_56804_iso_2_len_545_ver_3 Adenosylhomocysteinase 36 n n 4.516765305 3.284311277
1810 cra_locus_1810_iso_6_len_5044_ver_3 Multidrug resistance protein ABC transporter family 36 n y 4.612140149 4.731188673
32432 cra_locus_32432_iso_1_len_396_ver_3 Gene of unknown function 36 n n 4.658074349 4.235359447
55853 cra_locus_55853_iso_1_len_338_ver_3 S-adenosyl-L-homocystein hydrolase 36 n n 4.667239303 2.79540332
2310 cra_locus_2310_iso_1_len_2099_ver_3 Tubby; Cyclin-like F-box 36 n n 4.683460664 4.495874209
8230 cra_locus_8230_iso_5_len_1862_ver_3 Phosphoserine phosphatase 36 n n 4.841515287 4.991997942
6747 cra_locus_6747_iso_5_len_1697_ver_3 UDP-glucosyltransferase family 1 protein 36 n n 4.860342097 5.456030722
9086 cra_locus_9086_iso_5_len_1891_ver_3 Peptide transporter 36 n y 4.907356992 5.09761501
8928 cra_locus_8928_iso_4_len_3066_ver_3 Potassium transporter family protein 36 n y 4.931205546 4.850979399
7823 cra_locus_7823_iso_2_len_1499_ver_3 Catalytic/ hydrolase 36 n n 4.978040001 4.567673211
9450 cra_locus_9450_iso_4_len_2169_ver_3 External rotenone-insensitive NADPH dehydrogenase 36 n n 4.998263213 4.809043947
1227 cra_locus_1227_iso_6_len_1706_ver_3 Cytochrome P450 71D7 36 n n 5.000572456 5.252321037
8349 cra_locus_8349_iso_3_len_1344_ver_3 Cytochrome b5 36 n n 5.040826693 5.289797586
4729 cra_locus_4729_iso_5_len_1706_ver_3 Mitogen-activated protein kinase homolog MMK1 36 n n 5.103275218 5.032136117
126 cra_locus_126_iso_1_len_1595_ver_3 Senescence-associated protein 36 n n 5.151639669 5.679105654
205 cra_locus_205_iso_8_len_1925_ver_3 Aldose 1-epimerase 36 n n 5.203909798 4.937739855
6405 cra_locus_6405_iso_6_len_4766_ver_3 ATP binding protein 36 n n 5.229149511 5.114321211
1468 cra_locus_1468_iso_7_len_2400_ver_3 Jasmonic acid-amino acid-conjugating enzyme 36 n n 5.29495152 4.888986721
8301 cra_locus_8301_iso_3_len_2006_ver_3 Thylakoidal processing peptidase 2, chloroplastic 36 n n 5.320603815 5.476041389
1259 cra_locus_1259_iso_3_len_1357_ver_3 Pom30 protein 36 n n 5.438133135 5.454419393
879 cra_locus_879_iso_2_len_1928_ver_3 Dehydroquinate synthase 36 n n 5.466366093 5.387393562
5275 cra_locus_5275_iso_4_len_2521_ver_3 Receptor protein kinase 36 n n 5.480959801 4.99933711
2720 cra_locus_2720_iso_8_len_1822_ver_3 Multidrug resistance pump 36 n y 5.644467763 5.155923246
4226 cra_locus_4226_iso_5_len_2167_ver_3 Fructokinase 2 36 n n 6.077300689 5.48634754
4333 cra_locus_4333_iso_6_len_2424_ver_3 Methylenetetrahydrofolate reductase 36 n n 6.125186135 6.393503723
10652 cra_locus_10652_iso_3_len_2341_ver_3 Glucose-6-phosphate isomerase 36 n n 6.325812727 6.127707559
399 cra_locus_399_iso_5_len_1960_ver_3 Cytosolic 6-phosphogluconate dehydrogenase 36 n n 6.35133504 6.73794359
59882 cra_locus_59882_iso_1_len_336_ver_3 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase36 n n 6.596437267 6.664184144
2522 cra_locus_2522_iso_2_len_1526_ver_3 Loganic acid methyltransferase 36 y n 6.685155252 7.256161502
7012 cra_locus_7012_iso_4_len_835_ver_3 Cytochrome b5 36 n n 6.972462907 6.882104995
1852 cra_locus_1852_iso_8_len_3527_ver_3 Cystathionine gamma-synthase isoform 2 36 n n 6.994251596 6.735765855
1815 cra_locus_1815_iso_9_len_1294_ver_3 Plastid isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase isoform 136 y n 7.876117848 7.77363376
5563 cra_locus_5563_iso_3_len_426_ver_3 Gene of unknown function 36 n n 7.957340052 7.673627087
3269 cra_locus_3269_iso_1_len_329_ver_3 Methionine synthase 36 n n 7.974810345 8.179068102
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9802 cra_locus_9802_iso_3_len_906_ver_3 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase36 n n 7.995846278 8.006202634
16801 cra_locus_16801_iso_1_len_296_ver_3 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase36 n n 8.433426872 8.720271624
7197 cra_locus_7197_iso_1_len_671_ver_3 Glutathione s-transferase 36 n n 8.436011884 8.239631941
596 cra_locus_596_iso_2_len_582_ver_3 2-hydroxyisoflavanone dehydratase 36 n n 8.443072006 8.350329277
5891 cra_locus_5891_iso_1_len_642_ver_3 Adenosylhomocysteinase 36 n n 8.589310327 9.732041895
4840 cra_locus_4840_iso_6_len_2136_ver_3 Conserved gene of unknown function 435 n n 2.125680855 2.25954066
11051 cra_locus_11051_iso_2_len_928_ver_3 Type-A response regulator 435 n n 2.541564399 1.998191892
40962 cra_locus_40962_iso_1_len_384_ver_3 ATP-binding cassette transporter 435 n y 2.6726109 2.394179358
24716 cra_locus_24716_iso_1_len_1549_ver_3 Cytochrome P450 435 n n 2.822358976 2.676642027
5924 cra_locus_5924_iso_1_len_1312_ver_3 Metal transporter 435 n y 3.140909507 1.723659033
13084 cra_locus_13084_iso_2_len_1720_ver_3 Conserved gene of unknown function 435 n n 3.155336374 3.120688685
11045 cra_locus_11045_iso_1_len_2237_ver_3 Pathogen-inducible alpha-dioxygenase 435 n n 4.015898936 3.191834236
2087 cra_locus_2087_iso_5_len_1776_ver_3 DNA-damage inducible protein DDI1 435 n n 4.409798228 4.700484108
13992 cra_locus_13992_iso_2_len_843_ver_3 ATP-binding cassette transporter 435 n y 4.495560863 3.198079201
6707 cra_locus_6707_iso_4_len_1366_ver_3 ATP-binding cassette transporter 435 n y 4.522300615 3.61801542
8112 cra_locus_8112_iso_3_len_2201_ver_3 ERD6-like transporter 435 n y 4.592809819 4.491827448
32767 cra_locus_32767_iso_1_len_742_ver_3 NADH dehydrogenase 435 n n 5.397847447 5.780170968
4746 cra_locus_4746_iso_4_len_1655_ver_3 Cysteine protease 435 n n 5.697554219 6.16538138
16158 cra_locus_16158_iso_3_len_2097_ver_3 Peptide transporter 436 n y 2.025085509 2.148280108
57474 cra_locus_57474_iso_1_len_478_ver_3 Calmodulin 436 n n 2.332324119 2.592557499
14769 cra_locus_14769_iso_3_len_2466_ver_3 Exostosin family protein 436 n n 2.515447542 2.818339311
3942 cra_locus_3942_iso_9_len_1792_ver_3 UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter 436 n y 2.530395412 2.87302767
13551 cra_locus_13551_iso_1_len_437_ver_3 LysM receptor-like kinase 436 n n 2.829413236 1.747146751
32385 cra_locus_32385_iso_2_len_1608_ver_3 Conserved gene of unknown function 436 n n 2.903196418 3.080222743
8519 cra_locus_8519_iso_2_len_1521_ver_3 Histone deacetylase 436 n n 2.932172696 2.719586506
7790 cra_locus_7790_iso_3_len_1644_ver_3 F-box family protein 436 n n 3.033863452 2.667326741
16200 cra_locus_16200_iso_2_len_2362_ver_3 Transporter 436 n y 3.059604474 2.956757379
5874 cra_locus_5874_iso_1_len_1475_ver_3 Ribonuclease III 436 n n 3.39462389 2.992994967
4346 cra_locus_4346_iso_1_len_2082_ver_3 Mechanosensitive ion channel domain-containing protein 436 n n 3.515813357 3.646669586
1697 cra_locus_1697_iso_1_len_2819_ver_3 Receptor kinase 436 n n 3.593054922 4.123434446
131 cra_locus_131_iso_4_len_1380_ver_3 16-methoxy-2,3-dihydrotabersonine N-methyltransferase 436 y n 3.60245688 3.000090166
17006 cra_locus_17006_iso_1_len_2395_ver_3 GATA transcription factor 436 n n 3.639961431 3.192991058
7747 cra_locus_7747_iso_5_len_1534_ver_3 P-coumaroyl shikimate 3'-hydroxylase isoform 2 436 n n 3.644017763 3.91798543
811 cra_locus_811_iso_6_len_1980_ver_3 Sugar binding protein 436 n n 3.690025917 3.83163407
7567 cra_locus_7567_iso_3_len_2520_ver_3 Peptidase, trypsin-like serine and cysteine proteases 436 n n 3.700983401 3.788925792
13761 cra_locus_13761_iso_1_len_2494_ver_3 GRAS family transcription factor 436 n n 3.768703072 4.133727907
9821 cra_locus_9821_iso_2_len_1869_ver_3 3-hydroxyisobutyrate dehydrogenase 436 n n 3.960576578 3.700994494
6674 cra_locus_6674_iso_3_len_1498_ver_3 Zinc finger family protein 436 n n 3.963520364 3.527633387
7640 cra_locus_7640_iso_9_len_2908_ver_3 Potassium transporter 436 n y 4.003872042 3.838941685
1694 cra_locus_1694_iso_8_len_3396_ver_3 NRAMP family metal transporter 436 n y 4.019497325 4.052650643
10104 cra_locus_10104_iso_2_len_1571_ver_3 Hydroxycinnamoyl transferase 436 n n 4.033484673 4.625299717
4478 cra_locus_4478_iso_1_len_1840_ver_3 SFR6 (SENSITIVE TO FREEZING 6) 436 n n 4.283143929 4.407950917
10132 cra_locus_10132_iso_8_len_2383_ver_3 Acyl-CoA synthetase 436 n n 4.402817662 3.908822513
2788 cra_locus_2788_iso_4_len_3582_ver_3 Peptidyl-prolyl cis-trans isomerase CYP40 436 n n 4.434274599 4.771690178
1067 cra_locus_1067_iso_4_len_1465_ver_3 CAPIP1 436 n n 4.509714841 4.039954286
1665 cra_locus_1665_iso_8_len_3747_ver_3 Prf 436 n n 4.778329497 4.437261036
9431 cra_locus_9431_iso_6_len_1440_ver_3 Trafficking protein particle complex subunit 436 n n 4.996935529 4.737259513
23138 cra_locus_23138_iso_1_len_732_ver_3 USP family protein 436 n n 5.222182442 6.092205324
1189 cra_locus_1189_iso_3_len_2062_ver_3 Harpin-induced protein 436 n n 5.250290837 5.150380953
859 cra_locus_859_iso_5_len_1511_ver_3 Pyroglutamyl-peptidase I 436 n n 5.493599303 5.101381142
6502 cra_locus_6502_iso_4_len_1395_ver_3 Glutathione S-transferase 436 n n 5.795979888 6.436928034
1253 cra_locus_1253_iso_4_len_2391_ver_3 UDP-glucosyltransferase 436 n n 6.714108112 5.693138438
627 cra_locus_627_iso_9_len_1333_ver_3 Lactoylglutathione lyase 436 n n 7.038436182 6.830483517
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9.2 Replicates of VIGS-CrRO 
 
 
Replicate1 for CrRO Metabolite and qPCR profile upon VIGS of CrRO A.) Alkaloid profile VIGS of CrRO 
relative to empty vector control tissue in Little Bright Eyes VIGS-CrRO (n=18) VIGS-EV (n=8) ** p<0.01 B.) 
m/z 355 and m/z 397 profile for VIGS of CrRO relative to empty vector control tissue in Little Bright Eyes 
VIG-CrRO (n=18) VIGS-EV (n=8) ** p<0.01 C.) qPCR normalised expression of the CrRO gene in empty 
vector and CrRO silenced plant tissue VIGS-CrRO (n=8) VIGS-EV (n=8). All data presented is the mean + 
SEM. 
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Replicate 2 for CrRO Metabolite profile upon VIGS of CrRO A.) Alkaloid profile VIGS of CrRO relative to 
empty vector control tissue in Little Bright Eyes VIGS-CrRO (n=8) VIGS-EV (n=8) ** p<0.01 B.) m/z 355 and 
m/z 397 profile for VIGS of CrRO relative to empty vector control tissue in Little Bright Eyes VIG- CrRO(n=8) 
VIGS-EV (n=8) ** p<0.01. All data shown are mean + SEM. 
 
 
Replicate 2 for CrRO Metabolite profile upon VIGS of CrRO A.) Alkaloid profile VIGS of CrRO relative to 
empty vector control tissue in Little Bright Eyes VIGS-CrRO (n=10) VIGS-EV (n=8) ** p<0.01 B.) m/z 355 
and m/z 397 profile for VIGS of CrRO relative to empty vector control tissue in Little Bright Eyes VIG- 
CrRO(n=10) VIGS-EV (n=8) ** p<0.01. All data shown are mean + SEM.  
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9.3 Replicates of VIGS-CrMATE1952 
 
Replicate 1 Metabolite profile upon VIGS of CrMATE1952 A.) Alkaloid profile for VIGS of CrMATE1952 
relative to empty vector control tissue in Little Bright Eyes VIGS-CrMATE1952 (n=12) VIGS-EV (n=12) ** 
p<0.01 B.) m/z 391 profile for VIGS of CrMATE1952 relative to empty vector control tissue in Little Bright 
Eyes VIG-CrMATE1952 (n=12) VIGS-EV (n=12) ** p<0.01. . All data shown are mean + SEM. 
 
 
 
 
 
 
 
Replicate 2 Metabolite profile upon VIGS of CrMATE1952 A.) Alkaloid profile for VIGS of CrMATE1952 
relative to empty vector control tissue in Little Bright Eyes VIGS-CrMATE1952 (n=9) VIGS-EV (n=12) ** 
p<0.01 B.) m/z 391 profile for VIGS of CrMATE1952 relative to empty vector control tissue in Little Bright 
Eyes VIG- CrMATE1952 (n=9) VIGS-EV (n=12) ** p<0.01. All data shown are mean + SEM. 
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Replicate 3 Metabolite profile upon VIGS of CrMATE1952 A.) Alkaloid profile for VIGS of CrMATE1952 
relative to empty vector control tissue in Little Bright Eyes VIGS-CrMATE1952 (n=6) VIGS-EV (n=8) ** 
p<0.01 B.) m/z 391 profile for VIGS of CrMATE1952 relative to empty vector control tissue in Little Bright 
Eyes VIG- CrMATE1952 (n=6) VIGS-EV (n=8) ** p<0.01. All data shown are mean + SEM. 
 
 
9.4 VIGS Amino Acid Permease 
 
Metabolite profile upon VIGS of amino acid permease Alkaloid profile for VIGS of VIGS-1770 relative to 
empty vector control tissue in Little Bright Eyes VIGS-1770 (n=9) VIGS-EV (n=8) ** p<0.01. All data shown 
are mean + SEM. 
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9.5 Full length sequences for genes in this study 
Multidrug and Toxic Compound Extrusion Proteins (MATES) 
CrMATE10740 
ATGGATAGTAGTAATAAGAATCCGTTGCTAGTGAAAGAATACTCCGATTCCGATGGTAAAGGTAATGG
AGTAAAAACAATGATTAGTAGTTGTAGGTCTTCATCTAAAGGCTGGTGGAATAAGATATTGGATGTGG
AAGAAGCTAAAGGTCAAATTCTGTTTTCGTTGCCGATGATTCTTACTAATCTTTCTTATCACTTTATACTT
CTTACTTCCGTCATGTTCGCCGGTCATATTGGAGAACTTGAACTTGCCGCTGCAAATCTTGCTAATTCAT
GGGCGATTGTTACTGGTATTGCTCTCATGGTTGGACTAAGTGGTGCACTGGAAAGTTTGTGTGGACAA
GGATATGGAGCAAAGTTGTATAGTATGTTGGGGATATATCTACAGGCATCCTGCATAATATCATTCTTC
TTCTGTATTCTTCTATCCATCTTGTGGTGGTTCTCTGGTTCTGTCCTCACTTTATTACATCAAGATCCTCAA
ATAGCAAAAGCTGCCGGTCTCTATTTAAGGTTTCTCATACCAGGATTATTTGCATATGGAATGTTACAAA
GCCTCTTGAGATTTCTTCAGACACAATCCGTTGTTACTCCATTGGTTATCTTCTCAGTTCTACCTTTGATCC
TCCATATTGGAATTGCCTATTGTTTCACTCACTGGACATCATTTCCTTTCACCGGAGCAGCATTAGCTGCT
TCGTTCTCCTTCTGGTTATCAGTCATAATGTTAGCCTTATATGTTCTACGTGCAAGTAGATTTAAGCATAC
TTGGAAAGGTTTTTCAATGGAGTGTTTCAATCATATTGGACAGACCTTGAAGCTGGCTATACCGTGCGC
TGCAATGGTTTGTTTGGAGTACTGGGCTTTCGAGCTTCTCGTGTTATTAGCTGGCGTAATGCCAGATCC
AGAGATAACTACTTCCTTGATTGCAATATGTGTAAATACAGAATCCATTTCCTACATGTTTGCTTATGGT
CTCAGTGCAGCAACAAGCACAAGGGTTTCAAATGAGCTAGGAGCAGGGAATCCTGAGCGAGCCAAGA
AAGCTATGACGGTCACTTTGAAGCTTTGTGTGATTACGGCACTTGGTGTTGTTTCTGCTTTAGCATTTGG
CCATGATATCTGGGCTGGATTATTCAGTAATAGCCCAGTTATCATACAAAAGTATGCTTCAATGACACCA
TTTCTTGTGATCTCCATTTCCATTGATTTTTTCCAAGCAATCTTATCAGGTGTTGCCAGGGGATGTGGTTG
GCCACATTTAGCTGTGGGAATCAATTTGGGTGCATATTATTTTGTGGGCATGACAATTGCAGCTGTACT
TGGTTTCAAGGCGAAGTTGTACGCCAAGGGCTTGTGGACAGGCTTAATATGTGGTCTAAGCTGCCAGG
CTTGTGGGCTCTTGTTACTTTCATTGTTCACAAAATGGAAAAGAGTGGACTTGTCCTCCGATTGCAAAGA
AAATGAACAACAAATAGCTGAAGCTTGA 
CrMATE1952 
ATGGGTTCCAAACAAAACTATGAAATAAACCAACCACTGTTACTAAGTAACAACGGCGGTGGCAGCAG
TGCTATTACAGCTGCAGAGTCGCCAAAGGCGGCTAAGACGGTGGAGGAAAGGCAGTATGAGCTTAGT
GTTGAGTTAGAAAGGGTACTTTCCGATACATCTGTACCATTAGTGCCAAGACTCACCGCCGCCACTTGG
ATTGAGTTTAAGCTTCTCTTTCGGCTGGCGGCTCCAGCAGCCGCCGTTTATTTGATAAACTATGTAATGT
CTATGTTCACTCAAATATTTTCCGGGCATCTTGGGAATCTTGAGCTTGCTGCTGCTTCTCTTGGTAATAAT
GGTATCCAGACCTTCGCCTATGGTATCATGCTTGGAATGGGAAGTGCAGTGGAAACACTATGTGGACA
AGCATATGGAGCACAAAAACTAGACATGCTTGGAATATATCTCCAAAGATCAACAATTCTTCTAACCCT
AACAGGCATTGTTATTATGTTTGTTTACATATTCTCAAAACCAATCCTCCTTTTACTTGGCCAATCAGAAG
CCATAGCTGCAGCAGCTGCCTTATTTACTTATGGTCTTATCCCACAAATCTTTGCCTACGCAGCCAATTTC
CCAATCCAAAAGTTCTTACAAGCTCAAAGTATAGTGGCACCTAGTACTTATATATCAGCAGGAGCTATT
GTTTTCCATGTTTTGTTTAGTTGGTTAGCAATTTATAAGGTTGGACTTGGATTGTTCGGGGCATCTTTAG
TATTGAGTTTGTCTTGGTGGGTTGTTGTGGTTGGTCAGTTTATTTATATTCTATATAGTGATAGGACTAA
GGACACTTGGCGTGGATTTAGTGTTGAAGCTTTCCATGGACTTTGGAGCTTTTTTAAGTTGTCTGCTGCT
TCTGCTGTTATGCTTTGTTTGGAAGCTTGGTATTTTCAGATTCTTGTTCTTTTGGCTGGAATGCTTCCTGA
TCCTAAAATCGCTTTGGATTCCCTCTCCATTTGCATTACAATCTTGGGTTGGGTATTCATGATAGCCGTTG
GATTCAATGCTGCTGCCAGTGTGAGAGTAGGGAATGAACTAGGGGCAGGACATCCAAGGGCAGCTGC
325 
 
ATTTTCAGTAGTAATAGTGACAACAATGTCATTCATAATAGCAGTGATAATATCATTAGTGGTACTTGCT
TTGCGCTACAAAATTAGCTATATCTTTACCGAAGGTGAAGTTGTAAGCAATGCTGTTGCCGATATGTGT
CCCTTGCTCGCCATCACTCTTGTTCTTAATGGAATTCAACCTGTTTTATCCGGTGTTGCTGTTGGATGTGG
ATGGCAAGCTTTTGTTGCATATGTGAACGTTGGCTGTTATTACATTGTTGGTATCCCAACCGGTGCACTT
CTTGGGTTCTACTTCAAACTTGGAGCCAAGGGTATCTGGTCCGGTATGATTGGTGGGACATTGATGCAA
ACTATTATTCTCATCTGGTTTACTTATCGAACGGACTGGAAAAAAGAGGTGGATATAGCTCAAAGTAGG
TTGGATACATGGGAGGACAAGCCAAAATCTTTGTCCAATGAATAA 
locus_3327 
ATGGATCAAAGTTGTAGTAATGGAATGAATGAAGGTTTGCTGCAAAGTAAAAAAGAATCATCATCAGT
AGTTGGGGTTGGGGAGGAAATAATTAGTTCTGAGCTTGAAGAAATATTATCAGATACAAATATATCAC
AGTTACAGCGTCTCAAACGAGCAGTAGTCGTGGAAATGCGTACGCTATTCCGTCTTGCTGCACCTGCAT
GTGTCACCGCCTTGCTCGGTAATGTTGTTTCCATGTCCACTCAAATCTTCTGCGGACATGTTAGTAATCTT
GATCTTGCTGCCTCTTCCCTCGGCAATAATGGTATCCAACTCTTCGCCTACGGCCTCATGCTGGGAATGG
CAAGTGCAGCTGAGACTCTATGCGGGCAGGCATATGGAGCACACAAGTACGAGATGCTAGGCATCTAT
TTACAAAGATCAATAATCCTCCTTATGGGAACTGGATTACTCGTCATGTTAATTTACATTTTCTGCAAGCC
AATTTTGCTACTTCTAGGAGAATCAGAACAAGTGGCATCTGCAGCGGCACTATTTGTATACGGTCTTATC
CCACAAATATTTGCATATGCAGCCAATTTTCCAATACAAAAATTTCTGCAGGCACAGAGCATTATTAATC
CAAGTGCATATATATCAGTAGCTACACTTGTGGTGCACATCCCTTTGACATGGTTGGTTTTGTTTGTATT
GGATTGGGGTTTATTAGGCGCTTCGGCAGTATTGAGTTTTTCTTGGTGGATTATTGTTTTGGCACAATTT
ATTTACATTGTGAATAGTAAAAAGTGCAAAAAGACATGGACAGGTTTCAGTTTTCAGGCATTTACTGGA
TTATGGGATTTCTTGAAATTGTCTGCATCTTCGGCTGTAATGCTTTGTCTTGAGACTTGGTACTTTGACTT
TTTGATTCTCATTGCTGGTTTGCTTCCTAATCCTCAAATAACTTTGGATGCTCTTGCTATTTGCACCACAA
TCCTTGGATGGGTTTTCATGATTTCAGTGGGCTTCAATGCGGCAGCCAGTGTGAGGGTTAGCAATGAAT
TGGGGGCTGGGCATCCAAAATCAGCAGCATTTTCAGTGAAGGTTGTGACATTGAGTTCATTGGTGATTT
CAATAGTATGTGCAATTGTGGTACTGGTGTTGCGGCGGGTGATGAGTTATGCCTTCACCAGTGGTGAA
ACTGTTGCTAACGCCGTCTCCGATCTTGCTCCTCTCTTGGCCATCTCCATTGTTCTCAACGGCGTGCAGCC
TGTTTTGTCCGGGGTTGCGGTAGGATGCGGTTGGCAAGCATTTGTGGCGTATGTTAACGTTGGTTGTTA
TTACATAGTTGGGATTCCATTGGGTGCATTGCTCGGATTCAAATTCAATCTTGGTGTTAAGGGAATATG
GACAGGAATGGTGGGAGGAGTGGCCATGCAGACTGCTATCTTACTTTGGGTCACTTTGCGAACCAACT
GGGATCGAGAAGTGGAGATCACAAGGAATCGGTTAGATAAGTGGAATAAGACAAAGGTAGAGGCTG
CTGCTTTACTGAATAATTGA 
locus_8527 
ATGGAGTACTCCGAAGATGAAAGCCGAGGAACAGCGGCCTTACTGCAGCCGCCATCCCCAGCTGCTGT
GGACTCCCAGCAGTCGGAGGTCAGCTCAGAGCTGGAAAAGGTGCTGAGCGACACTGAATTAAGCTACT
GGAAACGCATCCGGGTGGCCACATGGATCGAACTCAAACTTTTGTTTCGGCTGGCTGCTCCAGCAATCG
GTGTTTACTTGATAAACAACTTCATGTCCCTTTCTACTCGCATCTTTGCTGGCCATCTCGGCAATCTTCAG
CTTGCTGCTGCCTCCTTAGGCAACCAGGGTATCCAATTATTCGCATACGGCCTCATGCTGGGGATGGGA
AGCGCAGTGGAAACATTATGCGGCCAAGCATACGGCGCTGGGAGACATGAAATGCTTGGAATTTACCT
CCAAAGAGCAACAGTAGTTCTTACACTAACCGGTCTACCAATGGTCTTCATCTACATTTTCTCAAAACCA
ATTCTAATTTTGCTAGGCGAATCCAAAACTTTGGCATCAGAAGCATCAATTTTTGTTTATGGCCTAATTCC
CCAAATCTTTGCATATGCAATAAATTTCCCAGTACAAAAATATCTACAAGCTCAAAGTATAGTGAAGCCA
AGTGCCTACATTTCATTGGCTACATTATGTCTTCATTTATTATTGAGTTGGGTTGTGGTTTATAAAATTGG
326 
 
GTTAGGGTTAATTGGTGCTTCATTGGTTTTGAGCTTATCATGGTGGATAATTGTGGTGGCTCAATTTGTG
TATATATTGATGAGTGAGAAATGCAAGGCTACTTGGATCGGATTCAGTTTTGAAGCTTTTAAAGGATTA
TGGGAATTTGTGAAATTATCAGCAGCATCAGCAGTTATGTTGTGTTTGGAGACATGGTATTTTCAGATT
TTGATTTTGATTACTGGATTGCTTAAGGATCCTCAGCTTGCCTTGGATGCTTTATCTGCCTGCTTGGGAG
TAAACGCTATTGTGTTCATGATTTCTGTTGGATTCAATGCAGCTGCTAGTGTGAGGGTTGGCAATGAAC
TTGGAGCAGGGCACCCCAAATCAGCTTCCTTTGCAGTTACAGTAGTGAATTTAGTTTCTTTCATCATAGC
CGTTATTGCCGCCGGAATAGTGCTTTCGTTACGCCACGTCATTAGCTACGCTTTTACCGACGGTGAAACT
GTGGCGGAGGCCGTCTCTGACTTATGCCCGCTCTTGGCTGTCACACTTGTTCTCAACGGTGTCCAACCA
GTTTTGTCCGGTGTAGCGGTGGGGTGTGGATGGCAAGCATTTGTTGCTTATGTAAACGTTGGGTGTTAC
TATGTGGTTGGCATTCCACTCGGTTGCATTCTCGGCTTCAAGTTTGATTTTGGTGTTAAGGGCATATGGT
TAGGTATGCTTGGAGGAACAATGATGCAGACCATAATCTTAGTATGGGTAACATTTCGTACCGACTGGA
ATAAGGAGGTGGAGAAAGCAAGAAACCGTCTGGACAAATGGGACGACATCAAAAAGCCTCTTTTGGT
GGATTAA 
locus_2720 (partial sequence) 
ATGGCGTTATGTTTGGAGCTATGGTACGTCACAGCAGTTATTCTAATGGTAGGAGGCTTGAAAGATGCT
GATGTTGCAGTTGCAGTTGATGCGGCTTCAATATGTATAAATTTGCACTTCTGGACGTTGATGCTTGCCC
TTGGTTTTAATGCATCAGTAAGTGTAAGAGTATCAAACGAATTGGGAGCTGGAAAACCAAAAGCTGCA
AAACTCTCAATTGTAGTACATATGTTAACAACTGGGGTTCTTGGAATTATATTTGCATCAACTATTTTGG
CCACAAGAAACCAATTTCCCAGAGTTTTCACAGATAAACCACAAGTAATTAAAGAAACCTCCAAGTTGG
GTTATCTTCTAGCAGCCTCTGTCTTTCTCAATGGCATTCAACCAGTTCTGCTCGGGGTGGCTGTTGGTGC
AGGATGGCAGTTCCCGGTTGCCATTCTAAATGTGATATGTTATTATGGGATTGGGCTTCCAATAGGAGC
CTTACTTGGTTTTAAGTTTAAGCTGGGCGTTCATGGCATATGGTGGGCAATGCTTGGTGGTAGCTTGCT
TCAGACAATTGCTCTGCTGATCATTGTTATTCGAACAAATTGGCACAAGCAGTCTCTTCAAGCTGAGGA
GCGGGTAAAAGAATGGGGAGGCCAAACAGAACCTCAACAAAGCTCATGA 
 
NPF transporters 
CrNPF2.9 
ATGGGAGACACCGAAGCACAGCTTCTCCAGCCAGGTCACAAGCAGAAAGGCGGTTGGATCACTTTCCC
TTTCATTTTAGCAACGAGGACTTTATTGACGCTTGCGGTAGCTGGATTTAGCTCTAATTTAATCGTTTACT
TGATCAACGAATTCAATGTGAATAGAATCGATTCTGCTCAAATATATAATGTTGTGAATGGTTGCATGG
CCCTATTCCCTCTTCTCCTTGCTATAATTGCCGATACTTTTCTGGGCTGTTTCAATGTCATCTGGATTTCTA
CCCTCATCTCTTTGATGGGGATGGCTCTGTTGACATTAACTTCCTCAATCACTTCACTAAGACCTCAACCA
TGTGCCGAAGGGTCAACCTTTTGCCAACAACCATCAGCATATCAATCCAGCATTCTGTTTTTGGCTCTGG
CCTTGCCATCTATAGGCTTTGCAGGAACCAGTTTTACAGTGGGAACAATGGGTGCACATCAATTAGACG
ATCCAAAGCATCAAGAAAATTTCTTCAACTGGTTTCTCTTTATCTGGAATGCTGCTTCAGTAATCAGTGG
CATTGGAATTGTCTATGTTCAAGATAATGTGAGTTGGTCATGGGGATTTGGTATTTGTGTTGCTTCAAAT
CTTCTGGGTTTGATCATTTTCTTGGCCGGAAAGCGTCTCTATCGTGATGTACAGCCACAGAAAAGTAGC
CCATTCAAGGATTTAGCTTGTGTTGTTGTTGCTGCTCTCTCTAAGAAGAAGCTCTCCTTGTCAAACAAAG
AAGAAGATTATTACAGCGAATTACCCGATAATGCTGAGGAACAACAACAACAAGAGGGCGTTACCCTT
TTACCTGCTACTGTACCTGATGAAAGTTTCAAGTTCTTGAATCATGCGGCTCTGGTAACTTCAGCAGATA
TCCAACCAGATGGTTCAATCAAGAAATCATGGAAACTATGCACAGTTAAACAGATTGAAGATCTCAAAA
327 
 
CCTTAATCAGATTATTCCCACTTTGGACAACTGGTTTCTTATTAACTATCCCAATGGGAGTACTTTCCAGT
TTAACAACCCTTCAAGCTCTAACAATGGATTGCTCCACTTTTTGGGGTCTCAAATATCCAGTAGGATCCA
TGTCTGTTTTCACTCTGTTAGCAGGTGCAATCTCTCTAACCTTTATAGACAGATTGATTTTCCCCATTTGT
CGAAAAATGGCTAAACCAATTAGACCCCTTCAAAGAATAGCCATTGGTCACATCATCAACGTGATCTCT
GTTGTCATTGCTGCCATTGTTGAACACAAGCGTCTACAATTAGCTCGAGCCCAGAAATTCCAAGGCAAA
ACGGACTCCGTCGTCGTGCCCATGTCAGTCTTCTGGTTAATTCCGCAATTGGCACTCTCCGGTACCGGA
GAAGCATTTCATTTTCCAGGACAAGCATTGTTGTATTACAAAGAATTTCCTGCATCACTCAAGAGTACTT
CGACAGCTATGTTGGCAATTCTTATAGCCATTGGGTATTATATGGGAACTTTCGTTATTGATGTTGTTAG
GAAAGTTACAGATTGGTTGCCGGAAGATATTAATCACGGAAGGCTGGATAATCTCTATTGGTTGGTTGC
TGTTCTTGGAGTACTGAATTTTGTGTATTATCTTGCTTGTGCTGGGGCGTACGAGTATAGTTCCGTCATG
GAGGATGAAGATGAAACAAATGATAATAAAATATATATGTAA 
 
CrNPF2.4 
ATGGCTGAAAAATCTTCTTCCATTGATGCTACTGAAAATGGTTTCGTTAAGATTAAAGAACCAAACCAC
AGAGGTGTCAAAGCCATGCCTTTTATCGTTGGAAACGAGACGTTTGAGAAGCTGGGAACACTTGGAAC
CTCAGCAAACCTTTTGATTTATCTGACCACTGTTTTTCATATGAAGTCAATTACTGCAACAAACCTCATTA
ACATCTTCAATGGCACATGCAATTTTGGAACCTTGCTTGGAGCTTTTTTCTCGGATACTTATTTTGGACGT
TACAAAACTCTCGGCTTTGCCTCTGTTTCCTCTACCTTGGGGATGCTTATACTAACCCTAACAGCTGCAAT
TTCAAAGTTGCATCCTCCTTCCTGTGAAAAAAACAGCAAAGCTTGTAGCGGACCGACGTCGGGGCAATT
CGCTTTCCTCTTCACTGCATTTTTGTTCTTAATAATTGGAGCAAGTGGAATAAGGCCATGTAATTTAGCC
TTTGGAGCTGATCAATTTAATCCCAATACTGAATCAGGAAGAAAAGGAACAAACAGTTTCTTCAATTGG
TATTATTTTACCTTTACATTTGCAATGATGGTTTCATTAACAGTCATTGTTTATGTTCAATCAAGTATCAG
TTGGGCACTTGGATTGGCTATTCCAACGTTTTTAATGTTGTTATCTTGCGTTTTCTTCTTCGTGGGTTCAA
GAATTTATGTTAAAGTCTTGCCGGAGGGTAGCCCTTTGACTAGTATGATGCAGGTTATTGTGGCTGCAT
TTAGAAAAAGAAAACTGAATTTACCAGATCATCAGCCTTGGGATTCTCTTTTTAATTACATTTCCCCAAG
TTCAATCAACTCAAAGCTTTCATACACAGATCAGTTCAGGTGGCTAAACAAAGCAGCAATTAAGACCTC
AAAAGACCATCTATACGCAGAAGGATCAACGGCAAATCCATGGAGACTATGCAGTATGCAACAAGTAG
AAGAAGTAAAATGTGTGATAAGATCAATTCCAATTTGGACATCAGGTGTTTTATACTATGTTGTACTAA
ACCAAATGAGCACTTATTTAGTGTTTCAAGCCCTTCAATCAGACAGAAGAATTGGCAAAACAAACTTCA
AAATCCCAGCAGCTTCTTACACAGTCTTCTCAATGCTAAGCCTTAGCATTTGGATACCAATTTATGATAG
AATCATCGTTCCATTTCTTCGAAAAATCACAAAAACAGAACAAGGAATAACAATTCTACAAAAAATGGG
ATTTGGATTGGTTATTGCAGTAATAACAATGGTTGTTTCAGCAATAATTGAAGATAAAAGAAGAGTAAT
TGCACTTACTAGGCCAATTGTTGGAATTGAAGAAAGAAAAGGGGGAATTTCTTCATTATCTGGATTTTG
GTTAGTACCTCAATTGGCTTTGGCTGGGATTTCAGAGGCATTTACTGTGATTGCTCAAGTTGAATTTTTC
TATAAACAATTTCCAGAGAATATGAGGAGCTTTGGTGGGTCATTTTTATTTTGCGGATTTGCAATTTCAA
GTTATTTGAGTAGTTTCTTGATATCAATTGTTCATAAAGTGACAAGAAATTCAAGTGGTGGAAATTGGTT
GGATGAAGATCTTAATAAGGCTAGATTGGATTATTTTTACTATTTGGTGGCTGGTTTGGAGGTTTTGAA
TTTTGGGTATTTTCTTGTTTGTGCTCATTGGTATAGATACAAAGAAACACAAAGCGGTAATGAAATTGCC
ATGGAACAAATATTGGATGAGCCCAAGAAGAACTTAGATGTGGTTTGA 
 
CrNPF2.6 
ATGGAGAAAAACGAGAAATTAGTCCCAAATGGCACAAAGGAAGATGGGAAAGTTGCTGCAAAAAATG
AGCCTAACTACAGAGGAATCAAGGCCATGCCATTTGTTCTTGGAAATGAAACATGTGAGAAATTGGGA
ACAATTGGGACCTCATCGAACTTGTCGGTTTATCTATCTACAGTGTTTCATATGAACACTATGTCTGCAA
ATAATGTAATAAACATCTTCAATGGAACTTGCTATCTTGGTTCCTTAGTTGGAGCTTTCTTGTGTGATACT
TATTTTGGTCGGTACAAAACTCTTGGGCTTGGCTCTGTAGCTTCATTCTTAGGAATGCTAATGCTGACAC
328 
 
TAACTGCTGCAATATCGACATTACATCCTACAAATTGTGACAACTCAGGTGATTGTAAAGGGCCATCAG
CAGGGCAAATGGCTTTCCTGGTAGGTGGATTTGTACTAATGGTAATTGGGGCTAGTGGCATTAGGCCA
TGTAACTTGGCCTTTGGAGCTGATCAGTTTAATCCCAATACTGAATCTGGAAGAAGAGGAATCAATAGT
TTCTTCAATTGGTATTATTTCACATACACTTTTGCTGTCATGGTGTCTGCTACCATCATTGTATACGTGCA
GTCGGATATAAGCTGGTCTATTGGTTTTGCAATTCCAACATCTCTCATGTTCTTATCTTGTGCGCTATTCT
TTGCCGGTACCTGGCTATACGTCAAAGTGTTACCACAAGGCAGTCCTATGACTAGTCTTGTGCAGGTTA
TTGTGGTTTCGGTCAAGAAGAGACGATTGAAGTTACCAGGGGAACCATCTTTGCTTTTTAACCACATTC
CTTCTAATGCTATCAACTCAAAACTCCCTCGAACAAATAACTTCAGGTTTCTTGATAAAGCAGCAATTTT
GACCCCTGAGGACAAAGTTAATCCTGATGGTTCAGCAGCCAACAAATGGAAACTCTGCAGCATTCAGC
AAGTTGAAGAAGTGAAATGTGTGTTGAGAGTTCTTCCTATATGGATTGCGGGCGTAATATTTCAAATTT
CAGTAACACAGCAATCAAATTATGTACCATTTCAAGCATTCCAAAGTGATAGGCACCTAATCAAAGGCA
ACAAATTCCAGATACCAGCAGGAACTTACAATGTCTTCTCCATGTTAGCTCTAACCATTTGGCTACCTAT
ATATGATAGGATCATCATCCCTCTGCTCCGTAGATGGACAAAAAAGGAAGACGGTATCACCCTACTACA
GAGGATGGGAGTTGGCATAGTTCTCTCCATTCTTTCAATGTTAGTATCAGCATTAGTAGAATCAAGAAG
GAGAAACTTGGCATTGACTCGTCCAACGCTAGGAATTCAAGAAGGTCAGGGCTCAATTTCATCCATGTC
TGCTTTGTGGTTTGTACCTCAGTTGGCACTAATGGGGCTTGCTGAAGGATTTACTTTCATTGGTGAAAAC
GAACTTTTCTACAAAGAATTCCCAGAAAACATGAGAAGCATTGCTGCATCTTTGGTGTTATGTGGGGTG
GCAGTGGCAAGCTACTTGACTTCTTTCATTGCTGAGATTGTTCATAAGACTACAAGGTCCGGGACAAGG
GATTGGTTGGCTCAAGATCTTAACAAGGCAAGATTAGATTACTTCTTTTACATGGTTGCTGTATTAGAG
GCACTGAATTTGGTTTATTTTCTGGTATGTGCCAAGTGGTATAGATACAAAGGAACGGGTGATCTTGGA
AAACTTGAAGTGGCAATGGAAAAATTAGAAACTGAAAAGCATCTAGTTTAA 
 
Reticuline Oxidase like enzymes 
CrRO_locus_5608 
ATGATAAAAAAAGTCCCAATAGTTCTTTCAATTTTCTGCTTTCTTCTTCTACTCTCATCATCCCATGGCTCA
ATTCCTGAAGCTTTTCTCAATTGTATTTCCAATAAATTTTCATTAGATGTATCCATTTTAAACATTCTTCAT
GTTCCCAGCAATTCTTCCTATGATTCTGTTCTCAAATCTACTATCCAAAATCCAAGATTCCTCAAATCACC
CAAGCCCTTAGCTATAATCACCCCAGTACTTCACTCCCATGTCCAATCTGCTGTTATCTGTACCAAACAA
GCCGGTTTACAAATTAGAATCCGAAGCGGAGGAGCTGATTACGAGGGCTTATCCTATCGTTCTGAGGTT
CCCTTTATTCTGCTAGATCTCCAGAATCTTCGATCAATTTCCGTTGATATTGAAGACAACAGCGCTTGGG
TCGAATCAGGAGCAACAATTGGTGAATTCTATCATGAGATAGCTCAGAACAGCCCTGTTCATGCGTTTC
CAGCTGGGGTCTCTTCCTCTGTTGGAATTGGCGGCCATTTGAGTAGCGGCGGTTTTGGTACATTGCTTC
GGAAATATGGATTAGCAGCCGATAATATAATCGATGCAAAAATTGTTGATGCCAGAGGCAGAATTCTT
GATAGGGAATCAATGGGAGAAGATCTATTTTGGGCTATTAGAGGAGGAGGAGGAGCTAGTTTTGGTG
TTATAGTTTCTTGGAAGGTTAAACTTGTAAAAGTCCCTCCGATGGTAACTGTTTTCATCTTGTCCAAGAC
TTATGAAGAAGGAGGTTTAGATCTTCTACACAAATGGCAATATATAGAACACAAACTCCCTGAAGATTT
ATTCCTTGCTGTAAGCATCATGGATGATTCATCTAGTGGAAATAAAACACTTATGGCAGGTTTTATGTCT
CTGTTTCTTGGAAAAACAGAGGACCTTCTGAAAGTAATGGCGGAAAATTTCCCACAACTTGGATTGAAA
AAGGAAGATTGCTTAGAAATGAATTGGATTGATGCAGCAATGTATTTTTCAGGACACCCAATTGGAGA
ATCCCGATCTGTGCTTAAAAACCGAGAATCTCATCTTCCAAAGACATGCGTTTCGATCAAATCAGACTTT
ATTCAAGAACCACAATCCATGGATGCATTGGAAAAGTTATGGAAGTTTTGTAGGGAAGAAGAAAATAG
TCCCATAATACTGATGCTTCCACTGGGGGGAATGATGAGTAAAATATCAGAATCAGAAATCCCATTTCC
TTACAGAAAAGATGTGATTTACAGTATGATATACGAAATAGTTTGGAATTGTGAAGACGATGAATCATC
GGAAGAATATATCGATGGATTGGGAAGGCTTGAGGAATTAATGACTCCATATGTGAAACAACCAAGAG
GTTCTTGGTTCAGCACCAGAAACCTTTATACCGGTAAAAATAAAGGTCCAGGAACAACTTATTCCAAAG
329 
 
CTAAAGAATGGGGATTTCGGTATTTTAATAATAATTTCAAAAAGTTGGCCCTTATCAAAGGACAAGTTG
ATCCAGAAAACTTCTTCTACTATGAACAAAGCATTCCCCCTCTCCATTTACAAGTCGAACTTTGA 
locus_2174 
ATGTCTCTTTTTCTTCCCCTTATATCCCTCCTCTGTTTTTGCCTTCTAAGTTCTTCACACTTTGTAGCCTCAG
ACTCCAATTATGACAAATTTTCTCAATGCCTAGAAACTAATTCAATCCCAGATGACCAAATCTCTAAAATT
CTGTATTCCAAAGGCAATTCTTCTTTTAACTCTGACCAAATCTCTAAAATTCTGTATTCCAAAGGCAATTC
TTCTTTTAACTCTGTTCTTGATGCCTATGTTAGAAACCGTCGTTTCAACACTTCTTCTACATCAAAACCAG
TTATAATTGTGACCCCTTTGTCAATAACCCATGTCCAAGCAACTATTTTATGTACCAAAAATTTAGGCCTA
CAACTCAAAATCCGAAGTGGTGGACATGACTATGAGGGGATCTCGTACGTATCTGAATCTCCTTTTGTG
ATTCTTGATATGTTCAATTTCAGAAACATTAGTATTGATGTTGAAAATGAAACCGCTTGGGTCCAATCTG
GTGCTACCCTTGGTGAACTTTATTATAGAATTTGGGAACAGAGCAAAGTTCTTGGATTCCCTGCTGGTG
TTTGCACAACAGTAGGAATTGGAGGCCATATAAGTGGCGGTGGGTATGGCGCAATGCTTAGAAAATTT
GGACTCGCTGTAGATAATTTGCTCGATGCCCAAGTCGTTGATGTGAAAGGCCGGGTTTTAGATCGAAGT
AGTATGGGTGAAGATCTCTTTTGGGCCATAAGTGGTGGTGGCGGTGCTAGTTTTGGTGTTATTTTGGGA
TATAAAATAAAGCTAGTTCAAGTGCCTAAAATTGTAACCGTTTTTCGAGTTGAAAAAAGGGCAGAAGA
GAATGCTTTAGAAATTGTTCATCGATGGCAAGATATTGCGGACAAGATCGATAATGATTTGTTCATTCG
GGTTCTTTTGCAACCTGTTAGTGGAAAAGGAAAAGCAAAAGGGCAGAAAACAATTAGAGCAACATTTA
TCGCATTGTTTCTCGGTGATTCCAATAGGCTTATGTCTGTGATGAATGGTCAATTTCCCGAATTGGGACT
CAAGAAAACAGATTGTTTAGAGATGAGTTGGATTCGATCTGTACTCTGGTGGGCGAATTTTGACAACAC
CACTAGTGAAAGTGTTCTTCTGAATCGAAACCCAGACTCAGTTAATTTCTTGAAGAGAAAATCAGATTA
TGTCCAGACGCCAATTCCTAAAGATGGGTTGGAATCAATTTTCAAGAAAATGGTTGAGTTGGGAAAAA
CTGGATTTGTTTTCAATCCTTATGGAGGAAAAATGGGTGAAATTCCTGAAAATGAAAAGCCATTTCCTC
ATCGTGCTGGAATTATTTACAAGATTCAGTACTCTGTGAATTGGGAAGACGAAGATCCTGCTTTAGACA
AGAAATACATTGCTGAAACAAGAGAATTATACAAATTCATGACACCTTTTGTGTCAAAAAATCCTAGAC
AAGCATTTCTGAATTATAGAGATCTTGATATTGGAACTACGAGCAATGGTAAAAATAGCTACAACGAAG
GAGAAGTATTCGGGTCAAAATATTTTAAGGGTAATTTTGATAGATTAGTGAAAGTGAAGACGATGATT
GATCCAGAAAATTTCTTTAGGAATGAACAAAGTATTCCTCCTCTACCGGTTAGGTCGTTGGGTGGGAGG
AAAGGTGGAAATTGA 
locus_5372 
ATGATATCACGATCTTTTTCTATTTCAGACACAATTCTTCAAGACAAATTTTACCAATGTATCAATCTTAA
TTCTGAGCTCTATATTCCTTTCTCCACAGCGTTTGTTACCCCAAACAATGCCACATTCAACTCTGTCTTAC
AATCTACTGCACAAAATCTTAGGTGTTTAATCCCTTCTGTACCAAAACCTCAACTGATTTTCACACCTTTA
GTTGAATCCCATGTCCAAGCTGCAGTTATTTGTGCCAAAGAACTCGGTATTCATCTCAGAGTACGAAGT
GGTGGTCATGACTATGAAGGACTTTCTTATATATCTGATGATACAGAATCCCCGTTCATTATTGTTGATC
TTGTTAAACTCCGATCTGTTAATGTAAATATTGGAGATGATAGTGCCTGGGTTGAGGCCGGTGCCACTG
TTGGTGAACTTTATTATAGAATTTCGGAGAAAAGCAGAACTCATGGATTTCCTGCTGGCCTTTGTTCAAG
TTTAGGAATTGGGGGACATATAACTGGAGGAGCATACGGATCTATGATGAGAAAATATGGTCTAGGA
GCTGATAATGTGCTTGATGCTAGAATTGTGGATTCAATTGGCAGAGTTCTTGATAGGCAATCAATGGGA
GAGGATCTTTTTTGGGCAATCAGGGGAGGTGGAGGAGCTAGTTTTGGGATTATTCTTGCTTGGAAGAT
CAAATTGGTACCTGTCCCTGCAATTGTGACAGTTTTTACTGTTCCAAAAACACTAGAACAAGGTGCTACA
AAAGTTCTATACAAATGGCAAGAAGTTGCCCCTAAAATTGATGAAGATCTTTTCATTAGAGTCATTATAC
AAAAGGGGGATAAAACAATTGTAACAGCCTATAACGCGTTGTTTCTTGGGGGAACAGATAGACTTGTT
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CAAGTAATGAATGAAAGTTTTCCCGAACTGGGATTGACTCGAAAAGATTGTATAGAGATGAGTTGGAT
TGAATCTGTACTATACATCGCTGGATATCCTCGGAACACGCCACCTGAAGTTCTTCTTCAGGGGAAGTC
ATTATTCAAGAACTATTTCAAAGCGAAATCAGATTTCATCAAGGAGCCAATTCCAGAAGAAGGACTTGA
AGGACTATGGAAAAGGGTTCTTGAAGAGGATTCACCATTGATGATTTGGAATCCATATGGTGGAATGA
TGAGTAAAATATCAGAATCTGAAATACCTTTTCCTCATAGAAAAGGGGTACTTTACAAAATCCAATACCT
TACAACATGGAATGATGAAAACAAAGAATCAGCAACAAAACATGTAGATTGGATAAGGAGACTATACA
ATTACATGGCTTCATATGCTTCAATGTTTCCAAGACAAGCTTATGTGAACTATAGAGATCTTGATTTGGG
AATGAACAAGAATGAGAACACAAGTTTTATTCAAGCAAGTGTTTGGGGTACTAAATATTTCAAGGACAA
TTACAATAGGCTAGTAAGAATCAAGACTAAAGTTGATCCTGATAACTTCTTCAGACATGAGCAGAGTAT
CCCAACACTTCAATTAACAAGTAATAAAAGAGGAAAGAGAAGAATCCATTGA 
 
 
Other Transporters 
CrPUP_1443_purine permease 
ATGGAAGATCAAGTTAGGAGCAGGAGCAAGGAGGCACTAAGAAGAACAATACTATTGCTAAGTTTCAT
GTCAATGTGCATAGGTTTTTGCGGCGGTCCTTTAATCACACGCCTTTATTTCCTTCATGGAGGCAGTAGA
ATTTGGCTAGCGGGTTTTTTACAAACTTGTGCATGCCCAATTATTCTAATCCCGTTATTAATTTCTTATTTT
TCTCGTCGAAAATCGGAAGGATCCAGCACGAAGATTATTTACATGAAGATTTCAACTAGTTTAGCCTGT
TTAATTATTGGTCTTTTTGTTGGTTTAATTAATTACTTATTTTCCTATGGTTTAGGACGTTTGCCAGTTTCA
ACCGCTACACTAATTACCACAACTCAGCTTGTTTTTACTGCAGTCTTTGCTTTTCTTCTCGTCAAGCAAAA
ATTTACTCCATTTTCAATAAATGCAATTATATTGTTGACAATTGGATCAGTTGTTTTGGGCTTGCAAGGA
AGTAAAGATAGGCCAGAAGGTGAAAGTAAGAAAATGTACAATTTAGGATTTGCTTTGACGTTTTTAGG
AGCAGCCGTGAGTGGGTTCGTGGCACCTTCTATTGAATTTGTTTACAAGAAAACGGGGATGGGAGATG
GATATACAAAGGTGTTGGAGACTCAGATTGTGATTTCTTTTTCTGCTTCCATATTCTCCTTGATTGGAAT
GCTAGCAAACCATGATTTCAAGGTAATTCCACGGGAGGCAAGAGAATTTCAACTTGGCGAAGCAAAAT
ACTATGGAATTCTGGTGTCGAGTGCCTTTGTTTGGCAATTCTACCTTGTGGGAATCGTTGGAGTAATCTT
CAACGGATCGTCTCTGCTGTCCGGAATTATTGGGGCCGTTCTAGTTCCGGTTTCAGAAGTTTTAGCGGT
TATTTTTTACCATGAAAAATTTACGGCAGAAAAGGGAGTTTCTCTGGGTCTCTGTATCTGGGGTTTGGTT
TCCCACTTCTACGGTGAGACAAAACATAGCCAAAACACAAGTCAAAACCAAGCATTCGAGACAAGCTCA
GGTGTTTCTCCACAGAGCAAAAAGGAAATTGAAGTAATTTCAAATGTCCCGTGA 
locus_1763_ABC transporter 
ATGGCTTTCAAGCCATTTGAATGGTACTGCCAGCCAGTGAAGAATGGTGTGTGGTCAAAGGCTGTGGA
CAATGCATTTGGAGTTTATACTCCATGTGCAACAGATTCCCTAGTTATCGGATTATCATACTTGGTTGTG
TTTGTGTTGTGCTTATATCGAATTTGGCTGACTGAGAAAGATTTTAAGGTCCAGAGATTCCGTTTGAGG
TCAAAGTATTTCAATTATGTGCTGGGACTGTTGGCCTTATATTGCACTGCAGAACCACTGTTCAGACTGG
TAATGGGTATTTCAACATTTAATGTAGATGGACAGAATGGTCTGGCTCCATACGAGGTTGTATCTCTGA
TCATTGAGGCTTTGGCTTGGTGTGCTGTGCTTGTGATGATTGGTCTGGAAACAAAAATCTATATCCGTG
AGGCTCGTTGGTTTCTGAGGTTTGCAATCATTTATGCTTTGATTGGGGATGCTGTGATGCTCAATCTTGT
GCTTGGTGTGAGGGAATTTTACGAACGATCTGTACTCTATTTGTATATCAGCGAGATTGTTGTCCAGGT
TTTATTTGGAGTGCTCCTGCTCTTCTATGTTCCAAATTTGGATCCTTATCCAGGATACACCCCTGTGGAAA
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CTGAATTTGTGGAGGATACTGCTTATGAAGAACTTCCTGGAGATGAGCAGATTTGTCCTGAGAGGCAT
GTCAATCTATTTTCCAAAATTACTTTTGCATGGATGCAACCCCTTATGAAACTGGGCTATAGACGACCTC
TAACAGATAAGGATGTGTGGAAACTGGACACTTGGGACAGGACGGAAACACTTATAAATGTGTTTCAG
AAATGTTGGGTTGAAGAGTCACAGAGGACTAAACCATGGCTTTTAAGAGCACTACATCGTGCACTTGG
CGGAAGATTTTGGTGGGGTGGCTTTTGGAAGATTGGTAATGATGTTTCCCAATTTATTGGGCCTCTTAT
ACTGAATCAGCTCTTGAAGTCCATGCAACAAGGAGAGCCAGCTTGGATTGGTTATATCTACGCATTTTT
GATTTTTGTTGGAGTGGTATTTGGGGTGTTATGTGAGGCACAATATTTTCAAAATGTGATGCGTGTTGG
TTATCGTTTGAGGTCAACCCTGATAGCTGCTGTTTTCAGGAAATCCCTAAGGCTAACCCATGAGAGTCG
TAAACAATTTGCAACTGGAAAGATAACCAATTTAATGACCACTGATTCTGAGGCACTACAGCAAATATG
CCAATCGCTCCATACTTTATGGTCTGCTCCTTTTCGTATCATTGTTGCCTTGGTCCTTCTTTACGATCAATT
GGGTGTTTCTTCCCTTGTTGGTGCACTAGGGCTAGTCCTCATGTTCCCAATTCAGACATTTGTGATAAGC
AAGATGCAGAAGTTATCAAAAGAAGGATTGCAGCGAACAGACAAGAGAATTGGACTCATGAATGAAA
TTTTGGCTGCCATGGACACTGTCAAATGTTATGCATGGGAGAATAGTTTCCAGAAGAAGGTTCAGGAT
GTACGTGATGATGAGCTGTCTTGGTTCCGGAAAGCCCAAATGTTAGGAGCGTTGAACAGTTTTATGCTG
AACAGTATTCCAGTTGTGGTGATTGTGATCTCATTTGGGATGTTCACTTTACTTGGAGGGGATCTTACAC
CTGCAAGGGCATTCACATCTCTTTCTTTGTTTGCTGTGTTGCGTTTTCCACTTTTCATGCTCCCAAACATA
ATAACGCAGGTGGTCAATGCAAATGTTTCTTTGAAACGTTTGGAGGAACTTCTATTAGCAGAAGAGAG
AATTCTTCTACCCAACCCCCCACTTGAACCAGGTCTTCCAGCCATCTCAATAAGGAATGGATGCTTCTCG
TGGGAATCAAAGGCAGAGAAACCTACATTATCAAATGTTAATTTGGATGTACCAGTTGGTAGCTTAGTG
GCAATTGTTGGCAGTACTGGAGAGGGAAAGACATCACTTGTATCAGCAATGCTTGGAGAGCTTCCAGC
AGTTACAGATGCAACGTCAGTTGTCCTCAGAGGATCAGTTGCTTTTGTCCCACAAGTTTCATGGATATTC
AACGCAACGGTAAGGGACAACATTCTGTTTGGATCTCCCTTTGAACCAGCACGATATGATAGGGCGAT
AGAGGTCACGTCGCTTCAGCATGACCTTGAATTGCTCCCTGGAGGTGATCTTACTGAAATTGGTGAAAG
AGGTGTAAACATTAGTGGAGGGCAAAAGCAAAGAGTGTCCATGGCTAGGGCTGTATATTCAAATTCAG
ATGTTTGCATATTCGATGACCCCCTAAGTGCTCTTGATGCTCATGTGGCTCGTCAGGTTTTCGAAAAATG
CATCAAGGGAGAACTCAGAGGAAAAACCAGAGTTCTTGTTACCAATCAGCTACACTTTCTTTCACAAGT
AGATAAAATTATCCTTGTGCACGATGGTATGGTGAAAGAGGAAGGAACCTTTGAAGAACTCTCAAATA
ATGGTGTGCTCTTTAAAAGACTGATGGAAAATGCGGGGAAAATGGAAGAATATGTGGAAGAAAAGGA
AAATGTTGAAAATACTGAAAATAAAACTTCTAATGCCATTGTTAATGGTGAGACCAATGGCTTGTTGAA
GGATCAAGACCCTGCAAACAAAAAGAAAGGAAAATCTATTCTTATCAAGCAGGAGGAACGTGAAACTG
GCGTTGTCAGTTGGAAAGTCTTAAACAGATACAAGAATGCACTGGGCGGCACTTGGGTAGTTATGATA
TTGTTTTTGTGTTATGTCCTAACGGAAGCTTTACGGATTTCAAGTAGTACATGGTTGAGTTATTGGACAG
ATAAAGGCGGTTCGAAAAATTATTCCCCCACTTTCTACAATTTGATCTACGCTCTCCTTTCATTCGGTCAA
GTAATGGTCACGCTGGCAAACTCATTTTGGTTGATCATCTCAAGTCTTTATGCTGCTCGAAAATTGCATG
ATGCCATGCTTGGCTCCATATTGAGAGCTCCAATGGTCTTCTTTCAGACGAATCCACTAGGGCGGATAA
TTAATAGATTTGCTAAGGATCTGGGTGACATAGACCGGATGGTTGCTCCATTTGTTAATATGTTTCTGG
GGCAAGTTTCACAGCTTTTTTCAACATTTGTGTTGATTGGAATAGTGAGCACCATGTCACTTTGGGCCAT
AATGCCCCTTCTTGTGCTGTTCTATGCAGCCTATCTGTACTATCAGAGTACAGCCCGTGAAGTAAAGCGC
TTAGATTCCATTAGCAGATCTCCTGTGTATGCACAGTTCGGAGAAGCACTCAATGGTCTAACAACTATTC
GTGCCTATAAAGCTTATGATAGAATGGCAAATATAAATGGGAAGTCAATGGACAACAATGTCAGGTTC
ACTCTTGTAACCATGAGTGGGAATCGCTGGCTTGCAATTCGTCTGGAGACTTTGGGGGGGCTTATGATT
TGGCTTACAGCAACTTTTGCTGTGATGCAGAATGGTAGGGCAGAAAACCAGCAAGAGTTTGCCTCCACT
ATGGGTTTACTTCTCAGTTATGCATTAAATATTACTAGTTTGTTGACTGCTGTACTTAGACTAGCTAGTAT
GGCCGAGAATAGTCTAAATTCCGTTGAGCGGGTTGGTACTTATATAGAGTTGCCTTCTGAAGGTCCAGC
TATCGTTAAGGACAACCGTCCCCCTCCTGGGTGGCCTTCTGCAGGATCTATTACTTTTGAGGATGTTGTC
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CTGCGTTATAGGCCTGAACTTCCTCCAGTCCTCCATGGTATATCATTCAAAATTCCTCCAAGTGACAAGG
TTGGGATAGTTGGTAGGACTGGAGCCGGGAAATCTAGCATGCTTAATGCTTTATTCCGACTTGTAGAAC
TGGAAAAAGGAAGAATCCTGATTGATGATTGTGATATTGGAAGATTTGGATTGATGGACCTCCGTAAA
GTTCTTGGCATTATACCACAATCTCCAGTTCTTTTCTCAGGAACCGTGAGATTCAATCTTGACCCCTTCAA
CGAACACAGTGAATTTGATCTTTGGGAGGCTCTGGAGAGGGCACATTTGAAAGATGTTATAATGAGAA
ATTCTTCGGGTCTGGATACAGAGGTCTCGGAGGCAGGAGAAAATTTTAGTGTTGGACAGAGGCAACTC
TTGAGTCTTGCCCGGGCGTTGCTTCGGAGATCAAAGATTCTTGTACTTGATGAAGCAACAGCAGCTGTT
GATGTTCGAACTGATGCTCTTATCCAGAAGACCATTAGGGAGGAATTTAAATCTTGCACAATGCTTATT
ATTGCTCATCGTTTAAATACCATAATCGACTGTGACAGGATTCTTCTGCTTGATTCTGGCCGGGTTGTTG
AATATGATACTCCAGAAAGACTGCTGCATAACGAAGAGAGTTCATTCTCTAAGATGGTGCAAAGTACA
GGTGCTGCTAATGCACAATACCTGCGCAGCTTAGTACTTGATGCAGGTGACAAAGTGGAGAGCGAAAA
GCCCCATCTAGATGGTCAAAGGAGATGGCTTGCCTCCTCACGCTGGGCAGCTGCCGCCCAGTTTGCATT
GGCTGTTAGCCTCACTTCATCACACAATGACCTCGTGCAGCTGGAAATCAACGAGGAAGACAATATTCT
TAAGAAAACAAGAGACGCTGTAATAACTCTACAGGGAGTTTTGGAAGGGAAGCATGATCAATCCATTA
CAGAAACCCTCGACCAATACCACGTTTCTAAGGATAGATGGTGGTCGGCTCTATATAAAATGATCGAAG
GTCTTGCCGTGATGAGTAGGCTGGCTCGAAATAGGCTTCATCAATCAGAATATGAATATCAAGACAAA
ACAATTGACTGGGATCATGTTGCCATGTAA 
locus_24210_WAT1 homologue 
ATGGGGTTGACTTCATGTTTAACAGAAGCTTTGCCTTATGCAGCCATGGTGTTTGAAGAAATTCTTCTG
GTTGGTTTAACTACACTCACCAAAAATGCCTTATCCAAAGGAATGGACCGCTATGCCTTTATGTTTTATG
CTAATGTGCTTGCTACTCTTATCCTCTTTCCTCTTTCTTTCATCTTCAAAAGAAAGGAAATTCCTCCTTTGA
GCTTCTCTCTTCTTGGCAAGTTTTTCTTCATAAGCTTGATTGGGGTTACAATTAACCAGAATGTTATATAT
GCTGGACTAGATTACAGCTCTCCCACACTTTTATCTGCCTTGAGGAACTTAATCCCAGCTTTCACCTTTTT
GCTTGCTGTTTTATTCAGGATGGAAATTTTGAATTTGAGAAGCTCAAGAAGTCAGATCAAGATTATAGG
AACATTGGTGACAATTTTAGGAGCATTAACTATAACCTTTTATAATGGTTTTCCAATTGGGTATTCAGGA
GATGAATCCTCATTGAAAAGATTTCTTGAATCACCAAACAATTTCTCTGCATTATTTTCAACACAAAGAA
ATTGGGCAATTGGAGGCCTCTGTTTTGTTATTTCAGCTTTATGCATTGCACTATGGATAACAGCTCAGGG
AGCAATTGTTAAGGAGTATCCATCAGAGTTAACCATTGTGGCATACTATTTCTTGTTTGGGACAATTCAA
TCTGCTGCAGTCTCTTTAGTTGGTGAAAGACATGAACCAAATCCTTGGACGATAAGGACAAATATTGAG
CTCCTCTCAGTTACCTGCTCAGCTTTAATTGGAAGTGTGATGGTATTTTTGTTGGATATATGGTGCATAC
ACAAAAAGGGACCTGTATTTGCAGCCATGTTCAAGCCTCTAGGCATTGCTATTGCTGCAATTGCTGGTG
TCATCTTTCTTGGCGAAACTCTCTACATTGGAACCATTATAGGATCAATTGTAATAATAATAGGTTTCTAT
GGAGTAATGTGGGCAAAGGCAAAAGAGAATGAAGATTTGTTAGATGATTATCTACCTTCATCTTCAAA
GAAGATGCCTTTGTTGCAAAATCTCAGAGATGATGTATAG 
locus_1770 amino acid permease 
ATGACAATTGGAAGCCAAAAACCAGCCAAAGAAAGGAAGTCCAGGAAGAGCAAAAAAGTTGTGGTTC
ATGAAAAATCACCCCTTTTGCCCACTAAGCATGAGGAGGATGCTGGGTTTGATGAGTTTGATGGAGCTT
CCTTCAGTGGGGCAGTTTTTAATCTGTCGACCACTATTGTTGGTGCTGGAATCATGGCCTTGCCAGCTAC
TATGAAAGTGCTGGGCCTTATTCCTGGGATTGCTGCTATCATCTTTATGGCATTCTTGACAGATGCTTCA
ATTGAGTTGTTGATTAGGTTTAGTAGAGCTTCTAAATCAGTTTCTTATGGAGGTGTTATGGGGGATGCC
TTTGGGAAGTATGGTCGCATGTTTCTGCAAATATGTGTTCTAGTAAACAACATAGGCGTCCTTGTTGTAT
ACATGATTATCATAGGTGATGTGCTTTCTGGAACAACATCAAGTGGGACTCACCATGCTGGTGTCTTGG
333 
 
AAGGATGGTTTGGAGTACACTGGTGGAATGGACGTTTTTTTGTTCTCCTAATCACTACCCTTGGCATCTT
TGCACCTTTGGCAAGTCTAAAGCGCATTGATTCTTTGAGGTTCACATCTGCATTATCAGTTGCACTAGCT
GTGGTCTTCCTAGTTATTACGGTGGGCATTACAGTTTTCAAACTGATCAATGGAACAGTGTTGATGCCT
AGACTACTTCCTGATGTGCATGATCTGACATCATTCTTTAAACTCTTCACTGTGGTTCCTATCCTTGTCAC
TGCTTACATCTGTCACTACAATGTTCACTCGATAGAAAATGAACTTGAAGACAACACCCAGATACAAGC
TGTTGTACGGACCTCACTTGCTCTGTGCTCATCTGTATATGTGATGACCAGCCTCTTTGGATTCCTCCTAT
TTGGTGATGCAACTCTTGACGATGTCCTTTCCAACTTTGACTCTAATCTGGGGATTCCTTATGGCTCCCT
GCTTAATGATGCCGTTCGCATTAGCTATGCTGCACACTTGATGCTCGTCTTCCCCATTGTGTTCTATCCGC
TGAGGTTGAACTTGGATGGCCTTCTCTTTCCGTCTGCTAGGCGCCTGACATCTGACAATCTGAGGTTCG
CATTATTAAGCATCAGTCTCATTGCCCTCATCTTTCTGGGTGCTAATTTCATACCCAGCATCTGGGACGCT
TTCCAATTTACTGGAGCAACTGCTGCTGTTTGCATTGGATTCATCTTCCCTGCTGCCATTACTCTCAGGG
ATCGATATGGTATAGCTACAAAGAGGGACAAGATCCTATGCATATTCATGATCGTCCTTGCTGTATTCTC
AAACGCGGTGGCCATATATAGTGATGCATATGCACTGTTCAAGAAAAATGCATCACCCAGCAAATGA 
 
Glutathione S-transferases 
locus_7197_GST1 
ATGGGTACAGAAAGCATAGAGAGAAAGAGAAAAAGAGATCAAGAAGAAACTGAAAAAATGGCTGAA
GAAAAGAGGGTTAAATTGCTGGGATTTTGGTCAAGTGCTTATAGTATAAGAGTAGATTTAGCACTCAAT
GCAAAGGGAATTCCATACGAATATCAAGATGAAGATCTGAGGAACAAAAGTGAATTGCTTCTGAAAAC
AAACCCAATTCACAAAAAAGTACCAGTTTTGATTCATAATGGAATTCCCGTTGCTGAATCTCTTATCGTC
CTCGAATACATCGATGATACTTGGCCTCAATCTCCCAAATTTGTCCCTGAGGATCCTCTCTTGAAGGCCA
AGATTCGTTTCTGGTCACACTTTGTCCACTTTCAGCTGTTCGAGAGCATGCTTCCAATAGCACTAACAGC
AGGGGAAGCACAAGAAAAGGCATTGGAGACATTTTATGGTAATCTAAAGACAATTGAAGATGGTACCA
AAGATCTTTTTGAAGATGGAAAGCCATTAATTGATGAAAACAACTTGAACTTGTTGGACATAATAATAT
GGTCAGTTCTTGGTCCTCACAAATCATTTGAAGAAGCTCTTGATTTGAAGCTTTTGGATCCTAAAAAATA
CCCATTTTTACACTCATGGGTTGGTGCCATTAACGGACTCAAGGCGGCAAAAAAGGCAATCCCAGATCA
TAATACTATGGTTACCCATCTTAAGCATTTCAGGCAAATGGCTCTCCAGCGCTCCGCACCCTCCTAA 
locus_6502_GST2 
ATGGCGAACGAGAAAGGAAAACTTAAGCTTCTTGGCTATTGGTTTAGCGCTTACTGCAAGAGGGTTGA
ACTAGCCCTTAATGCTAAAGGAATACCCTTTGAGTACCAAGAAGAAGATTTAACTAACAAGAGTGAATT
ACTCTTGAAATCTAATCCAGTCAAAAAGGTTCCTGTGGTTCTCCACAACGGGACACCCATATGTGAATCC
CTCATAATTCTTGAGTATATTGATGAAACTTGGACTAATTCTCCAAAACTTTTACCTGAGGATTCTGCTAC
TAGATCCAACTTTCGCTTTTGGGCAAGCTTCTTCCATATCCAGCTATTCGATAGCCTATATCCAGCGGTG
ACATCTGAGGGAGAGGAACAAGAAAAGGCCTTTTCCGTTTACTCTGCAAATCTGAAAACGGTTGAAGA
AGGAATTGCCGCCGAGTTTTTCGGCAGCGGCGGCGGACGAGAGGAGATAAAGTCGGAGGAGAATTTG
AACTTGGTAGATGTTGTCATATGGTCAGTTTTGGGTTGGTATAAAGCATTTGAATCAATAGAATTGAAC
ATTTTGGATGCTGACAAGTATCCATTAACATACTCATGGGTTACTAAGCTCAACAATCTGTCTGTTGTTA
AGAAAACAGCAGCTGATACTGCTAAAGTCGCCTCTGAAATCAACTTCTTCCGTAACCTCGGTCTCCAGA
AGGTCGCTGCTCATGCATGA 
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locus_2878_GST3 
ATGGCTGGAGAATTTGTTCTATTGGATACTTATGTGAGTATGTTTGGAATGAGGGCAAGAGTTGCTTTG
AATGAAAAGGGTTTGAATTACGAGTACAAAGAAGAGAATTTGGGCAGCAAAAGCCCTCTGCTTCTTCA
GATGAACCCAATTCATAAGAAAATCCCTGTTTTGATTCATAATGGAAAACCTATTTGTGAGTCCCTTATT
ATTGTTCAGTATTTAGATGAAATTTGTCCTGATAAGAATCCATTGTTGCCTACTGATCCTTATGAGAGAG
CTCAAGCTCGCTTTTGGGCTGATTATATTGACAAGAAGGTATACGATGCTGGAAGAAAAATATGGACA
ACAAAAGGGGAAGAGCAAGAAGCAGCCAAGAAAGAGTTCATTGAAATCCTCAAAACTTTGGAAGGTG
TACTTGGGGATAAACCATACTTTGGTGGTCAAGAATTTGGATTTGTGGATGTGGCTTTGATCCCATTTTA
CAGTTGGTTCCATGCCTATGAGACATCTGGAAATTTGAAGATAGAGCCAGAAGTTCCAAAACTAGTGG
CATGGGCCAAGAAGTGCATGCAAAGGGACAGTGTGGCAAAGGGACTTGCTGATCCTCACAAAGTTTAT
GAATTTATTTTGTCCATGAAGAAGAGGTTGGGAATTGAGTGA 
 
9.6 qPCR reference genes 
 
 
Relative expression level of the reference genes Rps9, RPP0C and CrN227 against VIGS-EV, VIGS-
CrMATE1952 and VIGS-CrRO tissue. As can be seen the reference gene and primers proposed by (Pollier 
et al., 2014), CrN227, resulted in greater variation between VIGS experiments than the previously 
characterised Rps9 and RPP0C primers that have been used in C. roseus VIGS experiments in our hands. 
Therefore Rps9 or RPP0C were preferentially used for data normalisation in the qPCR experiments. All 
data shown are mean + SEM. 
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9.7 Purification of strictosidine 
 
LC-MS chromatogram and mass spectra of purified strictosidine 
 
Proton NMR of purified strictosidine 
 
